<SEC-DOCUMENT>0001193125-24-221733.txt : 20240919
<SEC-HEADER>0001193125-24-221733.hdr.sgml : 20240919
<ACCEPTANCE-DATETIME>20240919061029
ACCESSION NUMBER:		0001193125-24-221733
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20240919
DATE AS OF CHANGE:		20240919

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNIVERSAL HEALTH SERVICES INC
		CENTRAL INDEX KEY:			0000352915
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				232077891
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135
		FILM NUMBER:		241308778

	BUSINESS ADDRESS:	
		STREET 1:		367 S GULPH RD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		6107683300

	MAIL ADDRESS:	
		STREET 1:		367 S GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LANCASTER HOSPITAL CORP
		CENTRAL INDEX KEY:			0000834441
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-139
		FILM NUMBER:		241308910

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		6107683300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BEHAVIORAL HEALTHCARE LLC
		CENTRAL INDEX KEY:			0000909173
		ORGANIZATION NAME:           	
		IRS NUMBER:				621516830
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-199
		FILM NUMBER:		241308969

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BEHAVIORAL HEALTHCARE CORP
		DATE OF NAME CHANGE:	19930715

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RAMSAY MANAGED CARE LLC
		CENTRAL INDEX KEY:			0000932275
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				721249464
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-158
		FILM NUMBER:		241308928

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RAMSAY MANAGED CARE INC
		DATE OF NAME CHANGE:	19941102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HORIZON HEALTH CORP /DE/
		CENTRAL INDEX KEY:			0000935007
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				752293354
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-40
		FILM NUMBER:		241308818

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			TX
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			TX
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HORIZON MENTAL HEALTH MANAGEMENT INC
		DATE OF NAME CHANGE:	19950106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Riveredge Hospital Holdings, Inc.
		CENTRAL INDEX KEY:			0001255302
		ORGANIZATION NAME:           	
		IRS NUMBER:				223682759
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-31
		FILM NUMBER:		241308809

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AERIES HEALTHCARE CORP
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BENCHMARK BEHAVIORAL HEALTH SYSTEM, INC.
		CENTRAL INDEX KEY:			0001255304
		ORGANIZATION NAME:           	
		IRS NUMBER:				930893928
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-198
		FILM NUMBER:		241308968

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOUNTIFUL PSYCHIATRIC HOSPITAL INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brynn Marr Hospital, Inc.
		CENTRAL INDEX KEY:			0001255306
		ORGANIZATION NAME:           	
		IRS NUMBER:				561317433
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-209
		FILM NUMBER:		241308979

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EAST CAROLINA PSYCHIATRIC SERVICES CORP
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GREAT PLAINS HOSPITAL, INC.
		CENTRAL INDEX KEY:			0001255307
		ORGANIZATION NAME:           	
		IRS NUMBER:				431328523
		STATE OF INCORPORATION:			MS
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-233
		FILM NUMBER:		241309002

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GREAT PLAINS HOSPITAL INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H.C. CORP
		CENTRAL INDEX KEY:			0001255309
		ORGANIZATION NAME:           	
		IRS NUMBER:				630870528
		STATE OF INCORPORATION:			AL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-230
		FILM NUMBER:		241308999

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H C CORP
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H C PARTNERSHIP
		CENTRAL INDEX KEY:			0001255310
		ORGANIZATION NAME:           	
		IRS NUMBER:				630862148
		STATE OF INCORPORATION:			AL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-144
		FILM NUMBER:		241308915

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAVENWYCK HOSPITAL INC
		CENTRAL INDEX KEY:			0001255311
		ORGANIZATION NAME:           	
		IRS NUMBER:				382409580
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-53
		FILM NUMBER:		241308827

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			PENNSYLVANIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			PENNSYLVANIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS LAUREL RIDGE HOSPITAL LP
		CENTRAL INDEX KEY:			0001255312
		ORGANIZATION NAME:           	
		IRS NUMBER:				432002326
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-07
		FILM NUMBER:		241308785

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TEXAS LAURAL RIDGE HOSPITAL LP
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS SAN MACROS TREATMENT CENTER LP
		CENTRAL INDEX KEY:			0001255314
		ORGANIZATION NAME:           	
		IRS NUMBER:				432002231
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-04
		FILM NUMBER:		241308782

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS WEST OAKS HOSPITAL LP
		CENTRAL INDEX KEY:			0001255315
		ORGANIZATION NAME:           	
		IRS NUMBER:				621864265
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-107
		FILM NUMBER:		241308879

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LAUREL OAKS BEHAVIORAL HEALTH CENTER, INC.
		CENTRAL INDEX KEY:			0001255321
		ORGANIZATION NAME:           	
		IRS NUMBER:				522090040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-137
		FILM NUMBER:		241308908

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PREMIER BEHAVIORAL SOLUTIONS OF ALABAMA, INC
		DATE OF NAME CHANGE:	20050808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RAMSAY YOUTH SERVICES OF ALABAMA INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RAMSAY YOUTH SERVICES OF GEORGIA INC
		CENTRAL INDEX KEY:			0001255322
		ORGANIZATION NAME:           	
		IRS NUMBER:				352174803
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-34
		FILM NUMBER:		241308812

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PALMETTO BEHAVIORAL HEALTH HOLDINGS, LLC
		CENTRAL INDEX KEY:			0001255323
		ORGANIZATION NAME:           	
		IRS NUMBER:				223600673
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-172
		FILM NUMBER:		241308942

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF SOUTH CAROLINA, INC
		DATE OF NAME CHANGE:	20050808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RAMSAY YOUTH SERVICES OF SOUTH CAROLINA INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SUNSTONE BEHAVIORAL HEALTH LLC
		CENTRAL INDEX KEY:			0001255327
		ORGANIZATION NAME:           	
		IRS NUMBER:				800051894
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-16
		FILM NUMBER:		241308794

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUNSTONE BEHAVIORAL HEALTH INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS CYPRESS CREEK HOSPITAL LP
		CENTRAL INDEX KEY:			0001255328
		ORGANIZATION NAME:           	
		IRS NUMBER:				621864266
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-09
		FILM NUMBER:		241308787

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HSA HILL CREST CORP
		CENTRAL INDEX KEY:			0001255962
		ORGANIZATION NAME:           	
		IRS NUMBER:				953900761
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-157
		FILM NUMBER:		241308927

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MICHIGAN PSYCHIATRIC SERVICES INC
		CENTRAL INDEX KEY:			0001255966
		ORGANIZATION NAME:           	
		IRS NUMBER:				382423002
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-182
		FILM NUMBER:		241308951

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEURO INSTITUTE OF AUSTIN LP
		CENTRAL INDEX KEY:			0001255967
		ORGANIZATION NAME:           	
		IRS NUMBER:				562274069
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-179
		FILM NUMBER:		241308949

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEDAR SPRINGS HOSPITAL, INC.
		CENTRAL INDEX KEY:			0001255968
		ORGANIZATION NAME:           	
		IRS NUMBER:				743081810
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-203
		FILM NUMBER:		241308973

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSI CEDAR SPRINGS HOSPITAL INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS HOSPITAL HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001255970
		ORGANIZATION NAME:           	
		IRS NUMBER:				621871091
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-08
		FILM NUMBER:		241308786

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSI HOSPITALS INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PSYCHIATRIC SOLUTIONS HOSPITALS, LLC
		CENTRAL INDEX KEY:			0001255976
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658476
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-161
		FILM NUMBER:		241308931

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS HOSPITALS INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PREMIER BEHAVIORAL SOLUTIONS, INC.
		CENTRAL INDEX KEY:			0001255982
		ORGANIZATION NAME:           	
		IRS NUMBER:				630857352
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-164
		FILM NUMBER:		241308934

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF CORAL GABLES INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PSYCHIATRIC SOLUTIONS OF VIRGINIA INC
		CENTRAL INDEX KEY:			0001255985
		ORGANIZATION NAME:           	
		IRS NUMBER:				621732340
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-160
		FILM NUMBER:		241308930

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF FLORIDA INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLLY HILL HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001255986
		ORGANIZATION NAME:           	
		IRS NUMBER:				621692189
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-42
		FILM NUMBER:		241308819

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF NORTH CAROLINA INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SHADOW MOUNTAIN BEHAVIORAL HEALTH SYSTEM, LLC
		CENTRAL INDEX KEY:			0001255987
		ORGANIZATION NAME:           	
		IRS NUMBER:				432001465
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-23
		FILM NUMBER:		241308801

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF OKLAHOMA INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PREMIER BEHAVIORAL SOLUTIONS OF FLORIDA, INC
		CENTRAL INDEX KEY:			0001256061
		ORGANIZATION NAME:           	
		IRS NUMBER:				650816927
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-165
		FILM NUMBER:		241308935

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RAMSAY YOUTH SERVICES OF FLORIDA INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC HOLDINGS, INC
		CENTRAL INDEX KEY:			0001266914
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				920189593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-223
		FILM NUMBER:		241308992

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARDENT HEALTH SERVICES INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001266918
		ORGANIZATION NAME:           	
		IRS NUMBER:				020567575
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-247
		FILM NUMBER:		241309015

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AHS CUMBERLAND HOSPITAL LLC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC PINNACLE POINTE HOSPITAL INC
		CENTRAL INDEX KEY:			0001266925
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658502
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-217
		FILM NUMBER:		241308986

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC SIERRA VISTA HOSPITAL INC
		CENTRAL INDEX KEY:			0001266927
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658512
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-215
		FILM NUMBER:		241308984

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC STREAMWOOD HOSPITAL INC
		CENTRAL INDEX KEY:			0001266929
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658515
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-214
		FILM NUMBER:		241308983

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VALLE VISTA HOSPITAL PARTNERS, LLC
		CENTRAL INDEX KEY:			0001266930
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658516
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-113
		FILM NUMBER:		241308924

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC VALLE VISTA HOSPITAL INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BLOOMINGTON MEADOWS G P
		CENTRAL INDEX KEY:			0001266932
		ORGANIZATION NAME:           	
		IRS NUMBER:				351858510
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-213
		FILM NUMBER:		241309029

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VALLE VISTA LLC
		CENTRAL INDEX KEY:			0001266943
		ORGANIZATION NAME:           	
		IRS NUMBER:				621740366
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-112
		FILM NUMBER:		241308884

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KIN OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KIN OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WILLOW SPRINGS LLC
		CENTRAL INDEX KEY:			0001266945
		ORGANIZATION NAME:           	
		IRS NUMBER:				621814471
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-104
		FILM NUMBER:		241308876

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		6152963000

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC ALHAMBRA HOSPITAL INC
		CENTRAL INDEX KEY:			0001266979
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658521
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-197
		FILM NUMBER:		241308967

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC BELMONT PINES HOSPITAL INC
		CENTRAL INDEX KEY:			0001266981
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658523
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-196
		FILM NUMBER:		241308966

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COLUMBUS HOSPITAL PARTNERS, LLC
		CENTRAL INDEX KEY:			0001266988
		ORGANIZATION NAME:           	
		IRS NUMBER:				621664739
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-194
		FILM NUMBER:		241308964

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC COLUMBUS HOSPITAL INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC FAIRFAX HOSPITAL INC
		CENTRAL INDEX KEY:			0001266989
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658528
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-228
		FILM NUMBER:		241308997

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC FOX RUN HOSPITAL INC
		CENTRAL INDEX KEY:			0001266992
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658531
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-227
		FILM NUMBER:		241308996

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC FREMONT HOSPITAL INC
		CENTRAL INDEX KEY:			0001266995
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658532
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-226
		FILM NUMBER:		241308995

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC HEALTH SERVICES OF NEVADA INC
		CENTRAL INDEX KEY:			0001267003
		ORGANIZATION NAME:           	
		IRS NUMBER:				880300031
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-225
		FILM NUMBER:		241308994

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC HERITAGE OAKS HOSPITAL INC
		CENTRAL INDEX KEY:			0001267005
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658494
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-224
		FILM NUMBER:		241308993

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC INTERMOUNTAIN HOSPITAL INC
		CENTRAL INDEX KEY:			0001267012
		ORGANIZATION NAME:           	
		IRS NUMBER:				621658493
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-222
		FILM NUMBER:		241308991

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lebanon Hospital Partners, LLC
		CENTRAL INDEX KEY:			0001267014
		ORGANIZATION NAME:           	
		IRS NUMBER:				621664738
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-136
		FILM NUMBER:		241308907

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC LEBANON HOSPITAL INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC MONTEVISTA HOSPITAL INC
		CENTRAL INDEX KEY:			0001267037
		ORGANIZATION NAME:           	
		IRS NUMBER:				880299907
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-220
		FILM NUMBER:		241308989

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC NORTHWEST PSYCHIATRIC HOSPITAL LLC
		CENTRAL INDEX KEY:			0001267038
		ORGANIZATION NAME:           	
		IRS NUMBER:				200085660
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-219
		FILM NUMBER:		241308988

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC OF INDIANA GENERAL PARTNERSHIP
		CENTRAL INDEX KEY:			0001267039
		ORGANIZATION NAME:           	
		IRS NUMBER:				621780700
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-218
		FILM NUMBER:		241308987

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NORTHERN INDIANA PARTNERS, LLC
		CENTRAL INDEX KEY:			0001267040
		ORGANIZATION NAME:           	
		IRS NUMBER:				621664737
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-177
		FILM NUMBER:		241308947

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC OF NORTHERN INDIANA INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wellstone Regional Hospital Acquisition, LLC
		CENTRAL INDEX KEY:			0001335540
		ORGANIZATION NAME:           	
		IRS NUMBER:				203062075
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-105
		FILM NUMBER:		241308877

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATION CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATION CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Summit Oaks Hospital, Inc.
		CENTRAL INDEX KEY:			0001335550
		ORGANIZATION NAME:           	
		IRS NUMBER:				201021210
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-17
		FILM NUMBER:		241308795

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSI Summit Hospital, Inc.
		DATE OF NAME CHANGE:	20050808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			North Spring Behavioral Healthcare, Inc.
		CENTRAL INDEX KEY:			0001335551
		ORGANIZATION NAME:           	
		IRS NUMBER:				201215130
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-178
		FILM NUMBER:		241308948

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Psychiatric Solutions of Leesburg, Inc.
		DATE OF NAME CHANGE:	20050808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cumberland Hospital Partners, LLC
		CENTRAL INDEX KEY:			0001335564
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-191
		FILM NUMBER:		241308961

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC Newco 2, LLC
		DATE OF NAME CHANGE:	20050808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC Mesilla Valley Hospital, LLC
		CENTRAL INDEX KEY:			0001335566
		ORGANIZATION NAME:           	
		IRS NUMBER:				202612295
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-221
		FILM NUMBER:		241308990

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Palmetto Lowcountry Behavioral Health, L.L.C.
		CENTRAL INDEX KEY:			0001335603
		ORGANIZATION NAME:           	
		IRS NUMBER:				571101380
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-170
		FILM NUMBER:		241308940

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Millwood Hospital, L.P.
		CENTRAL INDEX KEY:			0001335606
		ORGANIZATION NAME:           	
		IRS NUMBER:				201021264
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-181
		FILM NUMBER:		241309021

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Palmetto Behavioral Health System, L.L.C.
		CENTRAL INDEX KEY:			0001335607
		ORGANIZATION NAME:           	
		IRS NUMBER:				571101379
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-171
		FILM NUMBER:		241308941

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fort Lauderdale Hospital, Inc.
		CENTRAL INDEX KEY:			0001335611
		ORGANIZATION NAME:           	
		IRS NUMBER:				201021229
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-145
		FILM NUMBER:		241309027

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alliance Health Center, Inc.
		CENTRAL INDEX KEY:			0001335614
		ORGANIZATION NAME:           	
		IRS NUMBER:				640777521
		STATE OF INCORPORATION:			MS
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-250
		FILM NUMBER:		241309018

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Laurelwood Center, Inc.
		DATE OF NAME CHANGE:	20050808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canyon Ridge Hospital, Inc.
		CENTRAL INDEX KEY:			0001335621
		ORGANIZATION NAME:           	
		IRS NUMBER:				202935031
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-207
		FILM NUMBER:		241308977

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brentwood Acquisition-Shreveport, Inc.
		CENTRAL INDEX KEY:			0001335632
		ORGANIZATION NAME:           	
		IRS NUMBER:				200474854
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-212
		FILM NUMBER:		241308982

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brentwood Acquisition, Inc.
		CENTRAL INDEX KEY:			0001335702
		ORGANIZATION NAME:           	
		IRS NUMBER:				200773985
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-211
		FILM NUMBER:		241308981

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTERNATIVE BEHAVIORAL SERVICES, INC.
		CENTRAL INDEX KEY:			0001405898
		ORGANIZATION NAME:           	
		IRS NUMBER:				541757063
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-249
		FILM NUMBER:		241309017

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABS LINCS SC, INC
		CENTRAL INDEX KEY:			0001405905
		ORGANIZATION NAME:           	
		IRS NUMBER:				570840074
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-252
		FILM NUMBER:		241309030

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC RIVER PARK, INC.
		CENTRAL INDEX KEY:			0001405910
		ORGANIZATION NAME:           	
		IRS NUMBER:				202652863
		STATE OF INCORPORATION:			WV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-46
		FILM NUMBER:		241308822

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC SOUTH CAROLINA, INC.
		CENTRAL INDEX KEY:			0001405912
		ORGANIZATION NAME:           	
		IRS NUMBER:				203854241
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-45
		FILM NUMBER:		241309024

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC ST. SIMONS, INC.
		CENTRAL INDEX KEY:			0001405913
		ORGANIZATION NAME:           	
		IRS NUMBER:				203854107
		STATE OF INCORPORATION:			GA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-44
		FILM NUMBER:		241308821

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HORIZON HEALTH AUSTIN, INC.
		CENTRAL INDEX KEY:			0001405916
		ORGANIZATION NAME:           	
		IRS NUMBER:				208706107
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-41
		FILM NUMBER:		241309023

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KINGWOOD PINES HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001405927
		ORGANIZATION NAME:           	
		IRS NUMBER:				731726285
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-142
		FILM NUMBER:		241308913

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KIDS BEHAVIORAL HEALTH OF UTAH, INC.
		CENTRAL INDEX KEY:			0001405928
		ORGANIZATION NAME:           	
		IRS NUMBER:				621681825
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-143
		FILM NUMBER:		241308914

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUGHES CENTER, LLC
		CENTRAL INDEX KEY:			0001405929
		ORGANIZATION NAME:           	
		IRS NUMBER:				208711062
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-156
		FILM NUMBER:		241309022

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HORIZON MENTAL HEALTH MANAGEMENT, INC.
		CENTRAL INDEX KEY:			0001405930
		ORGANIZATION NAME:           	
		IRS NUMBER:				363709746
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-38
		FILM NUMBER:		241308816

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC POPLAR SPRINGS, INC.
		CENTRAL INDEX KEY:			0001405936
		ORGANIZATION NAME:           	
		IRS NUMBER:				200959684
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-47
		FILM NUMBER:		241308823

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC OHIO, INC.
		CENTRAL INDEX KEY:			0001405938
		ORGANIZATION NAME:           	
		IRS NUMBER:				201870446
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-49
		FILM NUMBER:		241309025

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC INDIANA, INC.
		CENTRAL INDEX KEY:			0001405940
		ORGANIZATION NAME:           	
		IRS NUMBER:				200768028
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-50
		FILM NUMBER:		241309026

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC AUGUSTA, INC.
		CENTRAL INDEX KEY:			0001405941
		ORGANIZATION NAME:           	
		IRS NUMBER:				203854156
		STATE OF INCORPORATION:			GA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-52
		FILM NUMBER:		241308826

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALVARY CENTER, INC.
		CENTRAL INDEX KEY:			0001405985
		ORGANIZATION NAME:           	
		IRS NUMBER:				200380961
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-208
		FILM NUMBER:		241308978

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATLANTIC SHORES HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001406004
		ORGANIZATION NAME:           	
		IRS NUMBER:				203788069
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-229
		FILM NUMBER:		241308998

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HICKORY TRAIL HOSPITAL, L.P.
		CENTRAL INDEX KEY:			0001406009
		ORGANIZATION NAME:           	
		IRS NUMBER:				204976326
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-43
		FILM NUMBER:		241308820

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC DELAWARE, INC.
		CENTRAL INDEX KEY:			0001406010
		ORGANIZATION NAME:           	
		IRS NUMBER:				203854210
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-51
		FILM NUMBER:		241308825

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SP BEHAVIORAL, LLC
		CENTRAL INDEX KEY:			0001406058
		ORGANIZATION NAME:           	
		IRS NUMBER:				205202539
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-20
		FILM NUMBER:		241308798

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SHC-KPH, LP
		CENTRAL INDEX KEY:			0001406062
		ORGANIZATION NAME:           	
		IRS NUMBER:				731726290
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-22
		FILM NUMBER:		241308800

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROLLING HILLS HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001406067
		ORGANIZATION NAME:           	
		IRS NUMBER:				205566098
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-29
		FILM NUMBER:		241308807

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SPRINGFIELD HOSPITAL, INC.
		CENTRAL INDEX KEY:			0001406080
		ORGANIZATION NAME:           	
		IRS NUMBER:				260388272
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-18
		FILM NUMBER:		241308796

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WINDMOOR HEALTHCARE OF PINELLAS PARK, INC.
		CENTRAL INDEX KEY:			0001406110
		ORGANIZATION NAME:           	
		IRS NUMBER:				593480410
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-102
		FILM NUMBER:		241308874

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FIRST HOSPITAL CORP OF VIRGINIA BEACH
		CENTRAL INDEX KEY:			0001406171
		ORGANIZATION NAME:           	
		IRS NUMBER:				541414205
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-189
		FILM NUMBER:		241308959

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZEUS ENDEAVORS, LLC
		CENTRAL INDEX KEY:			0001406188
		ORGANIZATION NAME:           	
		IRS NUMBER:				593653864
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-100
		FILM NUMBER:		241308872

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WINDMOOR HEALTHCARE INC.
		CENTRAL INDEX KEY:			0001406202
		ORGANIZATION NAME:           	
		IRS NUMBER:				232922437
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-103
		FILM NUMBER:		241308875

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIBERTY POINT BEHAVIORAL HEALTHCARE, LLC
		CENTRAL INDEX KEY:			0001406207
		ORGANIZATION NAME:           	
		IRS NUMBER:				201989730
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-135
		FILM NUMBER:		241308905

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			THREE RIVERS HEALTHCARE GROUP, LLC
		CENTRAL INDEX KEY:			0001406229
		ORGANIZATION NAME:           	
		IRS NUMBER:				203842446
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-02
		FILM NUMBER:		241308780

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DIAMOND GROVE CENTER, LLC
		CENTRAL INDEX KEY:			0001406247
		ORGANIZATION NAME:           	
		IRS NUMBER:				204537541
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-244
		FILM NUMBER:		241309028

	BUSINESS ADDRESS:	
		STREET 1:		6640 CAROTHERS PARKWAY, SUITE 500
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-312-5700

	MAIL ADDRESS:	
		STREET 1:		6640 CAROTHERS PARKWAY, SUITE 500
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNIVERSITY BEHAVIORAL, LLC
		CENTRAL INDEX KEY:			0001406249
		ORGANIZATION NAME:           	
		IRS NUMBER:				205202458
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-114
		FILM NUMBER:		241308953

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19402
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19402

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SAMSON PROPERTIES, LLC
		CENTRAL INDEX KEY:			0001406290
		ORGANIZATION NAME:           	
		IRS NUMBER:				593653863
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-25
		FILM NUMBER:		241308803

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			THREE RIVERS BEHAVIORAL HEALTH, LLC
		CENTRAL INDEX KEY:			0001406768
		ORGANIZATION NAME:           	
		IRS NUMBER:				571106645
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-03
		FILM NUMBER:		241308781

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Sahara, Inc.
		CENTRAL INDEX KEY:			0001513586
		ORGANIZATION NAME:           	
		IRS NUMBER:				203955217
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-123
		FILM NUMBER:		241308893

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aiken Regional Medical Centers, Inc.
		CENTRAL INDEX KEY:			0001513587
		ORGANIZATION NAME:           	
		IRS NUMBER:				232791808
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-251
		FILM NUMBER:		241309019

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arbour, Inc.
		CENTRAL INDEX KEY:			0001513588
		ORGANIZATION NAME:           	
		IRS NUMBER:				232238962
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-106
		FILM NUMBER:		241308878

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CCS/Lansing, Inc.
		CENTRAL INDEX KEY:			0001513592
		ORGANIZATION NAME:           	
		IRS NUMBER:				621681824
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-204
		FILM NUMBER:		241308974

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Children's Comprehensive Services, Inc.
		CENTRAL INDEX KEY:			0001513593
		ORGANIZATION NAME:           	
		IRS NUMBER:				621240866
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-195
		FILM NUMBER:		241308965

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Frontline Behavioral Health, Inc.
		CENTRAL INDEX KEY:			0001513595
		ORGANIZATION NAME:           	
		IRS NUMBER:				721539453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-237
		FILM NUMBER:		241309006

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			McAllen Medical Center, Inc.
		CENTRAL INDEX KEY:			0001513596
		ORGANIZATION NAME:           	
		IRS NUMBER:				233069210
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-185
		FILM NUMBER:		241308955

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Merion Building Management, Inc.
		CENTRAL INDEX KEY:			0001513597
		ORGANIZATION NAME:           	
		IRS NUMBER:				232309517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-183
		FILM NUMBER:		241308952

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Meridell Achievement Center, Inc.
		CENTRAL INDEX KEY:			0001513598
		ORGANIZATION NAME:           	
		IRS NUMBER:				741655289
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-184
		FILM NUMBER:		241308954

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Merridell Achievement Center, Inc.
		DATE OF NAME CHANGE:	20110222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Del Amo Hospital, Inc.
		CENTRAL INDEX KEY:			0001513599
		ORGANIZATION NAME:           	
		IRS NUMBER:				232646424
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-246
		FILM NUMBER:		241309014

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Northwest Texas Healthcare System, Inc.
		CENTRAL INDEX KEY:			0001513600
		ORGANIZATION NAME:           	
		IRS NUMBER:				232238976
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-176
		FILM NUMBER:		241308946

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Oak Plains Academy of Tennessee, Inc.
		CENTRAL INDEX KEY:			0001513601
		ORGANIZATION NAME:           	
		IRS NUMBER:				621725123
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-175
		FILM NUMBER:		241308945

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Park Healthcare Co
		CENTRAL INDEX KEY:			0001513602
		ORGANIZATION NAME:           	
		IRS NUMBER:				621166882
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-169
		FILM NUMBER:		241308939

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pennsylvania Clinical Schools, Inc.
		CENTRAL INDEX KEY:			0001513603
		ORGANIZATION NAME:           	
		IRS NUMBER:				621735966
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-166
		FILM NUMBER:		241308936

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Psychiatric Solutions, Inc.
		CENTRAL INDEX KEY:			0001513605
		ORGANIZATION NAME:           	
		IRS NUMBER:				232491707
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-159
		FILM NUMBER:		241308929

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			River Oaks, Inc.
		CENTRAL INDEX KEY:			0001513606
		ORGANIZATION NAME:           	
		IRS NUMBER:				720687735
		STATE OF INCORPORATION:			LA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-32
		FILM NUMBER:		241308810

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Southeastern Hospital Corp
		CENTRAL INDEX KEY:			0001513607
		ORGANIZATION NAME:           	
		IRS NUMBER:				621606554
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-21
		FILM NUMBER:		241308799

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sparks Family Hospital, Inc.
		CENTRAL INDEX KEY:			0001513608
		ORGANIZATION NAME:           	
		IRS NUMBER:				880159958
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-19
		FILM NUMBER:		241308797

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Stonington Behavioral Health, Inc.
		CENTRAL INDEX KEY:			0001513609
		ORGANIZATION NAME:           	
		IRS NUMBER:				200687971
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-66
		FILM NUMBER:		241308840

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Turning Point Care Center, Inc.
		CENTRAL INDEX KEY:			0001513610
		ORGANIZATION NAME:           	
		IRS NUMBER:				581534607
		STATE OF INCORPORATION:			GA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-37
		FILM NUMBER:		241308815

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Two Rivers Psychiatric Hospital, Inc.
		CENTRAL INDEX KEY:			0001513611
		ORGANIZATION NAME:           	
		IRS NUMBER:				232279129
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-97
		FILM NUMBER:		241308870

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Children's Services, Inc.
		CENTRAL INDEX KEY:			0001513612
		ORGANIZATION NAME:           	
		IRS NUMBER:				203577381
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-91
		FILM NUMBER:		241308864

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Holding Company, Inc.
		CENTRAL INDEX KEY:			0001513613
		ORGANIZATION NAME:           	
		IRS NUMBER:				232367472
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-89
		FILM NUMBER:		241308882

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Benton, Inc.
		CENTRAL INDEX KEY:			0001513614
		ORGANIZATION NAME:           	
		IRS NUMBER:				200930981
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-36
		FILM NUMBER:		241308814

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Cornerstone Holdings, Inc.
		CENTRAL INDEX KEY:			0001513615
		ORGANIZATION NAME:           	
		IRS NUMBER:				203184635
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-83
		FILM NUMBER:		241308857

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Cornerstone, Inc.
		CENTRAL INDEX KEY:			0001513616
		ORGANIZATION NAME:           	
		IRS NUMBER:				203184613
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-82
		FILM NUMBER:		241308856

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of D.C., Inc.
		CENTRAL INDEX KEY:			0001513617
		ORGANIZATION NAME:           	
		IRS NUMBER:				232896723
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-81
		FILM NUMBER:		241308855

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Delaware, Inc.
		CENTRAL INDEX KEY:			0001513618
		ORGANIZATION NAME:           	
		IRS NUMBER:				232369986
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-80
		FILM NUMBER:		241308854

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Denver, Inc.
		CENTRAL INDEX KEY:			0001513619
		ORGANIZATION NAME:           	
		IRS NUMBER:				205227927
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-79
		FILM NUMBER:		241308853

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Fairmount, Inc.
		CENTRAL INDEX KEY:			0001513620
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044432
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-77
		FILM NUMBER:		241308851

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Fuller, Inc.
		CENTRAL INDEX KEY:			0001513621
		ORGANIZATION NAME:           	
		IRS NUMBER:				232801395
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-76
		FILM NUMBER:		241308850

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Georgia, Inc.
		CENTRAL INDEX KEY:			0001513622
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044429
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-74
		FILM NUMBER:		241308848

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Greenville, Inc.
		CENTRAL INDEX KEY:			0001513623
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044427
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-73
		FILM NUMBER:		241308847

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Hampton, Inc.
		CENTRAL INDEX KEY:			0001513624
		ORGANIZATION NAME:           	
		IRS NUMBER:				232985430
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-72
		FILM NUMBER:		241308846

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Hartgrove, Inc.
		CENTRAL INDEX KEY:			0001513625
		ORGANIZATION NAME:           	
		IRS NUMBER:				232983574
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-71
		FILM NUMBER:		241308845

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Oklahoma, Inc.
		CENTRAL INDEX KEY:			0001513626
		ORGANIZATION NAME:           	
		IRS NUMBER:				233041933
		STATE OF INCORPORATION:			OK
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-67
		FILM NUMBER:		241308841

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Puerto Rico, Inc.
		CENTRAL INDEX KEY:			0001513627
		ORGANIZATION NAME:           	
		IRS NUMBER:				232937744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-60
		FILM NUMBER:		241308834

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of River Parishes, Inc.
		CENTRAL INDEX KEY:			0001513628
		ORGANIZATION NAME:           	
		IRS NUMBER:				232238966
		STATE OF INCORPORATION:			LA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-58
		FILM NUMBER:		241308832

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Spring Mountain, Inc.
		CENTRAL INDEX KEY:			0001513629
		ORGANIZATION NAME:           	
		IRS NUMBER:				200930346
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-133
		FILM NUMBER:		241308903

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Texoma, Inc.
		CENTRAL INDEX KEY:			0001513630
		ORGANIZATION NAME:           	
		IRS NUMBER:				205908627
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-130
		FILM NUMBER:		241308900

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Westwood Pembroke, Inc.
		CENTRAL INDEX KEY:			0001513632
		ORGANIZATION NAME:           	
		IRS NUMBER:				233061361
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-126
		FILM NUMBER:		241308896

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Wyoming, Inc.
		CENTRAL INDEX KEY:			0001513633
		ORGANIZATION NAME:           	
		IRS NUMBER:				203367209
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-125
		FILM NUMBER:		241308895

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC Properties, LLC
		CENTRAL INDEX KEY:			0001513635
		ORGANIZATION NAME:           	
		IRS NUMBER:				621660875
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-216
		FILM NUMBER:		241308985

	BUSINESS ADDRESS:	
		STREET 1:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emerald Coast Behavioral Hospital, LLC
		CENTRAL INDEX KEY:			0001513636
		ORGANIZATION NAME:           	
		IRS NUMBER:				270720873
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-241
		FILM NUMBER:		241309010

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fort Duncan Medical Center, L.P.
		CENTRAL INDEX KEY:			0001513637
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044530
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-239
		FILM NUMBER:		241309008

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Frontline Hospital, LLC
		CENTRAL INDEX KEY:			0001513638
		ORGANIZATION NAME:           	
		IRS NUMBER:				721539530
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-236
		FILM NUMBER:		241309005

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Frontline Residential Treatment Center, LLC
		CENTRAL INDEX KEY:			0001513639
		ORGANIZATION NAME:           	
		IRS NUMBER:				721539254
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-235
		FILM NUMBER:		241309004

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Horizon Health Hospital Services, LLC
		CENTRAL INDEX KEY:			0001513640
		ORGANIZATION NAME:           	
		IRS NUMBER:				203798133
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-39
		FILM NUMBER:		241308817

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keys Group Holdings LLC
		CENTRAL INDEX KEY:			0001513641
		ORGANIZATION NAME:           	
		IRS NUMBER:				621863023
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-154
		FILM NUMBER:		241308925

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Continuum, LLC
		CENTRAL INDEX KEY:			0001513642
		ORGANIZATION NAME:           	
		IRS NUMBER:				481274107
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-153
		FILM NUMBER:		241308923

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Education & Youth Services, LLC
		CENTRAL INDEX KEY:			0001513643
		ORGANIZATION NAME:           	
		IRS NUMBER:				621842126
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-152
		FILM NUMBER:		241308922

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Marion, LLC
		CENTRAL INDEX KEY:			0001513644
		ORGANIZATION NAME:           	
		IRS NUMBER:				743108285
		STATE OF INCORPORATION:			VA

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-151
		FILM NUMBER:		241308921

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Memphis, LLC
		CENTRAL INDEX KEY:			0001513645
		ORGANIZATION NAME:           	
		IRS NUMBER:				621837606
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-210
		FILM NUMBER:		241308980

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Newport News, LLC
		CENTRAL INDEX KEY:			0001513646
		ORGANIZATION NAME:           	
		IRS NUMBER:				320066225
		STATE OF INCORPORATION:			VA

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-192
		FILM NUMBER:		241308962

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Richland Center, LLC
		CENTRAL INDEX KEY:			0001513648
		ORGANIZATION NAME:           	
		IRS NUMBER:				481274207
		STATE OF INCORPORATION:			OH

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-149
		FILM NUMBER:		241308919

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone WSNC, L.L.C.
		CENTRAL INDEX KEY:			0001513649
		ORGANIZATION NAME:           	
		IRS NUMBER:				201943356
		STATE OF INCORPORATION:			NC

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-148
		FILM NUMBER:		241308918

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone/CCS Partners LLC
		CENTRAL INDEX KEY:			0001513650
		ORGANIZATION NAME:           	
		IRS NUMBER:				731657607
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-147
		FILM NUMBER:		241308917

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KMI Acquisition, LLC
		CENTRAL INDEX KEY:			0001513651
		ORGANIZATION NAME:           	
		IRS NUMBER:				205048153
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-141
		FILM NUMBER:		241308912

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			La Amistad Residental Treatment Center, LLC
		CENTRAL INDEX KEY:			0001513652
		ORGANIZATION NAME:           	
		IRS NUMBER:				581791069
		STATE OF INCORPORATION:			FL

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-140
		FILM NUMBER:		241308911

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone NPS LLC
		CENTRAL INDEX KEY:			0001513654
		ORGANIZATION NAME:           	
		IRS NUMBER:				680520286
		STATE OF INCORPORATION:			CA

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-150
		FILM NUMBER:		241308920

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Manatee Memorial Hospital, L.P.
		CENTRAL INDEX KEY:			0001513655
		ORGANIZATION NAME:           	
		IRS NUMBER:				232798290
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-134
		FILM NUMBER:		241308904

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ocala Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001513656
		ORGANIZATION NAME:           	
		IRS NUMBER:				320235544
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-174
		FILM NUMBER:		241308944

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pendleton Methodist Hospital, L.L.C.
		CENTRAL INDEX KEY:			0001513657
		ORGANIZATION NAME:           	
		IRS NUMBER:				753128254
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-167
		FILM NUMBER:		241308937

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PSJ Acquisition, LLC
		CENTRAL INDEX KEY:			0001513658
		ORGANIZATION NAME:           	
		IRS NUMBER:				264314533
		STATE OF INCORPORATION:			ND
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-163
		FILM NUMBER:		241308933

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TBD Acquisition, LLC
		CENTRAL INDEX KEY:			0001513659
		ORGANIZATION NAME:           	
		IRS NUMBER:				205048087
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-14
		FILM NUMBER:		241308792

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TBJ Behavioral Center, LLC
		CENTRAL INDEX KEY:			0001513660
		ORGANIZATION NAME:           	
		IRS NUMBER:				204865566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-13
		FILM NUMBER:		241308791

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tennessee Clinical Schools, LLC
		CENTRAL INDEX KEY:			0001513661
		ORGANIZATION NAME:           	
		IRS NUMBER:				621715237
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-10
		FILM NUMBER:		241308788

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Toledo Holding Co., LLC
		CENTRAL INDEX KEY:			0001513662
		ORGANIZATION NAME:           	
		IRS NUMBER:				270607591
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-01
		FILM NUMBER:		241308779

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Kentucky Holdings, L.L.C.
		CENTRAL INDEX KEY:			0001513663
		ORGANIZATION NAME:           	
		IRS NUMBER:				205396036
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-88
		FILM NUMBER:		241308862

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Bowling Green, LLC
		CENTRAL INDEX KEY:			0001513664
		ORGANIZATION NAME:           	
		IRS NUMBER:				200931121
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-85
		FILM NUMBER:		241308859

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Centennial Peaks, L.L.C.
		CENTRAL INDEX KEY:			0001513665
		ORGANIZATION NAME:           	
		IRS NUMBER:				263973154
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-84
		FILM NUMBER:		241308858

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Dover, L.L.C.
		CENTRAL INDEX KEY:			0001513666
		ORGANIZATION NAME:           	
		IRS NUMBER:				205093162
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-78
		FILM NUMBER:		241308852

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Doylestown, L.L.C.
		CENTRAL INDEX KEY:			0001513667
		ORGANIZATION NAME:           	
		IRS NUMBER:				208179692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-35
		FILM NUMBER:		241308813

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Lakeside, LLC
		CENTRAL INDEX KEY:			0001513668
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044425
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-70
		FILM NUMBER:		241308844

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Laurel Heights, L.P.
		CENTRAL INDEX KEY:			0001513669
		ORGANIZATION NAME:           	
		IRS NUMBER:				233045288
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-138
		FILM NUMBER:		241308909

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Parkwood, Inc.
		CENTRAL INDEX KEY:			0001513670
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044435
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-65
		FILM NUMBER:		241308839

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Peachford, L.P.
		CENTRAL INDEX KEY:			0001513671
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044978
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-64
		FILM NUMBER:		241308838

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Pennsylvania,Inc.
		CENTRAL INDEX KEY:			0001513672
		ORGANIZATION NAME:           	
		IRS NUMBER:				232842434
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-63
		FILM NUMBER:		241308837

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Provo Canyon, Inc.
		CENTRAL INDEX KEY:			0001513673
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044423
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-61
		FILM NUMBER:		241308835

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Ridge, LLC
		CENTRAL INDEX KEY:			0001513674
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044431
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-59
		FILM NUMBER:		241308833

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Rockford, LLC
		CENTRAL INDEX KEY:			0001513675
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044421
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-57
		FILM NUMBER:		241308831

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Salt Lake City, L.L.C.
		CENTRAL INDEX KEY:			0001513676
		ORGANIZATION NAME:           	
		IRS NUMBER:				260464201
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-56
		FILM NUMBER:		241308830

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Savannah, L.L.C.
		CENTRAL INDEX KEY:			0001513677
		ORGANIZATION NAME:           	
		IRS NUMBER:				200931196
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-55
		FILM NUMBER:		241308829

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Springwoods, L.L.C.
		CENTRAL INDEX KEY:			0001513678
		ORGANIZATION NAME:           	
		IRS NUMBER:				205395878
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-132
		FILM NUMBER:		241308902

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Summitridge, LLC
		CENTRAL INDEX KEY:			0001513679
		ORGANIZATION NAME:           	
		IRS NUMBER:				262203865
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-131
		FILM NUMBER:		241308901

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Timpanogos, Inc.
		CENTRAL INDEX KEY:			0001513680
		ORGANIZATION NAME:           	
		IRS NUMBER:				203687800
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-128
		FILM NUMBER:		241308898

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Oklahoma City LLC
		CENTRAL INDEX KEY:			0001513681
		ORGANIZATION NAME:           	
		IRS NUMBER:				202901605
		STATE OF INCORPORATION:			OK
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-124
		FILM NUMBER:		241308894

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS-Corona, Inc.
		CENTRAL INDEX KEY:			0001513682
		ORGANIZATION NAME:           	
		IRS NUMBER:				521247839
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-121
		FILM NUMBER:		241308891

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			United Healthcare of Hardin, Inc.
		CENTRAL INDEX KEY:			0001513683
		ORGANIZATION NAME:           	
		IRS NUMBER:				621244469
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-118
		FILM NUMBER:		241308888

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Universal Health Services of Palmdale, Inc.
		CENTRAL INDEX KEY:			0001513684
		ORGANIZATION NAME:           	
		IRS NUMBER:				233101502
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-117
		FILM NUMBER:		241308887

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Universal Health Services of Rancho Springs, Inc.
		CENTRAL INDEX KEY:			0001513685
		ORGANIZATION NAME:           	
		IRS NUMBER:				233059262
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-116
		FILM NUMBER:		241308886

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Valley Hospital Medical Center, Inc.
		CENTRAL INDEX KEY:			0001513686
		ORGANIZATION NAME:           	
		IRS NUMBER:				232117855
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-110
		FILM NUMBER:		241308906

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wekiva Springs Center, LLC
		CENTRAL INDEX KEY:			0001513687
		ORGANIZATION NAME:           	
		IRS NUMBER:				204865588
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-109
		FILM NUMBER:		241308881

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wellington Regional Medical Center, Inc
		CENTRAL INDEX KEY:			0001513688
		ORGANIZATION NAME:           	
		IRS NUMBER:				232306491
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-108
		FILM NUMBER:		241308880

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			McAllen Hospitals, L.P.
		CENTRAL INDEX KEY:			0001513836
		ORGANIZATION NAME:           	
		IRS NUMBER:				233069260
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-186
		FILM NUMBER:		241308956

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Anchor, L.P.
		CENTRAL INDEX KEY:			0001513837
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044975
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-86
		FILM NUMBER:		241308860

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Georgia Holdings, Inc.
		CENTRAL INDEX KEY:			0001513838
		ORGANIZATION NAME:           	
		IRS NUMBER:				233044428
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-75
		FILM NUMBER:		241308849

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of New Orleans, Inc.
		CENTRAL INDEX KEY:			0001513839
		ORGANIZATION NAME:           	
		IRS NUMBER:				720802368
		STATE OF INCORPORATION:			LA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-68
		FILM NUMBER:		241308842

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC Pennsylvania, LLC
		CENTRAL INDEX KEY:			0001514293
		ORGANIZATION NAME:           	
		IRS NUMBER:				205353753
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-48
		FILM NUMBER:		241308824

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Timberlawn, Inc.
		CENTRAL INDEX KEY:			0001514317
		ORGANIZATION NAME:           	
		IRS NUMBER:				232853139
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-129
		FILM NUMBER:		241308899

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wisconsin Avenue Psychiatric Center, Inc.
		CENTRAL INDEX KEY:			0001952275
		ORGANIZATION NAME:           	
		IRS NUMBER:				593480410
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-101
		FILM NUMBER:		241308873

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Salt Lake Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952278
		ORGANIZATION NAME:           	
		IRS NUMBER:				271365684
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-27
		FILM NUMBER:		241308805

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Valley Health System LLC
		CENTRAL INDEX KEY:			0001952280
		ORGANIZATION NAME:           	
		IRS NUMBER:				232937646
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-111
		FILM NUMBER:		241308883

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Funding, LLC
		CENTRAL INDEX KEY:			0001952284
		ORGANIZATION NAME:           	
		IRS NUMBER:				842891450
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-90
		FILM NUMBER:		241308863

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			University Behavioral Health of El Paso, LLC
		CENTRAL INDEX KEY:			0001952286
		ORGANIZATION NAME:           	
		IRS NUMBER:				208364461
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-115
		FILM NUMBER:		241308885

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Texas Oaks Psychiatric Hospital, L.P.
		CENTRAL INDEX KEY:			0001952288
		ORGANIZATION NAME:           	
		IRS NUMBER:				841618661
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-06
		FILM NUMBER:		241308784

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Psychiatric Realty, LLC
		CENTRAL INDEX KEY:			0001952289
		ORGANIZATION NAME:           	
		IRS NUMBER:				208364925
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-162
		FILM NUMBER:		241308932

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RR Recovery, LLC
		CENTRAL INDEX KEY:			0001952291
		ORGANIZATION NAME:           	
		IRS NUMBER:				260269878
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-28
		FILM NUMBER:		241308806

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Capitol Acquisition, LLC
		CENTRAL INDEX KEY:			0001952294
		ORGANIZATION NAME:           	
		IRS NUMBER:				882396608
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-98
		FILM NUMBER:		241308871

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHP, LP
		CENTRAL INDEX KEY:			0001952297
		ORGANIZATION NAME:           	
		IRS NUMBER:				203078922
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-92
		FILM NUMBER:		241308865

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHSL, L.L.C.
		CENTRAL INDEX KEY:			0001952300
		ORGANIZATION NAME:           	
		IRS NUMBER:				261544573
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-119
		FILM NUMBER:		241308889

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Beach 77, LP
		CENTRAL INDEX KEY:			0001952301
		ORGANIZATION NAME:           	
		IRS NUMBER:				203078353
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-202
		FILM NUMBER:		241308972

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Madera, Inc.
		CENTRAL INDEX KEY:			0001952302
		ORGANIZATION NAME:           	
		IRS NUMBER:				843480733
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-94
		FILM NUMBER:		241308867

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			National Deaf Academy, LLC
		CENTRAL INDEX KEY:			0001952304
		ORGANIZATION NAME:           	
		IRS NUMBER:				593653865
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-05
		FILM NUMBER:		241308783

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Riverside Medical Clinic Patient Services, L.L.C.
		CENTRAL INDEX KEY:			0001952308
		ORGANIZATION NAME:           	
		IRS NUMBER:				330848805
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-30
		FILM NUMBER:		241308808

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHSD, L.L.C.
		CENTRAL INDEX KEY:			0001952310
		ORGANIZATION NAME:           	
		IRS NUMBER:				261544392
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-120
		FILM NUMBER:		241308890

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CAT Seattle, LLC
		CENTRAL INDEX KEY:			0001952311
		ORGANIZATION NAME:           	
		IRS NUMBER:				452538281
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-205
		FILM NUMBER:		241308975

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UBH of Phoenix, LLC
		CENTRAL INDEX KEY:			0001952313
		ORGANIZATION NAME:           	
		IRS NUMBER:				270355566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-93
		FILM NUMBER:		241308866

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Milwaukee Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952314
		ORGANIZATION NAME:           	
		IRS NUMBER:				831464210
		STATE OF INCORPORATION:			WI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-180
		FILM NUMBER:		241308950

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Lancaster, LLC
		CENTRAL INDEX KEY:			0001952322
		ORGANIZATION NAME:           	
		IRS NUMBER:				813333435
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-69
		FILM NUMBER:		241308843

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Salt Lake Psychiatric Realty, LLC
		CENTRAL INDEX KEY:			0001952324
		ORGANIZATION NAME:           	
		IRS NUMBER:				262885163
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-26
		FILM NUMBER:		241308804

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CAT Realty, LLC
		CENTRAL INDEX KEY:			0001952325
		ORGANIZATION NAME:           	
		IRS NUMBER:				452538395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-206
		FILM NUMBER:		241308976

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Behavioral Health Management, LLC
		CENTRAL INDEX KEY:			0001952328
		ORGANIZATION NAME:           	
		IRS NUMBER:				272849780
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-201
		FILM NUMBER:		241308971

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mayhill Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952330
		ORGANIZATION NAME:           	
		IRS NUMBER:				274126263
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-187
		FILM NUMBER:		241308957

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Independence Physician Management, LLC
		CENTRAL INDEX KEY:			0001952334
		ORGANIZATION NAME:           	
		IRS NUMBER:				455296314
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-155
		FILM NUMBER:		241308926

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Sub III, LLC
		CENTRAL INDEX KEY:			0001952335
		ORGANIZATION NAME:           	
		IRS NUMBER:				474762288
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-122
		FILM NUMBER:		241308892

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Behavioral Health Realty, LLC
		CENTRAL INDEX KEY:			0001952340
		ORGANIZATION NAME:           	
		IRS NUMBER:				272849723
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-200
		FILM NUMBER:		241308970

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AZ Holding 4, LLC
		CENTRAL INDEX KEY:			0001952344
		ORGANIZATION NAME:           	
		IRS NUMBER:				834517050
		STATE OF INCORPORATION:			AZ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-190
		FILM NUMBER:		241308960

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UBH of Phoenix Realty, LLC
		CENTRAL INDEX KEY:			0001952348
		ORGANIZATION NAME:           	
		IRS NUMBER:				270355691
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-95
		FILM NUMBER:		241308868

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ridge Outpatient Counseling, L.L.C.
		CENTRAL INDEX KEY:			0001952350
		ORGANIZATION NAME:           	
		IRS NUMBER:				251872645
		STATE OF INCORPORATION:			KY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-33
		FILM NUMBER:		241308811

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Harbor Point Behavioral Health Center, Inc.
		CENTRAL INDEX KEY:			0001952353
		ORGANIZATION NAME:           	
		IRS NUMBER:				541465094
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-54
		FILM NUMBER:		241308828

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Temple Behavioral Healthcare Hospital, Inc.
		CENTRAL INDEX KEY:			0001952355
		ORGANIZATION NAME:           	
		IRS NUMBER:				832014977
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-11
		FILM NUMBER:		241308789

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Tucson, LLC
		CENTRAL INDEX KEY:			0001952357
		ORGANIZATION NAME:           	
		IRS NUMBER:				463600310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-127
		FILM NUMBER:		241308897

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UBH of Oregon, LLC
		CENTRAL INDEX KEY:			0001952358
		ORGANIZATION NAME:           	
		IRS NUMBER:				262343447
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-96
		FILM NUMBER:		241308869

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Phoenix, LLC
		CENTRAL INDEX KEY:			0001952363
		ORGANIZATION NAME:           	
		IRS NUMBER:				464207180
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-62
		FILM NUMBER:		241308836

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bridgeway, LLC
		CENTRAL INDEX KEY:			0001952364
		ORGANIZATION NAME:           	
		IRS NUMBER:				232238973
		STATE OF INCORPORATION:			AR
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-146
		FILM NUMBER:		241308916

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pasteur Healthcare Properties, LLC
		CENTRAL INDEX KEY:			0001952365
		ORGANIZATION NAME:           	
		IRS NUMBER:				861734170
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-168
		FILM NUMBER:		241308938

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Palm Point Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952372
		ORGANIZATION NAME:           	
		IRS NUMBER:				471584533
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-173
		FILM NUMBER:		241308943

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DHP 2131 K St, LLC
		CENTRAL INDEX KEY:			0001952373
		ORGANIZATION NAME:           	
		IRS NUMBER:				452919095
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-245
		FILM NUMBER:		241309013

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			District Hospital Partners, L.P.
		CENTRAL INDEX KEY:			0001952374
		ORGANIZATION NAME:           	
		IRS NUMBER:				232896725
		STATE OF INCORPORATION:			DC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-243
		FILM NUMBER:		241309012

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DVH Hospital Alliance LLC
		CENTRAL INDEX KEY:			0001952375
		ORGANIZATION NAME:           	
		IRS NUMBER:				812660258
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-242
		FILM NUMBER:		241309011

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FRN, INC.
		CENTRAL INDEX KEY:			0001952377
		ORGANIZATION NAME:           	
		IRS NUMBER:				320229751
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-238
		FILM NUMBER:		241309007

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coral Shores Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952378
		ORGANIZATION NAME:           	
		IRS NUMBER:				463794548
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-193
		FILM NUMBER:		241308963

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Schick Shadel Of Florida, LLC
		CENTRAL INDEX KEY:			0001952379
		ORGANIZATION NAME:           	
		IRS NUMBER:				383925621
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-24
		FILM NUMBER:		241308802

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TBD Acquisition II, LLC
		CENTRAL INDEX KEY:			0001952380
		ORGANIZATION NAME:           	
		IRS NUMBER:				822306092
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-15
		FILM NUMBER:		241308793

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Garfield Park Hospital, LLC
		CENTRAL INDEX KEY:			0001952381
		ORGANIZATION NAME:           	
		IRS NUMBER:				460775763
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-234
		FILM NUMBER:		241309003

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Forest View Psychiatric Hospital, Inc.
		CENTRAL INDEX KEY:			0001952382
		ORGANIZATION NAME:           	
		IRS NUMBER:				232285657
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-188
		FILM NUMBER:		241308958

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gulf Coast Treatment Center, Inc.
		CENTRAL INDEX KEY:			0001952383
		ORGANIZATION NAME:           	
		IRS NUMBER:				561341134
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-232
		FILM NUMBER:		241309001

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fannin Management Services, LLC
		CENTRAL INDEX KEY:			0001952384
		ORGANIZATION NAME:           	
		IRS NUMBER:				320456095
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-240
		FILM NUMBER:		241309009

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Temecula Valley Hospital, Inc.
		CENTRAL INDEX KEY:			0001952385
		ORGANIZATION NAME:           	
		IRS NUMBER:				461246570
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-12
		FILM NUMBER:		241308790

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gulph Mills Associates, LLC
		CENTRAL INDEX KEY:			0001952386
		ORGANIZATION NAME:           	
		IRS NUMBER:				455358222
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-231
		FILM NUMBER:		241309000

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ascend Health Corp
		CENTRAL INDEX KEY:			0001952402
		ORGANIZATION NAME:           	
		IRS NUMBER:				800109304
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-248
		FILM NUMBER:		241309016

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Midwest Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952648
		ORGANIZATION NAME:           	
		IRS NUMBER:				822409085
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-87
		FILM NUMBER:		241308861

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABS LINCS KY, LLC
		CENTRAL INDEX KEY:			0001952669
		ORGANIZATION NAME:           	
		IRS NUMBER:				611267294
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282135-253
		FILM NUMBER:		241309020

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d884117d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(5) <BR> Registration No. 333-282135 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman"><B>(To Prospectus dated September&nbsp;16, 2024) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g884117g01g01.jpg" ALT="LOGO" STYLE="width:1.38917in;height:0.472017in;">
 </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman"><B>Universal Health Services, Inc. </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>$500,000,000 4.625% Senior Secured Notes due 2029 </I></B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>$500,000,000 5.050% Senior Secured Notes due 2034 </I></B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest payable April 15 and October 15 </I></B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Issue price: 99.957% for the 2029 notes </I></B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; margin-left:11%; font-size:10pt; font-family:Times New Roman"><B><I>99.685% for the 2034 notes </I></B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman">Universal Health Services, Inc. is offering $500,000,000 aggregate principal amount of 4.625% Senior Secured Notes due 2029 (the &#147;2029 notes&#148;) and
$500,000,000 aggregate principal amount of 5.050% Senior Secured Notes due 2034 (the &#147;2034 notes&#148; and, together with the 2029 notes, the &#147;notes&#148;). The 2029 notes will bear interest at a rate of 4.625% per annum, and the 2034
notes will bear interest at a rate of 5.050% per annum. Universal Health Services, Inc. will pay interest on the notes semi-annually, in cash in arrears, on April 15 and October 15 for the 2029 notes, beginning on April 15, 2025, and on April 15 and
October 15 for the 2034 notes, beginning on April 15, 2025. Interest on each series of the notes will accrue from September&nbsp;26, 2024, and the 2029 notes will mature on October 15, 2029 and the 2034 notes will mature on October 15, 2034. </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman">We may redeem some or all of the 2029 notes at any time prior to September 15, 2029 at a price equal to 100% of the principal amount thereof, plus accrued and
unpaid interest, plus a &#147;make whole&#148; premium. We may redeem some or all of the 2034 notes at any time prior to July 15, 2034 at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, plus a
&#147;make-whole&#148; premium. If we experience specific kinds of changes of control and the notes have ceased to have investment grade ratings (including as a result of entering into an agreement that would result in such a change of control),
then we will be required to offer to repurchase the notes, as described in &#147;Description of the notes.&#148; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman">Each of our existing and future
subsidiaries that guarantees our senior secured credit facility or certain of our other indebtedness or indebtedness of subsidiary guarantors will guarantee the notes (the &#147;note guarantees&#148;). The notes will rank equally in right of payment
to all of our existing and future senior debt, but, to the extent of the value of the collateral (as defined below), will be effectively senior to our existing and future unsecured senior debt and any future junior lien obligations. The notes will
rank senior in right of payment to all of our existing and future subordinated debt. The note guarantees will rank equally in right of payment with all of our subsidiary guarantors&#146; existing and future senior debt and senior in right of payment
to all of our subsidiary guarantors&#146; existing and future subordinated debt. In addition, the notes will be structurally subordinated to the liabilities of our <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries. Under certain
circumstances, the subsidiary guarantors may be released from their note guarantees without the consent of the holders of the notes, including if the notes then have investment grade ratings, no default has occurred and is continuing, the guarantees
of other first lien and any junior lien obligations have been released and liens on the collateral securing all first lien obligations and any junior lien obligations have been released. Any note guarantee will also be released if that subsidiary
guarantor&#146;s guarantees of the senior credit facility, other first lien obligations and any junior lien obligations are released. </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman">The notes and the
note guarantees will be secured by first-priority liens, subject to permitted liens, on certain of our assets and certain assets of those guarantors that have pledged those assets to secure certain of our other indebtedness or indebtedness of those
subsidiary guarantors (the &#147;secured guarantors&#148;) now owned or acquired in the future by us and our secured guarantors (other than our real property and certain other excluded assets). Our obligations with respect to the notes, the
obligations of the secured guarantors under the note guarantees and the performance of all our and our secured guarantors&#146; other obligations under the indenture will be secured equally and ratably with our and our subsidiary guarantors&#146;
obligations under our senior secured credit facility, our 1.650% Senior Secured Notes due 2026 (the &#147;Existing 2026 Notes&#148;), our 2.650% Senior Secured Notes due 2030 (the &#147;Existing 2030 Notes&#148;) and our 2.650% Senior Secured Notes
due 2032 (the &#147;Existing 2032 Notes&#148;) by a perfected first-priority security interest, subject to permitted liens, in the collateral owned by us and our secured guarantors, whether now owned or hereafter acquired (the
&#147;collateral&#148;). However, the liens on the collateral securing the notes and the note guarantees of the secured guarantors will be released if (i)(x) the notes then have investment grade ratings, (y)&nbsp;no default has occurred and is
continuing and (z)&nbsp;the liens on the collateral securing all first lien obligations (including the senior secured credit facility, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes) and any junior lien obligations have
been released or (ii)&nbsp;the collateral under the senior secured credit facility, any other first lien obligations and any junior lien obligations has been released or no longer required to be pledged. See &#147;Description of the notes.&#148;
</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman">We intend to use the net proceeds of this offering and the new tranche A term loan facility (as described herein) to repay amounts outstanding under our
current tranche A term loan facility. See &#147;Use of proceeds.&#148; </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman"><B>Investing in the notes
involves risks. See &#147;<A HREF="#sup884117_7">Risk factors</A>&#148; beginning on page S-14 of this prospectus supplement and the matters discussed in the documents incorporated by reference in this prospectus supplement and the accompanying
prospectus for a discussion of certain risks that you should consider in connection with an investment in the notes. </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman"><B>Neither the Securities and
Exchange Commission (the &#147;SEC&#148;) nor any state securities commission or other regulatory body has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or
complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Public&nbsp;offering&nbsp;price(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Underwriting<BR>discount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proceeds to<BR>Universal&nbsp;Health<BR>Services,&nbsp;Inc.(1)<BR>(before expenses)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per<BR>note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per<BR>note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per<BR>note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7.5pt; font-family:Times New Roman">4.625% Senior Notes due 2029</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99.957</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">499,785,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.600</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99.357</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">496,785,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7.5pt; font-family:Times New Roman">5.050% Senior Notes due 2034</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99.685</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">498,425,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.650</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99.035</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">495,175,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman; " ALIGN="left">Plus accrued interest, if any, from, and including September 26, 2024, if the settlement date occurs after
that date. </P></TD></TR></TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7.5pt; font-family:Times New Roman">We expect that delivery of the notes will be made to investors in book-entry form through The Depository Trust Company on or
about September&nbsp;26, 2024. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" COLSPAN="9" NOWRAP ALIGN="center"><B><I>Joint book-running managers</I></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>BofA&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Truist&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>US&nbsp;Bancorp</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Wells&nbsp;Fargo&nbsp;Securities</B></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" NOWRAP><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>Mizuho</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>NatWest Markets</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>&#8195;&#8195;&#8195;PNC&nbsp;Capital&nbsp;Markets&nbsp;LLC</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><B>TD Securities</B></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><I>Senior co-managers </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Fifth&nbsp;Third&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>SMBC&nbsp;Nikko</B></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><I>Co-manager </I></B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I></I></B><B>KeyBanc Capital Markets</B><B><I> </I></B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>September 17, 2024 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>Table of Contents </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Prospectus Supplement</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_1">About this prospectus supplement</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-iii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_2">Market, ranking, industry data and forecasts</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-iv</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_3">Cautionary statement regarding forward-looking
statements</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-v</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_4">Summary</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_5">The offering</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_6">Summary historical and financial data</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_7">Risk factors</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_8">Use of proceeds</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-26</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_9">Capitalization</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-27</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_10">Description of other indebtedness</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-28</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_11">Description of the notes</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-30</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_12">Book-entry settlement and clearance</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-73</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_13">Material United States federal income tax
consequences</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-76</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_14">Certain ERISA considerations</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-81</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_15">Underwriting (conflicts of interest)</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-84</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_16">Legal matters</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-90</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_17">Experts</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-91</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_18">Available information</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-92</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#sup884117_19">Incorporation of certain documents by reference</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-93</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Prospectus </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_3">INCORPORATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_4">FORWARD-LOOKING AND CAUTIONARY STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_5">OUR COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_8">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_9">DESCRIPTION OF DEBT SECURITIES AND GUARANTEES OF DEBT
SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Universal Health Services, Inc. is a Delaware corporation. Our principal executive offices are located at Universal Corporate
Center, 367 South Gulph Road, P.O. Box 61558, King of Prussia, PA 19406, and our telephone number at that address is (610) <FONT STYLE="white-space:nowrap">768-3300.</FONT> Our website is located at www.uhs.com. Our website and the information
contained on our website are not part of this prospectus supplement, and you should rely only on the information contained or incorporated by reference in this prospectus supplement when making a decision as to whether to invest in the notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this prospectus supplement, unless otherwise indicated or the content otherwise requires, the terms &#147;UHS,&#148; &#147;our company,&#148;
&#147;us,&#148; &#147;we&#148; and &#147;our&#148; refer to Universal Health Services, Inc. and its consolidated subsidiaries. Universal Health Services, Inc. is a registered trademark of UHS of Delaware, Inc., the management company for, and a
wholly-owned subsidiary of, Universal Health Services, Inc. Universal Health Services, Inc. is a holding company and operates through its subsidiaries including its management company, UHS of Delaware,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Inc. All healthcare and management operations are conducted by subsidiaries of Universal Health Services, Inc. To the extent any reference to &#147;UHS&#148; or &#147;UHS facilities&#148; in this
prospectus supplement, including letters, narratives or other forms contained herein relates to our healthcare or management operations, it is referring to Universal Health Services, Inc.&#146;s subsidiaries including UHS of Delaware, Inc. Further,
the terms &#147;UHS,&#148; &#147;our company,&#148; &#147;us,&#148; &#147;we&#148; and &#147;our&#148; in such context similarly refer to the operations of Universal Health Services, Inc.&#146;s subsidiaries including UHS of Delaware, Inc. Any
reference to employees or employment contained herein refers to employment with or employees of the subsidiaries of Universal Health Services, Inc., including UHS of Delaware, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">References to &#147;underwriters&#148; refer to the firms listed on the cover page of this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_1"></A>About this prospectus supplement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document is in two parts. The first part is this prospectus supplement, which describes the terms of the offering of the notes and adds to and
supplements information contained in the accompanying prospectus and the documents incorporated by reference therein. The second part is the accompanying prospectus, which we refer to as the &#147;accompanying prospectus.&#148; The accompanying
prospectus contains a description of our debt securities and gives more general information, some of which may not apply to the notes. The accompanying prospectus also incorporates by reference documents that are described under &#147;Incorporation
by reference&#148; in that prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained or incorporated by reference in this prospectus supplement, in
the accompanying prospectus or in any free writing prospectus filed by us with the SEC. If information in this prospectus supplement is inconsistent with the accompanying prospectus, you should rely on this prospectus supplement. We have not, and
the underwriters have not, authorized any other person to provide you with additional or different information. If anyone provides you with additional, different or inconsistent information, you should not rely on it. You should not assume that the
information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus or in any such free writing prospectus is accurate as of any date other than the respective dates thereof. Our business, financial
condition, results of operations and prospects may have changed since those dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not, and the underwriters are not, making an offer of the
notes, or seeking any offers to buy the notes, in any jurisdiction where the offer or sale is not permitted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_2"></A>Market, ranking, industry data and forecasts </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement includes and incorporates by reference market share, ranking, industry data and forecasts that we obtained from industry
publications and surveys, public filings and internal company sources. Industry publications, surveys and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable, but there can be no
assurance as to the accuracy or completeness of included information. We have not independently verified any of the data from third-party sources, nor have we ascertained the underlying economic assumptions relied upon therein. Statements as to our
market position and ranking are based on market data currently available to us, management&#146;s estimates and assumptions we have made regarding the size of our markets within the healthcare industry. While we are not aware of any misstatements
regarding our industry data presented herein, our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#147;Risk factors&#148; in this prospectus supplement and in
the documents incorporated by reference herein. Neither we nor the underwriters can guarantee the accuracy or completeness of such information contained or incorporated by reference in this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_3"></A>Cautionary statement regarding forward-looking statements
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus contain &#147;forward-looking statements&#148; that reflect our current estimates,
expectations and projections about our future results, performance, prospects and opportunities. Forward-looking statements include, among other things, the information concerning our possible future results of operations, business and growth
strategies, financing plans, expectations that regulatory developments or other matters will not have a material adverse effect on our business or financial condition, our competitive position and the effects of competition, the projected growth of
the industry in which we operate, and the benefits and synergies to be obtained from our completed and any future acquisitions, and statements of our goals and objectives, and other similar expressions concerning matters that are not historical
facts. Words such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;predicts,&#148; &#147;potential,&#148; &#147;continue,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;future,&#148;
&#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;appears,&#148; &#147;projects&#148; and similar expressions, as well as statements in future tense, identify forward-looking statements. In evaluating those
statements, you should specifically consider various factors, including the risks related to healthcare industry trends and those set forth herein and those detailed in our filings with the SEC incorporated by reference herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times
at, or by which, such performance or results will be achieved. Forward-looking information is based on information available at the time and/or our good faith belief with respect to future events, and is subject to risks and uncertainties that could
cause actual performance or results to differ materially from those expressed in the statements. Such factors include, among other things, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the healthcare industry is labor intensive and salaries, wages and benefits are subject to inflationary
pressures, as are supplies expense and other operating expenses. In the past, staffing shortages have, at times, required us to hire expensive temporary personnel and/or enhance wages and benefits to recruit and retain nurses and other clinical
staff and support personnel. At certain facilities, particularly within our behavioral health care segment, there have been occasions when we were unable to fill all vacant positions and, consequently, we were required to limit patient volumes. We
have also experienced general inflationary cost increases related to certain of our other operating expenses. Many of these factors, which had a material unfavorable impact on our results of operations in prior years, have moderated more recently.
However, we cannot predict future inflationary increases, which if significant, could have a material unfavorable impact on our future results of operations. We have experienced inflationary pressures, primarily in personnel costs, although those
pressures have moderated more recently. The extent of any future impacts from inflation on our business and our results of operations will be dependent upon how long the elevated inflation levels persist and the extent to which the rate of inflation
further increases, if at all, neither of which we are able to predict. If elevated levels of inflation were to persist or if the rate of inflation were to accelerate, our expenses could increase faster than anticipated and we may utilize our capital
resources sooner than expected. Further, given the complexities of the reimbursement landscape in which we operate, our ability to pass on increased costs associated with providing healthcare to Medicare and Medicaid patients is limited due to
various federal, state and local laws, which in certain circumstances, limit our ability to increase prices; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in our acute care segment, we have experienced a significant increase in hospital based physician related
expenses, especially in the areas of emergency room care and anesthesiology. We have implemented various initiatives to mitigate the increased expense, to the degree possible, which has moderated the rate of increase. However, significant increases
in these physician related expenses could have a material unfavorable impact on our future results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the increase in interest rates during the past few years has increased our interest expense significantly
increasing our expenses and reducing our free cash flow and our ability to access the capital markets on favorable terms. As such, the effects of increased borrowing rates have adversely impacted our results of operations, financial condition and
cash flows. We cannot predict future changes to interest rates, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
however, significant increases in our borrowing rates could have a material unfavorable impact on our future results of operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">President Biden signed into law fiscal year 2024 appropriations to federal agencies for continuing projects and
activities through September&nbsp;30, 2024. We cannot predict whether or not there will be future legislation averting a federal government shutdown, however, our operating cash flows and results of operations could be materially unfavorably
impacted by a federal government shutdown; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on December&nbsp;29, 2022, the Consolidated Appropriations Act, 2023, was signed into law phasing out the
enhanced federal medical assistance percentage rate that states received during the <FONT STYLE="white-space:nowrap">COVID-19</FONT> public health emergency and fully eliminated the increase on December&nbsp;31, 2023. States were also permitted to
begin Medicaid eligibility redeterminations on March&nbsp;31, 2023, which has resulted in a decrease in Medicaid enrollment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to comply with the existing laws and government regulations, and/or changes in laws and government
regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increasing number of legislative initiatives have been passed into law that may result in major changes in the
health care delivery system on a national or state level. For example, Congress has reduced to $0 the penalty for failing to maintain health coverage that was part of the original Patient Protection and Affordable Care Act, as amended by the Health
and Education Reconciliation Act (collectively, the &#147;Legislation&#148;) as part of the Tax Cuts and Jobs Act. To date, the Biden administration has issued executive orders implementing a special enrollment period permitting individuals to
enroll in health plans outside of the annual open enrollment period and reexamining policies that may undermine the Legislation or the Medicaid program. The Inflation Reduction Act of 2022 (&#147;IRA&#148;) was passed on August&nbsp;16, 2022, which
among other things, allows for the Centers for Medicare and Medicaid Services (&#147;CMS&#148;) to negotiate prices for certain single-source drugs reimbursed under Medicare Part B and Part D. The American Rescue Plan Act&#146;s expansion of
subsidies to purchase coverage through a Legislation exchange, which the IRA continued through 2025, is anticipated to increase exchange enrollment. However, if the subsidies are not extended beyond 2025, exchange enrollment may be adversely
impacted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there have been numerous political and legal efforts to expand, repeal, replace or modify the Legislation, since
its enactment, some of which have been successful, in part, in modifying the Legislation, as well as court challenges to the constitutionality of the Legislation. The U.S. Supreme Court held in <I>California v. Texas</I> that the plaintiffs lacked
standing to challenge the Legislation&#146;s requirement to obtain minimum essential health insurance coverage, or the individual mandate. The Court dismissed the case without specifically ruling on the constitutionality of the Legislation. As a
result, the Legislation will continue to remain law, in its entirety, likely for the foreseeable future. On September&nbsp;7, 2022, the Legislation faced its most recent challenge when a Texas Federal District Court judge, in the case of
<I>Braidwood Management v. Becerra</I>, ruled that a requirement that certain health plans cover services without cost sharing violates the Appointments Clause of the U.S. Constitution and that the coverage of certain HIV prevention medication
violates the Religious Freedom Restoration Act. The decision was appealed to the U.S. Court of Appeals for the Fifth Circuit, which on June&nbsp;21, 2024, affirmed the District Court&#146;s ruling regarding preventive services recommended by United
States Preventive Services Task Force being unconstitutional. However, the Fifth Circuit overturned the nationwide injunction imposed by the District Court, preserving access to the majority of preventive services in dispute for now. The matter is
expected to be the subject of additional litigation, having been remanded in part to the District Court. The outcome and impacts of this litigation cannot be predicted. Any future efforts to challenge, replace or replace the Legislation or expand or
substantially amend its provision is unknown; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as part of the Consolidated Appropriations Act of 2021 (the &#147;CAA&#148;), Congress passed legislation aimed
at preventing or limiting patient balance billing in certain circumstances. The CAA addresses surprise medical bills stemming from emergency services, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT>
ancillary providers at </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-vi </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
<FONT STYLE="white-space:nowrap">in-network</FONT> facilities, and air ambulance carriers. The CAA prohibits surprise billing when
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> emergency services or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> services at an <FONT
STYLE="white-space:nowrap">in-network</FONT> facility are provided, unless informed consent is received. In these circumstances providers are prohibited from billing the patient for any amounts that exceed
<FONT STYLE="white-space:nowrap">in-network</FONT> cost-sharing requirements. HHS, the Department of Labor and the Department of the Treasury have issued rules to implement the legislation. The rules have limited the ability of our hospital-based
physicians to receive payments for services at usually higher <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> rates in certain circumstances, and, as a result, have caused us to increase subsidies to
these physicians or to replace their services at a higher cost level; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in June 2024, the U.S. Supreme Court issued its decision in <I>Loper Bright Enters. v. Raimondo</I> and
<I>Relentless, Inc. v. Department of Commerce</I>, which modified the regulatory interpretation standard established 40 years ago by <I>Chevron v. National Resources Defense Council</I>. <I>Chevron</I> doctrine generally required courts to defer to
federal agencies in their interpretation of federal statutes when a statute was silent or ambiguous with respect to a specific issue. In <I>Loper Bright</I>, the Supreme Court held that courts are no longer required to grant such deference, though
they may consider an agency&#146;s statutory interpretation. As it is highly regulated, the health care industry could be significantly impacted by the <I>Loper Bright</I> decision, particularly in the areas of Medicare reimbursement, decision
making by the Food&nbsp;&amp; Drug Administration and health care fraud and abuse compliance, where parties may no longer be able to rely on federal agencies&#146; policies, rules and guidance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">possible unfavorable changes in the levels and terms of reimbursement for our charges by third party payers or
government based payers, including Medicare or Medicaid in the United States, and government based payers in the United Kingdom; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to enter into managed care provider agreements on acceptable terms and the ability of our competitors
to do the same; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of known and unknown litigation, government investigations, inquiries, false claims act allegations,
and liabilities and other claims asserted against us and other matters, and the effects of adverse publicity relating to such matters, including, but not limited to, the March&nbsp;28, 2024, jury verdict (of compensatory damages of $60&nbsp;million
and punitive damages of $475 million) returned against The Pavilion Behavioral Health System (the &#147;Pavilion&#148;), one of our indirect subsidiaries, as disclosed in<I> Note 6 to the Condensed Consolidated Financial Statements&#151;Commitments
and Contingencies&#151;Legal Proceedings</I> in our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended June&nbsp;30, 2024<I>. </I>The Pavilion has filed post-trial motions, which were heard on August&nbsp;1,
2024 and August&nbsp;23, 2024. The Pavilion will pursue an appeal as appropriate depending on the court&#146;s resolution of post-trial motions. We are uncertain as to the ultimate financial exposure related to the Pavilion matter (which relates to
an occurrence in 2020) and we can make no assurances regarding timing or substance of its outcome, or the amount of damages that may be ultimately held recoverable after post-judgment proceedings and appeal. While the Pavilion has professional
liability insurance to cover a portion of these amounts, the resolution of this matter may have a material adverse effect on the Company. As of June&nbsp;30, 2024, without reduction for any potential amounts related to the above-mentioned Pavilion
matter, the Company and its subsidiaries have aggregate insurance coverage of approximately $221&nbsp;million remaining under commercial policies for matters applicable to the 2020 policy year (in excess of the applicable self-insured retention
amounts of $10&nbsp;million per occurrence for professional liability claims and $3&nbsp;million per occurrence for general liability claims). In the event the resolution of the Pavilion matter exhausts all or a significant portion of the remaining
commercial insurance coverage available to the Company and its subsidiaries related to other matters that occurred in 2020, or the Pavilion matter causes the posting of a large bond or other collateral during an appeal process, our future results of
operations and capital resources could be materially adversely impacted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competition from other healthcare providers (including physician owned facilities) in certain markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">technological and pharmaceutical improvements that increase the cost of providing, or reduce the demand for
healthcare; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-vii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain qualified personnel, nurses, physicians and other healthcare professionals and
the impact on our labor and related expenses resulting from a shortage of nurses, physicians and other healthcare professionals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">demographic changes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is a heightened risk of future cybersecurity threats, including ransomware attacks targeting healthcare
providers. If successful, future cyberattacks could have a material adverse effect on our business. Any costs that we incur as a result of a data security incident or breach, including costs to update our security protocols to mitigate such an
incident or breach could be significant. Any breach or failure in our operational security systems, or any third-party security systems that we rely on, can result in loss of data or an unauthorized disclosure of or access to sensitive or
confidential member or protected personal or health information and could result in violations of applicable privacy and other laws, significant penalties or fines, litigation, loss of customers, significant damage to our reputation and business,
and other liability or losses. We may also incur additional costs related to cybersecurity risk management and remediation. There can be no assurance that we or our service providers, if applicable, will not suffer losses relating to cyber-attacks
or other information security breaches in the future or that our insurance coverage will be adequate to cover all the costs resulting from such events; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of suitable acquisition and divestiture opportunities and our ability to successfully integrate
and improve our acquisitions since failure to achieve expected acquisition benefits from certain of our prior or future acquisitions could result in impairment charges for goodwill and purchased intangibles; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of severe weather conditions, including the effects of hurricanes and climate change;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our business, results of operations, financial condition, or stock price may be adversely affected if we are not
able to achieve our environmental, social and governance (&#147;ESG&#148;) goals or comply with emerging ESG regulations, or otherwise meet the expectations of our stakeholders with respect to ESG matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we receive revenues from various state and county-based programs, including Medicaid in all the states in which
we operate. We receive annual Medicaid revenues of approximately $100&nbsp;million, or greater, from each of Texas, Nevada, California, Illinois, Pennsylvania, Washington, D.C., Kentucky, Massachusetts, Mississippi, Virginia and Florida. We also
receive Medicaid disproportionate share hospital (DSH) payments in certain states including, most significantly, Texas. We are therefore particularly sensitive to potential reductions in Medicaid and other state-based revenue programs as well as
regulatory, economic, environmental and competitive changes in those states; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to continue to obtain capital on acceptable terms, including borrowed funds, to fund the future
growth of our business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inpatient acute care and behavioral health care facilities may experience decreasing admission and length of
stay trends; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial statements reflect large amounts due from various commercial and private payers and there can be no
assurance that failure of the payers to remit amounts due to us will not have a material adverse effect on our future results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Budget Control Act of 2011 (the &#147;2011 Act&#148;) imposed annual spending limits for most federal
agencies and programs aimed at reducing budget deficits by $917&nbsp;billion between 2012 and 2021, according to a report released by the Congressional Budget Office. Among its other provisions, the law established a bipartisan Congressional
committee, known as the Joint Select Committee on Deficit Reduction (the &#147;Joint Committee&#148;), which was tasked with making recommendations aimed at reducing future federal budget deficits by an additional $1.5 trillion over 10 years. The
Joint Committee was unable to reach an agreement by the November&nbsp;23, 2011 deadline and, as a result, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">across-the-board</FONT></FONT> cuts to discretionary, national defense and
Medicare spending were implemented on </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-viii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
March&nbsp;1, 2013 resulting in Medicare payment reductions of up to 2% per fiscal year with a uniform percentage reduction across all Medicare programs. Current legislation has extended these
reductions through 2032. We cannot predict whether Congress will restructure the implemented Medicare payment reductions or what other federal budget deficit reduction initiatives may be proposed by Congress going forward; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uninsured and <FONT STYLE="white-space:nowrap">self-pay</FONT> patients treated at our acute care facilities
unfavorably impact our ability to satisfactorily and timely collect our <FONT STYLE="white-space:nowrap">self-pay</FONT> patient accounts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in our business strategies or development plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have exposure to fluctuations in foreign currency exchange rates, primarily the pound sterling. We have
international subsidiaries that operate in the United Kingdom. We routinely hedge our exposures to foreign currencies with certain financial institutions in an effort to minimize the impact of certain currency exchange rate fluctuations, but these
hedges may be inadequate to protect us from currency exchange rate fluctuations. To the extent that these hedges are inadequate, our reported financial results or the way we conduct our business could be adversely affected. Furthermore, if a
financial counterparty to our hedges experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, we may experience material financial losses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of a shift of care from inpatient to lower cost outpatient settings and controls designed to reduce
inpatient services on our revenue; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other factors referenced herein or in our other filings with the Securities and Exchange Commission.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given these uncertainties, risks and assumptions, as outlined above, you are cautioned not to place undue reliance on such
forward-looking statements. Our actual results and financial condition could differ materially from those expressed in, or implied by, the forward-looking statements. Forward-looking statements speak only as of the date the statements are made. We
assume no obligation to publicly update any forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except as may be required by law. All forward-looking
statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Non-GAAP</FONT> financial measures </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We refer to the terms EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net
income attributable to UHS (as further described in &#147;Summary&#151;Summary historical and financial data&#148;) in various places in this prospectus supplement. These are supplemental financial measures that are not prepared in accordance with
generally accepted accounting principles in the United States (&#147;GAAP&#148;). Any analysis of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures should be used only in conjunction with results presented in accordance with GAAP.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our measurements of EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net income attributable to UHS may not be comparable to those of other
companies. Please see &#147;Summary&#151;Summary historical and financial data&#148; for a reconciliation of these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures to the most closely comparable financial measures calculated in
accordance with GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net income attributable to UHS are helpful to our
investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect of
certain items impacting our net income attributable to UHS, such as changes in the market value of shares of certain equity securities, the impact of ASU <FONT STYLE="white-space:nowrap">2016-09</FONT> (as defined herein) and other items that we
believe are <FONT STYLE="white-space:nowrap">non-operational</FONT> in nature, including, but not limited to, impairments of goodwill, long-lived and intangible assets, costs related to extinguishment of debt, gains/losses on sales of assets and
businesses, potential impacts of <FONT STYLE="white-space:nowrap">non-ordinary</FONT> acquisitions, divestitures, joint ventures or other strategic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ix </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transactions, and certain other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a more complete understanding of our
financial performance, these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the consolidated financial statements and notes thereto in our filings with the
SEC including our Annual Report on Form 10-K for the year ended December 31, 2023 and our Quarterly Reports on Forms <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;31, 2024 and for the quarter ended June&nbsp;30, 2024,
which are incorporated by reference herein. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be
alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to
other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-x </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_4"></A>Summary </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary highlights the information contained elsewhere in this prospectus supplement and the accompanying prospectus. Because this is only a summary,
it does not contain all the information that may be important to you. For a more complete understanding of this offering, we encourage you to read this entire prospectus supplement and the accompanying prospectus, and the documents incorporated by
reference herein and therein, including the sections entitled &#147;Risk factors&#148; beginning on page S-14 of this prospectus supplement and beginning on page 14 of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the
fiscal year ended December&nbsp;31, 2023, and risks we disclose in future filings with the SEC. You should read the following summary together with the more detailed information and consolidated financial statements and the notes to those statements
included or incorporated by reference elsewhere in this prospectus supplement. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our principal business is owning and operating, through our subsidiaries, acute care hospitals and outpatient facilities and behavioral health care facilities.
As of June&nbsp;30, 2024, we owned and/or operated 359 inpatient facilities and 48 outpatient and other facilities, including the following, located in 39 states, Washington, D.C., the United Kingdom and Puerto Rico: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">27 inpatient acute care hospitals, 27 free-standing emergency departments, 10 outpatient centers, one surgical
hospital, 185 inpatient behavioral health care facilities and 8 outpatient behavioral health care facilities located in the United States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">144 inpatient behavioral health care facilities and 2 outpatient behavioral health care facilities located in the
United Kingdom; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3 inpatient behavioral health care facilities located in Puerto Rico. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net revenues from our acute care hospitals, outpatient facilities and commercial health insurer accounted for 57% of our consolidated net revenues during each
of 2023 and 2022. Net revenues from our behavioral health care facilities and commercial health insurer accounted for 43% of our consolidated net revenues during each of 2023 and 2022. Our behavioral health care facilities located in the U.K.
generated net revenues of approximately $761&nbsp;million in 2023 and $685&nbsp;million in 2022. Total assets at our U.K. behavioral health care facilities were approximately $1.327&nbsp;billion as of December&nbsp;31, 2023 and $1.235&nbsp;billion
as of December&nbsp;31, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net revenues from our acute care hospitals, outpatient facilities and commercial health insurer accounted for 56% of our
consolidated net revenues during the six months ended June&nbsp;30, 2024, and 57% during the six months ended June&nbsp;30, 2023. Net revenues from our behavioral health care facilities and commercial health insurer accounted for 44% of our
consolidated net revenues during the six months ended June&nbsp;30, 2024, and 43% during the six months ended June&nbsp;30, 2023. Our behavioral health care facilities located in the U.K. generated net revenues of approximately $421&nbsp;million and
$358&nbsp;million during the six months ended June&nbsp;30, 2024 and 2023, respectively. Total assets at our U.K. behavioral health care facilities were approximately $1.36&nbsp;billion as of June&nbsp;30, 2024 and $1.327&nbsp;billion as of
December&nbsp;31, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Services provided by our hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care,
radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. We provide capital resources as well as a variety of management services to our facilities, including central purchasing,
information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2023, we served approximately 3.6&nbsp;million patients at our hospitals and outpatient facilities including approximately 7.9&nbsp;million patient days at
our inpatient hospitals. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our strengths </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Significant scale and geographic coverage</I>. We operate in 39 states, Washington, D.C., the United Kingdom and Puerto Rico. We believe our scale and
geographic reach allow us to operate more efficiently and provide higher quality care than our competitors and enhance our presence within our markets. We believe that scale also provides us a greater array of alternatives to manage our business.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Diversified payor mix and revenue base. </I>For the six months ended June&nbsp;30, 2024, we earned 24% of our behavioral health revenue from managed
care, 25% from managed Medicaid, 16% from Medicaid, 5% from Medicare, 6% from managed Medicare and 24% from other payors, including 12% earned in the United Kingdom. In our acute care business, we earned 32% of our revenue from managed care, 16%
from Medicare, 17% from managed Medicare, 11% from Medicaid, 7% from managed Medicaid and 17% from other payors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">That we earn Medicaid revenues in each
of the states in which we operate in the U.S., as well as Washington, D.C., helps to mitigate the effect of any changes in reimbursement policies in any one state. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Leading provider of behavioral healthcare services</I>. We are a national healthcare provider in the United States in a highly fragmented industry,
primarily competing against regional and local competitors. We believe being a national provider enables the development of important relationships and extensive referral networks within our markets and allows us to attract and retain qualified
behavioral healthcare professionals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Strong and sustainable acute care market position</I>. Our acute care segment is well positioned to benefit from
positive trends in the acute care industry, as the vast majority of our acute care hospitals are ranked first or second in terms of their market share in their respective markets. We believe the relationships and reputation we have established will
further enhance our presence in these markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Experienced management team</I>. Our senior management team has extensive experience in the healthcare
industry. Our senior management team has been with us for an average of more than 20 years. Our senior management team operates as a cohesive, complementary group and has extensive operating knowledge of the industry and understanding of the
regulatory environment in which it operates. Our senior managers have a successful track record in both operating our core business and integrating acquired assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Strong cash flow generation</I>. We have historically generated consistent free cash flow by profitably operating our business, actively managing working
capital and judiciously investing in capital expenditures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe community-based hospitals will remain the focal point of the healthcare delivery network, and we are committed to a philosophy of self-determination
for both our company and our hospitals. We plan to continue to grow our business and improve our financial performance by implementing our business strategy, the key elements of which are the following. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Leverage our diversified portfolio of market-leading facilities</I>. We own and operate a diversified portfolio of acute care hospitals and behavioral
health centers. Our acute care and behavioral health divisions each account for approximately half of our net revenues and enjoy market-leading positions. Our acute care units are concentrated in markets that are growing more rapidly than the
overall average growth rate in the United States. Our behavioral health division is among the largest in the nation in total hospitals, total beds and net patient revenue. Our leadership positions in our acute care and behavioral health businesses
help us with managed care contracting and help us to recruit key physicians, create opportunities for integrated support services, increase operating predictability and stability, increase cost effectiveness and enhance growth opportunities. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Focus on the quality and efficiency of our services</I>. Pressures to contain healthcare costs and
technological developments allowing more procedures to be performed on an outpatient basis have led payers to demand a shift to ambulatory or outpatient care wherever possible. We are responding to this trend by emphasizing the expansion of
outpatient services. In addition, in response to cost containment pressures, we continue to implement programs at our facilities designed to improve financial performance and efficiency while continuing to provide quality care, including more
efficient use of professional and paraprofessional staff, monitoring and adjusting staffing levels and equipment usage, improving patient management and reporting procedures and implementing more efficient billing and collection procedures. In
addition, we will continue to emphasize innovation in our response to the rapid changes in regulatory trends and market conditions while fulfilling our commitment to patients, physicians, employees, communities and other stakeholders. In addition,
our aggressive recruiting of highly qualified physicians and developing provider networks help to establish our facilities as an important source of quality healthcare in their respective communities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Improvement of operations of existing hospitals and services.</I> We also seek to increase the operating revenues and profitability of owned hospitals by
the introduction of new services, improvement of existing services, physician recruitment and the application of financial and operational controls. We are involved in continual development activities for the benefit of our existing facilities. From
time to time applications are filed with state health planning agencies to add new services in existing hospitals in states which require certificates of need (&#147;CONs&#148;). Although we expect that some of these applications will result in the
addition of new facilities or services to our operations, no assurances can be made for ultimate success by us in these efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Growth through
selective acquisition of additional hospital facilities</I>. We selectively seek opportunities to expand our base of operations by acquiring, constructing or leasing additional hospital facilities. We are committed to a program of rational growth
around our core businesses, while retaining the missions of the hospitals we manage and the communities we serve. Such expansion may provide us with access to new markets and new healthcare delivery capabilities. We also routinely examine our
facilities and consider divestiture of those facilities that we believe do not have the potential to contribute to our growth or operating strategy. In recent years our behavioral health services segment has been focused on efforts to partner with <FONT
STYLE="white-space:nowrap">non-UHS</FONT> acute care hospitals to help operate their behavioral health services. These arrangements include hospital purchases, leased beds and joint venture operating agreements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our industry </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe well-capitalized, comprehensive
and integrated health care delivery providers are well-positioned to benefit from the current industry trends, some of which include: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Aging population
and continued growth in the need for health care services</I>. According to the U.S. Census Bureau, the demographic age group of persons aged 65 and over is expected to significantly increase in size in the coming decades, from 58&nbsp;million in
2022 to 82&nbsp;million in 2050. As a result, the share of people aged 65 and over is expected to grow from approximately 17% to 23% of the population in 2050. CMS projects continued increases in hospital services based on the aging of the U.S.
population, advances in medical procedures, expansion of health coverage, increasing consumer demand for expanded medical services and increased prevalence of chronic conditions such as diabetes, heart disease and obesity. We believe these factors
will continue to drive increased utilization of health care services and the need for comprehensive, integrated hospital networks that can provide a wide array of essential and sophisticated health care. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Continued evolution of value-based reimbursement favors large-scale, comprehensive and integrated providers</I>. We believe the U.S. health care system is
continuing to evolve in ways that favor large-scale, comprehensive and integrated providers that provide high levels of quality care. Specifically, we believe there are a number of initiatives that will continue to gain importance in the foreseeable
future, including introduction of value-based payment methodologies tied to performance, quality and coordination of care, implementation of integrated </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
electronic health records and information, and an increasing ability for patients and consumers to make choices about all aspects of health care. We believe that we are well positioned to respond
to these emerging trends and have the resources, expertise and flexibility necessary to adapt in a timely manner to the changing health care regulatory and reimbursement environment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Acute care industry </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">According to CMS, health care
spending is expected to grow at an average rate of approximately 5.5% per year between 2022 and 2031 and to reach approximately $7.3 trillion by 2031. Over this time period, average annual health spending growth is projected to exceed average annual
gross domestic product (&#147;GDP&#148;) growth by 0.7% per year. By 2031, national health expenditures are expected to represent approximately 19.4% of the U.S. GDP. Hospital spending is expected to grow from approximately $1.3 trillion in 2022 to
approximately $2.2&nbsp;trillion in 2031. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The U.S. hospital industry includes acute care, rehabilitation and psychiatric facilities that are either
public (government owned and operated), <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> private (religious or secular) or <FONT STYLE="white-space:nowrap">for-profit</FONT> institutions (investor
owned). The American Hospital Association (&#147;AHA&#148;) estimates that there are approximately 6,100 hospitals in the United States. The AHA estimates, based upon its 2022 survey, that there are approximately 1,200 investor-owned community
hospitals (approximately 25% of all community hospitals). <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Not-for-profit</FONT></FONT> (approximately 3,000) or governmental entities (approximately 1,000) own the majority of the
remaining hospitals. These facilities offer a broad range of services, including internal medicine, general surgery, cardiology, oncology, orthopedics, OB/GYN, and emergency services. In addition, hospitals also offer other ancillary services
including psychiatric, diagnostic, rehabilitation, home care and outpatient surgery services. Over time, many services have shifted to the outpatient setting, and average length of community hospital stay declined from approximately 7.2 days in 1990
to approximately 5.4 days in 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The many factors that can influence a hospital&#146;s financial and operating performance include its size and
location, ownership structure (i.e., <FONT STYLE="white-space:nowrap">tax-exempt</FONT> or investor-owned), ability to participate in group purchasing organizations, service mix, number and location of competitors, and payor mix. According to CMS,
as of 2022, private insurance is the industry&#146;s largest payor at 30% of national health expenditures, followed by the Medicare program at 22% and Medicaid at 19%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acute care industry is characterized by a number of favorable industry dynamics that we believe will continue to sustain and increase demand.
Historically, the hospital sector has shown resilience during periods of economic recession. According to the U.S. Census Bureau, the number of Americans aged 65 and older is expected to significantly increase from 58&nbsp;million in 2022 to
82&nbsp;million by 2050. As the U.S. population continues to age, there is a growing prevalence of chronic diseases that lead to increased hospital utilization. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Behavioral health industry </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Overview </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">According to the National Institute of Mental Health, nearly one in five U.S. adults (approximately 57.8&nbsp;million in 2021), live with a mental illness,
representing 22.8% all U.S. adults. In 2021, among the 57.8&nbsp;million adults with any mental illness, 24.5&nbsp;million (47.2%) received mental health services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The behavioral healthcare industry is characterized by favorable supply and demand dynamics resulting from capacity contraction during the 1990s, which caused
increased occupancy rates. The reduction was largely driven by third-party payors who decreased reimbursement, implemented more stringent admission criteria and decreased the authorized length of stay. This reduced capacity is believed to have
resulted in an increase in the underserved patient population. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Types of behavioral facilities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acute inpatient psychiatric hospitals provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. The
acute setting provides <FONT STYLE="white-space:nowrap">24-hour</FONT> observation, daily intervention and monitoring by psychiatrists. Generally, due to the high patient turnover and the special security and health precautions required, acute
psychiatric hospitals have lower average occupancy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Residential treatment centers treat psychiatric patients in a
<FONT STYLE="white-space:nowrap">non-hospital</FONT> setting and focus primarily on children and adolescents. The facilities balance therapy activities with social, academic and other activities. Since the setting is less intensive, demands on
staffing, security, and oversight are generally lower than acute psychiatric hospitals. In contrast to acute care psychiatric facilities, however, occupancy can be managed more easily given a longer length of stay. Still, over time residential
treatment centers have continued to serve increasingly acute patients who would have been institutionalized in earlier years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our addiction treatment
centers treat patients struggling with substance use and mental health issues such as trauma, depression and anxiety. The specific treatment is an evidence-based approach that has been nationally recognized. The treatment approach will depend on the
individual needs of the patient and many treatment programs include both individual and group therapies as well as partial hospital and outpatient services. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Mental health parity </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Mental Health Parity and
Addiction Equity Act of 2008 (&#147;MHPAEA&#148;) requires that if a group health plan offers coverage for mental health or substance use disorder benefits, the financial requirements and treatment limitations for those benefits can be no more
restrictive than the predominant requirements and limitations applied to substantially all medical/surgical benefits. This applies to private and public sector employers with more than 50 employees, including self-insured and fully insured plans.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The MHPAEA aims to ensure that when coverage for mental health and substance use conditions is provided, it is generally comparable to coverage for
medical and surgical care. The Legislation extended parity protections by requiring coverage of mental health and substance use disorder benefits for millions of Americans in the individual and small group health insurance markets who lacked these
benefits and by expanding parity requirements to apply to millions of Americans whose coverage did not previously comply with those requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition, the Children&#146;s Health Insurance Program Reauthorization Act of 2009 requires that Children&#146;s Health Insurance Program (&#147;CHIP&#148;) plans that provide both medical and surgical benefits and mental health/ substance abuse
disorder benefits comply with the parity provisions of MHPAEA, in the same manner as a group health plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;30, 2016, CMS published a final
rule applying certain provisions of the MHPAEA to requirements for Medicaid managed care organizations, Medicaid alternative benefit plans and CHIP. The final rule requires that all beneficiaries who receive services through managed care
organizations, alternative benefit plans or CHIP be provided access to mental health and substance use disorder benefits that comply with parity standards, regardless of whether these services are provided through the managed care organization or
another service delivery system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mental health parity has remained a focus of Congress. Section&nbsp;13001 of the 21st Century Cures Act required the
Departments of Labor, Health and Human Services, and Treasury to develop compliance program guidance regarding mental health parity requirements that is updated every two years. It also included a requirement for audits of a group health plan or
issuer of group or individual health insurance coverage that has violated </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
MHPAEA five times to be subject to an audit of their plan documents in the following year to ensure compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Biden administration recently finalized new requirements for health plans to strengthen mental health parity laws by amending existing standards to
prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from using nonquantitative treatment limitation (NQTL) comparative analyses that place greater restrictions on access to mental health
and substance use disorder benefits as compared to medical/surgical benefits. Payers and employer-sponsored plans have been required to cover mental health and substance use benefits the same as they would for medical benefits under the Mental
Health Parity and Addiction Equity Act of 2008. Though the law was further strengthened in 2020, mental healthcare access is still fragmented and difficult to access nationwide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;9, 2024, the U.S. Departments of Health and Human Services, Labor, and the Treasury published a final rule that will, among other measures,
require plans to analyze the outcomes of their mental health coverage policies, including network size, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> payment policies and prior authorization
requirements. The new rule clarifies that plans cannot have more restrictive prior authorization standards or narrower networks for mental health and substance use benefits. The final rule will prohibit plans from using discriminatory information,
evidence, sources, or standards that systematically disfavor or are specifically designed to disfavor access to mental health and substance use benefits as compared to medical/surgical benefits when designing NQTLs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The final rule also finalized amendments to reflect the sunset of an election option that excluded self-funded
<FONT STYLE="white-space:nowrap">non-federal</FONT> government health plans from compliance with mental health and substance use parity standards. Parts of the final rule go into effect in 2025, and others in 2026. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this offering of the
notes, UHS intends to amend and restate the senior secured credit facility outstanding under its credit agreement to provide for a $1.3 billion amended revolving credit facility and a new $1.2&nbsp;billion replacement tranche A term loan facility,
concurrently with the closing of the offering of the notes. We plan to use the net proceeds of this offering and the new tranche A term loan facility to repay amounts outstanding under our current tranche A term loan facility, which were $2.2
billion as of June 30, 2024. We refer to (i)&nbsp;the entry into the amended revolving credit facility and the new replacement tranche A term loan facility pursuant to the amendment and restatement of our existing credit agreement, (ii)&nbsp;the
offering of the notes and (iii)&nbsp;the use of proceeds from the foregoing, collectively, as the &#147;Transactions.&#148; See &#147;Description of other indebtedness&#151;Credit agreement&#148; for more information about our senior secured credit
facility. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Universal Health
Services, Inc. is a Delaware corporation. Our principal executive offices are located at Universal Corporate Center, 367 South Gulph Road, P.O. Box 61558, King of Prussia, PA 19406. Our telephone number is (610)
<FONT STYLE="white-space:nowrap">768-3300.</FONT> Our website is located at www.uhs.com. Our website and the information contained on our website are not part of this prospectus supplement. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_5"></A>The offering </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summary contains basic information about the notes and is not intended to be complete. For a more complete understanding of the notes, the
guarantees and the collateral, please refer to the section entitled &#147;Description of the notes&#148; in this prospectus supplement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Issuer </P></TD>
<TD>Universal Health Services, Inc. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Securities offered </P></TD>
<TD>$500,000,000 aggregate principal amount of 4.625% Senior Secured Notes due 2029. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">$500,000,000 aggregate principal amount of 5.050% Senior Secured Notes due 2034. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Maturity date </P></TD>
<TD>The 2029 notes will mature on October 15, 2029. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The 2034 notes will mature on October 15, 2034. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Interest rate </P></TD>
<TD>Interest on the 2029 notes will be payable in cash and will accrue at a rate of 4.625% per annum. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Interest on the 2034 notes will be payable in cash and will accrue at a rate of 5.050% per annum. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Interest payment dates </P></TD>
<TD>The interest payment dates for the 2029 notes will be April 15 and October 15, commencing April 15, 2025, and for the 2034 notes will be April 15 and October 15, commencing April 15, 2025. Interest will accrue from September 26, 2024 for each
series of the notes. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Optional redemption </P></TD>
<TD>We may redeem some or all of the 2029 notes at any time prior to September 15, 2029, and some or all of the 2034 notes at any time prior to July 15, 2034, in each case at a price equal to 100% of the principal amount thereof, plus accrued and
unpaid interest, plus a &#147;make whole&#148; premium. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Change of control offer following a downgrade from investment grade ratings </P></TD>
<TD>Upon the occurrence of certain kinds of changes of control, if the notes have ceased to have investment grade ratings (including as a result of entering into an agreement that would result in such a change of control), holders of the notes of
each series will have the right to cause us to repurchase the notes of such series at 101% of the principal amount thereof, plus accrued and unpaid interest and additional interest, if any, to, but excluding, the repurchase date. See
&#147;&#151;Repurchase at the option of holders&#151;Change of control following a downgrade from investment grade ratings&#148; in the &#147;Description of the notes.&#148; Because the notes are expected to have investment grade ratings from both
Moody&#146;s Investors Service (&#147;Moody&#146;s&#148;) and Standard&nbsp;&amp; Poor&#146;s Ratings Services (&#147;S&amp;P&#148;) as of the issue date of the notes, this covenant will initially be suspended. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Note guarantees </P></TD>
<TD> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The notes will be guaranteed on a senior secured basis by all of our existing and future direct and indirect subsidiaries that guarantee our senior
secured credit facility or our other first lien obligations or any junior lien obligations. Under certain circumstances, the subsidiary guarantors may be released from their note guarantees without the
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0%; font-size:10pt; font-family:Times New Roman">
consent of the holders of the notes, including if the notes then have investment grade ratings, no default has occurred and is continuing, the guarantees of other first lien and any junior lien
obligations have been released and liens on the collateral securing all first lien obligations and any junior lien obligations have been released. Any note guarantee will also be released if that subsidiary guarantor&#146;s guarantees of the senior
credit facility, other first lien obligations and any junior lien obligations are released. See &#147;&#151;Guarantees&#148; and &#147;&#151;Release of collateral and guarantees upon investment grade rating event&#148; in the &#147;Description of
the notes.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">For the year ended December&nbsp;31, 2023, our subsidiaries in the United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries, represented approximately 5% of our net revenues, and
together with our remaining <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries represented less than 20% of our net revenues. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of June&nbsp;30, 2024, subsidiaries in the United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries, represented approximately 10% of our total assets excluding intercompany
assets, and together with our remaining <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries represented approximately 20% of our total assets excluding intercompany assets. As of June&nbsp;30, 2024, our
<FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries had less than $28&nbsp;million of long-term debt. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Collateral </P></TD>
<TD> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The notes and the note guarantees will be secured by first-priority liens, subject to permitted liens, on certain of our assets and certain assets of
those guarantors that have pledged those assets to secure certain of our other indebtedness or indebtedness of those subsidiary guarantors (the &#147;secured guarantors&#148;) now owned or acquired in the future by us and our secured guarantors
(other than our real property and certain other excluded assets). Our obligations with respect to the notes, the obligations of the subsidiary guarantors under the note guarantees and the performance of all our and our subsidiary guarantors&#146;
other obligations under the indenture will be secured equally and ratably with our and our secured guarantors&#146; obligations under our senior secured credit facility, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes by
a perfected first-priority security interest, subject to permitted liens, in the collateral owned by us and our secured guarantors, whether now owned or hereafter acquired. However, the liens on the collateral securing the notes and the note
guarantees of the secured guarantors will be released if (i)(x) the notes then have investment grade ratings, (y)&nbsp;no default has occurred and is continuing and (z)&nbsp;the liens on the collateral securing all first lien obligations (including
the senior secured credit facility, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes) and any&nbsp;junior lien obligations have been released or (ii)&nbsp;the collateral under the senior secured credit facility, any other
first lien obligations and any junior lien obligations has been released or no longer required to be pledged. As of the issue date of the notes, we expect the notes to have investment grade ratings from both Moody&#146;s and S&amp;P. However, as of
the issue date of </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0%; font-size:10pt; font-family:Times New Roman">
the notes, the condition in clause (i)(z) of the preceding sentence has not been met because the conditions to the release of the collateral under the senior secured credit facility have not been
met. See &#147;&#151;Release of collateral and guarantees upon investment grade rating event&#148; in the &#147;Description of the notes.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The notes and the note guarantees will not be secured by the assets of <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries. For a more detailed discussion, see &#147;&#151;Security generally&#148; in the
&#147;Description of the notes.&#148; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of the issue date of the notes, all of the guarantors will be secured guarantors. In the future, we may elect, in our discretion, to provide unsecured guarantees of the notes from certain other restricted
subsidiaries, and any such unsecured guarantors would also guarantee our senior secured credit facility and the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes. For a more detailed discussion, see &#147;&#151;Certain
covenants&#151;Additional subsidiary guarantees&#148; in the &#147;Description of the notes.&#148; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">No appraisal of the value of the collateral has been made in connection with this offering, and the value of the collateral in the event of liquidation may be materially different from the book value. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Some of our assets are excluded from the collateral, as described in &#147;&#151;Certain limitations on the collateral&#148; in the &#147;Description of the notes.&#148; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Ranking </P></TD>
<TD>The notes and the note guarantees will be our and the secured guarantors&#146; senior secured obligations and will: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rank senior in right of payment to any of our and the subsidiary guarantors&#146; future subordinated
indebtedness; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rank equally in right of payment with all of our and the subsidiary guarantors&#146; existing and future senior
indebtedness; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rank equally in right of payment with all existing and future indebtedness that shares in the first-priority
liens that secure the notes, including our obligations under our senior secured credit facility, the Existing 2026 Notes, the Existing 2030 Notes and Existing 2032 Notes to the extent of the value of the collateral; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rank effectively senior to our and the subsidiary guarantors&#146; existing and future unsecured indebtedness to
the extent of the value of the collateral; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be effectively subordinated to any of our and the subsidiary guarantors&#146; existing and future indebtedness
that is secured by assets that do not constitute collateral to the extent of the value of such assets; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be structurally subordinated to obligations of our <FONT STYLE="white-space:nowrap">non-guarantor</FONT>
subsidiaries. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we elect to add unsecured guarantors in the future, the note guarantees of such guarantors will be senior unsecured
obligations of </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:38%; font-size:10pt; font-family:Times New Roman">
the unsecured guarantors, rank senior in right of payment to any of the unsecured guarantors&#146; future subordinated indebtedness, rank equally in right of payment with the unsecured
guarantors&#146; existing and future senior indebtedness and rank effectively junior to all existing and future senior secured debt of the unsecured guarantors to the extent of the value of any assets securing such senior debt. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of June 30, 2024, our <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries had less than $28&nbsp;million of total long-term debt which would have been structurally senior to the notes.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Covenants </P></TD>
<TD>We will issue the notes under an indenture with U.S. Bank Trust Company, National Association, as trustee, and JPMorgan Chase Bank, N.A., as collateral agent, as supplemented (the &#147;Indenture&#148;). </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Indenture, among other things, limits our ability and the ability of our subsidiaries to: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consolidate, merge, sell or otherwise dispose of all or substantially all of its assets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">create mortgages on certain of our principal properties to secure debt; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engage in certain sale and lease-back transactions. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We intend to use the net proceeds of this offering and the new tranche A term loan facility to repay amounts outstanding under our current tranche A term loan facility. See &#147;Use of proceeds.&#148; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>In evaluating an investment in the notes, prospective investors should carefully consider, along with the other information in this prospectus supplement, the specific factors set forth under &#147;Risk factors&#148; in this prospectus
supplement and found in the documents incorporated herein by reference, as well as the other cautionary statements throughout this prospectus supplement, for risks involved with an investment in the notes. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_6"></A>Summary historical and financial data </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summary historical financial data of UHS as of June&nbsp;30, 2024 and for the six months ended June&nbsp;30, 2024 and 2023 and as of and for the
years ended December&nbsp;31, 2023, 2022 and 2021 has been derived from our consolidated financial statements filed with the SEC, including our unaudited consolidated financial statements as of June&nbsp;30, 2024 and for the six months ended
June&nbsp;30, 2024 and 2023 and our audited consolidated financial statements as of December&nbsp;31, 2023 and 2022 and for the three years ended December&nbsp;31, 2023, 2022 and 2021 incorporated by reference in this prospectus supplement. The
balance sheet data for the six months ended June&nbsp;30, 2024 is derived from our balance sheet as of June&nbsp;30, 2024, which is not incorporated by reference in this prospectus supplement. Our unaudited historical consolidated financial
statements have been prepared in accordance with GAAP for interim financial information and, in our opinion, consist only of normal and recurring adjustments necessary for a fair statement of the information set forth therein. Our historical results
are not necessarily indicative of our future results, and our results for any interim period are not necessarily indicative of our results that may be expected for a full year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The summary financial information should be read in conjunction with the historical financial statements and the accompanying notes of UHS, which are
incorporated by reference in this prospectus supplement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six months ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(Dollars in thousands, except ratios)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,751,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,015,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,281,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,399,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,642,117</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating charges:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries, wages and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,698,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,523,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,107,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,762,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,163,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,075,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,817,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,757,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,445,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,035,869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplies expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">791,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">760,283</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,532,828</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,474,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,427,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">288,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">285,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">568,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">581,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">533,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease and rental expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,926,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,456,828</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,106,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,395,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,279,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">825,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">558,828</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,175,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,003,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,363,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">206,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income) expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,891</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">718,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">438,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">940,426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">866,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,293,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">221,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">209,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">305,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">560,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">331,677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">719,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">656,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">987,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net income attributable to noncontrolling interests (&#147;NCI&#148;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,751</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(18,627</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,958</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to UHS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,986</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">334,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">717,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">675,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">991,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance sheet data (as of period end):</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">128,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">119,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,071,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,732,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,967,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,494,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,093,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,544,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,716,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,912,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,807,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,190,288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net debt(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,415,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,636,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,793,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,705,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,074,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UHS common stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,485,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,087,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,149,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,920,582</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,089,664</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six months ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(Dollars in thousands, except ratios)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flow data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,075,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">653,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,267,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">996,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">883,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(437,479</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(348,009</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(763,275</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(647,296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(914,466</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(628,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(329,599</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(493,945</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(318,400</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,068,950</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other financial data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital expenditures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">449,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">336,664</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">743,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">734,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">855,659</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EBITDA net of NCI(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,099,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">826,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,713,629</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,593,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,914,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA net of NCI(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,104,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">846,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,741,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,661,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,900,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted net income attributable to UHS(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">545,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">346,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">739,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">730,244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">991,677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leverage ratio(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.29x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.83x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.87x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.02x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.19x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leverage ratio Adjusted EBITDA net of NCI(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.27x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.70x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.82x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.89x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.21x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest coverage ratio(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.52x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.30x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.29x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.56x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.88x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest coverage ratio Adjusted EBITDA net of NCI(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.58x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.74x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.43x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.09x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.71x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Net debt is defined as total debt less cash and cash equivalents. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">EBITDA net of NCI (NCI is net income attributable to noncontrolling interests) represents net income
attributable to UHS before depreciation and amortization, interest expense and provision for income taxes. Adjusted EBITDA net of NCI excludes the impact of other (income) expense, net and the effect certain other items that we believe are <FONT
STYLE="white-space:nowrap">non-operational</FONT> in nature impacting our net income attributable to UHS. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Adjusted net
income attributable to UHS represents net income attributable to UHS, as adjusted to exclude the impact of the items set forth in the reconciliation table below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net income attributable to UHS are not measurements of operating performance
computed in accordance with GAAP and should not be considered as substitutes for operating income, net income or cash flows from operating activities computed in accordance with GAAP. EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net
income attributable to UHS have limitations as analytical tools. Some of the limitations are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net income attributable to UHS do not reflect our cash
expenditures, or future requirements for capital expenditures or contractual commitments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net income attributable to UHS do not reflect changes
in, or cash requirements for, our working capital needs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">EBITDA net of NCI and Adjusted EBITDA net of NCI do not reflect the significant interest expense or the cash
requirements necessary to service interest or principal payments on our debt, while Adjusted net income does not reflect the cash requirements necessary to service principal payments on our debt; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">although depreciation and amortization are <FONT STYLE="white-space:nowrap">non-cash</FONT> charges, the assets
being depreciated and amortized will often have to be replaced in the future, and EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net income attributable to UHS do not reflect any cash requirements for such replacements; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other companies in our industry may calculate EBITDA net of NCI, Adjusted EBITDA net of NCI and Adjusted net
income differently than we do, limiting their usefulness as comparative measures. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reconciliations of net income attributable to UHS to EBITDA net of NCI and Adjusted EBITDA net of NCI, and
of net income attributable to UHS to Adjusted net income attributable to UHS, are provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six months ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(Dollars in thousands, except<BR>ratios)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Reconciliation of net income attributable to UHS to EBITDA, net of NCI</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to UHS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,986</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">334,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">717,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">675,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">991,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">288,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">285,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">568,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">581,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">533,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">206,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">221,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">209,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">305,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EBITDA net of NCI</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,099,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">826,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,713,629</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,593,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,914,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income) expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,891</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for asset impairment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA net of NCI</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,104,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">846,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,741,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,661,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,900,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Reconciliation of net income attributable to UHS to Adjusted net income attributable to
UHS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to UHS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,986</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">334,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">717,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">675,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">991,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Plus/minus <FONT STYLE="white-space:nowrap">after-tax</FONT> adjustments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss (gain) on marketable securities held for sale (a)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(10,374</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impact of ASU <FONT STYLE="white-space:nowrap">2016-09</FONT> (b)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,612</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for asset impairment&nbsp;(c)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt extinguishment costs&nbsp;(d)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,884</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subtotal adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,299</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted net income attributable to UHS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">545,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">346,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">739,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">730,244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">991,677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents a decrease (increase) in the market value of shares of certain marketable securities held for
investment and classified as available for sale. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the impact of ASU <FONT STYLE="white-space:nowrap">2019-09,</FONT> &#147;Compensation &#150; Stock
Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&#148; (&#147;ASU <FONT STYLE="white-space:nowrap">2016-09&#148;).</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents an impairment charge to reduce the carrying value of real property assets of a certain facility. See
&#147;Item 7. Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Other Operating Results&#151;Provision for Asset Impairment&#148; in our Annual Report on Form 10-K for the year ended December&nbsp;31,
2023, which is incorporated by reference herein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents costs related to early extinguishment of debt in connection with financing transactions completed
during 2021. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our leverage ratio and leverage ratio Adjusted EBITDA net of NCI are calculated as the ratio of our total debt
as of the end of the period to our EBITDA net of NCI and Adjusted EBITDA net of NCI, respectively, for the period of four quarters ended as of the end of the period presented. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our interest coverage ratio and interest coverage ratio Adjusted EBITDA net of NCI are calculated as the ratio
of our EBITDA net of NCI and Adjusted EBITDA net of NCI to interest expense, net, respectively, for the period of four quarters ended as of the end of the period presented. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_7"></A>Risk factors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Any investment in the notes involves a high degree of risk. You should carefully consider the risks described below and all of the information contained or
incorporated by reference in this prospectus supplement and the accompanying prospectus before deciding whether to purchase the notes, including the &#147;Risk Factors&#148; section of our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 and our other subsequent filings under the Securities Exchange Act of 1934, as amended, which are incorporated by reference herein. The risks and uncertainties
described below and in the incorporated documents&nbsp;are not the only risks and uncertainties that we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations.
If any of those risks actually occurs, our business, financial condition and results of operations would suffer. The risks discussed below also include forward-looking statements, and our actual results may differ substantially from those discussed
in these forward-looking statements. See &#147;Cautionary statement regarding forward-looking statements&#148; in this prospectus supplement. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks related to the notes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to
generate sufficient cash to service all of our indebtedness, including the notes, and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to make scheduled payments on or refinance our debt obligations, including the notes, depends on our financial condition and operating performance,
which are subject to prevailing economic and competitive conditions and to certain financial, business, legislative, regulatory and other factors beyond our control. We may be unable to maintain a level of cash flows from operating activities
sufficient to permit us to pay the principal, premium, if any, and interest on our indebtedness, including the notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our cash flows and capital
resources are insufficient to fund our debt service obligations, we could face substantial liquidity problems and could be forced to reduce or delay investments and capital expenditures or to dispose of material assets or operations, seek additional
debt or equity capital or restructure or refinance our indebtedness, including the notes. We may not be able to effect any such alternative measures, if necessary, on commercially reasonable terms or at all and, even if successful, those alternative
actions may not allow us to meet our scheduled debt service obligations. The credit agreement that governs our senior secured credit facility, as described in &#147;Description of other indebtedness&#148; (the &#147;credit agreement&#148;),
restricts our ability to dispose of assets and use the proceeds from those dispositions and may also restrict our ability to raise debt or equity capital to be used to repay other indebtedness when it becomes due. We may not be able to consummate
those dispositions or to obtain proceeds in an amount sufficient to meet any debt service obligations then due. See &#147;Description of other indebtedness.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we conduct our operations through our subsidiaries, certain of which are not, or in the future may not be, guarantors of the notes or our other
indebtedness. Accordingly, repayment of our indebtedness, including the notes, is dependent on the generation of cash flow by our subsidiaries and their ability to make such cash available to us, by dividend, debt repayment or otherwise. Unless they
are guarantors of the notes or our other indebtedness, our subsidiaries do not have any obligation to pay amounts due on the notes or our other indebtedness or to make funds available for that purpose. Our subsidiaries may not be able to, or may not
be permitted to, make distributions to enable us to make payments in respect of our indebtedness, including the notes. Each subsidiary is a distinct legal entity, and, under certain circumstances, legal and contractual restrictions may limit our
ability to obtain cash from our subsidiaries. While the agreements governing certain of our other existing indebtedness limit the ability of our subsidiaries to incur consensual restrictions on their ability to pay dividends or make other
intercompany payments to us, these limitations are subject to qualifications and exceptions. In the event that we do not receive distributions from our subsidiaries, we may be unable to make required principal and interest payments on our
indebtedness, including the notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our inability to generate sufficient cash flows to satisfy our debt obligations, or to refinance our indebtedness on
commercially reasonable terms or at all, would materially and adversely affect our financial position and results of operations and our ability to satisfy our obligations under the notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we cannot make scheduled payments on our debt, we will be in default and holders of the notes could
declare all outstanding principal and interest to be due and payable, the lenders under our credit agreement could terminate their commitments to loan money, our secured lenders could foreclose against the assets securing their borrowings and we
could be forced into bankruptcy or liquidation. All of these events could result in your losing your investment in the notes offered hereby. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Despite our current level of indebtedness, we and our subsidiaries may still be able to incur substantially more debt. This could further exacerbate the
risks to our financial condition described above. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our subsidiaries may be able to incur significant additional indebtedness in the future.
Although our credit agreement contains restrictions on the incurrence of additional indebtedness and our credit agreement and the indentures governing the Existing 2026 Notes, the Existing 2030 Notes, the Existing 2032 Notes and the notes contain
restrictions on our ability to incur liens to secure additional indebtedness, these restrictions are subject to a number of qualifications and exceptions, and the additional indebtedness incurred in compliance with these restrictions could be
substantial. These restrictions also will not prevent us from incurring obligations that do not constitute indebtedness. In addition, if we incur any additional indebtedness secured by liens that rank equally with the notes, subject to collateral
arrangements, the holders of that debt will be entitled to share ratably with you in any proceeds distributed in connection with any insolvency, liquidation, reorganization, dissolution or other winding up of our company. This may have the effect of
reducing the amount of proceeds paid to you. These restrictions also will not prevent us from incurring obligations that do not constitute indebtedness. In addition, as of June&nbsp;30, 2024, we had $1.02 billion of aggregate available borrowing
capacity under our credit agreement, after giving effect to $3 million of letters of credit. In addition, the credit agreement allows us to request additional revolving or term loan commitments up to the sum of $750 million and additional amounts
such that the pro forma consolidated secured leverage ratio is not more than 3.75 to 1.00, and amounts borrowed under any such commitments would be secured on a first-priority lien basis by the same collateral securing our credit agreement, the
notes, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes. See &#147;Description of other indebtedness&#148; and &#147;Description of the notes.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The terms of our credit agreement and the indentures restrict our current and future operations, particularly our ability to respond to changes or to
take certain actions. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our credit agreement contains a number of restrictive covenants that impose significant operating and financial restrictions
on us and may limit our ability to engage in acts that may be in our long-term best interest, including restrictions on our ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur additional indebtedness and guarantee indebtedness; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pay dividends or make other distributions or repurchase or redeem capital stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prepay, redeem or repurchase certain debt; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make loans and investments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur liens; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into transactions with affiliates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">alter the businesses we conduct; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into agreements restricting our subsidiaries&#146; ability to pay dividends; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consolidate, merge or sell all or substantially all of our assets. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the restrictive covenants in the credit agreement require us to maintain specified financial ratios and satisfy other financial condition tests.
Our ability to meet those financial ratios and tests may be affected by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
events beyond our control, and we may be unable to meet them. In addition, the indentures governing the Existing 2026 Notes, the Existing 2030 Notes, the Existing 2032 Notes and the notes contain
restrictive covenants that limit our ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur liens or mortgages, as the case may be; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consolidate, merge or sell all or substantially all of our assets. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read the discussions under the headings &#147;Description of other indebtedness&#148; and &#147;&#151;Certain covenants&#148; in the
&#147;Description of the notes&#148; for further information about these covenants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A breach of the covenants under our credit agreement or under the
indentures could result in an event of default under the applicable indebtedness. Such a default may allow the creditors to accelerate the related debt and may result in the acceleration of any other debt to which a cross-acceleration or
cross-default provision applies. In addition, an event of default under our credit agreement would permit the lenders to terminate all commitments to extend further credit under the credit agreement. In the event our lenders or noteholders
accelerate the repayment of our borrowings, we and our subsidiaries may not have sufficient assets to repay that indebtedness. As a result of these restrictions, we may be: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limited in how we conduct our business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unable to raise additional debt or equity financing to operate during general economic or business downturns; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unable to compete effectively or to take advantage of new business opportunities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These restrictions may affect our ability to grow in accordance with our strategy. In addition, our financial results, our substantial indebtedness and our
credit ratings could adversely affect the availability and terms of our financing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our variable rate indebtedness subjects us to interest rate
risk, which could cause our debt service obligations to increase significantly. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Borrowings under our credit agreement are at variable rates of
interest and expose us to interest rate risk. If interest rates increase, our debt service obligations on the variable rate indebtedness will increase even though the amount borrowed remained the same, and our net income and cash flows, including
cash available for servicing our indebtedness, will correspondingly decrease. Assuming all revolving loans are fully drawn, each quarter point change in interest rates would result in a $3.25&nbsp;million change in annual interest expense on our
indebtedness under our revolving credit facility. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even though the holders of the notes will benefit from a first-priority lien on the collateral
that secures our credit agreement, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes, the representative of the lenders under the credit agreement will initially control actions with respect to that collateral.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the security agreement that relates to the collateral in which the lenders under the credit agreement and the holders of the notes, the
Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes have a first priority lien security interest, subject to permitted liens, any actions that may be taken with respect to such collateral (including the ability to commence any
judicial or <FONT STYLE="white-space:nowrap">non-judicial</FONT> foreclosure proceedings with respect to, seek to have a trustee, receiver, liquidator or similar official appointed for or over, attempt any action to take possession of, exercise any
right, remedy or power with respect to, or otherwise take any action to enforce its interests in or realize upon, or take any other action available to it in respect of, such collateral) will be in accordance with the terms of the security agreement
at the direction of the authorized representative of the lenders under the credit agreement until the earlier of (1)&nbsp;our obligations under the credit agreement are discharged (which discharge does not include certain refinancings or
replacements of the credit agreement) and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(2) 90 days after the occurrence of an event of default under the indenture governing the notes or other applicable agreements for a series of first priority lien obligations. Under the
circumstances described in clause (2)&nbsp;of the preceding sentence, the authorized representative of the holders of the indebtedness that represents the largest outstanding principal amount of indebtedness secured by a first-priority lien on the
collateral (other than the credit agreement) and has complied with the applicable notice provisions gains the right to take actions with respect to the collateral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if the authorized representative of the notes gains the right to direct the collateral agent in the circumstances described in clause (2)&nbsp;above, the
authorized representative must stop doing so (and those powers with respect to the collateral would revert to the authorized representative of the lenders under the credit agreement) if the lenders&#146; authorized representative has commenced and
is diligently pursuing any enforcement action with respect to the collateral or the grantor of the security interest in that collateral (whether our company or the applicable guarantor) is then a debtor under or with respect to (or otherwise subject
to) an insolvency or liquidation proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the credit agreement and the indentures permit us to issue additional series of notes that also
have a first-priority lien on the same collateral. As explained above, any time that the representative of the lenders under the credit agreement does not have the right to take actions with respect to the collateral, that right passes to the
authorized representative of the holders of the next largest outstanding principal amount of indebtedness secured by a first-priority lien on the collateral. If we issue additional first lien debt in the future in a greater principal amount than the
aggregate principal amount of the notes, then the authorized representative for those additional notes would be earlier in line to exercise rights than the applicable authorized representative for the notes offered hereby. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The notes will be structurally subordinated to all obligations of our existing and future subsidiaries that are not and do not become guarantors of the
notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be guaranteed by each of our existing and subsequently acquired or organized restricted subsidiaries that guarantee the
credit agreement, any other first lien obligations or any junior lien obligations or, if no such indebtedness is outstanding, by any such restricted subsidiaries that guarantee certain of our indebtedness or indebtedness of another guarantor in
excess of $50.0&nbsp;million. Our subsidiaries that do not guarantee the notes, including all of our <FONT STYLE="white-space:nowrap">non-domestic</FONT> subsidiaries, will have no obligation, contingent or otherwise, to pay amounts due under the
notes or to make any funds available to pay those amounts, whether by dividend, distribution, loan or other payment. The notes and guarantees will be structurally subordinated to all indebtedness and other obligations of any <FONT
STYLE="white-space:nowrap">non-guarantor</FONT> subsidiary such that in the event of insolvency, liquidation, reorganization, dissolution or other winding up of any subsidiary that is not a guarantor, all of that subsidiary&#146;s creditors
(including trade creditors and preferred stockholders, if any) would be entitled to payment in full out of that subsidiary&#146;s assets before we would be entitled to any payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the credit agreement, subject to some limitations, and the indentures permit these subsidiaries to incur additional indebtedness and will not
contain any limitation on the amount of other liabilities, such as trade payables, that may be incurred by these subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended
December&nbsp;31, 2023, our subsidiaries in the United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries, represented approximately 5% of our net revenues, and together with our remaining <FONT
STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries represented less than 20% of our net revenues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2024, subsidiaries in the
United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries, represented approximately 10% of our total assets excluding intercompany assets, and together with our remaining
<FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries represented approximately 20% of our total assets excluding intercompany assets. As of June&nbsp;30, 2024, our <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries had
less than $28&nbsp;million of long-term debt. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The guarantees of the notes may be automatically released upon the occurrence of certain events.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our subsidiaries that provide, or will provide, guarantees of the notes will be automatically released from those guarantees upon the
occurrence of certain events, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the notes have an investment grade rating from both Moody&#146;s and S&amp;P, no default has occurred and is
continuing, and the liens on the collateral securing all first lien obligations (including the credit agreement, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes) and any junior lien obligations have been or substantially
concurrently are released; provided that the guarantees are also released under all other first lien obligations and junior lien obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation of that subsidiary guarantor as an unrestricted subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the release or discharge of the guarantee by such subsidiary guarantor, any other first lien obligations and any
junior lien obligations (and if the subsidiary guarantor has become a guarantor under any &#147;additional indebtedness&#148; (as defined in &#147;Description of the notes&#148;), the release or discharge of the guarantee by such subsidiary
guarantor of such additional indebtedness), including any other guarantee that resulted in the creation of such guarantee, except (i)&nbsp;a discharge or release by or as a result of payment under such guarantee or (ii)&nbsp;by reason on the
termination of our senior credit facility; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sale or other disposition, including the sale of substantially all the assets, of that subsidiary guarantor.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any subsidiary guarantee is released, no holder of the notes will have a claim as a creditor against that subsidiary, and the
indebtedness and other liabilities, including trade payables and preferred stock, if any, whether secured or unsecured, of that subsidiary will be effectively senior to the claim of any holders of the notes. See &#147;&#151;Guarantees&#148; in the
&#147;Description of the notes.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There may not be sufficient collateral to pay all or any of the notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No appraisal of the value of the collateral has been made in connection with this offering, and the value of the collateral in the event of liquidation will
depend on market and economic conditions, the availability of buyers and other factors. Consequently, liquidating the collateral securing the notes may not produce proceeds in an amount sufficient to pay any amounts due on the notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair market value of the collateral securing the notes is subject to fluctuations based on factors that include, among others, the markets for the
collateral, the ability to sell the collateral in an orderly sale, general economic conditions, the availability of buyers and similar factors. The amount to be received upon a sale of the collateral would be dependent on numerous factors, including
but not limited to the actual fair market value of the collateral at such time and the timing and the manner of the sale. By its nature, portions of the collateral may be illiquid and may have no readily ascertainable market value. In the event of a
foreclosure, liquidation, bankruptcy or similar proceeding, the proceeds from any sale or liquidation of this collateral may not be sufficient to pay our obligations under the notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The collateral securing the notes also secures obligations under the credit agreement, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032
Notes may, subject to the terms of the credit agreement and the indentures, be pledged to secure other first lien and junior lien obligations. The amount of any such additional indebtedness secured by the collateral may be substantial. In the event
of a bankruptcy of us or any of the secured guarantors, holders of the notes may be deemed to have an unsecured claim to the extent that our obligations in respect of the notes and other indebtedness secured by a first priority lien exceed the fair
market value of the collateral securing the notes. In any bankruptcy proceeding with respect to us or any of the secured guarantors, the bankruptcy trustee, the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">debtor-in-possession</FONT></FONT> or competing creditors may assert that the fair market value of the collateral with respect to the notes and other indebtedness secured by a first
priority lien on the date of the bankruptcy filing was less than the then-current principal amount of the notes and other indebtedness secured by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a first priority lien. Upon a finding by the bankruptcy court that the notes are under-collateralized, the claims in the bankruptcy proceeding with respect to the notes would be bifurcated
between a secured claim and an unsecured claim, and the unsecured claim would not be entitled to the benefits of security in the collateral. In such event, the secured claims of the holders of the notes and other indebtedness secured by a first
priority lien would be limited to the value of the collateral. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain assets will be excluded from the collateral. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain assets are excluded from the collateral securing the notes, as described under &#147;&#151;Certain limitations on the collateral&#148; in the
&#147;Description of the notes,&#148; including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any interest in <FONT STYLE="white-space:nowrap">fee-owned</FONT> real property of the Issuer and the guarantors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any voting stock of any foreign subsidiaries in excess of 65% of the voting stock of those foreign subsidiaries,
unless any such foreign subsidiary is required to become a guarantor under the indenture governing the notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any deposit accounts (as defined in the New York UCC); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receivables sold pursuant to a receivables financing facility up to a maximum purchase price or loan of the
greater of $600.0&nbsp;million and 50% of the sum of (x)&nbsp;our accounts receivable, as set forth on our most recent balance sheet from time to time plus (y)&nbsp;the allowance for doubtful accounts with respect to such accounts receivable as set
forth in the footnotes to our financial statements; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">items as to which a security interest cannot be granted without violating contract rights or applicable law and
certain licenses in which a security interest cannot be created without breach of such license or applicable law. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in the
future, we may elect, in our discretion, to provide unsecured guarantees of the notes from certain other restricted subsidiaries that are not secured guarantors. If were elect to add unsecured guarantees, any assets held by those unsecured
guarantors would not be included in the collateral securing the notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an event of default occurs and the notes are accelerated, the notes will rank
equally with the holders of other unsubordinated and unsecured indebtedness with respect to those excluded assets. To the extent the claims of note holders exceed the value of the assets securing the notes and other liabilities, claims related to
the excluded assets will rank equally with the claims of the holders of any other unsecured indebtedness and other indebtedness secured by a first priority lien. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Your rights in the collateral may be adversely affected by the failure to perfect security interests in certain collateral acquired in the future.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The trustee and the collateral agent have no obligation to monitor, and we may fail to inform the trustee or the collateral agent of, the future
acquisition of property and rights that constitute collateral, and necessary action may not be taken to properly perfect the security interest in that after-acquired collateral. The collateral agent for the notes also has no obligation to monitor
the perfection of any security interest in favor of the notes against third parties. This failure may result in the loss of the security interest in any additional property or rights that constitute collateral or the priority of the security
interest in favor of the notes against third parties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rights of holders of the notes in the collateral may be adversely affected by the failure to
create or perfect security interests in certain collateral on a timely basis. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed to secure the notes and the guarantees by granting
first-priority liens, subject to permitted liens, on certain of our and the secured guarantors&#146; assets, other than our real property, accounts receivable sold pursuant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any future accounts receivable securitization program (subject to the limitations set forth in the security agreement) and certain other excluded assets, and to take other steps to assist in
perfecting the security interests granted in the collateral. We have a period of 30 days from the issue date of the notes before any applicable filings with the United States Patent and Trademark Office and the United States Copyright Office to
perfect the security interests granted in certain intellectual property must be filed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we or any secured guarantor were to become subject to a
bankruptcy proceeding, any liens recorded or perfected after the issue date would face a greater risk of being invalidated than if they had been recorded or perfected on the issue date. Liens recorded or perfected after the issue date may be treated
under bankruptcy law as if they were delivered to secure previously existing indebtedness. In bankruptcy proceedings commenced within 90 days of lien perfection, a lien given to secure previously existing debt is materially more likely to be avoided
as a preference by the bankruptcy court than if delivered and promptly recorded on the issue date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, if we or a secured guarantor were to file
for bankruptcy protection after the issue date of the outstanding notes and the liens had been perfected less than 90 days before commencement of such bankruptcy proceeding, the liens securing the notes may be especially subject to challenge as a
result of having been perfected after the issue date. To the extent that this challenge succeeded, you would lose the benefit of the security that the collateral was intended to provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, a failure, for any reason that is not permitted or contemplated under the security agreement and related documents, to perfect the security
interest in the properties included in the collateral package may result in a default under the indenture and other agreements governing the notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There are circumstances other than repayment or discharge of the notes under which the collateral securing the notes and guarantees will be released
automatically, without your consent or the consent of the trustee. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under various circumstances, collateral securing the notes will be released
automatically, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a sale, transfer or other disposal of the collateral in a transaction not prohibited under the indenture
governing the notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to collateral held by one or more secured guarantors, upon the release of those secured guarantors
from their note guarantees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent that such collateral is released or no longer required to be pledged pursuant to the terms of the
credit agreement, any other first lien obligations and any junior lien obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with the consent of the holders of at least 75% of the aggregate principal amount of the notes then outstanding
and affected thereby; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">following any date that the notes have an investment grade rating from both Moody&#146;s and S&amp;P, no default
has occurred and is continuing, and the liens on the collateral securing all first lien obligations (including the credit agreement, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes) and any junior lien obligations have
been or substantially concurrently are released. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the issue date of the notes, we expect the notes to have investment grade
ratings from both Moody&#146;s and S&amp;P. However, as of the issue date of the notes, the condition in the last bullet point above that the liens on the collateral securing all first lien obligations have been released will not have been met
because the credit agreement requires that we receive an investment grade corporate rating from both Moody&#146;s and S&amp;P and that certain other conditions be met. Accordingly, if we were to receive investment grade corporate ratings from both
rating agencies and the other conditions to release of the collateral under the credit agreement are met, or if we were to amend the credit agreement in the future to otherwise permit the release of the collateral, the collateral securing the notes
and the guarantees will be released. In that case, you would have an unsecured claim under the notes. We cannot assure you whether this will occur, nor can we predict whether any subsequent downgrade by one or both of the rating agencies may occur.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the other conditions described in the last bullet point above are met, the collateral will be
automatically released, and we and the secured guarantors will not be required to pledge the collateral for the benefit of the noteholders if the rating of the notes by either rating agency is later downgraded below investment grade, even though we
would be required to pledge the collateral for the benefit of the lenders under the credit agreement. If such a circumstance were to occur, the notes would be subordinated to the borrowings under the credit agreement, and any other first lien
obligations and junior lien obligations under which the lien on the collateral is not released, to the extent of the value of that collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
indenture governing the notes also permit us to designate one or more of our restricted subsidiaries that is a subsidiary guarantor of the notes as an unrestricted subsidiary. If we designate a subsidiary guarantor as an unrestricted subsidiary for
purposes of the indenture, all of the liens on any collateral owned by such subsidiary or any of its subsidiaries and any guarantees of the notes by such subsidiary or any of its subsidiaries will be released under the indenture governing the notes
but not necessarily under our credit agreement. Designation of an unrestricted subsidiary will reduce the aggregate value of the collateral securing the notes to the extent that liens on the assets of the unrestricted subsidiary and its subsidiaries
are released. In addition, the creditors of the unrestricted subsidiary and its subsidiaries will have a senior claim on the assets of such unrestricted subsidiary and its subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will in most cases have control over the collateral. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The security documents generally allow us and the secured guarantors to remain in possession of, to retain exclusive control over, to freely operate, and to
collect, invest and dispose of any income from, the collateral. These rights may adversely affect the value of the collateral at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>In the
event of our bankruptcy, the ability of the holders of the notes to realize upon the collateral will be subject to certain bankruptcy law limitations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ability of holders of the notes to realize upon the collateral will be subject to certain bankruptcy law limitations in the event of our bankruptcy. Under
applicable federal bankruptcy laws, upon the commencement of a bankruptcy case, an automatic stay goes into effect that, among other things, stays: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commencement or continuation of any action or proceeding against the debtor that was or could have been
commenced before the commencement of the bankruptcy case to recover a claim against the debtor that arose before the commencement of the bankruptcy case; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act to obtain possession of, or control over, property of the bankruptcy estate or the debtor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act to create, perfect or enforce any lien against property of the bankruptcy estate; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act to collect or recover a claim against the debtor that arose before the commencement of the bankruptcy
case. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thus, upon the commencement of a bankruptcy case, secured creditors are prohibited from repossessing their collateral from a
debtor, or from disposing of that collateral repossessed from such a debtor, without bankruptcy court approval. Moreover, applicable federal bankruptcy laws generally permit the debtor to continue to use, sell or lease collateral in the ordinary
course of its business even though the debtor is in default under the applicable debt instruments. Upon request from a secured creditor, the bankruptcy court will prohibit or condition the use, sale or lease of collateral as is necessary to provide
&#147;adequate protection&#148; of the secured creditor&#146;s interest in the collateral. The meaning of the term &#147;adequate protection&#148; may vary according to the circumstances but is intended generally to protect the value of the secured
creditor&#146;s interest in the collateral at the commencement of the bankruptcy case and may include cash payments or the granting of additional security, if and at such times as the court in its discretion determines any diminution in the value of
the collateral occurs as a result of the debtor&#146;s use, sale or lease of the collateral during the pendency of the bankruptcy case. In view of the lack of a precise definition of the term &#147;adequate protection&#148; and the broad
discretionary powers of a U.S. bankruptcy </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
court, we cannot predict whether payments under the notes would be made following commencement of and during a bankruptcy case, whether or when the trustee or collateral agent under the indenture
could foreclose upon or sell the collateral or whether or to what extent holders of notes would be compensated for any delay in payment or loss of value as a result of the use, sale or lease of their collateral through the requirement of
&#147;adequate protection.&#148; A creditor may seek relief from the stay from the bankruptcy court to take any of the acts described above that would otherwise be prohibited by the automatic stay. The U.S. bankruptcy court has broad discretionary
powers in determining whether to grant a creditor relief from the stay. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Any future pledge of collateral in favor of the holders of notes might be
voidable in bankruptcy. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any future pledge of collateral in favor of the holders of notes, including pursuant to the security documents delivered
after the date of the indenture governing the notes, might be voidable by the pledgor (as debtor in possession) or by its trustee in bankruptcy if certain events or circumstances exist or occur, including, under the bankruptcy code, if the pledgor
is insolvent at the time of the pledge, the pledge permits the holders of notes to receive a greater recovery than if the pledge had not been given and a bankruptcy proceeding in respect of the pledgor is commenced with 90 days following the pledge,
or, in certain circumstances, a longer period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The value of the collateral securing the notes may not be sufficient to secure post-petition
interest. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a bankruptcy, liquidation, dissolution, reorganization or similar proceeding against us, holders of the notes will only
be entitled to post-petition interest under the bankruptcy code to the extent that the value of their security interest in the collateral is greater than their <FONT STYLE="white-space:nowrap">pre-bankruptcy</FONT> claim. Holders of the notes that
have a security interest in the collateral with a value equal to or less than their <FONT STYLE="white-space:nowrap">pre-bankruptcy</FONT> claim will not be entitled to post-petition interest under the bankruptcy code. No appraisal of the fair
market value of the collateral has been prepared in connection with this offering, and the value of the holders&#146; interest in the collateral may not equal or exceed the principal amount of the notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Lien searches may not reveal all liens on the collateral. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot guarantee that the lien searches on the collateral that will secure the notes will reveal any or all existing liens on such collateral. Any such
existing liens, including undiscovered liens, could be significant, could be prior in ranking to the liens securing the notes and could have an adverse effect on the ability of the collateral agent to realize or foreclose upon the collateral
securing the notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be required to, but not be able to, repurchase the notes upon a change of control. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the indenture governing the notes, if the notes have ceased to have investment grade ratings from one or both of Moody&#146;s and
S&amp;P (including as a result of entering into an agreement that would result in specific kinds of changes of control), then we will be required to offer to repurchase the notes, as described in &#147;Description of the notes.&#148; Because the
notes are expected to have investment grade ratings from both rating agencies as of the issue date of the notes, this covenant will initially be suspended and will not apply unless the notes are later downgraded below investment grade by one or both
of the rating agencies or we enter into an agreement to undertake a transaction that would result in a specified kind of change of control and one or both of the rating agencies indicates that the transaction, if consummated, would cause such agency
to downgrade the rating of the notes below an investment grade rating. If the covenant then applies, we will be required to offer to repurchase all outstanding notes at 101% of their principal amount, plus accrued and unpaid interest to the purchase
date. Additionally, under the credit agreement, a change of control (as defined therein) constitutes an event of default that permits the lenders to accelerate the maturity of borrowings under the respective agreements and terminate their
commitments to lend. The source of funds for any purchase of the notes and repayment of borrowings under our credit agreement would be our available cash or cash generated from our subsidiaries&#146; operations or other sources, including
borrowings, sales of assets or sales of equity. We may not be able to repurchase the notes upon a change of control because we may not have sufficient financial resources to purchase all of the debt securities that are tendered upon a change of
control and repay our other indebtedness that will become due. If we fail to repurchase the notes in that circumstance, we will be in default </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the indenture. We may require additional financing from third parties to fund any such purchases, and we may be unable to obtain financing on satisfactory terms or at all. Further, our
ability to repurchase the notes may be limited by law. In order to avoid the obligations to repurchase the notes and events of default and potential breaches of the credit agreement, we may have to avoid certain change of control transactions that
would otherwise be beneficial to us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, some important corporate events, such as leveraged recapitalizations, may not, under the indenture,
constitute a &#147;change of control&#148; that would require us to repurchase the notes, even though those corporate events could increase the level of our indebtedness or otherwise adversely affect our capital structure, credit ratings or the
value of the notes. See &#147;&#151;Repurchase at the option of holders&#151;Change of control&#148; in the &#147;Description of the notes.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
exercise by the holders of notes of their right to require us to repurchase the notes pursuant to a change of control offer could cause a default under the agreements governing our other indebtedness, including future agreements, even if the change
of control itself does not, due to the financial effect of such repurchases on us. In the event a change of control offer is required to be made at a time when we are prohibited from purchasing notes, we could attempt to refinance the borrowings
that contain such prohibitions. If we do not obtain a consent or repay those borrowings, we will remain prohibited from purchasing notes. In that case, our failure to purchase tendered notes would constitute an event of default under the indenture
which could, in turn, constitute a default under our other indebtedness. Further, our ability to pay cash to the holders of notes upon a repurchase may be limited by our then existing financial resources. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Holders of the notes may not be able to determine when a change of control giving rise to their right to have the notes repurchased has occurred
following a sale of &#147;substantially all&#148; of our assets, if that covenant is then in effect. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The definition of change of control in the
indenture governing the notes includes a phrase relating to the sale or disposition of &#147;all or substantially all&#148; of our assets. There is no precise established definition of the phrase &#147;substantially all&#148; under applicable law,
and the interpretation of that phrase will likely depend upon particular facts and circumstances. Accordingly, the ability of a holder of notes to require us, if the covenant is then applicable, to repurchase its notes as a result of a sale of less
than all our assets to another person may be uncertain. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Federal and state fraudulent transfer laws may permit a court to void the notes, guarantees
and/or the grant of collateral, and if that occurs, you may not receive any payments on the notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Federal and state fraudulent transfer and
conveyance statutes may apply to the issuance of the notes and the incurrence of the guarantees of the notes. Under federal bankruptcy law and comparable provisions of state fraudulent transfer or conveyance laws, which may vary from state to state,
the notes or the guarantees thereof (or the grant of collateral securing any such obligations) could be voided as a fraudulent transfer or conveyance if we or any of the subsidiary guarantors, as applicable, (a)&nbsp;issued the notes or incurred the
guarantees with the intent of hindering, delaying or defrauding creditors or (b)&nbsp;received less than reasonably equivalent value or fair consideration in return for either issuing the notes or incurring the guarantees and, in the case of
(b)&nbsp;only, one of the following is also true at the time thereof: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or any of the subsidiary guarantors, as applicable, were insolvent or rendered insolvent by reason of the
issuance of the notes or the incurrence of the guarantees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of the notes or the incurrence of the guarantees left us or any of the subsidiary guarantors, as
applicable, with an unreasonably small amount of capital or assets to carry on the business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or any of the subsidiary guarantors intended to, or believed that we or such guarantor would, incur debts
beyond our or the subsidiary guarantor&#146;s ability to pay as they mature; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or any of the subsidiary guarantors were a defendant in an action for money damages, or had a judgment for
money damages docketed against us or the subsidiary guarantor if, in either case, the judgment is unsatisfied after final judgment. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As
a general matter, value is given for a transfer or an obligation if, in exchange for the transfer or obligation, property is transferred or a valid antecedent debt is secured or satisfied. A court would likely find that a subsidiary guarantor did
not receive reasonably equivalent value or fair consideration for its guarantee to the extent the subsidiary guarantor did not obtain a reasonably equivalent benefit directly or indirectly from the issuance of the notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot be certain as to the standards a court would use to determine whether or not we or the subsidiary guarantors were insolvent at the relevant time or,
regardless of the standard that a court uses, whether the notes or the guarantees would be subordinated to our or any of our guarantors&#146; other debt. In general, however, a court would deem an entity insolvent if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sum of its debts, including contingent and unliquidated liabilities, was greater than the fair saleable value
of all of its assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the present fair saleable value of its assets was less than the amount that would be required to pay its probable
liability on its existing debts, including contingent liabilities, as they become absolute and mature; or it could not pay its debts as they became due. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a court were to find that the issuance of the notes or the incurrence of a guarantee or the grant of security was a fraudulent transfer or conveyance, the
court could void the payment obligations under the notes or that guarantee, void the grant of collateral, subordinate the notes or that guarantee to presently existing and future indebtedness of ours or of the related guarantor or could require the
holders of the notes to repay any amounts received with respect to that guarantee. In the event of a finding that a fraudulent transfer or conveyance occurred, you may not receive any repayment on the notes. Further, the avoidance of the notes could
result in an event of default with respect to our and our subsidiaries&#146; other debt that could result in acceleration of that debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finally, as a
court of equity, the bankruptcy court may subordinate the claims in respect of the notes to other claims against us under the principle of equitable subordination if the court determines that (1)&nbsp;the holder of notes engaged in some type of
inequitable conduct, (2)&nbsp;the inequitable conduct resulted in injury to our other creditors or conferred an unfair advantage upon the holders of notes and (3)&nbsp;equitable subordination is not inconsistent with the provisions of the bankruptcy
code. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ratings of the notes may not reflect all risks of an investment in the notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be rated at time of original issue by at least two nationally recognized statistical rating organizations. The ratings of our notes will
primarily reflect our perceived financial strength and will change in accordance with the rating of our financial strength. Any rating is not a recommendation to purchase, sell or hold any particular security, including the notes. These ratings do
not comment as to market price or suitability for a particular investor. In addition, ratings at any time may be lowered or withdrawn in their entirety. The ratings of the notes may not reflect the potential impact of all risks related to structure
and other factors on any trading market for, or trading values of, your notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A lowering or withdrawal of the ratings assigned to our debt
securities by rating agencies may increase our future borrowing costs and reduce our access to capital. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any rating assigned to our debt could be
lowered or withdrawn entirely by a rating agency if, in that rating agency&#146;s judgment, future circumstances relating to the basis of the rating, such as adverse changes, so warrant. Consequently, real or anticipated changes in our credit
ratings will generally affect the market value of the notes. Credit ratings are not recommendations to purchase, hold or sell the notes. Additionally, credit ratings may not reflect the potential effect of risks relating to the structure or
marketing of the notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any future lowering of our ratings likely would make it more difficult or more expensive for us to obtain
additional debt financing. If any credit rating initially assigned to the notes is subsequently lowered or withdrawn for any reason, you may not be able to resell your notes without a substantial discount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There may be no public trading market for the notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes are a new issue of securities for which there is currently no established trading market. A market for the notes may not develop or, if one does
develop, it may not be maintained. If a market develops, the notes could trade at prices that may be higher or lower than the initial offering price or the price at which you purchased the notes, depending on many factors, including prevailing
interest rates, our financial performance, the amount of indebtedness we have outstanding, the market for similar securities and the time remaining to maturity of your notes. We have not applied and do not intend to apply for listing the notes on
any securities exchange or any automated quotation system. If an active market for the notes fails to develop or be sustained, the trading price and liquidity of the notes could be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>An increase in market rates could result in a decrease in the value of the notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, as market interest rates rise, notes bearing interest at a fixed rate generally decline in value because the premium, if any, over market interest
rates will decline. Consequently, if you purchase the notes and market interest rates increase, the market value of your notes may decline. We cannot predict the future level of market interest rates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_8"></A>Use of proceeds </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds to us from the offering of the notes, after deducting the underwriters&#146; discount and the estimated offering expenses,
will be approximately $989.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds of this offering and the new tranche A term loan facility to repay amounts
outstanding under our current tranche A term loan facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JPMorgan Chase Bank, N.A. acts as administrative agent and collateral agent under the senior
secured credit facility, and affiliates of certain of the underwriters are lenders under the senior secured credit facility and will receive a portion of the proceeds from the Transactions. See &#147;Underwriting (conflicts of interest).&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_9"></A>Capitalization </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash and cash equivalents and our capitalization as of June&nbsp;30, 2024 on an actual basis and on an as adjusted basis to
give effect to the Transactions and the application of the net proceeds as described under &#147;Use of proceeds,&#148; including the offering of the notes, replacement of the senior secured credit facility outstanding under our credit agreement
with an amended revolving credit facility and a new replacement tranche A term loan facility concurrently with the closing of the offering of the notes, and use of the net proceeds of this offering and the new tranche A term loan facility to repay
amounts outstanding under our current tranche A term loan facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth our capitalization as of June&nbsp;30, 2024: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on as adjusted basis to give effect to the Transactions as if each had occurred on June&nbsp;30, 2024.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of June&nbsp;30, 2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(Dollars in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;adjusted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">128,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">128,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt (including current maturities):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior secured credit facility<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revolving credit facility<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">176,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">198,171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tranche A term loan facility, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,198,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.65% Senior Secured Notes due 2026, net of unamortized discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">699,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">699,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.65% Senior Secured Notes due 2030, net of unamortized discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">798,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">798,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.65% Senior Secured Notes due 2032, net of unamortized discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">499,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">499,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.625% Senior Secured Notes due 2029 offered hereby, net of discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">499,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.050% Senior Secured Notes due 2034 offered hereby, net of discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">498,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other existing debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">186,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">186,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred financing costs, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,178</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(21,047</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,544,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,559,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,485,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,480,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,029,611</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,040,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of June&nbsp;30, 2024, our senior secured credit facility consisted of (i)&nbsp;a $1.2&nbsp;billion
aggregate amount revolving credit facility that is scheduled to mature in August 2026 (which, as of June&nbsp;30, 2024, had $1.02&nbsp;billion of aggregate available borrowing capacity, net of $177&nbsp;million of outstanding borrowings and
$3&nbsp;million of letters of credit), and (ii)&nbsp;a tranche A term loan facility with $2.20&nbsp;billion of outstanding borrowings as of June&nbsp;30, 2024. See &#147;Description of other indebtedness&#151;Credit agreement.&#148;
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As adjusted amount reflects expected additional borrowings under the revolving credit facility to provide funds
to be used, together with the net proceeds of this offering and the new tranche&nbsp;A term loan, to repay amounts outstanding under our current tranche&nbsp;A term loan facility and to pay related fees and expenses. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_10"></A>Description of other indebtedness </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following description of some important terms of some of our indebtedness is not complete and does not contain all the information that is important to
you. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June, 2022, we entered
into a ninth amendment to our credit agreement dated as of November&nbsp;15, 2010, as amended and restated as of September&nbsp;21, 2012, August&nbsp;7, 2014, October&nbsp;23, 2018, August&nbsp;24, 2021, and September&nbsp;10, 2021, among UHS, as
borrower, the several banks and other financial institutions from time to time parties thereto, as lenders, and JPMorgan Chase Bank, N.A., as administrative agent (the &#147;Credit Agreement&#148;). The ninth amendment provided for, among other
things, the following: (i)&nbsp;a new incremental tranche A term loan facility in the aggregate principal amount of $700&nbsp;million which is scheduled to mature on August&nbsp;24, 2026, and; (ii)&nbsp;replaced the option to make Eurodollar
borrowings (which bore interest by reference to the LIBO Rate) with Term Benchmark Loans, which bear interest by reference to the Secured Overnight Financing Rate (&#147;SOFR&#148;). The net proceeds generated from the incremental tranche A term
loan facility were used to repay a portion of the borrowings that were previously outstanding under our revolving credit facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30,
2024, our Credit Agreement provided for the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a $1.20&nbsp;billion aggregate amount revolving credit facility that is scheduled to mature in August, 2026
(which, as of June&nbsp;30, 2024, had $1.02&nbsp;billion of aggregate available borrowing capacity net of $177&nbsp;million of outstanding borrowings and $3&nbsp;million of letters of credit); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a tranche A term loan facility with $2.20&nbsp;billion of outstanding borrowings as of June&nbsp;30, 2024.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The tranche A term loan facility provides for installment payments of $30.0&nbsp;million per quarter through June, 2026. The unpaid
principal balance at June&nbsp;30, 2026 is payable on the August&nbsp;24, 2026 scheduled maturity date of the Credit Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrently with the
closing of the offering of the notes, UHS intends to enter into an amendment to the Credit Agreement which, among other things, which will provide a $1.3&nbsp;billion aggregate amount revolving credit facility that is scheduled to mature in
September 2029, and a tranche A term loan facility with an aggregate principal amount of $1.2&nbsp;billion. See &#147;Summary&#151;The transactions.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revolving credit and tranche A term loan borrowings under the Credit Agreement bear interest at our election at either (1)&nbsp;the ABR rate which is defined
as the rate per annum equal to the greatest of (a)&nbsp;the Wall Street Journal&#146;s prime rate, (b)&nbsp;the weighted average of the federal funds rate, plus 0.5% and (c)&nbsp;one month term SOFR rate plus 1%, in each case, plus an applicable
margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.25% to 0.625%, or (2)&nbsp;the one, three or six (or, if agreed to by all Lenders under the relevant facility, twelve) month term SOFR rate plus 0.1% (at our
election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.25% to 1.625%. As of June&nbsp;30, 2024, the applicable margins were 0.375% for
<FONT STYLE="white-space:nowrap">ABR-based</FONT> loans and 1.375% for SOFR-based loans under the revolving credit and term loan A facilities. The revolving credit facility includes a $125&nbsp;million
<FONT STYLE="white-space:nowrap">sub-limit</FONT> for letters of credit. The Credit Agreement is secured by certain assets of the Company and our material subsidiaries (which generally excludes asset classes such as substantially all of the
patient-related accounts receivable of our acute care hospitals, if sold to a receivables facility pursuant to the Credit Agreement, and certain real estate assets and assets held in joint-ventures with third parties) and is guaranteed by our
material subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Credit Agreement includes a material adverse change clause that must be represented at each draw. The Credit Agreement also
contains covenants that include a limitation on sales of assets, mergers, change of ownership, liens, indebtedness, transactions with affiliates, dividends and stock repurchases; and requires compliance with financial covenants including maximum
leverage. We were in compliance with all required covenants as of June&nbsp;30, 2024 and December&nbsp;31, 2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Existing senior secured notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2024, we had combined aggregate principal of $2.0&nbsp;billion from the following senior secured notes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$700&nbsp;million aggregate principal amount of 1.65% senior secured notes due in September, 2026, which were
issued on August&nbsp;24, 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$800&nbsp;million aggregate principal amount of 2.65% senior secured notes due in October, 2030, which were
issued on September&nbsp;21, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$500&nbsp;million of aggregate principal amount of 2.65% senior secured notes due in January, 2032, which were
issued on August&nbsp;24, 2021. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest on the Existing 2026 Notes is payable on March 1st and September 1st until the maturity date
of September&nbsp;1, 2026. Interest on the Existing 2030 Notes is payable on April 15th and October 15th, until the maturity date of October&nbsp;15, 2030. Interest on the Existing 2032 Notes is payable on January 15th and July 15th until the
maturity date of January&nbsp;15, 2032. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Existing 2026 Notes, Existing 2030 Notes and Existing 2032 Notes (collectively the &#147;Existing
Notes&#148;) were initially issued only to qualified institutional buyers under Rule 144A and to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> persons outside the United States in reliance on Regulation S under the Securities Act of 1933, as
amended (the &#147;Securities Act&#148;). In December 2022, we completed a registered exchange offer in which virtually all previously outstanding Existing Notes were exchanged for identical Existing Notes that were registered under the Securities
Act, and thereby became freely transferable (subject to certain restrictions applicable to affiliates and broker dealers). Notes originally issued under Rule 144A or Regulation S that were not exchanged remain outstanding and may not be offered or
sold in the United States absent registration under the Securities Act or an applicable exemption from registration requirements thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Existing
Notes are guaranteed (the &#147;Existing Guarantees&#148;) on a senior secured basis by all of our existing and future direct and indirect subsidiaries (the &#147;Existing Subsidiary Guarantors&#148;) that guarantee our Credit Agreement, or other
first lien obligations or any junior lien obligations. The Existing Notes and the Existing Guarantees are secured by first-priority liens, subject to permitted liens, on certain of the Company&#146;s and the Existing Subsidiary Guarantors&#146;
assets now owned or acquired in the future by the Company or the Existing Subsidiary Guarantors (other than real property, accounts receivable sold pursuant to the Company&#146;s existing receivables facility (as defined in the indentures pursuant
to which the Existing Notes were issued (the &#147;Existing Indentures&#148;)), and certain other excluded assets). The Company&#146;s obligations with respect to the Existing Notes, the obligations of the Existing Subsidiary Guarantors under the
Existing Guarantees, and the performance of all of the Company&#146;s and the Existing Subsidiary Guarantors&#146; other obligations under the Existing Indentures, are secured equally and ratably with the Company&#146;s and the Existing Subsidiary
Guarantors&#146; obligations under the Credit Agreement and the Existing Notes by a perfected first-priority security interest, subject to permitted liens, in the collateral owned by the Company and the Existing Subsidiary Guarantors, whether now
owned or hereafter acquired. However, the liens on the collateral securing the Existing Notes and the Existing Guarantees will be released if: (i)&nbsp;the Existing Notes have investment grade ratings; (ii)&nbsp;no default has occurred and is
continuing, and; (iii)&nbsp;the liens on the collateral securing all first lien obligations (including the Credit Agreement and the Existing Notes) and any junior lien obligations are released or the collateral under the Credit Agreement, any other
first lien obligations and any junior lien obligations is released or no longer required to be pledged. The liens on any collateral securing the Existing Notes and the Existing Guarantees will also be released if the liens on that collateral
securing the Credit Agreement, other first lien obligations and any junior lien obligations are released. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other UHS debt </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the indebtedness described above, we had approximately $187&nbsp;million of other indebtedness as of June&nbsp;30, 2024 that we expect to remain
outstanding following the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_11"></A>Description of the notes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is a description of the particular terms of the 4.625% Senior Secured Notes due 2029 (the &#147;<I>20</I><I>29 N</I>otes&#148;) and the 5.050% Senior
Secured Notes due 2034 (the &#147;<I>20</I><I>34 </I><I>Notes</I>&#148; and, together with the 2029 Notes, the &#147;<I>Notes</I>&#148;). In this description of the notes, all references to &#147;<I>we</I>,&#148; &#147;<I>us</I>&#148; or
&#147;<I>our</I>&#148; and the &#147;<I>Company</I>&#148; are to Universal Health Services, Inc. only (the &#147;<I>Issuer</I>&#148;) and not to any of its Subsidiaries. Although for convenience the 2029 Notes and the 2034 Notes are referred to as
the &#147;Notes,&#148; each will be issued as a separate series and will not together have any class voting rights. Accordingly, for purposes of this description of the notes, unless the context otherwise requires, references to the
&#147;Notes&#148; shall be deemed to refer to each series of Notes separately, and not to the 2029 Notes and the 2034 Notes on a combined basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Issuer will issue the Notes under an indenture, dated as of September&nbsp;26, 2024, among the Issuer, the Guarantors, U.S. Bank Trust Company, National Association, as trustee (the &#147;<I>Trustee</I>&#148;), and JPMorgan Chase Bank, N.A., as
collateral agent, as supplemented by the first supplemental indenture, to be dated as of September&nbsp;26, 2024 (collectively, the &#147;<I>Indenture</I>&#148;). The Indenture will set forth the specific terms applicable to the Notes. This
description is intended to be an overview of the material provisions of the Notes and the Indenture. This summary is not complete and is qualified in its entirety by reference to the Indenture. You should carefully read the summary below. The terms
of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (the &#147;<I>Trust Indenture Act</I>&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brief description of notes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be general senior secured obligations of the Issuer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be secured on a first-priority basis, subject to Permitted Liens, by the Collateral subject to a shared Lien
of equal priority with the existing and future First Lien Obligations, including the Senior Credit Facility Obligations, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be structurally subordinated to any existing and future Indebtedness and liabilities of <FONT
STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries, including the Issuer&#146;s Foreign Subsidiaries and any Unrestricted Subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be effectively subordinated to any existing and future Indebtedness of the Issuer and the Guarantors that is
secured by assets that do not constitute Collateral to the extent of the value of such assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will rank equally in right of payment with all existing and future senior Indebtedness of the Issuer and the
Guarantors but, to the extent of the value of the Collateral, will be effectively senior to all of the Issuer&#146;s and the Guarantors&#146; unsecured senior Indebtedness and any future Junior Lien Obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be senior in right of payment to any future subordinated Indebtedness of the Issuer; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will initially be unconditionally guaranteed on a joint and several basis by each Restricted Subsidiary that
guarantees the Senior Credit Facility, all of which Guarantors on the Issue Date will be Secured Guarantors. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Guarantees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Guarantors, as primary obligors and not merely as sureties, will jointly and severally fully and unconditionally guarantee, on a senior basis, the
performance and full and punctual payment when due, whether at maturity, by acceleration or otherwise, of all obligations of the Issuer under the Indenture and the Notes, whether for payment of principal of, premium, if any, or interest in respect
of the Notes, expenses, indemnification or otherwise, on the terms set forth in the Indenture by executing the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Restricted Subsidiaries
that guarantee the Senior Credit Facility will initially guarantee the Notes. As of the Issue Date, each of the Guarantors will be Secured Guarantors, and each of the Guarantees of such Secured </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Guarantors will be general senior secured obligations of such Secured Guarantors and will be secured by a first-priority lien, subject to Permitted Liens, on the Collateral. The Guarantees of the
Secured Guarantors will rank equally in right of payment with all existing and future senior Indebtedness of the Secured Guarantors but, to the extent of the value of the Collateral, will be effectively senior to all of the Secured Guarantors&#146;
unsecured senior Indebtedness and Junior Lien Obligations. The Guarantees of the Secured Guarantors will also be effectively subordinated to any existing and future Indebtedness of the Secured Guarantors that is secured by assets that do not
constitute Collateral to the extent of the value of such assets. In the future, if any Unsecured Guarantor guarantees the Notes as provided in &#147;&#151;Certain covenants&#151;Additional subsidiary guarantees,&#148; the Guarantee of such Unsecured
Guarantor will rank equally in right of payment with all existing and future senior Indebtedness of the Unsecured Guarantor, will rank pari passu with all of the Unsecured Guarantor&#146;s unsecured senior Indebtedness and will be effectively
subordinated to any secured Indebtedness of such Unsecured Guarantor to the extent of the value of the assets securing such secured Indebtedness. The Guarantees of all the Guarantors will be senior in right of payment to all existing and future
subordinated Indebtedness of each Guarantor. The Notes will be structurally subordinated to Indebtedness and other liabilities of Subsidiaries of the Issuer that do not guarantee the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not all of the Issuer&#146;s Subsidiaries will Guarantee the Notes. In the event of a bankruptcy, liquidation or reorganization of any of these <FONT
STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries, the <FONT STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries will pay the holders of their debt and their trade creditors before they will be able to distribute any of their
assets to the Issuer. None of our Subsidiaries that are Foreign Subsidiaries, <FONT STYLE="white-space:nowrap">non-Wholly</FONT> Owned Subsidiaries or Receivables Subsidiaries will guarantee the Notes. For the year ended December&nbsp;31, 2023, our
Subsidiaries in the United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries, represented approximately 5% of our net revenues, and together with our remaining <FONT STYLE="white-space:nowrap">non-guarantor</FONT>
Subsidiaries represented less than 20% of our net revenues. As of June&nbsp;30, 2024, our Subsidiaries in the United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries, represented approximately 10% of our total
assets excluding intercompany assets, and together with our remaining <FONT STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries represented less than 20% of our total assets excluding intercompany assets. As of June&nbsp;30, 2024, our <FONT
STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries had less than $28&nbsp;million of long-term debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The obligations of each Guarantor under
its Guarantee will be limited as necessary to prevent the Guarantee from constituting a fraudulent conveyance under applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any entity that makes
a payment under its Guarantee will be entitled upon payment in full of all guaranteed obligations under the Indenture to a contribution from each other Guarantor in an amount equal to such other Guarantor&#146;s pro rata portion of such payment
based on the respective net assets of all the Guarantors at the time of such payment determined in accordance with GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a Guarantee were rendered
voidable, it could be subordinated by a court to all other Indebtedness (including guarantees and other contingent liabilities) of such Guarantor, and, depending on the amount of such Indebtedness, such Guarantor&#146;s liability with respect to its
Guarantee could be reduced to zero. See &#147;Risk factors&#151;Risks related to the notes&#151;Federal and state fraudulent transfer laws may permit a court to void the notes, guarantees and/or the grant of collateral, and if that occurs, you may
not receive any payments on the notes.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Guarantee by a Guarantor will provide by its terms that it will be automatically and unconditionally
released and discharged upon: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(a) any sale, exchange or transfer (by merger or otherwise) of the Capital Stock of such Guarantor, after which
such Guarantor is no longer a Restricted Subsidiary, or all or substantially all the assets of such Guarantor, which sale, exchange or transfer is made in compliance with any applicable provisions of the Indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the release or discharge of the guarantee by such Guarantor of the Senior Credit Facility, any other First Lien
Obligations and any Junior Lien Obligations (and if the Guarantor has become a </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
guarantor under any Additional Indebtedness, the release or discharge of the guarantee by such Guarantor of such Additional Indebtedness), including any other guarantee that resulted in the
creation of such Guarantee, except (i)&nbsp;a discharge or release by or as a result of payment under such guarantee or (ii)&nbsp;by reason of the termination of the Senior Credit Facility; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the designation of any Restricted Subsidiary that is a Guarantor as an Unrestricted Subsidiary in compliance
with the applicable provisions of the Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the exercise by the Issuer of its legal defeasance option or covenant defeasance option as described under
&#147;&#151;Defeasance&#148; or the discharge of the Issuer&#146;s and the Guarantors&#146; obligations under the Indenture in accordance with the terms of the Indenture; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an Investment Grade Rating Event, but only (i)&nbsp;to the extent described under &#147;&#151;Release of
collateral and guarantees upon investment grade rating event&#148; (which includes the release by the Guarantor of its guarantees of all other First Lien Obligations and Junior Lien Obligations) and (ii)&nbsp;in the case of a Secured Guarantor, if
the Liens on the Collateral of such Secured Guarantor securing its Guarantee of the Notes and the Notes Obligations are also released at such time as described under &#147;&#151;Release of collateral and guarantees upon investment grade rating
event&#148;; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Guarantor delivering to the Trustee an Officers&#146; Certificate and an Opinion of Counsel, each stating
that all conditions precedent provided for in the Indenture and the Security Documents relating to such transaction have been complied with. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Holding company structure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer is a holding
company for its Subsidiaries, with no material operations of its own and only limited assets other than the Capital Stock of its Subsidiaries. Accordingly, the Issuer is dependent upon the distribution of the earnings of its Subsidiaries, whether in
the form of dividends, advances or payments on account of intercompany obligations, to service its debt obligations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Security generally </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The obligations of the Issuer with respect to the Notes, the obligations of the Secured Guarantors under their Guarantees, and the performance of all other
obligations of the Issuer and the Secured Guarantors under the Indenture will be secured by a perfected first-priority security interest, subject to Permitted Liens, in the Collateral owned by the Issuer and the Secured Guarantors, in each case
whether now owned or hereafter acquired subject to a shared Lien of equal priority with the obligations of the Issuer and the Secured Guarantors under the Senior Credit Facility and any other First Lien Obligations. First Lien Secured Parties other
than the Holders of the Notes have rights and remedies with respect to the Collateral that, if exercised, could also adversely affect the value of the Collateral on behalf of the Holders of the Notes, particularly the rights described below under
&#147;&#151;Intercreditor provisions in the security agreement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Collateral consists of certain of the assets of our company and of the Secured
Guarantors, including, without limitation, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the capital stock of the material domestic Wholly Owned Subsidiaries of the Issuer and the Secured Guarantors and
up to 65% of the Voting Stock of the first-tier Foreign Subsidiaries of the Issuer and the Secured Guarantors, except as provided in &#147;&#151;Certain limitations on the collateral&#148;; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accounts receivable, except as provided in &#147;&#151;Certain limitations on the collateral&#148;;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">equipment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general intangibles; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">intellectual property; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other investment property. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, the Collateral does not include the assets described in &#147;&#151;Certain limitations on the
collateral.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer and the Secured Guarantors are and will be able to incur additional Indebtedness in the future that could share in the
Collateral, including Additional First Lien Obligations, Junior Lien Obligations, Obligations secured by Permitted Liens or Mortgages (as applicable). The amount of such additional Obligations will be limited by the covenant described under
&#147;&#151;Limitations on mortgages,&#148; but the covenant is limited in scope and contains a number of exceptions. Under certain circumstances, the amount of any such additional Obligations could be significant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Trustee shall have no responsibility whatsoever to comply with any provision of, nor shall be charged with knowledge of, any document governing Additional
First Lien Obligations to which it is not a party. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>After-acquired collateral </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From and after the Issue Date and prior to the Collateral Release Date, subject to certain limitations and exceptions, if the Issuer or any Secured Guarantor
(i)&nbsp;acquires any property or asset that would constitute Collateral or (ii)&nbsp;creates any additional security interest upon any property or asset to secure any First Lien Obligations, it must grant a first-priority perfected security
interest (subject to Permitted Liens) upon such property as security for the Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liens with respect to the collateral </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer, the Secured Guarantors, the Trustee, the designated agents of each Series of other First Lien Obligations and the First Lien Collateral Agent will
enter into Security Documents with respect to the Collateral defining the terms of the security interests that secure the Notes and the Guarantees with respect to such Collateral. On the Issue Date, the Trustee will be authorized by the Holders of
Notes to enter into and will enter into the Security Documents with respect to the Collateral. These security interests will secure the payment and performance when due of all of the Obligations of the Issuer and the Secured Guarantors under the
Notes, the Indenture, the applicable Guarantees and the Security Documents, as provided in the Security Documents. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intercreditor provisions in the
security agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Security Agreement, the Holders of the Notes will be represented by the Trustee, and the holders of each Series of First
Lien Obligations will be represented by their designated agent (each, an &#147;<I>Authorized Representative</I>&#148;). The First Lien Collateral Agent is initially JPMorgan Chase Bank, N.A., in its capacity of collateral agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Security Agreement, the &#147;Applicable Authorized Representative&#148; has the right to direct foreclosures and take other actions with respect to
the Common Collateral. No Authorized Representative of any First Lien Obligations secured by the Common Collateral (other than the Applicable Authorized Representative) will instruct the First Lien Collateral Agent to take any action with respect to
the Common Collateral. The Applicable Authorized Representative will initially be the administrative agent under the Senior Credit Facility, and the Trustee will have no rights to take any action under the Security Agreement other than as the
Applicable Authorized Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The administrative agent under the Senior Credit Facility will remain the Applicable Authorized Representative
until the earlier of (1)&nbsp;the Discharge of Senior Credit Facility Obligations and (2)&nbsp;the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative Enforcement Date (such date, the &#147;<I>Applicable Authorized
Agent Date</I>&#148;). After the Applicable Authorized Agent Date, the Applicable Authorized Representative will be the Authorized Representative of the Series of First Lien Obligations that constitutes the largest outstanding principal amount of
any then outstanding Series of First Lien Obligations, other than the Senior Credit Facility Obligations, with respect to the Common Collateral (the &#147;<I>Major <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized
Representative</I>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The &#147;<I><FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative Enforcement
Date</I>&#148; is the date that is 90 days (throughout which <FONT STYLE="white-space:nowrap">90-day</FONT> period the applicable <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative was the Major <FONT
STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative) after the occurrence of both (a)&nbsp;an event of default, as defined in the Indenture or other applicable agreement for the Series of First Lien Obligations for which such
<FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative is an Authorized Representative, and (b)&nbsp;the First Lien Collateral Agent&#146;s and each other Authorized Representative&#146;s receipt of written notice from
that <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative certifying that (i)&nbsp;such <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative is the Major
<FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative and that an event of default, as defined in the Indenture or other applicable agreement for that Series of First Lien Obligations, has occurred and is continuing and
(ii)&nbsp;the First Lien Obligations of that Series are currently due and payable in full (whether as a result of acceleration thereof or otherwise) in accordance with the Indenture or other applicable agreement for that Series of First Lien
Obligations; <I>provided </I>that the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative Enforcement Date shall be stayed and shall not occur and shall be deemed not to have occurred with respect to any Common
Collateral (1)&nbsp;at any time the First Lien Collateral Agent has commenced and is diligently pursuing any enforcement action with respect to such Common Collateral or (2)&nbsp;at any time the Issuer or the Secured Guarantor that has granted a
security interest in such Common Collateral is then a debtor under or with respect to (or otherwise subject to) any Insolvency or Liquidation Proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as provided above, the Applicable Authorized Representative shall have the sole right to instruct the First Lien Collateral Agent to act or refrain
from acting with respect to the Common Collateral, the First Lien Collateral Agent shall not follow any instructions with respect to such Common Collateral from any Person (other than the Applicable Authorized Representative), and no Authorized
Representative (other than the Applicable Authorized Representative) will instruct the First Lien Collateral Agent to commence any judicial or <FONT STYLE="white-space:nowrap">non-judicial</FONT> foreclosure proceedings with respect to, seek to have
a trustee, receiver, liquidator or similar official appointed for or over, attempt any action to take possession of, exercise any right, remedy or power with respect to, or otherwise take any action to enforce its interests in or realize upon, or
take any other action available to it in respect of, the Common Collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the equal priority of the Liens, the First Lien Collateral
Agent, acting on the instructions of the Applicable Authorized Representative, may deal with the Common Collateral as if such Applicable Authorized Representative had a senior Lien on such Common Collateral. No Authorized Representative of any
Series of First Lien Obligations (other than the Applicable Authorized Representative) may contest, protest or object to any foreclosure proceeding or action brought by the First Lien Collateral Agent (acting on the instruction of the Applicable
Authorized Representative) or the Applicable Authorized Representative with respect to the Common Collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a First Lien Event of Default has
occurred and is continuing and the First Lien Collateral Agent is taking action to enforce rights in respect of any Common Collateral, or any distribution is made with respect to any Common Collateral in any bankruptcy case of the Issuer or any
Secured Guarantor, the proceeds of any sale, collection or other liquidation of any such Common Collateral by the First Lien Collateral Agent or any other First Lien Secured Party, as applicable, shall be applied among the First Lien Obligations to
the payment in full of the First Lien Obligations on a ratable basis, after payment of all amounts owing to the First Lien Collateral Agent and the Authorized Representatives, in their capacities as such. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Release of collateral </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Security Agreement, if
at any time the Applicable Authorized Representative forecloses upon or otherwise exercises remedies against any Common Collateral, then (whether or not any Insolvency or Liquidation Proceeding is pending at the time) the Liens in favor of the First
Lien Collateral Agent for the benefit of the Trustee and the Holders of the Notes and each other Series of First Lien Secured Parties upon such </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Common
Collateral will automatically be released and discharged. However, any proceeds of any Common Collateral realized therefrom will be applied as described under &#147;&#151;Intercreditor provisions in the security agreement.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer and the Secured Guarantors will be entitled to the release of property and other assets
constituting Collateral from the Liens securing the Notes, the Notes Obligations and the Guarantees of the Secured Guarantors under any one or more of the following circumstances: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to enable us to consummate the sale, transfer or other disposition of such property or assets (other than to
the Issuer or a Guarantor); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of one or more Secured Guarantors that are released from their Guarantees with respect to the Notes
pursuant to the terms of the Indenture, the release of the property and assets and Equity Interests of such Secured Guarantors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the extent that such Collateral is released or no longer required to be pledged pursuant to the terms of the
Senior Credit Facility, any other First Lien Obligations and any Junior Lien Obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">with the consent of the Holders of at least 75% of the aggregate principal amount of the Notes then outstanding
and affected thereby; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as described under &#147;&#151;Release of collateral and guarantees upon investment grade rating event&#148;;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a release of assets permitted not to be included in the Collateral pursuant to clause (7)&nbsp;under
&#147;&#151;Certain limitations on the collateral&#148; in connection with a Qualified Receivables Transaction (including any Receivables Financing) permitted under the Indenture; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as described under &#147;&#151;Modification and waiver&#148; below. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Liens on the Collateral securing the Notes and the applicable Guarantees also will be released upon (i)&nbsp;payment in full of the principal of, together
with accrued and unpaid interest on, the Notes and all other Obligations under the Indenture, the Guarantees and the Security Documents that are due and payable at or prior to the time such principal, together with accrued and unpaid interest, are
paid or (ii)&nbsp;a defeasance under the Indenture as described below under &#147;&#151;Defeasance&#148; or discharge of the Issuer&#146;s and the Guarantors&#146; Obligations under the Indenture in accordance with the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Liens securing the Senior Credit Facility Obligations are released in connection with the repayment (including cash collateralization of letters of
credit) of the Senior Credit Facility Obligations in full and termination of the commitments thereunder, the Liens on the Collateral securing the Notes, the Notes Obligations and the Guarantees of the Secured Guarantors will not be released, except
to the extent the Collateral or any portion thereof was disposed of in order to repay the Senior Credit Facility Obligations secured by the Collateral. From and after any such time when all the Liens securing the First Lien Obligations other than
the Notes and the Notes Obligations are released and the Liens on the Collateral securing the Notes remain in existence, if the Issuer or any Secured Guarantor acquires any property or asset constituting Collateral, it shall grant a first-priority
perfected security interest (subject to Permitted Liens) upon such property as security for the Notes to the extent then required under &#147;&#151;After-acquired collateral.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent the Trustee is required to execute any release or to direct the First Lien Collateral Agent to execute any release, prior thereto, the Trustee
shall have received an Officers&#146; Certificate and Opinion of Counsel that all conditions precedent to such release in the Indenture and the Security Documents have been complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any certificate or opinion required by Section&nbsp;314(d) of the Trust Indenture Act may be made by an Officer of the Company, except in cases where
Section&nbsp;314(d) requires that such certificate or opinion be made by an independent engineer, appraiser or other expert. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to
the contrary herein, the Issuer and its Subsidiaries will not be required to comply with all or any portion of Section&nbsp;314(d) of the Trust Indenture Act if they determine, in good faith based on advice of counsel, that under the terms of that
section and/or any interpretation or guidance as to the meaning thereof of the SEC and its staff, including &#147;no action&#148; letters or exemptive orders, all or any portion of Section&nbsp;314(d) of the Trust Indenture Act is inapplicable to
the released Collateral. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Without limiting the generality of the foregoing, certain no action letters issued by the SEC have permitted
the release of Liens on collateral securing indebtedness issued under an indenture qualified under the Trust Indenture Act without requiring the issuer to provide certificates and other documents under Section&nbsp;314(d) of the Trust Indenture Act
where such release occurs as a result of the release of such collateral from Liens securing a credit facility or other indebtedness. In addition, certain no action letters issued by the SEC have permitted the release of collateral from Liens
securing indebtedness issued under an indenture qualified under the Trust Indenture Act resulting from transactions in the ordinary course of the issuer&#146;s business without requiring the issuer to provide such certificates and other documents.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain limitations on the collateral </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Collateral securing the Notes will not include any of the following assets: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any interest in <FONT STYLE="white-space:nowrap">fee-owned</FONT> or leased real property of the Issuer and the
Secured Guarantors (except as provided for under the &#147;&#151;Limitations on mortgages&#148; section herein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any property to the extent that such grant of a security interest is prohibited by any requirements of law of a
governmental authority, requires a consent not obtained of any governmental authority pursuant to such requirement of law or is prohibited by, or constitutes a breach or default under or results in the termination of or requires any consent not
obtained under, any contract, license, agreement, instrument or other document evidencing or giving rise to such property (other than Investment Property or Pledged Stock issued by a Subsidiary of the Issuer or a Receivables Subsidiary) or, in the
case of any Investment Property or Pledged Stock issued by a Person that is not a Subsidiary of the Issuer or a Receivables Subsidiary, any applicable shareholder or similar agreement, except to the extent that such requirement of law or the term in
such contract, license, agreement, instrument or other document or shareholder or similar agreement providing for such prohibition, breach, default or termination or requiring such consent is ineffective under applicable law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any interest in any Voting Stock that is issued by any Foreign Subsidiary, if and to the extent that the
inclusion of such Voting Stock in the Collateral would cause the Collateral pledged by the Issuer or the applicable Secured Guarantor, as the case may be, to include in the aggregate more than 65% of the total outstanding Foreign Subsidiary Voting
Stock of such Foreign Subsidiary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Letter-of-Credit</FONT></FONT> Rights that do
not constitute Supporting Obligations (each as defined in the New York UCC); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Deposit Accounts (as defined in the New York UCC); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Intellectual property to the extent perfection of a security interest therein requires any filing to be made
outside of the United States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Receivables sold, or with respect to which Participation Interests are sold, and all Related Security and
Collections with respect to such Receivables pursuant to any Receivables Financing to the extent that the aggregate outstanding amount of the purchase price or loan from the applicable lenders or investors under all Receivables Financing at any time
does not exceed the greater of (i) $600.0&nbsp;million and (ii) 50% of accounts receivable, net, as shown on the Issuer&#146;s most recent consolidated balance sheet for which internal financial statements for the Issuer are available <I>plus
</I>the allowance for doubtful accounts with respect to such accounts receivable, as set forth in the footnotes to such financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Gift Shop Assets of the Issuer and any Secured Guarantor which is a party to a Receivables Financing that
includes the Gift Shop Assets; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the assets of any Unsecured Guarantor. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sufficiency of collateral </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair market value of the
Collateral is subject to fluctuations based on factors that include, among others, the condition of the health care industry, the ability to sell the Collateral in an orderly sale, general economic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions, the availability of buyers and similar factors. The amount to be received upon a sale of the Collateral would also be dependent on numerous factors, including, but not limited to, the
actual fair market value of the Collateral at such time and the timing and the manner of the sale. By their nature, portions of the Collateral may be illiquid and may have no readily ascertainable market value. Accordingly, there can be no assurance
that the Collateral can be sold in a short period of time or in an orderly manner. In addition, in the event of a bankruptcy, the ability of the Holders to realize upon any of the Collateral may be subject to certain bankruptcy law limitations as
described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain bankruptcy limitations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
right of the First Lien Collateral Agent acting at the direction of the Applicable Authorized Representative to repossess and dispose of the Collateral upon the occurrence of an Event of Default would be significantly impaired by any Bankruptcy Law
in the event that a bankruptcy case were to be commenced by or against the Issuer or any Secured Guarantor prior to the First Lien Collateral Agent having repossessed and disposed of the Collateral. Upon the commencement of a case for relief under
the Bankruptcy Code, a secured creditor such as the First Lien Collateral Agent is prohibited from repossessing its security from a debtor in a bankruptcy case, or from disposing of security without bankruptcy court approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In view of the broad equitable powers of a U.S. bankruptcy court, it is impossible to predict how long payments under the Notes could be delayed following
commencement of a bankruptcy case, whether or when the First Lien Collateral Agent acting at the direction of the Applicable Authorized Representative could repossess or dispose of the Collateral, the value of the Collateral at any time during a
bankruptcy case or whether or to what extent Holders of the Notes would be compensated for any delay in payment or loss of value of the Collateral. The Bankruptcy Code permits the payment and/or accrual of post-petition interest, costs and
attorneys&#146; fees to a secured creditor during a debtor&#146;s bankruptcy case only to the extent the value of such creditor&#146;s interest in the Collateral is determined by the bankruptcy court to exceed the aggregate outstanding principal
amount of the obligations secured by the Collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, in the event a domestic or foreign bankruptcy court determines that the value of the
Collateral is not sufficient to repay all amounts due on the Notes, the Holders of the Notes would hold secured claims only to the extent of the value of the Collateral to which the Holders of the Notes are entitled, and unsecured claims with
respect to such shortfall. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Principal, maturity and interest </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer will issue initially $500,000,000 aggregate principal amount of 2029 Notes and $500,000,000 aggregate principal amount of 2034 Notes in this
offering. The 2029 Notes will mature on October 15, 2029 and the 2034 Notes will mature on October 15, 2034. The 2029 Notes will bear interest at the rate of 4.625% per annum and the 2034 Notes will bear interest at the rate of 5.050% per annum,
each computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months, commencing on the Issue Date. Interest on the Notes will be payable twice a year on April 15 and
October 15, beginning on April 15, 2025, for the 2029 Notes, and on April 15 and October 15, beginning on April 15, 2025, for the 2034 Notes. Interest payable on any Note that is punctually paid or duly provided for on any interest payment date
shall be paid to the person in whose name such Note is registered at the close of business on April 1 and October 1, for the 2029 Notes, or April 1 and October 1, for the 2034 Notes, as the case may be, preceding such interest payment date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer may issue additional Notes of any series from time to time after this offering under the Indenture (any such Notes of such series,
&#147;<I>Additional Notes</I>&#148;). Each series of Notes and any Additional Notes of such series subsequently issued under the Indenture will be treated as a single class for all purposes under the Indenture, including waivers, amendments,
redemptions and offers to purchase;<I> provided</I>, <I>however</I>, that any Additional Notes that are not fungible with the Notes of the applicable series for United States federal income tax purposes
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
will be issued under a separate CUSIP number. Unless the context requires otherwise, references to &#147;Notes&#148; for all purposes of the Indenture and this &#147;Description of the
notes&#148; include any Additional Notes of such series that are actually issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will be issued in book-entry form only. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mandatory redemption; offers to purchase; open market purchases </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer will not be required to make any mandatory redemption or sinking fund payments with respect to the Notes. However, under certain circumstances, the
Issuer may be required to offer to purchase Notes as described under the caption &#147;&#151;Repurchase at the option of holders.&#148; The Issuer may at any time and from time to time purchase Notes in the open market or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Optional redemption </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to September 15, 2029 (one
month prior to the maturity date of the 2029 Notes) in the case of the 2029 Notes or July 15, 2034 (three months prior to the maturity date of the 2034 Notes) in the case of the 2034 Notes (each such date, a &#147;Par Call Date&#148;), we may redeem
such Notes at our option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three&nbsp;decimal places) equal to the greater of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(a) the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the applicable Par Call Date) on a semiannual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day</FONT> months) at the Treasury Rate plus 20 basis points, in the case of the 2029 Notes, or 25 basis points, in the case of the 2034 Notes, <I>less</I> (b)&nbsp;interest accrued to, but excluding, the
redemption date, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">100% of the principal amount of the Notes to be redeemed, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>plus</I>, in either case, accrued and unpaid interest on the principal amount being redeemed to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On or after the applicable Par Call Date, we may redeem the applicable series of Notes at our option, in whole or in part, at any time and from time to time,
at a redemption price equal to 100% of the principal amount of such Notes being redeemed plus accrued and unpaid interest on the principal amount being redeemed to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Treasury Rate</I>&#148; means, with respect to any redemption date, the yield determined by us in accordance with the following two paragraphs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by us after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third business day preceding the redemption date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release
published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or publication) (&#147;<I>H.15</I>&#148;) under the caption &#147;U.S. government
securities&#151;Treasury constant maturities&#151;Nominal&#148; (or any successor caption or heading) (&#147;<I>H.15 TCM</I>&#148;). In determining the Treasury Rate, we shall select, as applicable: (1)&nbsp;the yield for the Treasury constant
maturity on H.15 exactly equal to the period from the redemption date to the applicable Par Call Date (the &#147;<I>Remaining Life</I>&#148;); or (2)&nbsp;if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life,
the two yields&#151;one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life&#151;and shall
interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on
H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such
Treasury constant maturity from the redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If on the third business day preceding the redemption date H.15 TCM or any successor designation or
publication is no longer published, we shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second business day preceding such redemption date
of the United States Treasury security maturing on, or with a maturity that is closest to, the applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the applicable Par Call Date but there are two or more
United States Treasury securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity date preceding the applicable Par Call Date and one with a maturity date following the applicable Par Call Date, we shall
select the United States Treasury security with a maturity date preceding the applicable Par Call Date. If there are two or more United States Treasury securities maturing on the applicable Par Call Date or two or more United States Treasury
securities meeting the criteria of the preceding sentence, we shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked
prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security
shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Trustee shall have no obligation to calculate or verify the calculation of the redemption price. Our actions and determinations in determining the
redemption price shall be conclusive and binding for all purposes, absent manifest error. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Redemption procedure </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any notice of any redemption may be given prior to the redemption thereof, and any such redemption or notice may, at the Issuer&#146;s discretion, be subject
to one or more conditions precedent, including, but not limited to, completion of a financing transaction or other corporate transaction. Notes called for redemption will become due on the date fixed for redemption. Notices of redemption will be
delivered at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed at its registered address. The notice of redemption for the Notes will state, among other things, the amount of Notes to be
redeemed, if less than all of the outstanding Notes are to be redeemed, the redemption date, the redemption price (or the method of calculating it) and each place that payment will be made upon presentation and surrender of Notes to be redeemed. If
the Trustee is to deliver the notice to the Holders then (i)&nbsp;the notice should be given to the Trustee at least five business days prior to the date the notice is to be delivered (or such shorter period as the Trustee shall agree) and
(ii)&nbsp;Trustee shall receive an Officers&#146; Certificate and an Opinion of Counsel. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless we default in payment of the redemption price, interest
will cease to accrue on any Notes that have been called for redemption on the redemption date. If the Issuer redeems less than all of the outstanding Notes of any series, the registrar and paying agent shall select the Notes of such series to be
redeemed in the manner described under &#147;&#151;Repurchase at the option of holders&#151;Selection and notice.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as set forth above, the
Notes will not be redeemable by us prior to maturity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Denominations, registration and transfer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer will issue the Notes in registered form and in denominations of $2,000 or any integral multiple of $1,000 in excess thereof. We have appointed the
Trustee as security registrar. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Repurchase at the option of holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change of control following a downgrade from investment grade ratings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the Issue Date, we expect the Notes to have Investment Grade Ratings from both Rating Agencies. Accordingly, the covenant described in this subsection
&#147;&#151;Change of control following a downgrade from investment grade ratings&#148; (the &#147;<I>Suspended Covenant</I>&#148;) will initially be suspended as of the Issue Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, if on any date following the Issue Date, one or both of the Rating Agencies (a)&nbsp;withdraw their Investment Grade Rating or downgrade the rating
assigned to the Notes below an Investment Grade Rating and, thereafter, the Issuer or any of its Affiliates enters into an agreement to effect a transaction that would result in a Change of Control or (b)&nbsp;the Issuer or any of its Affiliates
enters into an agreement to effect a transaction that would result in a Change of Control and one or both of the Rating Agencies indicate that if consummated, such transaction (alone or together with any related recapitalization or refinancing
transactions) would cause such Rating Agency to withdraw its Investment Grade Rating or downgrade the ratings assigned to the Notes below an Investment Grade Rating, then the Issuer and the Subsidiaries will thereafter be subject to the Suspended
Covenant under the Indenture with respect to future events, including, without limitation, a proposed transaction described in clause (b)&nbsp;above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Suspended Covenant will provide that if a Change of Control occurs, unless the Issuer has previously or concurrently delivered a redemption notice with respect to all the outstanding Notes as described under &#147;&#151;Optional redemption,&#148;
the Issuer will make an offer to purchase all of the Notes of each series pursuant to the offer described below (the &#147;<I>Change of Control Offer</I>&#148;) at a price in cash (the &#147;<I>Change of Control Payment</I>&#148;) equal to 101% of
the aggregate principal amount of the Notes of such series plus accrued and unpaid interest, if any, to the date of purchase, subject to the right of Holders of the Notes of record on the relevant record date to receive interest due on the relevant
interest payment date. Within 30 days following any Change of Control, the Issuer will deliver notice of such Change of Control Offer, with a copy to the Trustee and the registrar, to each Holder of Notes to the address of such Holder appearing in
the security register with a copy to the Trustee and the registrar, or otherwise deliver such notice in accordance with the procedures of DTC, with the following information: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that a Change of Control Offer is being made pursuant to the covenant entitled &#147;Change of control
following a downgrade from investment grade ratings&#148; and that all Notes properly tendered pursuant to such Change of Control Offer will be accepted for payment by the Issuer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the purchase price and the purchase date, which will be no earlier than 30 days nor later than 60 days from the
date such notice is delivered (the &#147;<I>Change of Control Payment Date</I>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that any Note not properly tendered will remain outstanding and continue to accrue interest;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that unless the Issuer defaults in the payment of the Change of Control Payment, all Notes accepted for payment
pursuant to the Change of Control Offer will cease to accrue interest on the Change of Control Payment Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that Holders electing to have any Notes purchased pursuant to a Change of Control Offer will be required to
surrender such Notes, with the form entitled &#147;Option of Holder to Elect Purchase&#148; on the reverse of such Notes completed, to the paying agent specified in the notice at the address specified in the notice prior to the close of business on
the third Business Day preceding the Change of Control Payment Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that Holders will be entitled to withdraw their tendered Notes and their election to require the Issuer to
purchase such Notes; <I>provided </I>that the paying agent receives, not later than the close of business on the 30th day following the date of the Change of Control notice, a facsimile transmission or letter setting forth the name of the Holder of
the Notes, the principal amount of Notes tendered for purchase, and a statement that such Holder is withdrawing its tendered Notes and its election to have such Notes purchased; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that Holders tendering less than all of their Notes of any series will be issued new Notes of such series and
such new Notes will be equal in principal amount to the unpurchased portion of the Notes of such series </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
surrendered. The unpurchased portion of the Notes of such series must be equal to $2,000 or an integral multiple of $1,000 in excess thereof; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the other instructions, as determined by us, consistent with the covenant described hereunder, that a Holder
must follow. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer will comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act
and any other securities laws and regulations thereunder to the extent such laws or regulations are applicable in connection with the repurchase of Notes pursuant to a Change of Control Offer. To the extent that the provisions of any securities laws
or regulations conflict with the provisions of the Indenture, the Issuer will comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations described in the Indenture by virtue thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the Issuer will, to the extent permitted by law, </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">accept for payment all Notes issued by it or portions thereof properly tendered pursuant to the Change of
Control Offer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deposit with the paying agent an amount equal to the aggregate Change of Control Payment in respect of all
Notes or portions thereof so tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deliver, or cause to be delivered, to the Trustee for cancellation the Notes so accepted together with an
Officers&#146; Certificate to the Trustee stating the aggregate principal amount of such Notes or portions thereof that have been tendered to and purchased by the Issuer and an Opinion of Counsel, in each case, stating that all conditions precedent
to the consummation of the Change of Control Offer have been complied with. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Senior Credit Facility provides, and future credit
agreements or other agreements relating to senior Indebtedness to which the Issuer becomes a party may provide, that certain change of control events with respect to the Issuer would constitute a default thereunder (including a Change of Control
under the Indenture). If we experience a change of control that triggers a default under our Senior Credit Facility, we could seek a waiver of such default or seek to refinance our Senior Credit Facility. In the event we do not obtain such a waiver
or refinance the Senior Credit Facility, such default could result in amounts outstanding under our Senior Credit Facility being declared due and payable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer&#146;s ability to pay cash to the Holders of the Notes following the occurrence of a Change of Control may be limited by its then-existing
financial resources. Therefore, sufficient funds may not be available when necessary to make any required repurchases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Change of Control purchase
feature of the Notes may in certain circumstances make more difficult or discourage a sale or takeover of us and, thus, the removal of incumbent management. The Change of Control purchase feature is a result of negotiations between the Underwriters
and us. We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we could decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions,
refinancings or other recapitalizations, that would not constitute a Change of Control under the Indenture, but that could increase the amount of Indebtedness outstanding at such time or otherwise affect our capital structure or credit ratings.
Certain provisions under the Indenture relative to the Issuer&#146;s obligation to make an offer to repurchase the Notes as a result of a Change of Control may be waived or modified with the written consent of the Holders of a majority in principal
amount of the Notes. The Indenture will not contain any covenants or provisions that may afford Holders of the Notes protection in the event of a highly leveraged transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer will not be required to make a Change of Control Offer following a Change of Control if a third party makes the Change of Control Offer in the
manner, at the times and otherwise in compliance with the requirements set forth in the Indenture applicable to a Change of Control Offer made by us and purchases all Notes validly tendered and not withdrawn under such Change of Control Offer.
Notwithstanding anything to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
contrary herein, a Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change of Control, if a definitive agreement is in place for the Change of Control
at the time of making of the Change of Control Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The definition of &#147;Change of Control&#148; includes a disposition of all or substantially all
of the assets of the Issuer to any Person. Although there is a limited body of case law interpreting the phrase &#147;substantially all,&#148; there is no precise established definition of the phrase under applicable law. Accordingly, in certain
circumstances there may be a degree of uncertainty as to whether a particular transaction would involve a disposition of &#147;all or substantially all&#148; of the assets of the Issuer. As a result, it may be unclear as to whether a Change of
Control has occurred and whether a Holder of Notes may require the Issuer to make an offer to repurchase the Notes as described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The provisions
under the Indenture relating to the Issuer&#146;s obligation to make an offer to repurchase the Notes as a result of a Change of Control may be waived or modified with the written consent of the Holders of a majority in principal amount of the
Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selection and notice </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Issuer is
redeeming less than all of the Notes of any series issued by it at any time, the Notes of such series will be selected for redemption (a)&nbsp;if the Notes of such series are listed on any national securities exchange, in compliance with the
requirements of the principal national securities exchange on which the Notes of such series are listed, (b)&nbsp;on a pro rata basis to the extent practicable or (c)&nbsp;by lot or such other similar method in accordance with the procedures of DTC.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notices of purchase or redemption shall be delivered at least 10 days (or, the case of notice under &#147;&#151;Repurchase at the option of
holders&#151;Change of control following a downgrade from investment grade ratings,&#148; 30 days) but not more than 60 days before the purchase or redemption date to each Holder of Notes at such Holder&#146;s registered address or otherwise in
accordance with the procedures of DTC, except that redemption notices may be delivered more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the Notes or a satisfaction and discharge of the
Indenture. If any Note of a series is to be purchased or redeemed in part only, any notice of purchase or redemption that relates to such Note of such series shall state the portion of the principal amount thereof that has been or is to be purchased
or redeemed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer will issue a new Note of any series in a principal amount equal to the unredeemed portion of the original Note of such series in
the name of the Holder upon cancellation of the original Note. Notes called for redemption become due on the date fixed for redemption. On and after the redemption date, interest ceases to accrue on Notes of such series or portions thereof called
for redemption. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Release of collateral and guarantees upon investment grade rating event </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If on any date following the Issue Date, (a)(i) the Notes have Investment Grade Ratings from both Rating Agencies and (ii)&nbsp;no Default has occurred and is
continuing under the Indenture (the occurrence of the events described in the foregoing clauses (i)&nbsp;and (ii)&nbsp;being collectively referred to as an &#147;<I>Investment Grade Rating Event</I>&#148;), and (b)&nbsp;the terms of all other First
Lien Obligations and Junior Lien Obligations provide that the Liens on the Collateral securing such First Lien Obligations and Junior Lien Obligations shall be, and substantially concurrently are, released, then, beginning on that day (such date,
the &#147;<I>Collateral Release Date</I>&#148;), the Guarantees shall be released (to the extent the guarantees by the Guarantors of all other First Lien Obligations and Junior Lien Obligations are also released, whether or not such other guarantees
can be reinstated), the Liens on the Collateral securing the Notes, the Notes Obligations and the Guarantees of the Secured Guarantors shall be released, and the Issuer and its Restricted Subsidiaries will not be subject to the covenant under
&#147;&#151;Additional subsidiary guarantees&#148; (the &#147;<I>Guarantees Covenant</I>&#148;) or the covenant under &#147;&#151;After-acquired collateral.&#148; In the event the Collateral and Guarantees are released and the Guarantees Covenant is
no longer in effect upon an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Investment Grade Rating Event, the Collateral and the Guarantees will not be reinstated upon any subsequent downgrade or withdrawal of the Investment Grade Ratings, even if the Collateral and the
Guarantees are reinstated with respect to other First Lien Obligations and Junior Lien Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the Issue Date, we expect the Notes to have
Investment Grade Ratings from both Rating Agencies and that an Investment Grade Rating Event will have occurred. However, as of the Issue Date, the condition in clause (b)&nbsp;of the preceding paragraph has not been met because the conditions to
the release of the Collateral under the Senior Credit Facility have not been met. In order for the Collateral to be released under the terms of the Senior Credit Facility, we must receive an investment grade corporate rating from both Moody&#146;s
and S&amp;P, no default or event of default shall have occurred and be continuing under the Senior Credit Facility and the Liens on the Collateral securing the Existing 2026 Notes, the Existing 2030 Notes, the Existing 2032 Notes and the Notes must
be released contemporaneously. Accordingly, if we were to receive investment grade corporate ratings from both Rating Agencies and the other conditions to release of the Collateral under the Senior Credit Facility were met, or if we were to amend
the Senior Credit Facility in the future to otherwise permit the release of the Collateral, the Collateral securing the Notes and the Guarantees would be released. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain covenants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth below are summaries of
certain covenants contained in the Indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Limitations on mortgages </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nothing in the Indenture or in the Notes shall in any way restrict or prevent the Issuer or any Subsidiary from incurring any Indebtedness; <I>provided</I>,
<I>however</I>, that the Indenture will provide that neither the Issuer nor any of its Subsidiaries will issue, assume or guarantee any Indebtedness or obligation secured by Mortgages (other than Permitted Liens) upon any Principal Property, unless
the Notes shall be secured equally and ratably with (or prior to) such Indebtedness. This restriction will not apply to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages securing all or any part of the purchase price of property acquired or cost of construction of
property or cost of additions, substantial repairs, alterations or improvements or property, if the Indebtedness and the related Mortgages are incurred within 12 months of the later of the acquisition or completion of construction and full operation
or additions, repairs, alterations or improvements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages existing on property at the time of its acquisition by the Issuer or a Subsidiary or on the property
of a Person at the time of the acquisition of such Person by the Issuer or a Subsidiary (including acquisitions through merger or consolidation); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages to secure Indebtedness on which the interest payments to holders of the related Indebtedness are
excludable from gross income for federal income tax purposes under Section&nbsp;103 of the Code; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages in favor of the Issuer or any Subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages existing on the date of the Indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages in favor of a government or governmental entity that (i)&nbsp;secure Indebtedness which is guaranteed
by the government or governmental entity, (ii)&nbsp;secure Indebtedness incurred to finance all or some of the purchase price or cost of construction of goods, products or facilities produced under contract or subcontract for the government or
governmental entity, or (iii)&nbsp;secure Indebtedness incurred to finance all or some of the purchase price or cost of construction of the property subject to the Mortgage; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages incurred in connection with the borrowing of funds where such funds are used to repay, within 120
days after entering into such Mortgage, Indebtedness in the same principal amount secured by other Mortgages on Principal Property with at least the same appraised Fair Market Value; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extension, renewal or replacement of any Mortgage referred to in clauses (a)&nbsp;through (g) above;
<I>provided</I> the amount secured is not increased and such extension, renewal or replacement Mortgage relates to the same property. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Limitations on sale and lease-back transactions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Indenture will provide that neither the Issuer nor any Subsidiary will, after the Issue Date, enter into any Sale and Lease-Back Transaction with respect
to any Principal Property with another person (other than with the Issuer or a Subsidiary) unless either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer or such Subsidiary could incur Indebtedness secured by a mortgage on the property to be leased
without equally and ratably securing the Notes; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">within 150 days, the Issuer applies the greater of the net proceeds of the sale of the leased property or the
fair value of the leased property, net of all Notes delivered under the Indenture, to the voluntary retirement of the Funded Debt of the Issuer and its Restricted Subsidiaries and/or the acquisition or construction of a Principal Property.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing limitation shall not apply to any Sale and Lease-Back Transaction that is in effect on the Issue Date and any renewals or
extensions thereof; <I>provided </I>that if any Principal Property is substituted for a Principal Property that is a subject of a Sale and Lease-Back Transaction that is in effect on the Issue Date, for purposes of &#147;&#151;Certain
covenants&#151;Exempted transactions,&#148; any increase in Attributable Indebtedness shall be counted as Indebtedness for purposes of the calculation set forth thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exempted transactions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the
foregoing provisions described above under &#147;&#151;Limitations on mortgages&#148; and &#147;&#151;Limitations on sale and lease-back transactions,&#148; if the aggregate outstanding principal amount of all Indebtedness of the Issuer and its
Subsidiaries that is subject to and not otherwise permitted under these restrictions does not exceed 15.0% of the Consolidated Net Tangible Assets of the Issuer and its Subsidiaries, then: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer or any of its Subsidiaries may issue, assume or guarantee Indebtedness secured by Mortgages without
any requirement to equally and ratably secure the notes; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer or any of its Subsidiaries may enter into any Sale and Lease-Back Transaction.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Additional subsidiary guarantees </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At any time prior to the Collateral Release Date, if any Restricted Subsidiary of the Issuer other than a Guarantor (i)&nbsp;guarantees any Indebtedness under
the Senior Credit Facility, any other First Lien Obligations or any Junior Lien Obligations or (ii)&nbsp;if the Issuer or the Guarantors have no Indebtedness outstanding, and all commitments thereunder have been terminated under the Senior Credit
Facility, any other First Lien Obligations or any Junior Lien Obligations, guarantees any Additional Indebtedness, then within 30 days thereof, the Issuer shall cause such Restricted Subsidiary to execute and deliver to the Trustee a supplemental
indenture pursuant to which such Restricted Subsidiary will guarantee payment of the Notes on the same terms and conditions as those applicable to the Guarantors under the Indenture and will deliver to the Trustee an Officers&#146; Certificate and
Opinion of Counsel that such supplemental indenture is authorized or permitted by the Indenture, and an Opinion of Counsel that such supplemental indenture has been duly authorized, executed and delivered and constitutes a legally valid and
enforceable obligation (subject to customary qualifications and exceptions). In addition, at any time prior to the Collateral Release Date, if such Restricted Subsidiary grants any Lien to secure any Indebtedness described in clause (i)&nbsp;or
(ii)&nbsp;above, such Restricted Subsidiary shall grant a first-priority perfected security interest in the Collateral as security for the Notes, shall execute and deliver to the Trustee joinders to any applicable Security Document for the benefit
of the holders of the Notes and shall be a &#147;Secured Guarantor&#148; for all purposes under the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thereafter, such Restricted Subsidiary
will be a Guarantor with respect to the Notes until such Restricted Subsidiary&#146;s Guarantee with respect to the Notes is released in accordance with the Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Issuer may elect, in its sole discretion, to cause any Restricted Subsidiary that is not
otherwise required to be a Guarantor to become a Guarantor by complying with the applicable provisions of the second preceding paragraph until such Restricted Subsidiary&#146;s Guarantee with respect to the Notes is released in accordance with the
Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, any Restricted Subsidiary that becomes a Guarantor pursuant to the third preceding paragraph will be an Unsecured
Guarantor unless such Restricted Subsidiary grants any Lien to secure any Indebtedness described in clause (i)&nbsp;or (ii)&nbsp;of the third preceding paragraph above, in which case, and only such case, such Restricted Subsidiary shall grant a
first-priority perfected security interest in the Collateral as security for the Notes and shall execute and deliver to the Trustee joinders to any applicable Security Document for the benefit of the holders of the Notes, upon which such Restricted
Subsidiary shall be a &#147;Secured Guarantor&#148; for all purposes under the Indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SEC reports </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding that the Issuer may not be subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act or otherwise report on an
annual and quarterly basis on forms provided for such annual and quarterly reporting pursuant to rules and regulations promulgated by the SEC, if not filed electronically with the SEC through EDGAR (or any successor system), the Issuer will file
with the SEC (to the extent permitted by the Exchange Act), and make available to the Trustee and the Holders, without cost to any Holder, the annual and quarterly reports and the information, documents and other reports (or copies of such portions
of any of the foregoing as the SEC may by rules and regulations prescribe) that are specified in Sections 13 and 15(d) of the Exchange Act with respect to U.S. issuers within the time periods specified therein or in the relevant forms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that the Issuer is not permitted to file such reports, documents and information with the SEC pursuant to the Exchange Act, the Issuer will
nevertheless make available such Exchange Act reports, documents and information to the Trustee and the Holders as if the Issuer were subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act within the time periods
specified therein or in the relevant forms, which requirement may be satisfied by posting such reports, documents and information on its website within the time periods specified by this covenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, no later than five Business Days after the date the quarterly and annual financial information for the prior fiscal period have been furnished
pursuant to the two preceding paragraphs, the Issuer shall also hold live quarterly conference calls with the opportunity to ask questions of management. No fewer than three Business Days prior to the date such conference call is to be held, the
Issuer shall issue a press release to the appropriate U.S. wire services announcing such quarterly conference call for the benefit of the Trustee, the Holders, beneficial owners of the Notes, prospective investors in the Notes, and securities
analysts and market making financial institutions, which press release shall contain the time and the date of such conference call and direct the recipients thereof to contact an individual at the Issuer (for whom contact information shall be
provided in such notice) to obtain information on how to access such quarterly conference call. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Issuer has designated any of its Subsidiaries as
Unrestricted Subsidiaries and such Unrestricted Subsidiaries, either individually or collectively, would otherwise have been a Significant Subsidiary, then the quarterly and annual financial information required by the second and third preceding
paragraphs shall include a reasonably detailed presentation, as determined in good faith by Senior Management of the Issuer, either on the face of the financial statements or in the footnotes to the financial statements and in the
&#147;Management&#146;s discussion and analysis of financial condition and results of operations&#148; section, of the financial condition and results of operations of the Issuer and its Restricted Subsidiaries separate from the financial condition
and results of operations of the Unrestricted Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this covenant, the Issuer and the Guarantors will be deemed to have furnished
the reports to the Trustee and the Holders as required by this covenant if the Issuer has filed such reports with the SEC via the EDGAR filing system and such reports are publicly available. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Indenture, an &#147;<I>Event of Default</I>&#148; applicable to the Notes of any series means: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to pay the principal or any premium on the Notes of such series when due; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to pay any interest on the Notes of such series when due, and such default continues for a period of 30
days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to perform, or the breach of, any of our other applicable covenants or warranties in the Indenture with
respect to such series, and such default continues for a period of 60 days after written notice by Holders of at least 25% in principal amount of the outstanding Notes of such series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default under any mortgage, indenture or instrument under which there is issued or by which there is secured or
evidenced any Indebtedness for money borrowed by the Issuer or any of its Restricted Subsidiaries (or the payment of which is guaranteed by the Issuer or any of its Restricted Subsidiaries), other than Indebtedness owed to the Issuer or a Restricted
Subsidiary, whether such Indebtedness or guarantee now exists, or is created after the Issue Date, which default: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">is caused by a failure to pay principal of, or interest or premium, if any, on such Indebtedness prior to the
expiration of the grace period provided in such Indebtedness (&#147;<I>payment default</I>&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results in the acceleration of such Indebtedness prior to its maturity (the &#147;<I>cross acceleration
provision</I>&#148;), </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">and, in each case, the principal amount of any such Indebtedness, together with the principal
amount of any other such Indebtedness under which there has been a payment default or the maturity of which has been so accelerated, aggregates $100.0&nbsp;million or more; <I>provided </I>that in connection with any series of Convertible Notes,
(a)&nbsp;any conversion of such Indebtedness by a holder thereof into shares of Common Stock, cash or a combination of cash and shares of Common Stock, (b)&nbsp;the rights of holders of such Indebtedness to convert into shares of Common Stock, cash
or a combination of cash and shares of Common Stock and (c)&nbsp;the rights of holders of such Indebtedness to require any repurchase by the Issuer of such Indebtedness in cash upon a fundamental change shall not, in itself, constitute an Event of
Default under this clause. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by the Issuer or any Significant Subsidiary or group of Restricted Subsidiaries that, taken together (as
of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary to pay final judgments aggregating in excess of $100.0&nbsp;million (net of any amounts that a
reputable and creditworthy insurance company has acknowledged liability for in writing), which judgments are not paid, discharged or stayed for a period of 60 days or more after such judgment becomes final (the &#147;<I>judgment default
provision</I>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">events in bankruptcy, insolvency or reorganization of the Issuer or any Significant Subsidiary or group of
Restricted Subsidiaries that, taken together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Guarantee of any Significant Subsidiary or group of Guarantors that, taken together (as of the latest audited
consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary shall for any reason cease to be in full force and effect or be declared null and void or any responsible officer of any
Guarantor that is a Significant Subsidiary or group of Guarantors that, taken together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary, as the
case may be, denies that it has any further liability under its Guarantee or gives notice to such effect, other than by reason of the termination of the Indenture or the release of any such Guarantee in accordance with the Indenture; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent applicable, with respect to any Collateral having a Fair Market Value in excess of
$100.0&nbsp;million, individually or in the aggregate, (a)&nbsp;the security interest under the Security Documents, at any time, ceases to be in full force and effect for any reason other than in accordance with the terms of the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Indenture and the Security Documents, (b)&nbsp;any security interest created thereunder or under the Indenture is declared invalid or unenforceable by a court of competent jurisdiction or
(c)&nbsp;the Issuer or any Secured Guarantor asserts, in any pleading in any court of competent jurisdiction, that any such security interest is invalid or unenforceable. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any Event of Default (other than events in bankruptcy, insolvency or reorganization) with respect to the Notes of a series occurs and is continuing, either
the Trustee or the Holders of at least 25% in aggregate principal amount of the outstanding Notes of such series may declare the principal amount of, premium, if any, and accrued and unpaid interest, if any, on all the Notes of such series to be due
and payable immediately. If an Event of Default constituting an event in bankruptcy, insolvency or reorganization above occurs and is continuing, the principal of, premium, if any, and accrued and unpaid interest, if any, on all the Notes of such
series will become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. The Holders of a majority in principal amount of the outstanding Notes of a series may waive all past defaults
(except with respect to nonpayment of principal, premium or interest) and rescind any such acceleration with respect to the Notes of such series and its consequences if (1)&nbsp;rescission would not conflict with any judgment or decree of a court of
competent jurisdiction, (2)&nbsp;all existing Events of Default, other than the nonpayment of the principal of, premium, if any, and interest on the Notes of such series that have become due solely by such declaration of acceleration, have been
cured or waived, and (3)&nbsp;all amounts due to the Trustee in each of its capacities under the Indenture have been paid in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a
declaration of acceleration of the Notes of a series because an Event of Default described in the fourth bullet point of the second preceding paragraph has occurred and is continuing, the declaration of acceleration of the Notes of such series shall
be automatically annulled if the default triggering such Event of Default shall be remedied or cured by the Issuer or a Restricted Subsidiary or waived by the holders of the relevant Indebtedness within 20 days after the declaration of acceleration
with respect thereto and if (1)&nbsp;the annulment of the acceleration of the Notes of such series would not conflict with any judgment or decree of a court of competent jurisdiction and (2)&nbsp;all existing Events of Default, except nonpayment of
principal, premium, if any, or interest on the Notes of such series that became due solely because of the acceleration of the Notes of such series, have been cured or waived. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than the duties of the Trustee during a default to act with the required standard of care, the Trustee is not obligated to exercise any of its rights or
powers under the Indenture at the request or direction of any of the Holders unless the Holders shall have offered to the Trustee indemnity and/or security satisfactory to it. Subject to these indemnification provisions and the other terms of the
Indenture, the Holders of a majority in aggregate principal amount of the outstanding Notes of the applicable series may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust
or power conferred on the Trustee, with respect to the Notes of such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will furnish the Trustee annually with a statement as to our performance
of certain obligations under the Indenture. Upon becoming aware of any Default or Event of Default, we will deliver to the Trustee a notice specifying such Default or Event of Default. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and waiver </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Without holder consent
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Without the consent of any Holders of Notes of the applicable series, the Issuer, any Guarantor (with respect to a Guarantee or the Indenture to
which it is a party) and the Trustee may amend or supplement the Indenture, any Security Document and any Guarantee or Notes of such series for any of the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to evidence the succession of another corporation to the Issuer and the assumption by such successor of the
covenants of the Issuer in compliance with the requirements set forth in the Indenture; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add to the covenants for the benefit of the Holders or to surrender any right or power herein conferred upon
the Issuer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add any additional Events of Default; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to change or eliminate any of the provisions of the Indenture; <I>provided </I>that any such change or
elimination shall become effective only when there are no outstanding Notes of such series created prior to the execution of such supplemental indenture that are entitled to the benefit of such provision and as to which such supplemental indenture
would apply; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add a Guarantor to the Notes of such series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to supplement any of the provisions of the Indenture to such extent necessary to permit or facilitate the
defeasance and discharge of the Notes of such series; <I>provided </I>that any such action does not adversely affect the interests of the Holders of the Notes of such series in any material respect; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to evidence and provide for the acceptance of appointment hereunder by a successor Trustee or collateral agent
and to add to or change any of the provisions of the Indenture necessary to provide for or facilitate the administration of the trusts by more than one Trustee or for the Trustee to act as collateral agent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to cure any ambiguity, to correct or supplement any provision of the Indenture which may be defective or
inconsistent with any other provision; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to conform the text of the Indenture, the Notes of such series, the Guarantees or the Security Documents to any
provision of this &#147;Description of the notes&#148; section to the extent that such provision in such &#147;Description of the notes&#148; section was intended to be a verbatim recitation of a provision of the Indenture, the Notes of such series,
the Guarantees or the Security Documents; <I>provided </I>that, in each instance, the Issuer delivers to the Trustee an Officers&#146; Certificate to such effect; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to change any place or places where the principal of and premium, if any, and interest, if any, on the Notes of
such series shall be payable, the Notes of such series may be surrendered for registration or transfer, the Notes of such series may be surrendered for exchange, and notices and demands to or upon the Issuer may be served; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to mortgage, pledge, hypothecate or grant any other Lien in favor of the First Lien Collateral Agent for the
benefit of the Trustee and the Holders of the Notes of such series, as additional security for the payment and performance of all or any portion of the Obligations, in any property or assets, including any which are required to be mortgaged, pledged
or hypothecated, or in which a Lien is required to be granted in favor of the First Lien Collateral Agent for the benefit of the Trustee and the Holders of the Notes of such series pursuant to the Indenture, any of the Security Documents or
otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to release Collateral from the Lien of the Indenture and the Security Documents when permitted or required by
the Security Documents or the Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add Additional First Lien Secured Parties to any Security Documents in accordance with such Security
Documents; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">comply with any requirement of the SEC in connection with any required qualification of the Indenture under the
Trust Indenture Act. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the incurrence of any Junior Lien Obligations permitted under the terms of the Indenture,
without the consent of any Holder of Notes of such series, the First Lien Collateral Agent shall, on behalf of the holders of the First Lien Obligations, enter into a customary intercreditor agreement with the representative of such Junior Lien
Obligations. The Trustee and First Lien Collateral Agent shall be entitled to rely upon an Officers&#146; Certificate certifying that such Junior Lien Obligations, as the case may be, were incurred and secured in compliance with the Indenture and
the Security Documents, and no Opinion of Counsel shall be required in connection therewith (unless the Trustee is an Applicable Authorized Representative). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>With holder consent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer and the Trustee may modify and amend the Indenture, any Guarantee or any Security Document with the consent of the Holders of a majority in
aggregate principal amount of the outstanding Notes of the applicable series; however, we must have the consent of the Holder of each outstanding Note of such series affected to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">change the stated maturity of the principal of, or installment of interest, if any, on, such Notes of such
series, or reduce the principal amount thereof or the interest thereon or any premium payable upon redemption thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">change the currency in which the principal of (and premium, if any) or interest on such Notes of such series
are denominated or payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">waive a Default or Event of Default in the payment of principal of, premium, if any, or interest on the Notes
of such series (except a rescission of acceleration of the Notes of such series by the Holders of at least a majority in aggregate principal amount of the then outstanding Notes of such series with respect to a nonpayment default and a waiver of the
payment default that resulted from such acceleration); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reduce the premium payable upon the redemption or repurchase of any Note of such series or change the time at
which any Note of such series may be redeemed or repurchased as described above under &#147;&#151;Optional redemption&#148; or &#147;&#151;Repurchase at the option of holders&#151;Change of control following a downgrade from investment grade
ratings,&#148; whether through an amendment or waiver of provisions in the covenants, definitions or otherwise (except amendments to the definitions of &#147;Change of Control&#148; and &#147;Permitted Holders&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">impair the right of any Holder to receive payment of principal of, premium, if any, or interest on such
Holder&#146;s Notes of such series on or after the due dates therefor or impair the right to institute suit for the enforcement of any payment on or after the stated maturity thereof (or, in the case of redemption, on or after the redemption date);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">modify the provisions that require Holder consent to modify or amend the Indenture or that permit Holders to
waive compliance with certain provisions of the Indenture or certain defaults; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make any change to or modify the ranking of such Notes of such series or the ranking of the Liens with respect
to such Notes of such series that would adversely affect the Holders; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">except as expressly permitted by the Indenture, modify the Guarantees of any Significant Subsidiary in any
manner adverse to the Holders of the Notes of such series. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, without the consent of at least 75% in aggregate principal
amount of Notes of such series then outstanding, an amendment, supplement or waiver may not modify any Security Document or the provisions of the Indenture dealing with the Security Documents or application of trust moneys, or otherwise release any
Collateral, in any manner materially adverse to the Holders of the Notes of such series other than in accordance with the Indenture and the Security Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Holders of a majority in aggregate principal amount of the outstanding Notes of the applicable series may, on behalf of all Holders of Notes of such
series, waive any past default under the Indenture with respect to Notes of such series. However, such Holders may not waive a past default in the payment of principal, premium or interest, or any sinking fund installment with respect to the Notes
of such series, or waive a covenant or provision that cannot be modified or amended, without the consent of the Holders of each outstanding Note of such series affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, merger, sale or lease of assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer may consolidate with or merge into, or transfer or lease all or substantially all of its assets to, another Person (whether or not the Issuer is the
surviving corporation) without the consent of the Holders of the Notes under the Indenture if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Issuer is the surviving entity or the Person formed by or surviving any such consolidation or merger, or to
whom any such transfer or lease will have been made, is a corporation, partnership, limited partnership, limited liability corporation or trust organized or existing under the laws of the United States, any state thereof, the District of Columbia,
or any territory thereof (the Issuer or such Person, as the case may be, being herein called the &#147;<I>Successor Person</I>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Successor Person assumes the Issuer&#146;s obligations under the Notes and under the Indenture, as if the
Successor Person were an original party to the Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">after giving effect to such consolidation or merger or such conveyance, transfer or lease, no Event of Default,
and no event which, after notice or lapse of time or both, would become an Event of Default, shall have occurred and be continuing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, as a result of any such consolidation or merger or such conveyance, transfer or lease, properties or assets
of the Issuer would become subject to a mortgage, pledge, lien, security interest or other encumbrance that would not be permitted by the Indenture, the Issuer or the Successor Person, as the case may be, shall take such steps as shall be necessary
to effectively secure all the Notes equally and ratably with (or prior to) all Indebtedness secured thereby; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each Guarantor, unless it is the other party to the transactions described above, shall have by supplemental
indenture confirmed that its Guarantee shall apply to such Person&#146;s obligations under the Indenture and the Notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the Collateral Release Date, the Collateral owned by the Successor Person will (a)&nbsp;continue to
constitute Collateral under the Indenture and the Security Documents, (b)&nbsp;be subject to a Lien in favor of the First Lien Collateral Agent for the benefit of the Trustee and the Holders of the Notes and (c)&nbsp;not be subject to any other
Lien, other than Permitted Liens; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the Collateral Release Date, to the extent any assets of the Person which is merged or consolidated with
or into the Successor Person are assets of the type which would constitute Collateral under the Security Documents, the Successor Person will take such action as may be reasonably necessary to cause such property and assets to be made subject to the
Lien of the Security Documents in the manner and to the extent required in the Indenture or any of the Security Documents and shall take all reasonably necessary action so that such Lien is perfected to the extent required by the Security Documents;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Issuer has delivered to the Trustee an Officers&#146; Certificate and an Opinion of Counsel each stating that
such consolidation, merger, conveyance, transfer or lease and such supplemental indenture comply with this covenant and that all conditions precedent (including, without limitation, under the Indenture and the Security Documents) provided for
relating to such transaction have been complied with. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to certain limitations described in the Indenture, the Successor Person
will succeed to, and be substituted for, the Issuer under the Notes and the Guarantees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Defeasance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may, upon compliance with the conditions described in this paragraph, exercise our option to be discharged from our obligations under the applicable series
of Notes (except for certain obligations, including obligations to issue temporary Notes, register Notes, replace mutilated, destroyed, lost or stolen Notes and maintain an office or agency for payment and money for Note payments held in trust).
Upon our exercise of such option, we will not be subject to the limitations in the Indenture discussed in the above sections (&#147;<I>legal defeasance</I>&#148;). In order to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exercise this legal defeasance option, we must, among other things, (i)&nbsp;deposit with the Trustee, for the benefit of the Holders, trust money or U.S. government obligations that are
sufficient (as certified by a nationally recognized independent public accountant designated by the Issuer) to pay all principal, premium and interest on the Notes of such series, (ii)&nbsp;deliver to the Trustee an Opinion of Counsel to the effect
that the deposit and related legal defeasance would not cause the beneficial owners of the Notes of such series to recognize income, gain or loss for United States federal income tax purposes (which Opinion of Counsel shall be based on a ruling from
the Internal Revenue Service or a change in applicable United States federal income tax law) and (iii)&nbsp;deliver to the Trustee an Officers&#146; Certificate and an Opinion of Counsel to the effect that (a)&nbsp;the deposit and related legal
defeasance would not&nbsp;result in the delisting of the Notes of such series from any national securities exchange (if so listed) and (b)&nbsp;all conditions precedent under the Indenture and the Security Documents relating to the legal defeasance
of the Notes of such series have been complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also, upon compliance with the conditions described in this paragraph, exercise our option to
be released from our obligations under the covenants described under &#147;&#151;Certain covenants,&#148; &#147;&#151;Repurchase at the option of holders&#148; and &#147;&#151;SEC reports&#148; with respect to the applicable series of Notes. Upon
our exercise of such option, we may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, and such omission to comply shall not constitute a Default or an Event of Default
(&#147;<I>covenant</I> <I>defeasance</I>&#148;). In order to exercise this covenant defeasance option, we must, among other things, (i)&nbsp;deposit with the Trustee, for the benefit of the Holders, trust money or U.S. government obligations that
are sufficient (as certified by a nationally recognized independent public accountant designated by the Issuer) to pay all principal, premium and interest on the Notes of such series, (ii)&nbsp;deliver to the Trustee an Opinion of Counsel to the
effect that the deposit and related covenant defeasance would not cause the beneficial owners of the Notes of such series to recognize income, gain or loss for United States federal income tax purposes and (iii)&nbsp;deliver to the Trustee an
Officers&#146; Certificate and an Opinion of Counsel to the effect that (a)&nbsp;the deposit and related covenant defeasance would not&nbsp;result in the delisting of the Notes of such series from any national securities exchange (if so listed) and
(b)&nbsp;all conditions precedent under the Indenture and the Security Documents relating to the covenant defeasance of the Notes of such series have been complied with. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notices </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notices to Holders will be delivered to the
addresses of the holders listed in the security register. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will construe the Indenture and the Notes in accordance with the laws of the State of New York. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concerning the trustee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Trustee has normal banking
relationships with us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain definitions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Additional First Lien Obligations</I>&#148; means Obligations in respect of any Indebtedness incurred after the Issue Date that is secured by a Lien
on the Common Collateral pursuant to the applicable First Lien Security Documents, which Lien is permitted to be incurred under the Indenture, the Security Documents and all other then-existing First Lien Security Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Additional First Lien Secured Parties</I>&#148; means the holders of any Additional First Lien Obligations and any Authorized Representative with
respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Additional Indebtedness</I>&#148; means Indebtedness of the Issuer for borrowed money (excluding Indebtedness under the Senior
Credit Facility, any First Lien Obligations or any Junior Lien Obligations) under any debt securities or term loans broadly syndicated to institutional investors in a principal amount in excess of $50.0&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Affiliate</I>&#148; of any specified Person means any other Person directly or indirectly
controlling or controlled by or under direct or indirect common control with such specified Person. For purposes of this definition, &#147;<I>control</I>&#148; (including, with correlative meanings, the terms &#147;<I>controlling</I>,&#148;
&#147;<I>controlled by</I>&#148; and &#147;<I>under common control with</I>&#148;), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of
such Person, whether through the ownership of voting securities, by agreement or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Applicable Authorized Representative</I>&#148;
means, (1)&nbsp;with respect to any Common Collateral, (i)&nbsp;until the earlier of (x)&nbsp;the Discharge of Senior Credit Facility Obligations and (y)&nbsp;the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative
Enforcement Date, the administrative agent under the Senior Credit Facility and (ii)&nbsp;from and after the earlier of (x)&nbsp;the Discharge of Senior Credit Facility Obligations and (y)&nbsp;the
<FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative Enforcement Date, the Major <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative and (2)&nbsp;with respect to any Collateral that is not
Common Collateral, the Authorized Representative of the Series of First Lien Obligations that is secured by such Collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt,
with respect to actions with respect to Collateral that is not Common Collateral, (a)&nbsp;the Authorized Representative of the Series of First Lien Obligations secured by such Collateral shall have the sole right to instruct the First Lien
Collateral Agent to act or refrain from acting with respect to the Collateral that is not Common Collateral, (b)&nbsp;the First Lien Collateral Agent shall not follow any instructions with respect to such Collateral that is not Common Collateral
from any Person (other than such Authorized Representative), and (c)&nbsp;no Authorized Representative (other than the Authorized Representative of the Series of First Lien Obligations secured by such Collateral) will instruct the First Lien
Collateral Agent to commence any judicial or <FONT STYLE="white-space:nowrap">non-judicial</FONT> foreclosure proceedings with respect to, seek to have a trustee, receiver, liquidator or similar official appointed for or over, attempt any action to
take possession of, exercise any right, remedy or power with respect to, or otherwise take any action to enforce its interests in or realize upon, or take any other action available to it in respect of, the Collateral that is not Common Collateral.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Attributable Indebtedness</I>&#148; in respect of a Sale and Lease-Back Transaction means, as at the time of determination, the present value
(discounted at the interest rate implicit in the transaction) of the total obligations of the lessee for rental payments during the remaining term of the lease included in such Sale and Lease-Back Transaction (including any period for which such
lease has been extended), determined in accordance with GAAP; <I>provided</I>, <I>however</I>, that if such Sale and Lease-Back Transaction results in a Capitalized Lease Obligation, the amount of Indebtedness represented thereby will be determined
in accordance with the definition of &#147;Capitalized Lease Obligations.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Authorized Representative</I>&#148; means: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of any Senior Credit Facility Obligations or the Credit Agreement Secured Parties (as defined in
the Security Agreement), the administrative agent under the Senior Credit Facility, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of the Existing 2026 Notes Obligations, the Existing 2030 Notes Obligations and the Existing 2032
Notes Obligations or the holders of the Existing 2026 Notes, the holders of the Existing 2030 Notes and the holders of the Existing 2032 Notes, U.S. Bank Trust Company, National Association (as successor to MUFG Union Bank, N.A. in the case of the
Existing 2030 Notes), as trustee for the holders of the Existing 2026 Notes, the holders of the Existing 2030 Notes and the holders of the Existing 2032 Notes, respectively, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of the Notes Obligations or the Holders, the Trustee, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of any Series of Additional First Lien Obligations or Additional First Lien Secured Parties that
become subject to the Security Agreement, the Authorized Representative named for such Series in the applicable joinder agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Bankruptcy Code</I>&#148; means Title 11 of the United States Code, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Bankruptcy Law</I>&#148; means the Bankruptcy Code and any similar federal, state or foreign law
for the relief of debtors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Base Security Agreement</I>&#148; means the Amended and Restated Collateral Agreement, dated as of August&nbsp;7,
2014, by and among the Issuer, the subsidiary grantors named therein, the First Lien Collateral Agent and the Authorized Representatives, as supplemented by the Additional Authorized Representative Joinders, dated as of June&nbsp;3, 2016 and
September&nbsp;21, 2020, respectively, and as the same may be further amended, restated or modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Business Day</I>&#148;
means each day which is not a Legal Holiday. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Capital Stock</I>&#148; means: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a corporation, corporate stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of an association or business entity, any and all shares, interests, participations, rights or
other equivalents (however designated) of corporate stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a partnership or limited liability company, partnership or membership interests (whether general
or limited); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other interest or participation that confers on a Person the right to receive a share of the profits and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">losses of, or distributions of assets of, the issuing Person. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Capitalized Lease Obligations</I>&#148; means an obligation that is required to be classified and accounted for as a capitalized lease for financial
reporting purposes in accordance with GAAP, and the amount of Indebtedness represented by such obligation will be the capitalized amount of such obligation at the time any determination thereof is to be made as determined in accordance with GAAP,
and the stated maturity thereof will be the date of the last payment of rent or any other amount due under such lease prior to the first date such lease may be terminated without penalty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Cash Equivalents</I>&#148; means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">United States dollars; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">euros or any national currency of any participating member state of the EMU or such local currencies held by
the Issuer and its Restricted Subsidiaries from time to time in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">securities issued or directly and fully and unconditionally guaranteed or insured by the U.S. government (or
any agency or instrumentality thereof the securities of which are unconditionally guaranteed as a full faith and credit obligation of the U.S. government) with maturities of 24 months or less from the date of acquisition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">certificates of deposit, time deposits and eurodollar time deposits with maturities of one year or less from
the date of acquisition, bankers&#146; acceptances with maturities not exceeding one year and overnight bank deposits, in each case with any commercial bank having capital and surplus of not less than $500.0&nbsp;million in the case of U.S. banks
and $100.0&nbsp;million (or the U.S. dollar equivalent as of the date of determination) in the case of <FONT STYLE="white-space:nowrap">non-U.S.</FONT> banks; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">repurchase obligations for underlying securities of the types described in clauses (3)&nbsp;and (4) entered
into with any financial institution meeting the qualifications specified in clause (4)&nbsp;above; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">commercial paper rated at least <FONT STYLE="white-space:nowrap">P-1</FONT> by Moody&#146;s or at least <FONT
STYLE="white-space:nowrap">A-1</FONT> by S&amp;P and in each case maturing within 24 months after the date of creation thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">marketable short-term money market and similar securities having a rating of at least <FONT
STYLE="white-space:nowrap">P-2</FONT> or <FONT STYLE="white-space:nowrap">A-2</FONT> from either Moody&#146;s or S&amp;P, respectively (or, if at any time neither Moody&#146;s nor S&amp;P shall be rating such obligations, an equivalent rating from
another Rating Agency) and in each case maturing within 24 months after the date of creation thereof; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">investment funds investing 95% of their assets in securities of the types described in clauses (1)&nbsp;through
(7) above; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">readily marketable direct obligations issued by any state, commonwealth or territory of the United States or
any political subdivision or taxing authority thereof having an Investment Grade Rating from either Moody&#146;s or S&amp;P with maturities of 24 months or less from the date of acquisition; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indebtedness or Preferred Stock issued by Persons with a rating of A or higher from S&amp;P or A2 or higher
from Moody&#146;s with maturities of 24 months or less from the date of acquisition; and (11)&nbsp;Investments with average maturities of 24 months or less from the date of acquisition in money market funds rated
<FONT STYLE="white-space:nowrap">AAA-</FONT> (or the equivalent thereof) or better by S&amp;P or Aaa3 (or the equivalent thereof) or better by Moody&#146;s. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, Cash Equivalents shall include amounts denominated in currencies other than those set forth in clauses (1)&nbsp;and
(2)&nbsp;above; <I>provided </I>that such amounts are converted into any currency listed in clauses (1)&nbsp;and (2)&nbsp;as promptly as practicable and in any event within ten Business Days following the receipt of such amounts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>CFC</I>&#148; means a &#147;controlled foreign corporation&#148; within the meaning of Section&nbsp;957(a) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Change of Control</I>&#148; means the occurrence of any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any &#147;person&#148; or &#147;group&#148; of related persons (as such terms are used in Sections 13(d) and
14(d) of the Exchange Act), other than one or more Permitted Holders, becomes the beneficial owner (as defined in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act, except
that such person or group shall be deemed to have &#147;beneficial ownership&#148; of all shares that any such person or group has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly or
indirectly, of more than 50% of the total voting power of the Voting Stock of the Issuer or any of its direct or indirect parent entities (or their successors by merger, consolidation or purchase of all or substantially all of their assets);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the sale, assignment, conveyance, transfer, lease or other disposition (other than by way of merger or
consolidation), in one or a series of related transactions, of all or substantially all of the assets of the Issuer and its Restricted Subsidiaries taken as a whole to any &#147;person&#148; (as such term is used in Sections 13(d) and 14(d) of the
Exchange Act) other than transactions with a Permitted Holder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the adoption by the stockholders of the Issuer of a plan or proposal for the liquidation or dissolution of the
Issuer. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Code</I>&#148; means the Internal Revenue Code of 1986, as amended, or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Collateral</I>&#148; means all property and assets of the Issuer or any Secured Guarantor, whether owned on the Issue Date or thereafter acquired, in
which Liens are, from time to time, granted or purported to be granted to secure the Notes and the Guarantees pursuant to the Indenture and the Security Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Collateral Release Date</I>&#148; has the meaning assigned to such term under &#147;&#151;Release of collateral and guarantees upon investment grade
rating event.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Collections</I>&#148; means (a)&nbsp;with respect to any Receivable, all cash collections and other cash proceeds of such
Receivable, including, without limitation, all cash proceeds of Related Security with respect to such Receivable, and all funds deemed to have been received by the applicable Issuer or the Secured Guarantors or any other Person with respect thereto,
and (b)&nbsp;with respect to any Participation Interest, all cash collections and other cash proceeds of the Receivable underlying such Participation Interest, including, without limitation, all cash proceeds of Related Security with respect to such
Participation Interest, and all funds deemed to have been received by the Issuer or the Secured Guarantors or any other Person with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Common Collateral</I>&#148; means, at any time, Collateral in which the holders of two or more Series of First Lien Obligations (or their respective
Authorized Representatives or the First Lien Collateral Agent on behalf of such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Authorized Representative) hold a valid security interest at such time. If more than two Series of First Lien Obligations are outstanding at any time and the holders of less than all Series of
First Lien Obligations hold a valid security interest in any Collateral at such time then such Collateral shall constitute Common Collateral for those Series of First Lien Obligations that hold a valid security interest in such Collateral at such
time and shall not constitute Common Collateral for any Series which does not have a valid security interest in such Collateral at such time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Common Stock</I>&#148; means with respect to any Person, any and all shares, interest or other participations in, and other equivalents (however
designated and whether voting or nonvoting) of such Person&#146;s common stock whether or not outstanding on the Issue Date and includes, without limitation, all series and classes of such common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Consolidated Coverage Ratio</I>&#148; means as of any date of determination, with respect to any Person, the ratio of (x)&nbsp;the aggregate amount
of Consolidated EBITDA of such Person for the period of the most recent four consecutive fiscal quarters ending prior to the date of such determination for which financial statements prepared on a consolidated basis in accordance with GAAP are
available to (y)&nbsp;Consolidated Interest Expense for such four fiscal quarters; <I>provided</I>, <I>however</I>, that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the Issuer or any Restricted Subsidiary: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has Incurred any Indebtedness since the beginning of such period that remains outstanding on such date of
determination or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio includes an Incurrence of Indebtedness, Consolidated EBITDA and Consolidated Interest Expense for such period will be calculated after giving
effect on a pro forma basis to such Indebtedness as if such Indebtedness had been Incurred on the first day of such period (except that in making such computation, the amount of Indebtedness under any revolving Credit Facility outstanding on the
date of such calculation will be deemed to be (i)&nbsp;the average daily balance of such Indebtedness during such four fiscal quarters or such shorter period for which such facility was outstanding or (ii)&nbsp;if such facility was created after the
end of such four fiscal quarters, the average daily balance of such Indebtedness during the period from the date of creation of such facility to the date of such calculation) and the discharge of any other Indebtedness repaid, repurchased, redeemed,
retired, defeased or otherwise discharged with the proceeds of such new Indebtedness as if such discharge had occurred on the first day of such period; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has repaid, repurchased, redeemed, retired, defeased or otherwise discharged any Indebtedness since the
beginning of the period that is no longer outstanding on such date of determination or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio includes a discharge of Indebtedness (in each case, other than
Indebtedness Incurred under any revolving Credit Facility unless such Indebtedness has been permanently repaid and the related commitment terminated and not replaced), Consolidated EBITDA and Consolidated Interest Expense for such period will be
calculated after giving effect on a pro forma basis to such discharge of such Indebtedness, including with the proceeds of such new Indebtedness, as if such discharge had occurred on the first day of such period; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if since the beginning of such period, the Issuer or any Restricted Subsidiary will have disposed of any assets
or disposed of or discontinued (as defined under GAAP) any company, division, operating unit, segment, business, group of related assets or line of business or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio
includes such a transaction: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Consolidated EBITDA for such period will be reduced by an amount equal to the Consolidated EBITDA (if
positive) directly attributable to the assets that are the subject of such disposition or discontinuation for such period or increased by an amount equal to the Consolidated EBITDA (if negative) directly attributable thereto for such period; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consolidated Interest Expense for such period will be reduced by an amount equal to the Consolidated Interest
Expense directly attributable to any Indebtedness of the Issuer or any Restricted Subsidiary </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
repaid, repurchased, redeemed, retired, defeased or otherwise discharged (to the extent the related commitment is permanently reduced) with respect to the Issuer and its continuing Restricted
Subsidiaries in connection with such transaction for such period (or, if the Capital Stock of any Restricted Subsidiary is sold, the Consolidated Interest Expense for such period directly attributable to the Indebtedness of such Restricted
Subsidiary to the extent the Issuer and its continuing Restricted Subsidiaries are no longer liable for such Indebtedness after such sale); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if since the beginning of such period the Issuer or any Restricted Subsidiary (by merger or otherwise) will
have made an Investment in any Restricted Subsidiary (or any Person that becomes a Restricted Subsidiary or is merged with or into the Issuer or a Restricted Subsidiary) or an acquisition of assets, including any acquisition of assets occurring in
connection with a transaction causing a calculation to be made hereunder, which constitutes all or substantially all of a company, division, operating unit, segment, business, group of related assets or line of business, Consolidated EBITDA and
Consolidated Interest Expense for such period will be calculated after giving pro forma effect thereto (including the Incurrence of any Indebtedness) as if such Investment or acquisition occurred on the first day of such period; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if since the beginning of such period any Person (that subsequently became a Restricted Subsidiary or was
merged with or into the Issuer or any Restricted Subsidiary since the beginning of such period) will have Incurred any Indebtedness or discharged any Indebtedness, made any disposition or any Investment or acquisition of assets that would have
required an adjustment pursuant to clause (1), (2) or (3)&nbsp;above if made by the Issuer or a Restricted Subsidiary during such period, Consolidated EBITDA and Consolidated Interest Expense for such period will be calculated after giving pro forma
effect thereto as if such transaction occurred on the first day of such period. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this definition, whenever pro forma
effect is to be given to any calculation under this definition, the pro forma calculations will be determined in good faith by a responsible financial or accounting officer of the Issuer (including pro forma expense and cost reductions calculated on
a basis consistent with Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act). If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest expense on such Indebtedness will be
calculated as if the rate in effect on the date of determination had been the applicable rate for the entire period (taking into account any Interest Rate Agreement applicable to such Indebtedness if such Interest Rate Agreement has a remaining term
in excess of 12 months). If any Indebtedness that is being given pro forma effect bears an interest rate at the option of the Issuer, the interest rate shall be calculated by applying such optional rate chosen by the Issuer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Consolidated EBITDA</I>&#148; means, with respect to any Person for any period, the Consolidated Net Income of such Person for such period: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">increased (without duplication) by the following items to the extent deducted in calculating such Consolidated
Net Income: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consolidated Interest Expense; <I>plus</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consolidated Income Taxes; <I>plus</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">consolidated depreciation expense; <I>plus</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">consolidated amortization expense or impairment charges recorded in connection with the application of
Accounting Standards Codification Topic 350, <I>Intangibles&#151;Goodwill and Other, </I>or Topic 360<I>, Property, Plant and Equipment</I>; <I>plus</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">other <FONT STYLE="white-space:nowrap">non-cash</FONT> charges reducing Consolidated Net Income, including any
write-offs or write-downs (excluding any such <FONT STYLE="white-space:nowrap">non-cash</FONT> charge to the extent it represents an accrual of or reserve for cash charges in any future period or amortization of a prepaid cash expense that was
capitalized at the time of payment; <I>provided</I> that the Issuer is permitted to add back non-cash charges representing an accrual or reserve relating to any legal, administrative or governmental claim, litigation, investigation or proceedings,
even if cash charges may be anticipated in any future period, so long as adding back such non-cash charges is consistent with the Issuer&#146;s past practice in its publicly reported &#147;EBITDA&#148; or
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
&#147;Adjusted EBITDA&#148; included in its annual or quarterly earnings reports) and noncash compensation expense recorded from grants of stock appreciation or similar rights, stock options,
restricted stock or other rights to officers, directors or employees; <I>plus</I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extraordinary, <FONT STYLE="white-space:nowrap">non-recurring</FONT> or unusual cash expenses or losses,
including, without limitation, severance costs, relocation costs, consolidation and closing costs, integration and facilities opening costs, business optimization costs, transition costs, restructuring costs, signing, retention or completion
bonuses, and curtailments or modifications to pension and post-retirement employee benefit plans, in each case so long as adding back such expenses or losses is consistent with the Issuer&#146;s past practice in its publicly reported
&#147;EBITDA&#148; or &#147;Adjusted EBITDA&#148; included in its annual or quarterly earnings reports; <I>plus</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any <FONT STYLE="white-space:nowrap">non-recurring</FONT> fees, charges or expenses paid in connection with the
Transactions within 180 days of the Issue Date that were deducted in computing Consolidated Net Income. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">decreased (without duplication) by the following items to the extent included in calculating such Consolidated
Net Income: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">non-cash</FONT> items increasing Consolidated Net Income of such Person for
such period (excluding any items which represent the reversal of any accrual of, or reserve for, anticipated cash charges that reduced Consolidated EBITDA in any prior period), <I>plus</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extraordinary, <FONT STYLE="white-space:nowrap">non-recurring</FONT> or unusual cash gains or income so
long as deducting such gains or income is consistent with the Issuer&#146;s past practice in its publicly reported &#147;EBITDA&#148; or &#147;Adjusted EBITDA&#148; included in its annual or quarterly earnings reports, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">increased or decreased (without duplication) to eliminate the following items reflected in Consolidated Net
Income: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any unrealized net gain or loss resulting in such period from Hedging Obligations and the application of
Accounting Standards Codification Topic 815, <I>Derivatives and Hedging</I>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any net gain or loss resulting in such period from currency translation gains or losses related to currency
remeasurements of Indebtedness; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">effects of adjustments (including the effects of such adjustments pushed down to the Issuer and its Restricted
Subsidiaries) in any line item in such Person&#146;s consolidated financial statements pursuant to GAAP resulting from the application of accounting in relation to any completed acquisition. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Consolidated Income Taxes</I>&#148; means, with respect to any Person for any period, taxes imposed upon such Person or other payments required to be
made by such Person by any governmental authority which taxes or other payments are calculated by reference to the income or profits or capital of such Person or such Person and its Restricted Subsidiaries (to the extent such income or profits were
included in computing Consolidated Net Income for such period), including, without limitation, state, franchise and similar taxes and foreign withholding taxes regardless of whether such taxes or payments are required to be remitted to any
governmental authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Consolidated Interest Expense</I>&#148; means, for any period, the total interest expense of the Issuer and its
consolidated Restricted Subsidiaries, whether paid or accrued, plus, to the extent not included in such interest expense: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interest expense attributable to Capitalized Lease Obligations and the interest portion of rent expense
associated with Attributable Indebtedness in respect of the relevant lease giving rise thereto, determined as if such lease were a capitalized lease in accordance with GAAP and the interest component of any deferred payment obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">amortization of debt discount (including the amortization of original issue discount resulting from the
issuance of Indebtedness at less than par) and debt issuance cost; <I>provided</I>, <I>however</I>, that any amortization of bond premium will be credited to reduce Consolidated Interest Expense unless, pursuant to GAAP, such amortization of bond
premium has otherwise reduced Consolidated Interest Expense; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">non-cash</FONT> interest expense, but any
<FONT STYLE="white-space:nowrap">non-cash</FONT> interest income or expense attributable to the movement in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> valuation of Hedging Obligations or other
derivative instruments pursuant to GAAP shall be excluded from the calculation of Consolidated Interest Expense; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">commissions, discounts and other fees and charges owed with respect to letters of credit and bankers&#146;
acceptance financing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the interest expense on Indebtedness of another Person that is guaranteed by such Person or one of its
Restricted Subsidiaries or secured by a Lien on assets of such Person or one of its Restricted Subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">costs associated with entering into Hedging Obligations (including amortization of fees) related to
Indebtedness; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interest expense of such Person and its Restricted Subsidiaries that was capitalized during such period;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the product of (a)&nbsp;all dividends paid or payable, in cash, Cash Equivalents or Indebtedness or accrued
during such period on any series of Disqualified Stock of such Person or on Preferred Stock of its Restricted Subsidiaries that are not Guarantors payable to a party other than the Issuer or a Wholly Owned Subsidiary, times (b)&nbsp;a fraction, the
numerator of which is one and the denominator of which is one minus the then current combined federal, state, provincial and local statutory tax rate of such Person, expressed as a decimal, in each case, on a consolidated basis and in accordance
with GAAP; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Receivables Fees; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cash contributions to any employee stock ownership plan or similar trust to the extent such contributions
are used by such plan or trust to pay interest or fees to any Person (other than the Issuer and its Restricted Subsidiaries) in connection with Indebtedness Incurred by such plan or trust. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purpose of calculating the Consolidated Coverage Ratio, the calculation of Consolidated Interest Expense shall include all interest expense (including
any amounts described in clauses (1)&nbsp;through (10)&nbsp;above) relating to any Indebtedness of the Issuer or any Restricted Subsidiary described in the final paragraph of the definition of &#147;Indebtedness.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, total interest expense will be determined (i)&nbsp;after giving effect to any net payments made or received by the Issuer and
its Subsidiaries with respect to Interest Rate Agreements and (ii)&nbsp;exclusive of amounts classified as other comprehensive income in the balance sheet of the Issuer. Notwithstanding anything to the contrary contained herein, without duplication
of clause (9)&nbsp;above, commissions, discounts, yield and other fees and charges Incurred in connection with any transaction pursuant to which the Issuer or its Restricted Subsidiaries may sell, convey or otherwise transfer or grant a security
interest in any accounts receivable or related assets shall be included in Consolidated Interest Expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Consolidated Net Income</I>&#148;
means, for any period, the net income (loss) of the Issuer and its consolidated Restricted Subsidiaries determined on a consolidated basis in accordance with GAAP; <I>provided</I>, <I>however</I>, that there will not be included in such Consolidated
Net Income on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any net income (loss) of any Person if such Person is not a Restricted Subsidiary or that is accounted for by
the equity method of accounting, except that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subject to the limitations contained in clauses (3)&nbsp;through (7) below, the Issuer&#146;s equity in the net
income of any such Person for such period will be included in such Consolidated Net Income up to the aggregate amount of cash actually distributed by such Person during such period to the Issuer or a Restricted Subsidiary as a dividend or other
distribution (subject, in the case of a dividend or other distribution to a Restricted Subsidiary, to the limitations contained in clause (2)&nbsp;below); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer&#146;s equity in a net loss of any such Person (other than an Unrestricted Subsidiary) for such
period will be included in determining such Consolidated Net Income to the extent such loss has been funded with cash from the Issuer or a Restricted Subsidiary; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any net income (but not loss) of any Restricted Subsidiary (other than a Subsidiary that is a Guarantor) if
such Restricted Subsidiary is subject to prior government approval or other restrictions due to the operation of its charter or any agreement, instrument, judgment, decree, order statute, rule or government regulation (which have not been waived),
directly or indirectly, on the payment of dividends or the making of distributions by such Restricted Subsidiary, directly or indirectly, to the Issuer, except that: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subject to the limitations contained in clauses (3)&nbsp;through (7) below, the Issuer&#146;s equity in the net
income of any such Restricted Subsidiary for such period will be included in such Consolidated Net Income up to the aggregate amount of cash that could have been distributed by such Restricted Subsidiary during such period to the Issuer or another
Restricted Subsidiary as a dividend (subject, in the case of a dividend to another Restricted Subsidiary, to the limitation contained in this clause); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer&#146;s equity in a net loss of any such Restricted Subsidiary for such period will be included in
determining such Consolidated Net Income; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any gain or loss (less all fees and expenses relating thereto) realized upon sales or other dispositions of any
assets of the Issuer or such Restricted Subsidiary, other than in the ordinary course of business, as determined in good faith by the Board of Directors of the Issuer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any income or loss from discontinued operations and any gain or loss on disposal of discontinued operations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any income (loss) from the early extinguishment of Indebtedness or Hedging Obligations or other derivative
instruments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extraordinary gain or loss; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any net income (loss) included in the consolidated statement of operations as noncontrolling interests due to
the application of Accounting Standards Codification Topic 810, <I>Consolidation</I>; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cumulative effect of a change in accounting principles. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Consolidated Net Tangible Assets</I>&#148; means, with respect to any Person, the total amount of assets (less applicable reserves and other properly
deductible items) after deducting therefrom (a)&nbsp;all current liabilities as disclosed on the consolidated balance sheet of such Person (excluding any thereof which are by their terms extendible or renewable at the option of the obligor thereon
to a time more than 12 months after the time as of which the amount thereof is being computed and further excluding any deferred income taxes that are included in current liabilities) and (b)&nbsp;all goodwill, trade names, trademarks, patents,
unamortized debt discount and expense and other like intangible assets, all as set forth on the most recent consolidated balance sheet of the Issuer and computed in accordance with generally accepted accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Convertible Notes</I>&#148; means Indebtedness of the Issuer that is optionally convertible into Common Stock of the Issuer (and/or cash based on the
value of such Common Stock) and/or Indebtedness of a Subsidiary of the Issuer that is optionally exchangeable for Common Stock of the Issuer (and/or cash based on the value of such Common Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Credit Facilities</I>&#148; means, with respect to the Issuer or any of its Restricted Subsidiaries, one or more debt facilities, including the
Senior Credit Facility and any Qualified Receivables Transaction, or other financing arrangements (including, without limitation, commercial paper facilities or indentures) providing for revolving credit loans, term loans, receivables financing,
letters of credit or other long-term Indebtedness, including any notes, mortgages, guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals,
restatements or refundings thereof and any indentures or credit facilities or commercial paper facilities that replace, refund or refinance any part of the loans, notes, other credit facilities or commitments thereunder, including any such
replacement, refunding or refinancing facility or indenture that increases the amount permitted to be borrowed thereunder or alters the maturity thereof or adds Restricted Subsidiaries as additional borrowers or guarantors thereunder and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
whether by the same or any other agent, lender or group of lenders and whether or not the original administrative agent, lenders, trustees or other agents are parties thereto and whether provided
under the original Senior Credit Facility, the Existing Receivables Facility or any other credit agreement or indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Default</I>&#148; means
any event that is, or with the passage of time or the giving of notice or both would be, an Event of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Discharge of Senior Credit
Facility Obligations</I>&#148; means, with respect to any Common Collateral, the date on which the Senior Credit Facility Obligations are no longer secured by such Common Collateral; <I>provided </I>that the Discharge of Senior Credit Facility
Obligations shall not be deemed to have occurred in connection with a refinancing of such Senior Credit Facility Obligations with additional First Lien Obligations secured by such Common Collateral under an agreement relating to Additional First
Lien Obligations which has been designated in writing by the administrative agent under such refinancing Senior Credit Facility to the First Lien Collateral Agent and each other Authorized Representative as the Senior Credit Facility for purposes of
the Security Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Disqualified Stock</I>&#148; means, with respect to any Person, any Capital Stock of such Person which, by its terms, or
by the terms of any security into which it is convertible or for which it is putable or exchangeable, or upon the happening of any event, matures or is mandatorily redeemable (other than solely as a result of a change of control or asset sale)
pursuant to a sinking fund obligation or otherwise, or is redeemable at the option of the holder thereof (other than solely as a result of a change of control or asset sale), in whole or in part, in each case prior to the date 91 days after the
earlier of the maturity date of the Notes or the date the Notes are no longer outstanding; <I>provided</I>, <I>however</I>, that if such Capital Stock is issued to any plan for the benefit of employees of the Issuer or its Subsidiaries or by any
such plan to such employees, such Capital Stock shall not constitute Disqualified Stock solely because it may be required to be repurchased by the Issuer or its Subsidiaries in order to satisfy applicable statutory or regulatory obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Domestic Subsidiary</I>&#148; means any Subsidiary of the Issuer organized under the laws of the United States, any state, territory or commonwealth
thereof or the District of Columbia (other than any such Subsidiary that is treated as a disregarded entity for United States federal income tax purposes, is a CFC or substantially all of whose assets consist (directly or indirectly through
disregarded entities) of the Equity Interests and/or Indebtedness of one or more CFCs). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>EMU</I>&#148; means the economic and monetary union as
contemplated in the Treaty on European Union. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Equity Interests</I>&#148; means Capital Stock and all warrants, options or other rights to
acquire Capital Stock, but excluding any debt security that is convertible into, or exchangeable for, Capital Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Exchange Act</I>&#148;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2026
Notes</I>&#148; means the $700.0&nbsp;million aggregate principal amount of 1.65% senior secured notes due 2026 issued by the Issuer and outstanding on the Issue Date and any Additional Notes (as defined in the Existing 2026/2032 Notes Indenture)
issued with respect to the initial 1.65% senior secured notes due 2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2026/2032 Notes Indenture</I>&#148; means the indenture, dated
as of August&nbsp;24, 2021, among the Issuer, the guarantors party thereto, U.S. Bank Trust Company, National Association, as trustee, and JPMorgan Chase Bank, N.A. as collateral agent, as amended, supplemented or otherwise modified from time to
time, as it relates to the Existing 2026 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2026 Notes Obligations</I>&#148; means Obligations in respect of the Existing 2026
Notes, the Existing 2026/2032 Notes Indenture or the Security Documents as they relate to the Existing 2026 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2026 Notes Secured
Parties</I>&#148; means, at any relevant time, the holders of Existing 2026 Notes Obligations at such time, including without limitation U.S. Bank Trust Company, National Association (as successor to MUFG Union Bank, N.A.), as trustee for the
holders of the Existing 2026 Notes, the registrar, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
paying agent and transfer agent, and the holders of Existing 2026 Notes (including the holders of any Additional Notes (as defined in the Existing 2026/2032 Notes Indenture) subsequently issued
under and in compliance with the terms of the Existing 2026/2032 Notes Indenture). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2030 Notes</I>&#148; means the $800.0&nbsp;million
aggregate principal amount of 2.65% senior secured notes due 2030 issued by the Issuer and outstanding on the Issue Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2030 Notes
Indenture</I>&#148; means the indenture, dated as of September&nbsp;21, 2020, among the Issuer, the guarantors party thereto, U.S. Bank Trust Company, National Association (as successor to MUFG Union Bank, N.A.), as trustee, and JPMorgan Chase Bank,
N.A. as collateral agent, as amended, supplemented or otherwise modified from time to time, as it relates to the Existing 2030 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing
2030 Notes Obligations</I>&#148; means Obligations in respect of the Existing 2030 Notes, the Existing 2030 Notes Indenture or the Security Documents as they relate to the Existing 2030 Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2030 Notes Secured Parties</I>&#148; means, at any relevant time, the holders of Existing 2030 Notes Obligations at such time, including
without limitation U.S. Bank Trust Company, National Association (as successor to MUFG Union Bank, N.A.), as trustee for the holders of the Existing 2030 Notes, the registrar, paying agent and transfer agent, and the holders of Existing 2030 Notes
(including the holders of any Additional Notes (as defined in the Existing 2030 Notes Indenture) subsequently issued under and in compliance with the terms of the Existing 2030 Notes Indenture). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2032 Notes</I>&#148; means the $500.0&nbsp;million aggregate principal amount of 2.65% senior secured notes due 2032 issued by the Issuer
and outstanding on the Issue Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2032 Notes Obligations</I>&#148; means Obligations in respect of the Existing 2032 Notes, the
Existing 2026/2032 Notes Indenture or the Security Documents as they relate to the Existing 2032 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing 2032 Notes Secured
Parties</I>&#148; means, at any relevant time, the holders of Existing 2032 Notes Obligations at such time, including without limitation U.S. Bank Trust Company, National Association, as trustee for the holders of the Existing 2032 Notes, the
registrar, paying agent and transfer agent, and the holders of Existing 2032 Notes (including the holders of any Additional Notes (as defined in the Existing 2026/2032 Notes Indenture) subsequently issued under and in compliance with the terms of
the Existing 2026/2032 Notes Indenture). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing Receivables Facility</I>&#148; means the receivables facility governed by (a)&nbsp;the Amended
and Restated Credit and Security Agreement, dated as of October&nbsp;27, 2010 (as amended, amended and restated, modified, renewed or replaced from time to time), among the borrowers identified therein, UHS Receivables Corp., as Collection Agent,
UHS of Delaware, Inc., as Servicer, Universal Health Services, Inc., as Performance Guarantor, PNC Bank, National Association, as LC Bank and Administrative Agent, and the certain other parties thereto and (b)&nbsp;each of the Receivables Sale
Agreements referred to in such Amended and Restated Credit and Security Agreement, between the respective Grantors and &#147;Buyers&#148; specified therein, in each case, as the same may be amended or otherwise modified from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Fair Market Value</I>&#148; means, with respect to any asset or liability, the fair market value of such asset or liability as determined by the
Chief Executive Officer and the Chief Financial Officer of the Issuer in good faith; <I>provided </I>that if the fair market value exceeds $50.0&nbsp;million, such determination shall be made by the Board of Directors of the Issuer or an authorized
committee thereof in good faith (including as to the value of all <FONT STYLE="white-space:nowrap">non-cash</FONT> assets and liabilities). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>First Lien Collateral Agent</I>&#148; shall mean JPMorgan Chase Bank, N.A., in its capacity as collateral agent for the lenders and other secured
parties under the Senior Credit Facility, the Indenture and the other First Lien Documents, together with its successors and permitted assigns exercising substantially the same rights and powers; and, in each case, <I>provided </I>that if such First
Lien Collateral Agent is not JPMorgan Chase Bank, N.A., </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such First Lien Collateral Agent shall have become a party to the Security Agreement, any intercreditor agreement with respect to Junior Lien Obligations and the other applicable First Lien
Security Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>First Lien Documents</I>&#148; means the credit, guarantee and security documents governing the First Lien Obligations,
including, without limitation, the Indenture and the First Lien Security Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>First Lien Event of Default</I>&#148; means an &#147;Event
of Default&#148; under and as defined in the Senior Credit Facility, the Existing 2026/2032 Notes Indenture, the Existing 2030 Notes Indenture, the Indenture or any other First Lien Documents governing First Lien Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>First Lien Obligations</I>&#148; means, collectively, (a)&nbsp;all Senior Credit Facility Obligations, (b)&nbsp;the Notes Obligations, (c)&nbsp;the
Existing 2026 Notes Obligations, (d)&nbsp;the Existing 2030 Notes Obligations, (e)&nbsp;the Existing 2032 Notes Obligations and (f)&nbsp;any Series of Additional First Lien Obligations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>First Lien Secured Parties</I>&#148; means (a)&nbsp;the Credit Agreement Secured Parties (as defined in the Security Agreement), (b) the Notes Secured
Parties, (c)&nbsp;the Existing 2026 Notes Secured Parties, (d)&nbsp;the Existing 2030 Notes Secured Parties, (e)&nbsp;the Existing 2032 Notes Secured Parties and (f)&nbsp;any Additional First Lien Secured Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>First Lien Security Documents</I>&#148; means the Security Documents and any other agreement, document or instrument pursuant to which a Lien is
granted or purported to be granted securing First Lien Obligations or under which rights or remedies with respect to such Liens are governed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Foreign Subsidiary</I>&#148; means, with respect to any Person, any Restricted Subsidiary of such Person that is not a Domestic Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Foreign Subsidiary Voting Stock</I>&#148; means the voting Capital Stock of any Foreign Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Funded Debt</I>&#148; means any Indebtedness for money borrowed, created, issued, incurred, assumed or guaranteed that would, in accordance with
generally accepted accounting principles, be classified as long-term debt, but in any event including all Indebtedness for money borrowed, whether secured or unsecured, maturing more than one year, or extendible at the option of the obligor to a
date more than one year, after the date of determination thereof (excluding any amount thereof included in current liabilities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>GAAP</I>&#148;
means generally accepted accounting principles in the United States as in effect on the Issue Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Gift Shop Assets</I>&#148; means all cash
and other amount paid or owed to the Issuer or any Secured Guarantor for purchases from its gift shops or cafeterias and all goods held for sale in any such gift shop or cafeteria. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Guarantee</I>&#148; means the guarantee by any Guarantor of the Issuer&#146;s Obligations under the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Guarantor</I>&#148; means each Restricted Subsidiary that Guarantees the Notes in accordance with the terms of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Hedging Obligations</I>&#148; means, with respect to any Person, the obligations of such Person under any interest rate swap agreement, interest rate
cap agreement, interest rate collar agreement, commodity swap agreement, commodity cap agreement, commodity collar agreement, foreign exchange contract, currency swap agreement or similar agreement providing for the transfer or mitigation of
interest rate or currency risks either generally or under specific contingencies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Holder</I>&#148; means the Person in whose name a Note is
registered on the registrar&#146;s books. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Incur</I>&#148; means issue, create, assume, Guarantee, incur or otherwise become liable for;
<I>provided</I>, <I>however</I>, that any Indebtedness or Capital Stock of a Person existing at the time such Person becomes a Restricted Subsidiary (whether by merger, consolidation, acquisition or otherwise) will be deemed to be Incurred by such
Restricted Subsidiary at the time it becomes a Restricted Subsidiary; and the terms &#147;<I>Incurred</I>&#148; and &#147;<I>Incurrence</I>&#148; have meanings correlative to the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Indebtedness</I>&#148; means, with respect to any Person on any date of determination (without
duplication): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal of and premium (if any) in respect of indebtedness of such Person for borrowed money;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal of and premium (if any) in respect of obligations of such Person evidenced by bonds, debentures,
notes or other similar instruments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component of all obligations of such Person in respect of letters of credit, bankers&#146;
acceptances or other similar instruments (including reimbursement obligations with respect thereto except to the extent such reimbursement obligation relates to a trade payable and such obligation is satisfied within 30 days of Incurrence);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component of all obligations of such Person to pay the deferred and unpaid purchase price of
property (including <FONT STYLE="white-space:nowrap">earn-out</FONT> obligations), which purchase price is due after the date of placing such property in service or taking delivery and title thereto, except (i)&nbsp;any such balance that constitutes
a trade payable or similar obligation to a trade creditor, in each case accrued in the ordinary course of business and (ii)&nbsp;any <FONT STYLE="white-space:nowrap">earn-out</FONT> obligation until the amount of such obligation becomes a liability
on the balance sheet of such Person in accordance with GAAP; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Capitalized Lease Obligations and all Attributable Indebtedness of such Person (whether or not such items would
appear on the balance sheet of the guarantor or obligor); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component or liquidation preference of all obligations of such Person with respect to the
redemption, repayment or other repurchase of any Disqualified Stock or, with respect to any Subsidiary that is not a Guarantor, any Preferred Stock (but excluding, in each case, any accrued dividends); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component of all Indebtedness of other Persons secured by a Lien on any asset of such Person,
whether or not such Indebtedness is assumed by such Person; <I>provided</I>, <I>however</I>, that the amount of such Indebtedness will be the lesser of (a)&nbsp;the Fair Market Value of such asset at such date of determination and (b)&nbsp;the
amount of such Indebtedness of such other Persons; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component of Indebtedness of other Persons to the extent Guaranteed by such Person (whether or
not such items would appear on the balance sheet of the guarantor or obligor); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the extent not otherwise included in this definition, net obligations of such Person under Hedging
Obligations (the amount of any such obligations to be equal at any time to the termination value of such agreement or arrangement giving rise to such Obligation that would be payable by such Person at such time); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the extent not otherwise included in this definition, the amount of Obligations outstanding under the legal
documents entered into as part of a Qualified Receivables Transaction on any date of determination that would be characterized as principal if such Qualified Receivables Transaction were structured as a secured lending transaction rather than as a
purchase. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, money borrowed and set aside at the time of the Incurrence of any Indebtedness in order to <FONT
STYLE="white-space:nowrap">pre-fund</FONT> the payment of interest on such Indebtedness shall not be deemed to be &#147;Indebtedness&#148;; <I>provided </I>that such money is held to secure the payment of such interest. In addition, for the
avoidance of doubt, obligations of any Person under a Permitted Bond Hedge or a Permitted Warrant shall not be deemed to be &#147;Indebtedness.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition, &#147;<I>Indebtedness</I>&#148; of any Person shall include Indebtedness described in the preceding paragraph that would not appear as a liability on the balance sheet of such Person if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Indebtedness is the obligation of a partnership or joint venture that is not a Restricted Subsidiary (a
&#147;<I>Joint Venture</I>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person or a Restricted Subsidiary of such Person is a general partner of the Joint Venture (a
&#147;<I>General Partner</I>&#148;); and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there is recourse, by contract or operation of law, with respect to the payment of such Indebtedness to
property or assets of such Person or a Restricted Subsidiary of such Person; </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">and then such Indebtedness shall be
included in an amount not to exceed: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the lesser of (i)&nbsp;the net assets of the General Partner and (ii)&nbsp;the amount of such obligations to
the extent that there is recourse, by contract or operation of law, to the property or assets of such Person or a Restricted Subsidiary of such Person; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if less than the amount determined pursuant to clause (a)&nbsp;immediately above, the actual amount of such
Indebtedness that is recourse to such Person or a Restricted Subsidiary of such Person, if the Indebtedness is evidenced by a writing and is for a determinable amount. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Insolvency or Liquidation Proceeding</I>&#148; means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any case commenced by or against the Issuer or any Secured Guarantor under any Bankruptcy Law for the relief of
debtors, any other proceeding for the reorganization, recapitalization or adjustment or marshalling of the assets or liabilities of the Issuer or any Secured Guarantor, any receivership or assignment for the benefit of creditors relating to the
Issuer or any Secured Guarantor or any similar case or proceeding relative to the Issuer or any Secured Guarantor or its creditors, as such, in each case whether or not voluntary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any liquidation, dissolution, marshalling of assets or liabilities or other winding up of or relating to the
Issuer or any Secured Guarantor, in each case whether or not voluntary and whether or not involving bankruptcy or insolvency; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other proceeding of any type or nature in which substantially all claims of creditors of the Issuer or any
Secured Guarantor are determined and any payment or distribution is or may be made on account of such claims. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>interest</I>&#148; with respect to the Notes means interest with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Interest Rate Agreement</I>&#148; means, with respect to any Person, any interest rate protection agreement, interest rate future agreement, interest
rate option agreement, interest rate swap agreement, interest rate cap agreement, interest rate collar agreement, interest rate hedge agreement or other similar agreement or arrangement as to which such Person is party or a beneficiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Investment Grade Rating</I>&#148; means a rating equal to or higher than Baa3 (or the equivalent) by Moody&#146;s and
<FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P, or an equivalent rating by any other Rating Agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Investment
Property</I>&#148; means (i)&nbsp;all &#147;investment property&#148; as such term is defined in <FONT STYLE="white-space:nowrap">Section&nbsp;9-102(a)(49)</FONT> of the New York UCC (other than any Foreign Subsidiary Voting Stock excluded from the
definition of &#147;Pledged Stock&#148;) and (ii)&nbsp;whether or not constituting &#147;investment property&#148; as so defined, all Pledged Notes and all Pledged Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Investments</I>&#148; means, with respect to any Person, all investments by such Person in other Persons (including Affiliates) in the form of loans
(including guarantees), advances or capital contributions (excluding accounts receivable, trade credit, advances to customers, commissions, travel and similar advances to officers and employees, in each case made in the ordinary course of business),
purchases or other acquisitions for consideration of Indebtedness, Equity Interests or other securities issued by any other Person and investments that are required by GAAP to be classified on the balance sheet (excluding the footnotes) of the
Issuer in the same manner as the other investments included in this definition to the extent such transactions involve the transfer of cash or other property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Issue Date</I>&#148; means September 26, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Joinder to the Security Agreement</I>&#148; means the Additional Authorized Representative Joinder Agreement, to be dated as of September&nbsp;26,
2024, entered into by the Issuer, the subsidiary grantors named therein, the First Lien Collateral Agent, the Authorized Representatives and the Trustee as an Additional Authorized Representative. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Junior Lien Obligations</I>&#148; means the Obligations with respect to Indebtedness permitted to
be incurred under the Indenture which by its terms is or will be secured on a basis junior to the Liens securing the Notes pursuant to an intercreditor agreement; <I>provided </I>such Liens are permitted to be incurred under the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Legal Holiday</I>&#148; means a Saturday, a Sunday or a day on which commercial banking institutions are not required to be open in the State of New
York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Lien</I>&#148; means, with respect to any asset, any mortgage, lien (statutory or otherwise), pledge, hypothecation, charge, security
interest, preference, priority or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention agreement, any lease in the
nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any jurisdiction; <I>provided </I>that
in no event shall an operating lease be deemed to constitute a Lien. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Major <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized
Representative</I>&#148; has the meaning set forth under &#147;&#151;Intercreditor provisions in the security agreement.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Moody&#146;s</I>&#148; means Moody&#146;s Investors Service, Inc. and any successor to its rating agency business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Mortgages</I>&#148; means mortgages, liens, pledges or other encumbrances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>net income</I>&#148; means, with respect to any Person, the net income (loss) of such Person, determined in accordance with GAAP and before any
reduction in respect of Preferred Stock dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>New York UCC</I>&#148; means the Uniform Commercial Code as from time to time in effect in
the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I><FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative</I>&#148; means, at any time with
respect to any Common Collateral, any Authorized Representative that is not the Applicable Authorized Representative at such time with respect to such Common Collateral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I><FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Debt</I>&#148; means Indebtedness of a Person: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as to which neither the Issuer nor any Restricted Subsidiary (a)&nbsp;provides any guarantee or credit support
of any kind (including any undertaking, guarantee, indemnity, agreement or instrument that would constitute Indebtedness) or (b)&nbsp;is directly or indirectly liable (as a guarantor or otherwise); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no default with respect to which (including any rights that the holders thereof may have to take enforcement
action against an Unrestricted Subsidiary) would permit (upon notice, lapse of time or both) any holder of any other Indebtedness of the Issuer or any Restricted Subsidiary to declare a default under such other Indebtedness or cause the payment
thereof to be accelerated or payable prior to its stated maturity; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the explicit terms of which provide there is no recourse against any of the assets of the Issuer or its
Restricted Subsidiaries, except that Standard Securitization Undertakings shall not be considered recourse. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Notes
Obligations</I>&#148; means Obligations in respect of the Notes, the Indenture or the Security Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Notes Secured Parties</I>&#148; means,
at any relevant time, the holders of Notes Obligations at such time, including without limitation the Trustee, the registrar, paying agent and transfer agent, and the Holders (including the Holders of any Additional Notes subsequently issued under
and in compliance with the terms of the Indenture). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Obligations</I>&#148; means all advances to, and debts, liabilities, obligations, covenants
and duties arising under any Indebtedness, whether or not direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including any principal, interest (including
any interest accruing subsequent to the filing of a petition in bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest is an allowed claim under applicable
state, federal or foreign law), premium, penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and bankers&#146; acceptances), damages and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other liabilities, and guarantees of payment of such principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities, payable under the documentation
governing such Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Officer</I>&#148; means the Chairman of the Board, the Chief Executive Officer, the President, any Executive Vice
President, Senior Vice President or Vice President, the Treasurer or the Secretary of the Issuer or a Guarantor, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Officers&#146;
Certificate</I>&#148; means a certificate signed on behalf of the Issuer by two Officers of the Issuer or on behalf of a Guarantor by two Officers of such Guarantor, one of whom must be the principal executive officer, the principal financial
officer, the treasurer or the principal accounting officer of the Issuer or Guarantor, as applicable, that meets the requirements set forth in the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Opinion of Counsel</I>&#148; means a written opinion from legal counsel who is acceptable to the Trustee. The counsel may be an employee of or
counsel to the Issuer or the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Participation Interest</I>&#148; means with respect to any Receivable, a beneficial interest in the
Issuer&#146;s or the applicable Secured Guarantor&#146;s right, title and interest, whether now owned or hereafter arising and wherever located, in, to and under (i)&nbsp;such Receivable, (ii)&nbsp;all Related Security and Collections with respect
to such Receivable and (iii)&nbsp;all proceeds of such Receivable, Related Security and Collections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Permitted Bond Hedge</I>&#148; means any
call options or capped call options referencing the Issuer&#146;s Common Stock purchased by the Issuer concurrently with the issuance of Convertible Notes to hedge the Issuer&#146;s or any Subsidiary issuer&#146;s obligations under such
Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Permitted Holders</I>&#148; means Alan B. Miller, Marc D. Miller, A. Miller Family, LLC, MMA Family LLC and any trust or other
entity owned by or formed for the benefit of the spouses, children, descendants and other family members of Alan B. Miller and Marc D. Miller. Any Person or group whose acquisition of beneficial ownership constitutes a Change of Control in respect
of which a Change of Control Offer is made in accordance with the requirements of the Indenture (or would result in a Change of Control Offer in the absence of the waiver of such requirement by Holders in accordance with the Indenture) will
thereafter constitute additional Permitted Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Permitted Liens</I>&#148; means, with respect to any Person: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens for taxes not yet due or that are being contested in good faith by appropriate proceedings, provided that
adequate reserves with respect thereto are maintained on the books of the Issuer or its Subsidiaries, as the case may be, in conformity with GAAP; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">carriers&#146;, warehousemen&#146;s, mechanics&#146;, materialmen&#146;s, repairmen&#146;s or other like Liens
arising in the ordinary course of business that are not overdue for a period of more than 30 days or that are being contested in good faith by appropriate proceedings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pledges or deposits in connection with workers&#146; compensation, unemployment insurance and other social
security legislation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deposits to secure the performance of bids, trade contracts (other than for borrowed money), leases, statutory
obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">easements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT>
restrictions and other similar encumbrances incurred in the ordinary course of business that, in the aggregate, are not substantial in amount and that do not in any case materially detract from the value of the property subject thereto or materially
interfere with the ordinary conduct of the business of the Issuer or any of its Subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens in existence on the Issue Date (other than Liens described in clauses (7), (8) and (10)&nbsp;of this
definition); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Collateral Release Date, Liens in existence on the Issue Date securing Indebtedness permitted by
the Senior Credit Facility; <I>provided </I>that no such Lien is spread to cover any additional property after the Issue Date and that the amount of Indebtedness secured thereby is not increased; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Collateral Release Date, Liens created pursuant to the Security Documents (including, for the
avoidance of doubt, Liens securing the Senior Credit Facility, the Notes, the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any interest or title of a lessor under any lease entered into by the Issuer or any Subsidiary in the ordinary
course of its business and covering only the assets so leased; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Collateral Release Date, Liens arising out of the Existing Receivables Facility and any future
Qualified Receivables Transaction (including any Receivables Financing); <I>provided </I>that the aggregate outstanding amount of the purchase price or loan from the lenders or investors under the Existing Receivables Facility and all other
Qualified Receivables Transactions (including any Receivables Financing) shall not at any time exceed the greater of (i) $600.0&nbsp;million and (ii) 50% of accounts receivable, net, as shown on the Issuer&#146;s most recent consolidated balance
sheet for which internal financial statements for the Issuer are available <I>plus </I>the allowance for doubtful accounts with respect to such accounts receivable, as set forth in the footnotes to such financial statements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Lien existing on any asset of any Person at the time such Person becomes a Subsidiary and not created in
contemplation of such event; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Lien existing on any asset prior to the acquisition thereof by the Issuer or a Subsidiary and not created
in contemplation of such acquisition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Lien securing Indebtedness incurred to refinance, replace, renew or refund amend, extend or modify, as a
whole or in part, Indebtedness that was previously so secured pursuant to clauses (6), (7), (8), (11), (12) and (13)&nbsp;of this definition; <I>provided </I>that any such Lien is limited to all or part of the same property or assets (plus
improvements, accessions, proceeds or dividends or distributions in respect thereof) that secured (or, under the written arrangements under which the original Lien arose, could secure) the Indebtedness being refinanced or is in respect of property
that is the security for a Permitted Lien hereunder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Collateral Release Date, Liens not otherwise permitted by this section so long as the aggregate
outstanding principal amount of the obligations secured thereby does not exceed (as to the Issuer and all Subsidiaries) $350.0&nbsp;million at any one time. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this definition, the term &#147;<I>Indebtedness</I>&#148; shall be deemed to include interest on such Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Permitted Warrant</I>&#148; means any call option in respect of the Issuer&#146;s Common Stock sold by the Issuer concurrently with the issuance of
Convertible Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Person</I>&#148; means any individual, corporation, limited liability Issuer, partnership, joint venture, association, joint
stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Pledged
Notes</I>&#148; means all promissory notes listed in the Collateral Agreement, all intercompany notes at any time issued to the Issuer or the Secured Guarantors and all other promissory notes issued to or held by the Issuer or the Secured Guarantors
(other than promissory notes issued in connection with extensions of trade credit by the Issuer or the Secured Guarantors in the ordinary course of business). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Pledged Stock</I>&#148; means the shares of Capital Stock, together with any other shares, stock certificates, options, interests or rights of any
nature whatsoever in respect of the Capital Stock of any Person that may be issued or granted to, or held by, any grantor; <I>provided</I> that in no event shall more than 65% of the total outstanding Foreign Subsidiary Voting Stock of any Foreign
Subsidiary be required to be pledged under the Security Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Preferred Stock</I>&#148; means any Equity Interest with preferential rights of payment of
dividends or upon liquidation, dissolution or winding up. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Principal Property</I>&#148; means any property, plant, equipment or facility of the
Issuer or any of its Restricted Subsidiaries, except that any property, plant, equipment or facility of the Issuer or any of its Restricted Subsidiaries which does not equal or exceed 3% of the Issuer&#146;s Consolidated Net Tangible Assets shall
not constitute a Principal Property of the Issuer unless its Board of Directors or its management deems it to be material to the Issuer and its Restricted Subsidiaries, taken as a whole. Accounts receivable, inventory and Equity Interests of the
Issuer or any of its Restricted Subsidiaries are not &#147;Principal Property&#148;; <I>provided</I>, <I>however</I>, that individual items of property, plant, equipment or individual facilities of the Issuer or any of its Restricted Subsidiaries
shall not be combined in determining whether that property, plant, equipment or facility constitutes a Principal Property of the Issuer, whether or not they are the subject of the same transaction or series of transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Qualified Receivables Transaction</I>&#148; means any transaction or series of transactions that may be entered into by the Issuer or any of its
Restricted Subsidiaries pursuant to which the Issuer or any of its Restricted Subsidiaries may sell, convey or otherwise transfer to (1)&nbsp;a Receivables Subsidiary (in the case of a transfer by the Issuer or any of its Restricted Subsidiaries)
and (2)&nbsp;any other Person (in the case of a transfer by a Receivables Subsidiary), or may grant a security interest in, any Receivables (whether now existing or arising in the future) of the Issuer or any of its Restricted Subsidiaries, and any
assets related thereto, all contracts and all Guarantees or other obligations in respect of such accounts receivable, the proceeds of such Receivables and other assets that are customarily transferred (including, without limitation, assets of the
type transferred pursuant to the Existing Receivables Facility) or in respect of which security interests are customarily granted, in connection with asset securitizations involving Receivables. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Rating Agencies</I>&#148; means Moody&#146;s and S&amp;P or if Moody&#146;s or S&amp;P or both shall not make a rating on the Notes publicly
available, a nationally recognized statistical rating agency or agencies, as the case may be, selected by the Issuer which shall be substituted for Moody&#146;s or S&amp;P or both, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Receivable</I>&#148; means all Indebtedness and other obligations owed to the Issuer or a Secured Guarantor (including, without limitation, any
Indebtedness, obligation or interest constituting an account, chattel paper, instrument or general intangible) arising in connection with the sale of goods or rendering of services by the Issuer or such Secured Guarantor (including any Account (as
defined in the New York UCC)) including, without limitation, the obligation to pay any finance charges or similar amounts with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Receivables Fees</I>&#148; means any fees or interest paid to purchasers or lenders providing the financing in connection with a Qualified
Receivables Transaction, factoring agreement or other similar agreement, including any such amounts paid by discounting the face amount of receivables or participations therein transferred in connection with a Qualified Receivables Transaction,
factoring agreement or other similar arrangement, regardless of whether any such transaction is structured as <FONT STYLE="white-space:nowrap">on-balance</FONT> sheet or <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet or through a
Restricted Subsidiary or an Unrestricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Receivables Financing</I>&#148; means the Existing Receivables Facility and any future
financing arrangement among the Issuer, certain Subsidiaries of the Issuer, including Receivables Subsidiaries, and certain other parties pursuant to which Subsidiaries of the Issuer will sell substantially all of their accounts receivable from time
to time to Receivables Subsidiaries, which will, in turn, sell or pledge such receivables to certain third-party lenders or investors for a purchase price or loan from such lenders or investors, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Receivables Subsidiary</I>&#148; means any Subsidiary formed for the purpose of facilitating or entering into one or more Qualified Receivables
Transactions, and in each case engages only in activities reasonably related or incidental thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Related Security</I>&#148; means with respect to any Receivable: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all of the Issuer&#146;s and Secured Guarantor&#146;s interest in the inventory and goods (including returned
or repossessed inventory or goods), if any, the sale, financing or lease of which by the Issuer and Secured Guarantor gave rise to such Receivable, and all insurance contracts with respect thereto, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all other security interests or liens and property subject thereto from time to time, if any, purporting to
secure payment of such Receivable, whether pursuant to a contract related to such Receivable or otherwise, together with all financing statements and security agreements describing any collateral securing such Receivable, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all guaranties, letters of credit, insurance and other agreements or arrangements of whatever character from
time to time supporting or securing payment of such Receivable whether pursuant to a contact related to such Receivable or otherwise, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all service contracts and other contracts and agreements associated with such Receivable,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all records related to such Receivable, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all of the Issuer&#146;s and Secured Guarantor&#146;s right, title and interest (if any) in any deposit or
other account into which such Receivables are paid or deposited, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all proceeds of any of the foregoing. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Restricted Subsidiary</I>&#148; means, at any time, any direct or indirect Subsidiary of the Issuer that is not then an Unrestricted Subsidiary;
<I>provided</I>, <I>however</I>, that upon an Unrestricted Subsidiary&#146;s ceasing to be an Unrestricted Subsidiary, such Subsidiary shall be included in the definition of &#147;Restricted Subsidiary.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>S&amp;P</I>&#148; means Standard&nbsp;&amp; Poor&#146;s Ratings Services and any successor to its rating agency business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Sale and Lease-Back Transaction</I>&#148; means any arrangement providing for the leasing by the Issuer or any of its Restricted Subsidiaries for a
period of more than three years of any Principal Property, which property is to be sold or transferred by the Issuer or such Subsidiary to a third Person in contemplation of such leasing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>SEC</I>&#148; means the U.S. Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Secured Guarantor&#148;</I> means each Guarantor which has granted a security interest pursuant to the Security Documents to secure such
Guarantor&#146;s Guarantee of the Notes and the Notes Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Securities Act</I>&#148; means the Securities Act of 1933, as amended, and
the rules and regulations of the SEC promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Security Agreement</I>&#148; means the Joinder to the Security Agreement, together
with the Base Security Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Security Documents</I>&#148; means, collectively, the Security Agreement, any intercreditor agreement related
to the Junior Lien Obligations, other security agreements relating to the Collateral and instruments filed and recorded in appropriate jurisdictions to preserve and protect the Liens on the Collateral (including, without limitation, financing
statements under the Uniform Commercial Code of the relevant states) applicable to the Collateral, each as in effect on the Issue Date (as applicable) and as amended, amended and restated, modified, renewed or replaced from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Senior Credit Facility</I>&#148; means the senior credit agreement dated as of November&nbsp;15, 2010 and as amended on March&nbsp;15, 2011,
September&nbsp;21, 2012, May&nbsp;16, 2013, August&nbsp;7, 2014, June&nbsp;7, 2016, October&nbsp;23, 2018, August&nbsp;24, 2021, June&nbsp;23, 2022 and on the Issue Date, among the Issuer, the lenders party thereto in their capacities as lenders
thereunder and JPMorgan Chase Bank, N.A., as Administrative Agent, including any guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals,
restatements, replacements (which may occur after the termination of such senior credit agreement), refundings or refinancings thereof and any indentures or credit facilities or commercial paper facilities with banks or other institutional lenders
or investors that replace (which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
replacement may occur after the termination of such senior credit agreement or other facility), refund or refinance any part of the loans, notes, other credit facilities or commitments
thereunder, including any such replacement, refunding or refinancing facility or indenture that increases the amount borrowable thereunder or alters the maturity thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Senior Credit Facility Obligations</I>&#148; means &#147;Obligations&#148; as defined in the Senior Credit Facility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Series</I>&#148; means (a)&nbsp;with respect to the First Lien Secured Parties, each of (i)&nbsp;the Credit Agreement Secured Parties (in their
capacities as such), (ii) the holders of the Existing 2026 Notes, the holders of the Existing 2030 Notes, the holders of the Existing 2032 Notes and U.S. Bank Trust Company, National Association (as successor to MUFG Union Bank, N.A. in the case of
the Existing 2030 Notes), as trustee for the holders of the Existing 2026 Notes, the Existing 2030 Notes and the Existing 2032 Notes, collectively, (iii)&nbsp;the Holders and the Trustee (in its capacity as such) and (iv)&nbsp;the Additional First
Lien Secured Parties that become subject to the Security Agreement after the date hereof that are represented by a common Authorized Representative (in its capacity as such for such Additional First Lien Secured Parties) and (b)&nbsp;with respect to
any First Lien Obligations, each of (i)&nbsp;the Senior Credit Facility Obligations, (ii)&nbsp;the Existing 2026 Notes Obligations, the Existing 2030 Notes Obligations and the Existing 2032 Notes Obligations, (iii)&nbsp;the Notes Obligations with
respect to the 2029 Notes, (iv)&nbsp;the Notes Obligations with respect to the 2034 Notes and (v)&nbsp;Additional First Lien Obligations incurred pursuant to any applicable agreement, which, pursuant to any joinder agreement, are to be represented
under the Security Agreement by a common Authorized Representative (in its capacity as such for such Additional First Lien Obligations). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Significant Subsidiary</I>&#148; means any Restricted Subsidiary that would be a &#147;Significant Subsidiary&#148; as defined in Article 1, Rule <FONT
STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X,</FONT> promulgated pursuant to the Securities Act, as such regulation is in effect on the Issue Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Standard Securitization Undertakings</I>&#148; means representations, warranties, covenants and indemnities entered into by the Issuer or any
Restricted Subsidiary that are reasonably customary in securitization of Qualified Receivables Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Subsidiary</I>&#148; means, with
respect to any Person: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any corporation, association, or other business entity (other than a partnership, joint venture, limited
liability company or similar entity) of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at
the time of determination owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof or is consolidated under GAAP with such Person at such time; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any partnership, joint venture, limited liability company or similar entity of which more than 50% of the
equity ownership, whether in the form of membership, general, special or limited partnership interests or otherwise, is owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a
combination thereof or is consolidated under GAAP with such Person at such time. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>total assets</I>&#148; means the total assets
of the Issuer and its Restricted Subsidiaries on a consolidated basis, as shown on the most recent consolidated balance sheet of the Issuer or such other Person as may be expressly stated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Transactions</I>&#148; means, collectively, (i) the entry into the amended revolving credit facility and the new replacement tranche A term loan
facility pursuant to the amendment and restatement of our Senior Credit Facility, (ii) the offering of the Notes and (iii) the use of proceeds from the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Underwriters</I>&#148; means J.P. Morgan Securities LLC, BofA Securities, Inc., Truist Securities, Inc., U.S. Bancorp Investments, Inc., Wells Fargo
Securities, LLC, Goldman Sachs &amp; Co., LLC, Mizuho Securities USA LLC, NatWest Markets Securities Inc., PNC Capital Markets LLC, TD Securities (USA) LLC, Fifth Third Securities, Inc., SMBC Nikko Securities America, Inc. and KeyBanc Capital
Markets Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Unrestricted Subsidiary</I>&#148; means: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Subsidiary of the Issuer which at the time of determination shall be designated an Unrestricted Subsidiary
by the Board of Directors of the Issuer in the manner provided below; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Subsidiary of an Unrestricted Subsidiary. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors of the Issuer may designate any Subsidiary of the Issuer (including any newly acquired or newly formed Subsidiary or a Person becoming
a Subsidiary through merger or consolidation or investment therein) to be an Unrestricted Subsidiary only if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Subsidiary or any of its Subsidiaries does not own any Capital Stock or Indebtedness of or have any
investment in, or own or hold any Lien on any property of, any other Subsidiary of the Issuer that is not a Subsidiary of the Subsidiary to be so designated or otherwise an Unrestricted Subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all the Indebtedness of such Subsidiary and its Subsidiaries shall, at the date of designation, and will at all
times thereafter, consist of <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Debt; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Subsidiary, either alone or in the aggregate with all other Unrestricted Subsidiaries, does not operate,
directly or indirectly, all or substantially all of the business of the Issuer and its Subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Subsidiary is a Person with respect to which neither the Issuer nor any of its Restricted Subsidiaries has
any direct or indirect obligation: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to subscribe for additional Capital Stock of such Person; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to maintain or preserve such Person&#146;s financial condition or to cause such Person to achieve any specified
levels of operating results; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">on the date such Subsidiary is designated an Unrestricted Subsidiary, such Subsidiary is not a party to any
agreement, contract, arrangement or understanding with the Issuer or any Restricted Subsidiary with terms substantially less favorable to the Issuer than those that might have been obtained from Persons who are not Affiliates of the Issuer.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any such designation by the Board of Directors of the Issuer shall be evidenced to the Trustee by filing with the Trustee a resolution
of the Board of Directors of the Issuer, certified by the Secretary or an Assistant Secretary of the Issuer, giving effect to such designation and an Officers&#146; Certificate certifying that such designation complies with the foregoing conditions.
If, at any time, any Unrestricted Subsidiary would fail to meet the foregoing requirements as an Unrestricted Subsidiary, it shall thereafter cease to be an Unrestricted Subsidiary for purposes of the Indenture and any Indebtedness of such
Subsidiary shall be deemed to be Incurred as of such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors of the Issuer may designate any Unrestricted Subsidiary to be a
Restricted Subsidiary; <I>provided </I>that immediately after giving effect to such designation, no Default or Event of Default shall have occurred and be continuing or would occur as a consequence thereof and either: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer and its Restricted Subsidiaries on a consolidated basis would have had a Consolidated Coverage Ratio
of at least 2.00 to 1.00; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Consolidated Coverage Ratio for the Issuer and its Restricted Subsidiaries would be greater than such ratio
for the Issuer and its Restricted Subsidiaries immediately prior to such designation, in each case on a pro forma basis taking into account such designation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Unsecured Guarantors</I>&#148; means each of the Guarantors other than the Secured Guarantors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Voting Stock</I>&#148; of any Person as of any date means the Capital Stock of such Person that is at the time entitled to vote in the election of
the board of directors of such Person. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Wholly Owned Subsidiary</I>&#148; of any Person means a Subsidiary of such Person, 100% of the
outstanding Equity Interests of which (other than directors&#146; qualifying shares) shall at the time be owned by such Person or by one or more Wholly Owned Subsidiaries of such Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_12"></A>Book-entry settlement and clearance </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Book-entry, delivery and form </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be
represented by one or more permanent global notes in registered form without interest coupons (the &#147;Global Notes&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Global Notes will be
deposited upon issuance with the trustee as custodian for The Depository Trust Company (&#147;DTC&#148;), in New York, New York, and registered in the name of DTC&#146;s nominee, Cede&nbsp;&amp; Co., in each case for credit to an account of a direct
or indirect participant in DTC as described below. Beneficial interests in the Global Notes may be held through the Euroclear System (&#147;Euroclear&#148;) and Clearstream Banking, S.A. (&#147;Clearstream&#148;) (as indirect participants in DTC).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as set forth below, the Global Notes may be transferred, in whole but not in part, only to another nominee of DTC or to a successor of DTC or its
nominee. Beneficial interests in the Global Notes may not be exchanged for certificated notes, and owners of beneficial interests in the Global Notes will not be entitled to receive physical delivery of certificated Notes, except in the limited
circumstances described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transfers of beneficial interests in the Global Notes will be subject to the applicable rules and procedures of DTC and
its direct or indirect participants (including, if applicable, those of Euroclear and Clearstream), which may change from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Global Notes will
be exchangeable for certificated notes registered in the names of holders other than the depositary or its nominee only if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such depositary notifies us that it is unwilling or unable to continue as the depositary for such Global Note or
such depositary ceases to be a clearing agency registered under the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we execute and deliver to the trustee an officer&#146;s certificate to the effect that such Global Note will be
so exchangeable; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an Event of Default with respect to the notes represented by such Global Note has occurred and is continuing.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Depositary procedures </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following description of the operations and procedures of DTC, Euroclear and Clearstream are provided solely as a matter of convenience. These operations and procedures are solely within the control of the respective settlement systems and are
subject to changes by them. We and the underwriters take no responsibility for these operations and procedures and urge investors to contact the system or their participants directly to discuss these matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC has advised us that DTC is a limited-purpose trust company created to hold securities for its participating organizations (collectively, the
&#147;Participants&#148;) and to facilitate the clearance and settlement of transactions in those securities between Participants through electronic book-entry changes in accounts of its Participants. The Participants include securities brokers and
dealers (including the underwriters), banks, trust companies, clearing corporations and certain other organizations. Access to DTC&#146;s system is also available to other entities such as banks, brokers, dealers and trust companies that clear
through or maintain a custodial relationship with a Participant, either directly or indirectly (collectively, the &#147;Indirect Participants&#148;). Persons who are not Participants may beneficially own securities held by or on behalf of DTC only
through the Participants or the Indirect Participants. The ownership interests in, and transfers of ownership interests in, each security held by or on behalf of DTC are recorded on the records of the Participants and Indirect Participants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC has also advised us that, pursuant to procedures established by it: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon deposit of the Global Notes, DTC will credit the accounts of Participants designated by the underwriters
with portions of the principal amount of the Global Notes; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ownership of these interests in the Global Notes will be shown on, and the transfer of ownership of these
interests will be effected only through, records maintained by DTC (with respect to the Participants) or by the Participants and the Indirect Participants (with respect to other owners of beneficial interests in the Global Notes).
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors in the Global Notes who are Participants in DTC&#146;s system may hold their interests therein directly through DTC.
Investors in the Global Notes who are not Participants may hold their interests therein indirectly through organizations (including Euroclear and Clearstream) which are Participants in such system. Euroclear and Clearstream may hold interests in the
Global Notes on behalf of their participants through customers&#146; securities accounts in their respective names on the books of their respective depositaries. All interests in a Global Note, including those held through Euroclear or Clearstream,
may be subject to the procedures and requirements of DTC. Those interests held through Euroclear or Clearstream may also be subject to the procedures and requirements of such systems. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The laws of some states require that certain persons take physical delivery in definitive form of securities that they own. Consequently, the ability to
transfer beneficial interests in a Global Note to such Persons will be limited to that extent. Because DTC can act only on behalf of Participants, which in turn act on behalf of Indirect Participants, the ability of a person having beneficial
interests in a Global Note to pledge such interests to Persons that do not participate in the DTC system, or otherwise take actions in respect of such interests, may be affected by the lack of a physical certificate evidencing such interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Owners of an interest in the Global Notes will not have notes registered in their names, will not receive physical delivery of certificated notes (except in
the limited circumstances described below) and will not be considered the registered owners or &#147;holders&#148; thereof under the Indenture for any purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payments in respect of the principal of, and interest and premium, if any, on a Global Note registered in the name of DTC or its nominee will be payable to
DTC in its capacity as the registered Holder under the Indenture. Under the terms of the Indenture, we and the trustee will treat the persons in whose names the notes, including the Global Notes, are registered as the owners of the notes for the
purpose of receiving payments and for all other purposes. Consequently, neither we, the trustee nor any agent of us or the trustee has or will have any responsibility or liability for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any aspect of DTC&#146;s records or any Participant&#146;s or Indirect Participant&#146;s records relating to or
payments made on account of beneficial ownership interests in the Global Notes or for maintaining, supervising or reviewing any of DTC&#146;s records or any Participant&#146;s or Indirect Participant&#146;s records relating to the beneficial
ownership interests in the Global Notes; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other matter relating to the actions and practices of DTC or any of its Participants or Indirect
Participants. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC has advised us that its current practice, at the due date of any payment in respect of securities such as the notes,
is to credit the accounts of the relevant Participants with the payment on the payment date unless DTC has reason to believe it will not receive payment on such payment date. Each relevant Participant is credited with an amount proportionate to its
beneficial ownership of an interest in the principal amount of the notes as shown on the records of DTC. Payments by the Participants and the Indirect Participants to the beneficial owners of notes will be governed by standing instructions and
customary practices and will be the responsibility of the Participants or the Indirect Participants and will not be the responsibility of DTC, the trustee or us. Neither we nor the trustee will be liable for any delay by DTC or any of its
Participants in identifying the beneficial owners of the notes, and we and the trustee may conclusively rely on and will be protected in relying on instructions from DTC or its nominee for all purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transfers between Participants in DTC will be effected in accordance with DTC&#146;s procedures, and will be
settled in <FONT STYLE="white-space:nowrap">same-day</FONT> funds, and transfers between participants in Euroclear and Clearstream will be effected in accordance with their respective rules and operating procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cross-market transfers between the Participants in DTC, on the one hand, and Euroclear or Clearstream participants, on the other hand, will be effected
through DTC in accordance with DTC&#146;s rules on behalf of Euroclear or Clearstream, as the case may be, by its depositary; however, such cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may
be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (Brussels time) of such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement
requirements, deliver instructions to its respective depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the relevant Global Note in DTC, and making or receiving payment in accordance with
normal procedures for <FONT STYLE="white-space:nowrap">same-day</FONT> funds settlement applicable to DTC. Euroclear participants and Clearstream participants may not deliver instructions directly to the depositaries for Euroclear or Clearstream.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC has advised us that it will take any action permitted to be taken by a Holder of Notes only at the direction of one or more Participants to whose
account DTC has credited the interests in the Global Notes and only in respect of such portion of the aggregate principal amount of the notes as to which such Participant or Participants has or have given such direction. However, if there is an
event of default under the notes, DTC reserves the right to exchange the Global Notes for certificated notes and to distribute such notes to its Participants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although DTC, Euroclear and Clearstream have agreed to the foregoing procedures to facilitate transfers of interests in the Global Notes among participants in
DTC, Euroclear and Clearstream, they are under no obligation to perform or to continue to perform such procedures, and may discontinue such procedures at any time. None of us, the Trustee or any of our or its respective agents will have any
responsibility for the performance by DTC, Euroclear or Clearstream or their respective Participants or Indirect Participants of their respective obligations under the rules and procedures governing their operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Same-day</FONT> settlement and payment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will make payments in respect of the notes represented by the Global Notes (including principal, premium, if any, and interest) by wire transfer of
immediately available funds to the accounts specified by the Global Note holder. We will make all payments of principal, interest and premium, if any, with respect to Certificated Notes by wire transfer of immediately available funds to the accounts
specified by the Holders of the Certificated Notes or, if no such account is specified, by mailing a check to each such Holder&#146;s registered address. The notes represented by the Global Notes are expected to be eligible to trade in DTC&#146;s <FONT
STYLE="white-space:nowrap">Same-Day</FONT> Funds Settlement System, and any permitted secondary market trading activity in such notes will, therefore, be required by DTC to be settled in immediately available funds. We expect that secondary trading
in any Certificated Notes will also be settled in immediately available funds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because of time zone differences, the securities account of a Euroclear or
Clearstream participant purchasing an interest in a Global Note from a Participant in DTC will be credited, and any such crediting will be reported to the relevant Euroclear or Clearstream participant, during the securities settlement processing day
(which must be a business day for Euroclear and Clearstream) immediately following the settlement date of DTC. DTC has advised us that cash received in Euroclear or Clearstream as a result of sales of interests in a Global Note by or through a
Euroclear or Clearstream participant to a Participant in DTC will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or
Clearstream following DTC&#146;s settlement date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_13"></A>Material United States federal income tax consequences </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the material United States federal income tax consequences, as of the date of this prospectus supplement, of the purchase,
ownership and disposition of the notes. This summary deals only with notes held as capital assets (generally property held for investment) by persons who purchase the notes for cash upon original issuance at their &#147;issue price,&#148; which for
each series will be the first price at which a substantial amount of the notes of such series is sold to the investors (excluding sales to bond houses, brokers or similar persons or organizations acting in the capacity of underwriter, placement
agent or wholesaler). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used herein, a &#147;U.S. holder&#148; means a beneficial owner of the notes that is for United States federal income tax
purposes any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (or any other entity treated as a corporation for United States federal income tax purposes)
created or organized in or under the laws of the United States, any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate the income of which is subject to United States federal income taxation regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if it (1)&nbsp;is subject to the primary supervision of a court within the United States and one or more
United States persons have the authority to control all substantial decisions of the trust or (2)&nbsp;has a valid election in effect under applicable United States Treasury regulations to be treated as a United States person. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used herein, the term <FONT STYLE="white-space:nowrap">&#147;non-U.S.</FONT> holder&#148; means a beneficial owner of the notes (other than an entity
treated as a partnership for United States federal income tax purposes) that is not a U.S. holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any entity classified as a partnership for United
States federal income tax purposes holds notes, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. If you are a partnership or a partner in a partnership considering an
investment in the notes, you should consult your own tax advisors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary is for general information only, and does not purport to discuss all
aspects of United States federal income taxation that may be important to a particular holder in light of its investment or tax circumstances, or to represent a detailed description of the United States federal income tax consequences applicable to
you if you are a person subject to special tax treatment under the United States federal income tax laws, including, without limitation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a dealer in securities or currencies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a bank or other financial institution; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a regulated investment company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a real estate investment trust; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap">tax-exempt</FONT> entity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an insurance company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a person holding the notes as part of a hedging, integrated, conversion or constructive sale transaction or a
straddle; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trader in securities that has elected the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> method of accounting for your securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a person liable for alternative minimum tax; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a partnership, S corporation or other pass-through entity for United States federal income tax purposes (or an
investor in such an entity); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a U.S. holder whose &#147;functional currency&#148; is not the U.S. dollar; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a U.S. holder that holds its notes through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker or other <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> intermediary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;controlled foreign corporation&#148;; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;passive foreign investment company&#148;; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a person required to accelerate the recognition of any item of gross income with respect to the notes as a result
of such income being recognized on an applicable financial statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust or estate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a qualified retirement plan, individual retirement account or other tax deferred account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a government (or instrumentality or agency thereof); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a United States expatriate. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary is based on the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), United States Treasury regulations, administrative rulings and
official pronouncements of the Internal Revenue Service (&#147;IRS&#148;) and judicial decisions, all as of the date hereof. Those authorities may be changed, possibly on a retroactive basis, so as to result in United States federal income tax
consequences different from those summarized below. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance that the IRS will not take, or that a court would not sustain,
positions concerning the United States federal income tax consequences of the purchase, ownership or disposition of the notes that are different from those discussed below. This summary is not exhaustive of all possible tax considerations and does
not represent a detailed description of United States federal income tax consequences, nor does it address United States federal estate, gift or alternative minimum tax laws, the Medicare tax on certain investment income or the effects of any state,
local or <FONT STYLE="white-space:nowrap">non-United</FONT> States tax laws. It is not intended to be, and should not be construed to be, legal or tax advice to any particular purchaser of notes. This summary does not address any tax reporting
requirements except as expressly discussed below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are considering the purchase of notes, you should consult your own tax advisors concerning the
particular United States federal income tax consequences to you of the purchase, ownership and disposition of the notes, as well as the consequences to you arising under other United States federal tax laws (including the estate, gift or alternative
minimum tax laws and the Medicare tax on certain investment income) and under the laws of any other taxing jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material tax consequences to
U.S. holders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the material United States federal income tax consequences that will apply to you if you are a U.S. holder
of the notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stated interest</I>. Stated interest on the notes generally will be taxable to you as ordinary income at the time it is received or
accrued, depending on your method of accounting for United States federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the stated principal amount of the notes of a series
exceeds their issue price by an amount that is equal to or greater than a statutorily-defined de minimis amount, the notes of such series will be treated as issued with &#147;original issue discount&#148; for United States federal income tax
purposes in an amount equal to such excess, and a U.S. holder will be required to include such original issue discount in income (as ordinary income) as it accrues (in accordance with a constant yield method) in advance of the receipt of cash
payments attributable to such original issue discount, regardless of the U.S. holder&#146;s regular method of accounting for United States federal income tax purposes. We believe, and this summary assumes, that the notes will not be issued with
original issue discount for United States federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Sale, exchange, retirement, redemption or other taxable disposition of
notes</I>. Upon the sale, exchange, retirement, redemption or other taxable disposition of a note, you generally will recognize gain or loss equal to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the difference, if any, between the amount realized upon the sale, exchange, retirement, redemption or other taxable disposition (less an amount equal to any accrued and unpaid stated interest,
which will be taxable as interest income if not previously included in income as discussed above) and the adjusted tax basis of the note. Your adjusted tax basis in a note will, in general, be your cost for that note. Any gain or loss will be
capital gain or loss and will be long-term capital gain or loss if at the time of the sale, exchange, retirement, redemption or other taxable disposition the note has been held by you for more than one year. Long-term capital gains of <FONT
STYLE="white-space:nowrap">non-corporate</FONT> holders are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the material United States federal income tax consequences that will apply to you if you are a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of the notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>United States federal withholding tax</I>. Subject to the discussion of backup
withholding and FATCA below, United States federal withholding tax will not apply to any payment of interest on the notes under the &#147;portfolio interest rule,&#148; provided that: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interest paid on the notes is not effectively connected with your conduct of a trade or business in the United
States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you do not actually (or constructively) own 10% or more of the total combined voting power of all classes of our
voting stock within the meaning of the Code and applicable United States Treasury regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are not a controlled foreign corporation that is related to us actually or constructively through stock
ownership; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are not a bank whose receipt of interest on the notes is described in Section&nbsp;881(c)(3)(A) of the Code;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">either (a)&nbsp;you provide your name and address on an IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT>
or Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> as applicable (or other applicable form), and certify, under penalties of perjury, that you are not a United States person as defined under the Code or
(b)&nbsp;you hold your notes through certain foreign intermediaries and satisfy the certification requirements of applicable United States Treasury regulations. Special certification rules apply to <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holders that are pass-through entities rather than corporations or individuals. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you cannot satisfy the requirements described above,
payments of interest made to you will be subject to a 30% United States federal withholding tax, unless you provide the applicable withholding agent with a properly executed: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or Form <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> as applicable (or other applicable form), certifying an exemption from or reduction in withholding under the benefit of an applicable income tax treaty; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IRS Form <FONT STYLE="white-space:nowrap">W-8ECI</FONT> (or other applicable form) certifying that interest paid
on the notes is not subject to withholding tax because it is effectively connected with your conduct of a trade or business in the United States and includible in your gross income (as discussed below under &#147;&#151;United States federal income
tax&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 30% United States federal withholding tax generally will not apply to any payment of principal or gain that you realize
on the sale, exchange, retirement, redemption or other taxable disposition of a note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>United States federal income tax</I>. If you are engaged in a
trade or business in the United States and interest on the notes is effectively connected with the conduct of that trade or business (and, if required by an applicable income tax treaty, is attributable to a United States permanent establishment),
then you will be subject to United States federal income tax on that interest on a net income basis in generally the same manner as if you were a United States person as defined under the Code. In addition, if you are a foreign corporation, you may
be subject to a branch profits tax equal to 30% (or a lower applicable income tax treaty rate) of your effectively connected </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
earnings and profits, subject to adjustments. If interest received with respect to the notes is effectively connected income (whether or not a treaty applies), the 30% withholding tax described
above will not apply, provided the certification requirements discussed above in &#147;&#151;United States federal withholding tax&#148; are satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion of backup withholding and FATCA below, any gain realized on the sale, exchange, retirement, redemption or other taxable disposition
of a note generally will not be subject to United States federal income tax unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with your conduct of a trade or business in the United States (and, if required
by an applicable income tax treaty, is attributable to a United States permanent establishment), in which case such gain generally will be subject to United States federal income tax (and possibly branch profits tax) in the same manner as discussed
above with respect to effectively connected interest; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are an individual who is present in the United States for 183 days or more in the taxable year of that
disposition, and certain other conditions are met, in which case, unless an applicable income tax treaty provides otherwise, you generally will be subject to a flat 30% United States federal income tax on any gain recognized, which may be offset by
certain United States source losses. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that any amount received on the sale, exchange, retirement, redemption or other
taxable disposition of a note is attributable to accrued but unpaid interest on the note, such amount generally will subject to, or exempt from, tax to the same extent as described above with respect to interest paid on the notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information reporting and backup withholding </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>U.S.
holders</I>.&#8195;In general, information reporting requirements will apply to payments of interest on the notes and the proceeds of the sale or other taxable disposition (including a retirement or redemption) of a note paid to you (unless you are
an exempt recipient such as a corporation). Backup withholding (currently at a rate of 24%) may apply to such payments if you fail to provide a taxpayer identification number and a certification that you are not subject to backup withholding or if
you are subject to backup withholding because you previously failed to report in full dividend and interest income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Backup withholding is not an
additional tax and any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against your United States federal income tax liability provided the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders</I>. Generally, information reporting will apply to the amount of interest paid to you and the
amount of tax, if any, withheld with respect to those payments. Copies of the information returns reporting such interest payments and any withholding may also be made available to the tax authorities in the country in which you reside under the
provisions of an applicable income tax treaty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, you will not be subject to backup withholding with respect to payments of interest on the
notes that are made to you provided that the applicable withholding agent does not have actual knowledge or reason to know that you are a United States person as defined under the Code, and such withholding agent has received from you the required
certification that you are a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder described above in the fifth bullet point under &#147;&#151;Material tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders&#151;United States
federal withholding tax.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information reporting and, depending on the circumstances, backup withholding will apply to the proceeds of a sale or
other taxable disposition (including a retirement or redemption) of notes within the United States or conducted through certain United States-related financial intermediaries, unless you certify to the payor under penalties of perjury that you are a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (and the payor does not have actual knowledge or reason to know that you are a United States person as defined under the Code), or you otherwise establish an exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax and any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against your
United States federal income tax liability provided the required information is timely furnished to the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional withholding requirements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Sections 1471 through 1474 of the Code (such Sections commonly referred to as &#147;FATCA&#148;), a 30% United States federal withholding tax may apply
to any interest paid on the notes to (i)&nbsp;a &#147;foreign financial institution&#148; (as specifically defined in the Code) which does not provide sufficient documentation, typically on IRS Form <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> evidencing either (x)&nbsp;an exemption from FATCA, or (y)&nbsp;its compliance (or deemed compliance) with FATCA (which may alternatively be in the form of compliance with an intergovernmental
agreement with the United States) in a manner which avoids withholding, or (ii)&nbsp;a <FONT STYLE="white-space:nowrap">&#147;non-</FONT> financial foreign entity&#148; (as specifically defined in the Code) which does not provide sufficient
documentation, typically on IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> evidencing either (x)&nbsp;an exemption from FATCA, or (y)&nbsp;adequate information regarding certain substantial United
States beneficial owners of such entity (if any). The foregoing rules generally will apply whether the foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity is the beneficial owner of the notes or an
intermediary. If an interest payment is both subject to withholding under FATCA and subject to the withholding tax discussed above under &#147;&#151;Material tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders&#151;United
States federal withholding tax,&#148; an applicable withholding agent may credit the withholding under FATCA against, and therefore reduce, such other withholding tax.&#8195;While withholding under FATCA would also have applied to payments of gross
proceeds from the sale or other taxable disposition of notes, proposed United States Treasury regulations (upon which taxpayers may rely until final regulations are issued) eliminate FATCA withholding on payments of gross proceeds entirely. You
should consult your own tax advisors regarding these rules and whether they may be relevant to your ownership and disposition of the notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_14"></A>Certain ERISA considerations </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of certain considerations associated with the purchase of the notes, or any interest therein, by (i)&nbsp;employee benefit plans
that are subject to Title I of the Employee Retirement Income Security Act of 1974, as amended, or ERISA, (ii)&nbsp;plans, individual retirement accounts and other arrangements that are subject to Section&nbsp;4975 of the Internal Revenue Code of
1986, as amended, or the Code, or provisions under any other U.S. or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> federal, state, local or other laws or regulations that are similar to such provisions of ERISA or the Code (collectively,
&#147;Similar Laws&#148;), and (iii)&nbsp;entities whose underlying assets are considered to include &#147;plan assets&#148; of any such plan, account or arrangement, (each, a &#147;Plan&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General fiduciary matters </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ERISA and the Code impose
certain duties on persons who are fiduciaries of a Plan subject to Title I of ERISA or Section&nbsp;4975 of the Code (a &#147;Covered Plan&#148;), and prohibit certain transactions involving the assets of a Covered Plan and its fiduciaries or other
interested parties. Under ERISA and the Code, any person who exercises any discretionary authority or control over the administration of a Covered Plan or the management or disposition of the assets of a Covered Plan, or who renders investment
advice for a fee or other compensation to a Covered Plan, is generally considered to be a fiduciary of the Covered Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In considering an investment in
the notes, or any interest therein, with a portion of the assets of any Plan, a fiduciary should determine whether the investment is in accordance with the documents and instruments governing the Plan and such assets and the applicable provisions of
ERISA, the Code and any Similar Law relating to the fiduciary&#146;s duties to the Plan including, without limitation, the prudence, diversification, delegation of control, conflicts of interest and prohibited transaction provisions of ERISA, the
Code and any other applicable Similar Law. The fiduciary of a Plan should consider the Plan&#146;s particular circumstances and all of the facts and circumstances of the investment, including, but not limited to, the matters discussed above under
&#147;Risk Factors,&#148; in determining whether an investment in the notes, or any interest therein, satisfies these requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Plan should
consider the fact that none of UHS, the guarantors or the underwriters or any of their respective affiliates (collectively, the &#147;Transaction Parties&#148;) is acting as a fiduciary to any Plan with respect to the decision to purchase or hold
the notes, or any interest therein, in connection with the initial sale and offering, of the notes, or any interest therein, and that the Transaction Parties have financial interests in the Plan&#146;s purchase and holding of the notes, or any
interest therein, which interests may conflict with the interest of the Plan. The Transaction Parties are not undertaking to provide impartial investment advice or advice based on any particular investment need, or to give advice in a fiduciary
capacity, with respect to the decision to purchase the notes, or any interest therein, in connection with the initial sale and offering of the notes, or any interest therein. All communications, correspondence and materials from the Transaction
Parties with respect to the notes, or any interest therein, are intended to be general in nature and are not directed at any specific purchaser of the notes, or any interest therein, and do not constitute advice regarding the advisability of
investment in the notes, or any interest therein, for any specific purchaser. The decision to purchase and hold the notes, or any interest therein, must be made by each prospective Plan purchaser on an arm&#146;s-length basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prohibited transaction issues </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;406 of ERISA
and Section&nbsp;4975 of the Code prohibit Covered Plans from engaging in specified transactions involving plan assets with persons or entities who are &#147;parties in interest,&#148; within the meaning of Section 3(14) of ERISA, or
&#147;disqualified persons,&#148; within the meaning of Section&nbsp;4975 of the Code, unless an exemption is available. A party in interest or disqualified person who engages in a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited
transaction may be subject to excise taxes and other penalties and liabilities under ERISA and the Code. In addition, the fiduciary of the Covered Plan that engages in such a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction
may be subject to penalties and liabilities under ERISA and the Code. The acquisition and/or holding of notes, or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interest therein, by a Covered Plan with respect to which any of the Transaction Parties is or is considered to be a party in interest or a disqualified person may constitute or result in a
direct or indirect prohibited transaction under Section&nbsp;406 of ERISA and/or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4975 of the Code, unless the investment is acquired and is
held in accordance with an applicable statutory, class or individual prohibited transaction exemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this regard, the U.S. Department of Labor has
issued prohibited transaction class exemptions, or &#147;PTCEs,&#148; that may apply to the acquisition and holding of the notes, or any interest therein. These class exemptions include, without limitation, PTCE 84-14, as amended, with respect to
transactions determined by independent qualified professional asset managers, PTCE 90-1 with respect to insurance company pooled separate accounts, PTCE 91-38 with respect to bank collective investment funds, PTCE 95-60 with respect to life
insurance company general accounts and PTCE 96-23 with respect to transactions determined by in-house asset managers. In addition, Section&nbsp;408(b)(17) of ERISA and Section&nbsp;4975(d)(20) of the Code provide relief from the prohibited
transaction provisions of ERISA and Section&nbsp;4975 of the Code for certain transactions between a Covered Plan and a person that is a party in interest or disqualified person with respect to the Covered Plan solely by reason of providing services
to the Covered Plan or a relationship with such a service provider, provided that neither the person transacting with the Covered Plan nor any of its affiliates (directly or indirectly) have or exercise any discretionary authority or control or
render any investment advice with respect to the assets of any Covered Plan involved in the transaction and provided further that the Covered Plan pays no more than, and receives no less than, adequate consideration in connection with the
transaction. Fiduciaries of Covered Plans considering acquiring and/or holding the notes, or any interest therein, in reliance on these or any other exemption should carefully review the exemption to ensure it is applicable. There can be no
assurance that any of the foregoing exemptions or any other exemption will be available with respect to all possible prohibited transactions that may arise in connection with the acquisition and holding of the notes, or any interest therein, or that
all of the conditions of any such exemptions will be satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Plans and entities that are (or whose assets constitute the assets of) governmental plans
(as defined in Section&nbsp;3(32) of ERISA), church plans (as defined in section 3(33) of ERISA) that have not made an election under section 410(d) of the Code and <FONT STYLE="white-space:nowrap">non-United</FONT> States plans (as described in
Section&nbsp;4(b)(4) of ERISA), while not subject to the fiduciary responsibility provisions of Title I of ERISA or the prohibited transaction provisions of Title I of ERISA or Section&nbsp;4975 of the Code, may nevertheless be subject to Similar
Laws that include similar requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because of the foregoing, the notes, or any interest therein, should not be purchased or held by any person
investing &#147;plan assets&#148; of any Plan, unless such purchase and holding will not constitute a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction under ERISA or the Code or a similar violation of any applicable Similar
Laws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Representation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, by acceptance of
a note, or any interest therein, each purchaser and subsequent transferee of a note, or any interest therein, will be deemed to have represented and warranted that (A) either (i) it is not a Plan and no portion of the assets used by such purchaser
or transferee to acquire or hold the note, or any interest therein, constitutes the assets of any Plan or (ii) the purchase, holding and disposition of the note, or any interest therein, by such purchaser or transferee will not constitute a
non-exempt prohibited transaction under Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code or a similar violation under any applicable Similar Laws, and (B) none of UHS, the guarantors nor any of their respective affiliates will at any time
be relied upon as its fiduciary with respect to any decision by the purchaser or subsequent transferee to acquire, hold, dispose of or transfer the note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing discussion is general in nature and is not intended to be all inclusive. Due to the complexity of these rules and the penalties that may be
imposed upon persons involved in <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transactions, it is particularly important that fiduciaries, or other persons considering purchasing the notes, or any interest
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
therein, on behalf of, or with the assets of, any Plan, consult with their counsel regarding the potential applicability of ERISA, Section&nbsp;4975 of the Code and any Similar Laws to such
investment and whether an exemption would be applicable to the purchase and holding of the notes, or any interest therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_15"></A>Underwriting (conflicts of interest) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms and subject to the conditions contained in the underwriting agreement dated as of the date of this prospectus supplement, the underwriters
named below, for whom J.P. Morgan Securities LLC, BofA Securities, Inc., Truist Securities, Inc., U.S. Bancorp Investments, Inc. and Wells Fargo Securities, LLC are acting as representatives (the &#147;representatives&#148;), have severally agreed
to purchase from us, and we have agreed to sell, the aggregate principal amount of the notes of each series listed opposite their names below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of&nbsp;2029<BR>Notes to be Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of&nbsp;2034<BR>Notes to be Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Bancorp Investments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs &amp; Co., LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NatWest Markets Securities Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TD Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fifth Third Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBanc Capital Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The obligations of the underwriters under the underwriting agreement, including their agreement to purchase the notes from us,
are several and not joint. The underwriting agreement provides that the underwriters will purchase all of the notes being sold pursuant to the underwriting agreement if any of them are purchased. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offering of the notes by the underwriters is subject to receipt and acceptance and subject to the underwriters&#146; right to reject any order in whole or
in part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the underwriting agreement, we have agreed that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We will not offer, sell, contract to sell or otherwise dispose of any of our debt securities with a tenor of more
than one year (other than the notes offered hereby) from the date of this prospectus supplement through and including the closing date, without the prior consent of the representatives. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We will indemnify the several underwriters against certain liabilities, including liabilities under the
Securities Act, or contribute to payments that the underwriters may be required to make in respect of those liabilities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been
advised by the representatives that the underwriters propose to offer the notes directly to the public at the applicable public offering price set forth on the cover page of this prospectus supplement, and the underwriters may sell the notes to
certain dealers at the applicable public offering price less a concession not in excess of (i) 0.350% of the aggregate principal amount of the 2029 notes and (ii) 0.400% of the aggregate principal amount of the 2034 notes. The underwriters may
allow, and such dealers may reallow, a concession not in excess of (i) 0.250% of the aggregate principal amount of the 2029 notes and (ii) 0.250% of the aggregate principal amount of the 2034 notes to certain other dealers. After the initial
offering of the notes to the public, the underwriters may change the public offering price and concession and other selling terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table shows the underwriting discount that we are to pay to the underwriters in connection
with this offering (expressed as a percentage of the principal amount of each series of the notes). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Paid&nbsp;by&nbsp;us</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per 2029 Note</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.600</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per 2034 Note</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.650</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that our total expenses for this offering, excluding the underwriting discount, will be approximately $3.0 million
payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each series of the notes is a new issue of securities with no established trading market. We have not applied for and do not intend to
apply for listing of the notes on any securities exchange or for quotation of the notes on any automated dealer quotation system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters have
advised us that they intend to make a market in each series of the notes, but they are not obligated to do so. The underwriters may discontinue any market making in the notes at any time in their sole discretion. Accordingly, we cannot assure you
that a liquid trading market will develop for the notes, that you will be able to sell your notes at a particular time or that the prices that you receive when you sell will be favorable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should be aware that the laws and practices of certain countries require investors to pay stamp taxes and other charges in connection with purchases of
securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the offering of the notes, the underwriters may engage in overallotment, stabilizing transactions and syndicate covering
transactions. Overallotment involves sales in excess of the offering size, which creates a short position for the underwriters. Stabilizing transactions involve bids to purchase the notes in the open market for the purpose of pegging, fixing or
maintaining the price of the notes. Syndicate covering transactions involve purchases of the notes in the open market after the distribution has been completed in order to cover short positions. Stabilizing transactions and syndicate covering
transactions may have the effect of preventing or retarding a decline in the market price of the notes or cause the price of the notes to be higher than it would otherwise be in the absence of those transactions. If the underwriters engage in
stabilizing or syndicate covering transactions, they may discontinue them at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Settlement cycle </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is expected that delivery of the notes will be made against payment therefor on or about September 26, 2024, which is the seventh business day following the
date hereof (such settlement cycle being referred to as &#147;T+7&#148;). Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), trades in the secondary market
generally are required to settle in one business day unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes prior to one business day before the delivery of the notes hereunder will be
required, by virtue of the fact that the notes initially will settle in T+7, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement. Purchasers of the notes who wish to trade the notes prior to one
business day before the delivery of the notes hereunder should consult their own advisors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include sales and trading,
commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and <FONT STYLE="white-space:nowrap">non-financial</FONT> activities and services.
Certain of the underwriters and their respective affiliates have provided, and may in the future provide, a variety of these services to us and to persons and entities with relationships with us, for which they have received or will receive
customary fees and expenses. In particular, JPMorgan Chase Bank, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
N.A., an affiliate of J.P. Morgan Securities LLC, acted as a joint lead arranger and acts as administrative agent under our senior secured credit facility, and affiliates of certain of the other
underwriters act as lenders and, in some cases, as joint lead arrangers and agents, under our senior secured credit facility. As a result, these affiliates of certain underwriters will receive a portion of the proceeds of the Transactions as a
result of the repayment of the outstanding borrowings under our current tranche A term loan facility. See &#147;&#151;Conflicts of interest&#148; below. These affiliates of certain underwriters are also acting as lenders and, in some cases, joint
lead arrangers and agents, in connection with our amended revolving credit facility and new tranche A term loan facility. An affiliate of U.S. Bancorp Investments, Inc. acts as trustee and JPMorgan Chase Bank, N.A. acts as collateral agent under the
indentures governing our existing senior secured notes and will act as trustee and collateral agent, respectively, under the indenture that will govern the Notes. In addition, affiliates of certain underwriters are counterparties to our interest
rate swap agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of the underwriters or their affiliates has a lending relationship with us, certain of those underwriters or their
affiliates routinely hedge, certain other of those underwriters or their affiliates are likely to hedge and certain other of those underwriters or their affiliates may hedge their credit exposure to us consistent with their customary risk management
policies. Typically, these underwriters and their affiliates would hedge such exposure by entering into transactions which consist of either the purchase of credit default swaps or the creation of short positions in our securities, including
potentially the notes offered hereby. Any such credit default swaps or short positions could adversely affect future trading prices of the notes offered hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business activities, the underwriters and their respective affiliates, officers, directors and employees may purchase,
sell or hold a broad array of investments and actively trade securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments for their own account and for the accounts of their customers, and such
investment and trading activities may involve or relate to assets, securities and/or instruments of our company (directly, as collateral securing other obligations or otherwise) and/or persons and entities with relationships with us. The
underwriters and their respective affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such assets, securities or instruments and may
at any time hold, or recommend to clients that they should acquire, long and/or short positions in such assets, securities and instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conflicts
of interest </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Affiliates of certain of the underwriters, including BofA Securities, Inc., Truist Securities, Inc. U.S. Bancorp Investments, Inc., Wells
Fargo Securities, LLC, Mizuho Securities USA LLC, PNC Capital Markets LLC, TD Securities (USA) LLC and SMBC Nikko Securities America, Inc., will receive at least 5% of the net proceeds of this offering in connection with the repayment of outstanding
borrowings under the existing tranche A term loan facility. See &#147;Use of proceeds.&#148; Accordingly, this offering is being made in compliance with the requirements of FINRA Rule 5121. In accordance with that rule, no &#147;qualified
independent underwriter&#148; is required, because the notes are expected to be rated investment grade. None of the representatives will confirm sales to any account over which it exercises discretionary authority without the prior written approval
from the account holder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Offering restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in the European Economic Area (EEA) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail
investor in the European Economic Area (&#147;EEA&#148;). For these purposes,(a) a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client as defined in point (11)&nbsp;of Article 4(1) of Directive 2014/65/EU (as amended or
superseded, &#147;MiFID II&#148;); or (ii)&nbsp;a customer within the meaning of Directive (EU) 2016/97 (as amended or superseded, the &#147;Insurance Distribution Directive&#148;), where that customer would not qualify as a professional client as
defined in point (10)&nbsp;of Article 4(1) of MiFID II; or (iii)&nbsp;not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended or superseded, the &#147;Prospectus Regulation&#148;) and (b)&nbsp;the expression &#147;offer&#148;
includes the communication in any form and by any means of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sufficient information on the terms of the offer and the notes to be offered so as to enable an investor to decide to purchase or subscribe for the notes. Consequently no key information document
required by Regulation (EU) No 1286/2014 (as amended or superseded, the &#147;PRIIPs Regulation&#148;) for offering or selling the notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or
selling the notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. This prospectus supplement and the accompanying prospectus have been prepared on the basis that any offer of the
notes in any Member State of the EEA will be made pursuant to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of the notes. This prospectus supplement and the accompanying prospectus are not a
prospectus for the purposes of the Prospectus Regulation. References to Regulations or Directives include, in relation to the United Kingdom, those Regulations or Directives. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail
investor in the United Kingdom (the &#147;UK&#148;). For these purposes, (a)&nbsp;a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client, as defined in point (8)&nbsp;of Article 2 of Regulation (EU) No 2017/565 as it
forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended by the European Union (Withdrawal Agreement) Act 2020 (&#147;EUWA&#148;); or (ii)&nbsp;a customer within the meaning of the provisions of the UK&#146;s
Financial Services and Markets Act 2000 (the &#147;FSMA&#148;) and any rules or regulations made under the FSMA to implement the Insurance Distribution Directive, where that customer would not qualify as a professional client, as defined in point
(8)&nbsp;of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (iii)&nbsp;not a qualified investor as defined in Article 2 of the Prospectus Regulation as it forms part of domestic law by virtue of
the EUWA (the &#147;UK Prospectus Regulation&#148;); and (b)&nbsp;the expression &#147;offer&#148; includes the communication in any form and by any means of sufficient information on the terms of the offer and the notes to be offered so as to
enable an investor to decide to purchase or subscribe for the notes. Consequently, no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#147;UK PRIIPs Regulation&#148;) for
offering or selling the notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the notes or otherwise making them available to any retail investor in the UK may be unlawful under
the UK PRIIPs Regulation. This prospectus supplement and the accompanying prospectus have been prepared on the basis that any offer of the notes in the UK will be made pursuant to an exemption under the UK Prospectus Regulation from the requirement
to publish a prospectus for any offer of the notes. This prospectus supplement and the accompanying prospectus are not a prospectus for the purposes of the UK Prospectus Regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the UK, this prospectus supplement and the accompanying prospectus are being distributed only to, and are directed only at, persons who are &#147;qualified
investors&#148; (as defined in the Prospectus Regulation as it forms part of domestic law by virtue of the UK Prospectus Regulation) who are (i)&nbsp;persons having professional experience in matters relating to investments falling within Article
19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the &#147;Order&#148;), (ii) high net worth entities falling within Article 49(2)(a) to (d)&nbsp;of the Order, or (iii)&nbsp;persons to whom it would
otherwise be lawful to distribute it, all such persons together being referred to as &#147;Relevant Persons.&#148; In the UK, the notes are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such
notes will be engaged in only with, Relevant Persons. This prospectus supplement and the accompanying prospectus and their contents are confidential and should not be distributed, published or reproduced (in whole or in part) or disclosed by any
recipients to any other person in the UK. Any person in the UK that is not a Relevant Person should not act or rely on this prospectus supplement and the accompanying prospectus or their contents. The notes are not being offered to the public in the
UK. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each underwriter (i)&nbsp;has not offered or sold and will not offer or sell in Hong Kong, by means of any document, any notes other than (a)&nbsp;to
&#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Laws of Hong Kong) (the &#147;SFO&#148;) and any rules made thereunder or (b)&nbsp;in other circumstances which do not result in the document being a &#147;prospectus&#148; as defined in
the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong Kong) or which do not constitute an offer to the public within the meaning of that Ordinance and (ii)&nbsp;has not issued or had in its possession for the
purposes of issue, and will not issue or have in its possession for the purposes of issue, whether in Hong Kong or elsewhere, any advertisement, invitation or document relating to the notes, which is directed at, or the contents of which are likely
to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to the notes which are or are intended to be disposed of only to persons outside Hong Kong or only to
&#147;professional investors&#148; as defined in the SFO and any rules made thereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each underwriter acknowledges that this prospectus supplement has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly,
each underwriter represents, warrants and agrees that it has not offered or sold any notes or caused such notes to be made the subject of an invitation for subscription or purchase and will not offer or sell such notes or cause such notes to be made
the subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute, this prospectus supplement or any other document or material in connection with the offer or sale, or invitation
for subscription or purchase, of such notes, whether directly or indirectly, to persons in Singapore other than: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to an institutional investor (as defined in Section&nbsp;4A of the Securities and Futures Act (Chapter 289) of
Singapore, as modified or amended from time to time (the &#147;SFA&#148;)) pursuant to Section&nbsp;274 of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to a relevant person (as defined in Section&nbsp;275(2) of the SFA) pursuant to Section&nbsp;275(1) of the SFA,
or any person pursuant to Section&nbsp;275(1A) of the SFA, and in accordance with the conditions specified in Section&nbsp;275 of the SFA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where the notes are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business
of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">securities or securities based derivatives contracts (each
term as defined in Section&nbsp;239(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired
the notes pursuant to an offer made under Section&nbsp;275 of the SFA, except: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in
Section&nbsp;275(1A), or Section&nbsp;276(4)(i)(B) of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where the transfer is by operation of law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as specified in Section&nbsp;276(7) of the SFA; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and
Securities-Based Derivatives Contracts) Regulations 2018. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Singapore Securities and Futures Act Product Classification </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Solely for the purposes of its obligations pursuant to sections 309B(1)(a) and 309B(1)(c) of the SFA and the Securities and Futures (Capital Markets Products)
Regulations 2018, unless otherwise specified before an offer of notes, the Company has determined, and hereby notifies all relevant persons (as defined in Section&nbsp;309A of the SFA) that the notes are &#147;prescribed capital markets
products&#148; (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment
Products and MAS Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective
investors in Japan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange
Law of Japan (the &#147;Financial Instruments and Exchange Law&#148;) and each underwriter has agreed that it will not offer or sell the notes, directly or indirectly, in Japan or to, or for the benefit of, any &#147;resident&#148; of Japan (which
term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or
to or for the benefit of a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Law and any other applicable laws, regulations and
ministerial guidelines of Japan in effect at the relevant time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National
Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument <FONT STYLE="white-space:nowrap">31-103</FONT>
Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the notes must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
supplement or the accompanying prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities
legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal
advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a
<FONT STYLE="white-space:nowrap">non-Canadian</FONT> jurisdiction, section 3A.4) of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> Underwriting Conflicts (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriters are
not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_16"></A>Legal matters </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of the notes and certain legal matters will be passed upon for us by Norton Rose Fulbright US LLP, New York, New York and Matthew D. Klein,
Senior Vice President and General Counsel of UHS. Warren J. Nimetz, a director of ours who owns less than 1% of our outstanding capital stock, is a partner of Norton Rose Fulbright US LLP. Mr.&nbsp;Nimetz also serves as trustee of certain trusts for
the benefit of our Chief Executive Officer and his family. Certain legal matters will be passed upon for the underwriters by Simpson Thacher&nbsp;&amp; Bartlett LLP, New York, New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_17"></A>Experts </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included in
Management&#146;s Report on Internal Control Over Financial Reporting) incorporated in this Prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 have been so
incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_18"></A>Available information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a reporting company and file annual, quarterly and current reports, proxy statements and other information with the SEC. Our filings with the SEC are
available to the public on the SEC&#146;s website at http://www.sec.gov. Those filings are also available to the public on, or accessible through, our website under the heading &#147;For Investors.&#148; However, we are not incorporating these
documents into this prospectus supplement, except to the extent set forth below under &#147;Incorporation of certain documents by reference.&#148; You should rely only on the information contained in this prospectus supplement or specifically
incorporated herein in making a decision to purchase the notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained or incorporated by reference in this
prospectus supplement, in the accompanying prospectus or in any free writing prospectus filed by us with the SEC. If information in this prospectus supplement is inconsistent with the accompanying prospectus, you should rely on this prospectus
supplement. We have not, and the underwriters have not, authorized any other person to provide you with additional or different information. If anyone provides you with additional, different or inconsistent information, you should not rely on it.
You should not assume that the information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus or in any such free writing prospectus is accurate as of any date other than the respective dates
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement contains summaries of certain agreements, including the indentures governing each series of notes offered hereby, our
senior secured credit facilities and certain other agreements. The descriptions of these agreements contained in this prospectus supplement do not purport to be complete and are subject to, or qualified in their entirety by reference to, the
definitive agreements. Copies of the definitive agreements will be made available without charge to you by writing or telephoning our secretary at the address and telephone number below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sup884117_19"></A>Incorporation of certain documents by reference </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement incorporates by reference specified information contained in documents that we have filed with the SEC, which means that we are
disclosing important information to you by referring you to these documents. The information incorporated by reference is an important part of this prospectus supplement. The information incorporated by reference from a specified report is as of the
date of such report, or the date specified in such report, and such information may have changed subsequent to such date. Information in this prospectus supplement automatically updates and supersedes information in documents that are incorporated
by reference in this prospectus supplement. Information in a document incorporated by reference in this prospectus supplement automatically updates and supersedes information in earlier documents that are incorporated by reference in this prospectus
supplement. Any statement contained in the filings (or portions of filings) incorporated by reference in this prospectus supplement will be deemed to be modified or superseded for purposes of this prospectus supplement to the extent that a statement
contained in this prospectus supplement or in any filing by us with the SEC prior to the completion of this offering modifies, conflicts with or supersedes such statement. Any statement so modified or superseded will not be deemed, except as so
modified or superseded, to constitute a part of this prospectus supplement. We are not, however, incorporating by reference any documents or portions thereof that are not deemed &#147;filed&#148; with the SEC or any information furnished pursuant to
Item 2.02 or 7.01 of Form <FONT STYLE="white-space:nowrap">8-K</FONT> or exhibits related thereto furnished pursuant to Item 9.01 of Form <FONT STYLE="white-space:nowrap">8-K.</FONT> We incorporate by reference the documents listed below: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024021175/uhs-20231231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2023 filed with the SEC on February 27, 2024 (SEC File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">information specifically incorporated by reference into our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024021175/uhs-20231231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended December&nbsp;31, 2023 from our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000119312524086555/d631163ddef14a.htm">Schedule 14A</A>
filed with the SEC on April&nbsp;4, 2024 (SEC File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended March&nbsp;31,
2023, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024055683/uhs-20240331.htm">May&nbsp;8, 2024</A>, and for the period ended June&nbsp;
30, 2024 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024094006/uhs-20240630.htm">August&nbsp;8, 2024</A> (SEC File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024000014/uhs-20231227.htm">January&nbsp;2,
 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024035902/uhs-20240321.htm">March&nbsp;25, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024038889/uhs-20240328.htm">April&nbsp;
1, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024060793/uhs-20240515.htm">May&nbsp;16, 2024</A> (SEC File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT> and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all documents filed by us under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this
prospectus supplement and before the termination of any offering to which this prospectus supplement relates (other than information furnished pursuant to Item 2.02 or Item 7.01 of any Current Report on Form
<FONT STYLE="white-space:nowrap">8-K,</FONT> unless expressly stated otherwise therein). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In reviewing any agreements incorporated by
reference, please remember that they are included to provide you with information regarding the terms of such agreements and are not intended to provide any other factual or disclosure information about Universal Health Services, Inc. The agreements
may contain representations and warranties by Universal Health Services, Inc., which should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove
to be inaccurate. The representations and warranties were made only as of the date of the relevant agreement or such other date or dates as may be specified in such agreement and are subject to more recent developments. Accordingly, these
representations and warranties alone may not describe the actual state of affairs as of the date they were made or at any other time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will provide
without charge to each person, including a beneficial owner, to whom this prospectus supplement is delivered, upon his or her written or oral request, a copy of any or all documents referred to above which have been or may be incorporated by
reference into this prospectus supplement, excluding exhibits to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
those documents unless they are specifically incorporated by reference into those documents. You may request a copy of these filings at no cost, by writing or telephoning our secretary at the
following address and telephone number: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Universal Health Services, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Universal Corporate Center 367 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">South Gulph Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">P.O. Box 61558
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">King of Prussia, Pennsylvania </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19406-0958 Attention: Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(610) <FONT STYLE="white-space:nowrap">786-3300</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g878488g08g08.jpg" ALT="LOGO" STYLE="width:1.42417in;height:0.566918in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Universal Health Services, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt
Securities </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Universal Health Services, Inc. may offer and sell shares of our common stock from time to time in amounts, at prices and on terms that will
be determined at the time of any such offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Universal Health Services, Inc. may, from time to time, offer to sell debt securities
(together with our common stock described in this prospectus, the &#147;securities&#148;), including debt securities guaranteed by certain of our direct and indirect subsidiaries and which may be secured by certain of our assets and assets of our
subsidiaries and senior, pari passu or subordinate to our other outstanding debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus describes some of the general terms
that may apply to these securities. We will provide the specific terms of these securities, including their offering prices, in supplements to this prospectus. Each prospectus supplement will also describe the specific manner in which we will offer
the applicable securities. Each prospectus supplement may also add, update or change information contained in this prospectus. You should carefully read both this prospectus and any applicable prospectus supplement before you invest. This prospectus
may not be used to sell securities unless accompanied by the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Universal Health Services, Inc.&#146;s
Class&nbsp;B common stock is listed on the New York Stock Exchange under the symbol &#147;UHS.&#148; On September&nbsp;13, 2024, the reported last sale price on the New York Stock Exchange for our Class&nbsp;B common stock was $232.56 per share. We
will provide information in any applicable prospectus supplement regarding the trading market, if any, for any debt securities we may offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These securities may be offered and sold to or through one or more underwriters, dealers and agents or directly to purchasers or through a
combination of these methods, on a continuous or delayed basis. You can find additional information about our plan of distribution for the securities under the heading &#147;Plan of Distribution&#148; beginning on page 25 of this prospectus. We will
also describe the plan of distribution for any particular offering of these securities in the applicable prospectus supplement. This prospectus may not be used to sell our securities unless it is accompanied by a prospectus supplement. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in our securities involves risks. You should consider the <A HREF="#toc878488_6">risk&nbsp;factors</A> described in any
accompanying prospectus supplement or any documents we incorporate by reference herein or therein. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and
Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This prospectus is dated September&nbsp;16, 2024 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_3">INCORPORATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_4">FORWARD-LOOKING AND CAUTIONARY STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_5">OUR COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_8">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_9">DESCRIPTION OF DEBT SECURITIES AND GUARANTEES OF DEBT
SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc878488_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information contained or incorporated by reference in this prospectus, in any accompanying prospectus
supplement or in any related free writing prospectus filed by us with the Securities and Exchange Commission (the &#147;SEC&#148;). We have not authorized any other person to provide you with different information, or to make any representations
other than those contained in, or incorporated by reference into, this prospectus, any applicable prospectus supplement or any related free writing prospectuses. If anyone provides you with different, inconsistent or additional information, you
should not rely on it. You should not assume that the information contained or incorporated by reference in this prospectus and any prospectus supplement or in any such free writing prospectus is accurate as of any date other than the respective
dates thereof. Our business, financial condition, results of operations and prospects may have changed since those dates. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities by anyone in any
jurisdiction in which such offer or solicitation is not authorized or in which the person making such offer or solicitation is not qualified to do so or to any person to whom it is an unlawful to make such offer or solicitation. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, including any information incorporated by reference herein, is part of a registration statement that we filed with the SEC
under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), utilizing an automatic &#147;shelf&#148; registration process. Under this shelf registration process, we may, from time to time, sell in one or more offerings any of our
securities described in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus provides you with a general description of the securities that we may offer.
Each time we sell securities, we will provide a prospectus supplement that will contain specific information about the terms of that offering, including the specific amounts, prices and terms of the securities offered. The prospectus supplement may
also add, update or change information contained in this prospectus. You should read carefully the section entitled &#147;Forward-Looking and Cautionary Statements&#148; beginning on page&nbsp;4. If any information in this prospectus is inconsistent
with the applicable prospectus supplement, you should rely on the information in the prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before purchasing any
securities, you should carefully read both this prospectus and any applicable prospectus supplement, together with additional information described under the heading &#147;Where You Can Find More Information&#148; and &#147;Incorporation by
Reference.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used herein, unless otherwise stated or indicated by context, references to &#147;Universal Health Services,
Inc.,&#148; the &#147;Company,&#148; &#147;UHS,&#148; &#147;we,&#148; &#147;our&#148; or &#147;us&#148; refer to Universal Health Services, Inc. and its affiliates. The term &#147;affiliates&#148; means direct and indirect subsidiaries and certain
partnerships and joint ventures in which such subsidiaries are partners. The terms &#147;facilities&#148; or &#147;hospitals&#148; refer to entities owned and operated by affiliates of UHS and the term &#147;employees&#148; refers to employees of
affiliates of UHS. With respect to debt securities, the term &#147;issuer&#148; means Universal Health Services, Inc. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Universal Health Services, Inc. files certain reports with the SEC, including annual reports
on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> quarterly reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> and current reports on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K.</FONT> Universal Health Services, Inc. is
an electronic filer, and the SEC maintains an Internet website at http://www.sec.gov that contains the reports and other information filed electronically. Our website address is www.uhs.com. Please note that the SEC&#146;s and our website addresses
are provided as inactive textual references only. We make available free of charge, through our website, Universal Health Services, Inc.&#146;s annual reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> quarterly reports on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-Q,</FONT> current reports on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K,</FONT> and all amendments to those reports, together with all other materials Universal Health Services, Inc. files with or
furnishes to the SEC, as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. The information provided on or accessible through the SEC&#146;s and our website is not part of this prospectus, and is
therefore not incorporated by reference unless such information is specifically referenced elsewhere in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
and any prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all of the information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided
below. Whenever a reference is made in this prospectus or any prospectus supplement to a contract or other document of ours, the reference is only a summary and you should refer to the exhibits that are a part of the registration statement for a
copy of the contract or other document. You may review a copy of the registration statement and the documents incorporated by reference herein through the SEC&#146;s Internet web site referenced above. You may inspect a copy of the registration
statement through the SEC&#146;s website, as provided above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_3"></A>INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to incorporate by reference information into this prospectus. This means that we can disclose important information to you
by referring you to another document. Any information referred to in this way is considered part of this prospectus from the date we file that document. Any reports filed by us with the SEC after the date of this prospectus and before the date that
the offering of the securities by means of this prospectus is terminated will automatically update and, where applicable, supersede any information contained in this prospectus or incorporated by reference in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus incorporates by reference the documents listed below that Universal Health Services, Inc. has previously filed with the SEC.
These documents contain important information about us. Any information referred to in this way is considered part of this prospectus from the date Universal Health Services, Inc. filed that document. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate by reference the documents listed below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Universal Health Services, Inc.&#146;s Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024021175/uhs-20231231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2023 filed with the SEC on February&nbsp;27, 2024 (SEC File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">information specifically incorporated by reference into our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024021175/uhs-20231231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended December&nbsp;31, 2023 from our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000119312524086555/d631163ddef14a.htm">Schedule 14A</A>
filed with the SEC on April&nbsp;4, 2024 (SEC File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Universal Health Services, Inc.&#146;s Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for
the period ended March&nbsp;31, 2023, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024055683/uhs-20240331.htm">May&nbsp;8, 2024</A>, and for the period ended June&nbsp;
30, 2024 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024094006/uhs-20240630.htm">August&nbsp;8, 2024</A> (SEC File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Universal Health Services, Inc.&#146;s Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed
with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024000014/uhs-20231227.htm">January&nbsp;2, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024035902/uhs-20240321.htm">March&nbsp;25,
2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024038889/uhs-20240328.htm">April&nbsp;1, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000095017024060793/uhs-20240515.htm">May&nbsp;16, 2024</A> (SEC
File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of Universal Health Services, Inc.&#146;s Class&nbsp;B common stock, par value $0.01 per share,
contained in and previously filed as <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000156459020006793/uhs-ex45_148.htm">Exhibit 4.5</A> to the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year
ended December&nbsp;31, 2019 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000156459020006793/uhs-10k_20191231.htm">February&nbsp;26, 2020</A> (SEC File <FONT STYLE="white-space:nowrap">No.&nbsp;001-10765);</FONT> and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All documents filed by Universal Health Services, Inc. under Sections 13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) after the date of this prospectus and before the termination of any offering to which this prospectus relates (other than information furnished pursuant to Item 2.02 or Item 7.01 of any
Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> unless expressly stated otherwise therein). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
reviewing any agreements incorporated by reference, please remember that they are included to provide you with information regarding the terms of such agreements and are not intended to provide any other factual or disclosure information about
Universal Health Services, Inc. The agreements may contain representations and warranties by Universal Health Services, Inc. which should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk
to one of the parties if those statements prove to be inaccurate. The representations and warranties were made only as of the date of the relevant agreement or such other date or dates as may be specified in such agreement and are subject to more
recent developments. Accordingly, these representations and warranties alone may not describe the actual state of affairs as of the date they were made or at any other time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide without charge to each person, including any beneficial owner, to whom this prospectus is delivered, upon his or her written
or oral request, a copy of any or all documents referred to above which have been or may be incorporated by reference into this prospectus, excluding exhibits to those documents unless they </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
are specifically incorporated by reference into those documents. You may request copies of those documents, at no cost, by writing or calling us at the following address or telephone number: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">UNIVERSAL HEALTH SERVICES, INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Universal Corporate Center </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">367
South Gulph Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">King of Prussia, Pennsylvania 19406 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(610) <FONT STYLE="white-space:nowrap">768-3300</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn.: Investor Relations </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_4"></A>FORWARD-LOOKING AND CAUTIONARY STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, the documents incorporated by reference in this prospectus and our other public statements contain &#147;forward-looking
statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect our current estimates, expectations and projections about our future results, performance, prospects and opportunities. Forward-looking
statements include, among other things, the information concerning our possible future results of operations, business and growth strategies, financing plans, expectations that regulatory developments or other matters will not have a material
adverse effect on our business or financial condition, our competitive position and the effects of competition, the projected growth of the industry in which we operate, and the benefits and synergies to be obtained from our completed and any future
acquisitions, and statements of our goals and objectives, and other similar expressions concerning matters that are not historical facts. Words such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148;
&#147;predicts,&#148; &#147;potential,&#148; &#147;continue,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;future,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;appears,&#148;
&#147;projects&#148; and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be
accurate indications of the times at, or by which, such performance or results will be achieved. Forward-looking information is based on information available at the time and/or our good faith belief with respect to future events, and is subject to
risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. In evaluating those statements, you should specifically consider the following important factors, along with the risk
factors identified under &#147;Risk Factors&#148; and the risk factors incorporated by reference herein, which could affect future results and cause those results to differ materially from those expressed in the forward-looking statements: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the healthcare industry is labor intensive and salaries, wages and benefits are subject to inflationary
pressures, as are supplies expense and other operating expenses. In the past, staffing shortages have, at times, required us to hire expensive temporary personnel and/or enhance wages and benefits to recruit and retain nurses and other clinical
staff and support personnel. At certain facilities, particularly within our behavioral health care segment, there have been occasions when we were unable to fill all vacant positions and, consequently, we were required to limit patient volumes. We
have also experienced general inflationary cost increases related to certain of our other operating expenses. Many of these factors, which had a material unfavorable impact on our results of operations in prior years, have moderated more recently.
However, we cannot predict future inflationary increases, which if significant, could have a material unfavorable impact on our future results of operations. We have experienced inflationary pressures, primarily in personnel costs, although those
pressures have moderated more recently. The extent of any future impacts from inflation on our business and our results of operations will be dependent upon how long the elevated inflation levels persist and the extent to which the rate of inflation
further increases, if at all, neither of which we are able to predict. If elevated levels of inflation were to persist or if the rate of inflation were to accelerate, our expenses could increase faster than anticipated and we may utilize our capital
resources sooner than expected. Further, given the complexities of the reimbursement landscape in which we operate, our ability to pass on increased costs associated with providing healthcare to Medicare and Medicaid patients is limited due to
various federal, state and local laws, which in certain circumstances, limit our ability to increase prices; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in our acute care segment, we have experienced a significant increase in hospital based physician related
expenses, especially in the areas of emergency room care and anesthesiology. We have implemented various initiatives to mitigate the increased expense, to the degree possible, which has moderated the rate of increase. However, significant increases
in these physician related expenses could have a material unfavorable impact on our future results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the increase in interest rates during the past few years has increased our interest expense significantly
increasing our expenses and reducing our free cash flow and our ability to access the capital markets on favorable terms. As such, the effects of increased borrowing rates have adversely impacted our results
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
of operations, financial condition and cash flows. We cannot predict future changes to interest rates, however, significant increases in our borrowing rates could have a material unfavorable
impact on our future results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">President Biden signed into law fiscal year 2024 appropriations to federal agencies for continuing projects and
activities through September&nbsp;30, 2024. We cannot predict whether or not there will be future legislation averting a federal government shutdown, however, our operating cash flows and results of operations could be materially unfavorably
impacted by a federal government shutdown; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on December&nbsp;29, 2022, the Consolidated Appropriations Act, 2023, was signed into law phasing out the
enhanced federal medical assistance percentage rate that states received during the <FONT STYLE="white-space:nowrap">COVID-19</FONT> public health emergency and fully eliminated the increase on December&nbsp;31, 2023. States were also permitted to
begin Medicaid eligibility redeterminations on March&nbsp;31, 2023, which has resulted in a decrease in Medicaid enrollment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to comply with the existing laws and government regulations, and/or changes in laws and government
regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increasing number of legislative initiatives have been passed into law that may result in major changes in the
health care delivery system on a national or state level. For example, Congress has reduced to $0 the penalty for failing to maintain health coverage that was part of the original Patient Protection and Affordable Care Act, as amended by the Health
and Education Reconciliation Act (collectively, the &#147;Legislation&#148;) as part of the Tax Cuts and Jobs Act. To date, the Biden administration has issued executive orders implementing a special enrollment period permitting individuals to
enroll in health plans outside of the annual open enrollment period and reexamining policies that may undermine the Legislation or the Medicaid program. The Inflation Reduction Act of 2022 (&#147;IRA&#148;) was passed on August&nbsp;16, 2022, which
among other things, allows for the Centers for Medicare and Medicaid Services (&#147;CMS&#148;) to negotiate prices for certain single-source drugs reimbursed under Medicare Part B and Part D. The American Rescue Plan Act&#146;s expansion of
subsidies to purchase coverage through a Legislation exchange, which the IRA continued through 2025, is anticipated to increase exchange enrollment. However, if the subsidies are not extended beyond 2025, exchange enrollment may be adversely
impacted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there have been numerous political and legal efforts to expand, repeal, replace or modify the Legislation, since
its enactment, some of which have been successful, in part, in modifying the Legislation, as well as court challenges to the constitutionality of the Legislation. The U.S. Supreme Court held in <I>California v. Texas</I> that the plaintiffs lacked
standing to challenge the Legislation&#146;s requirement to obtain minimum essential health insurance coverage, or the individual mandate. The Court dismissed the case without specifically ruling on the constitutionality of the Legislation. As a
result, the Legislation will continue to remain law, in its entirety, likely for the foreseeable future. On September&nbsp;7, 2022, the Legislation faced its most recent challenge when a Texas Federal District Court judge, in the case of
<I>Braidwood Management v. Becerra</I>, ruled that a requirement that certain health plans cover services without cost sharing violates the Appointments Clause of the U.S. Constitution and that the coverage of certain HIV prevention medication
violates the Religious Freedom Restoration Act. The decision was appealed to the U.S. Court of Appeals for the Fifth Circuit, which on June&nbsp;21, 2024, affirmed the District Court&#146;s ruling regarding preventive services recommended by United
States Preventive Services Task Force being unconstitutional. However, the Fifth Circuit overturned the nationwide injunction imposed by the District Court, preserving access to the majority of preventive services in dispute for now. The matter is
expected to be the subject of additional litigation, having been remanded in part to the District Court. The outcome and impacts of this litigation cannot be predicted. Any future efforts to challenge, replace or replace the Legislation or expand or
substantially amend its provision is unknown; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as part of the Consolidated Appropriations Act of 2021 (the &#147;CAA&#148;), Congress passed legislation aimed
at preventing or limiting patient balance billing in certain circumstances. The CAA addresses </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
surprise medical bills stemming from emergency services, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> ancillary providers at <FONT
STYLE="white-space:nowrap">in-network</FONT> facilities, and air ambulance carriers. The CAA prohibits surprise billing when <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> emergency services or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> services at an <FONT STYLE="white-space:nowrap">in-network</FONT> facility are provided, unless informed consent is received. In these circumstances providers
are prohibited from billing the patient for any amounts that exceed <FONT STYLE="white-space:nowrap">in-network</FONT> cost-sharing requirements. HHS, the Department of Labor and the Department of the Treasury have issued rules to implement the
legislation. The rules have limited the ability of our hospital-based physicians to receive payments for services at usually higher <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> rates in certain
circumstances, and, as a result, have caused us to increase subsidies to these physicians or to replace their services at a higher cost level; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in June 2024, the U.S. Supreme Court issued its decision in <I>Loper Bright Enters. v. Raimondo </I>and
<I>Relentless, Inc. v. Department of Commerce</I>, which modified the regulatory interpretation standard established 40 years ago by <I>Chevron v. National Resources Defense Council</I>. <I>Chevron</I> doctrine generally required courts to defer to
federal agencies in their interpretation of federal statutes when a statute was silent or ambiguous with respect to a specific issue. In <I>Loper Bright</I>, the Supreme Court held that courts are no longer required to grant such deference, though
they may consider an agency&#146;s statutory interpretation. As it is highly regulated, the health care industry could be significantly impacted by the <I>Loper Bright</I> decision, particularly in the areas of Medicare reimbursement, decision
making by the Food&nbsp;&amp; Drug Administration and health care fraud and abuse compliance, where parties may no longer be able to rely on federal agencies&#146; policies, rules and guidance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">possible unfavorable changes in the levels and terms of reimbursement for our charges by third party payers or
government based payers, including Medicare or Medicaid in the United States, and government based payers in the United Kingdom; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to enter into managed care provider agreements on acceptable terms and the ability of our competitors
to do the same; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of known and unknown litigation, government investigations, inquiries, false claims act allegations,
and liabilities and other claims asserted against us and other matters, and the effects of adverse publicity relating to such matters, including, but not limited to, the March&nbsp;28, 2024, jury verdict (of compensatory damages of $60&nbsp;million
and punitive damages of $475 million) returned against The Pavilion Behavioral Health System (the &#147;Pavilion&#148;), one of our indirect subsidiaries, as disclosed in<I> Note 6 to the Condensed Consolidated Financial Statements&#151;Commitments
and Contingencies&#151;Legal Proceedings</I> in our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended June&nbsp;30, 2024<I>. </I>The Pavilion has filed post-trial motions, which were heard on August&nbsp;1,
2024 and August&nbsp;23, 2024. The Pavilion will pursue an appeal as appropriate depending on the court&#146;s resolution of post-trial motions. We are uncertain as to the ultimate financial exposure related to the Pavilion matter (which relates to
an occurrence in 2020) and we can make no assurances regarding timing or substance of its outcome, or the amount of damages that may be ultimately held recoverable after post-judgment proceedings and appeal. While the Pavilion has professional
liability insurance to cover a portion of these amounts, the resolution of this matter may have a material adverse effect on the Company. As of June&nbsp;30, 2024, without reduction for any potential amounts related to the above-mentioned Pavilion
matter, the Company and its subsidiaries have aggregate insurance coverage of approximately $221&nbsp;million remaining under commercial policies for matters applicable to the 2020 policy year (in excess of the applicable self-insured retention
amounts of $10&nbsp;million per occurrence for professional liability claims and $3&nbsp;million per occurrence for general liability claims). In the event the resolution of the Pavilion matter exhausts all or a significant portion of the remaining
commercial insurance coverage available to the Company and its subsidiaries related to other matters that occurred in 2020, or the Pavilion matter causes the posting of a large bond or other collateral during an appeal process, our future results of
operations and capital resources could be materially adversely impacted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competition from other healthcare providers (including physician owned facilities) in certain markets;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">technological and pharmaceutical improvements that increase the cost of providing, or reduce the demand for
healthcare; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain qualified personnel, nurses, physicians and other healthcare professionals and
the impact on our labor and related expenses resulting from a shortage of nurses, physicians and other healthcare professionals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">demographic changes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is a heightened risk of future cybersecurity threats, including ransomware attacks targeting healthcare
providers. If successful, future cyberattacks could have a material adverse effect on our business. Any costs that we incur as a result of a data security incident or breach, including costs to update our security protocols to mitigate such an
incident or breach could be significant. Any breach or failure in our operational security systems, or any third-party security systems that we rely on, can result in loss of data or an unauthorized disclosure of or access to sensitive or
confidential member or protected personal or health information and could result in violations of applicable privacy and other laws, significant penalties or fines, litigation, loss of customers, significant damage to our reputation and business,
and other liability or losses. We may also incur additional costs related to cybersecurity risk management and remediation. There can be no assurance that we or our service providers, if applicable, will not suffer losses relating to cyber-attacks
or other information security breaches in the future or that our insurance coverage will be adequate to cover all the costs resulting from such events; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of suitable acquisition and divestiture opportunities and our ability to successfully integrate
and improve our acquisitions since failure to achieve expected acquisition benefits from certain of our prior or future acquisitions could result in impairment charges for goodwill and purchased intangibles; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of severe weather conditions, including the effects of hurricanes and climate change;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our business, results of operations, financial condition, or stock price may be adversely affected if we are not
able to achieve our environmental, social and governance (&#147;ESG&#148;) goals or comply with emerging ESG regulations, or otherwise meet the expectations of our stakeholders with respect to ESG matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we receive revenues from various state and county-based programs, including Medicaid in all the states in which
we operate. We receive annual Medicaid revenues of approximately $100&nbsp;million, or greater, from each of Texas, Nevada, California, Illinois, Pennsylvania, Washington, D.C., Kentucky, Massachusetts, Mississippi, Virginia and Florida. We also
receive Medicaid disproportionate share hospital (DSH) payments in certain states including, most significantly, Texas. We are therefore particularly sensitive to potential reductions in Medicaid and other state-based revenue programs as well as
regulatory, economic, environmental and competitive changes in those states; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to continue to obtain capital on acceptable terms, including borrowed funds, to fund the future
growth of our business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inpatient acute care and behavioral health care facilities may experience decreasing admission and length of
stay trends; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial statements reflect large amounts due from various commercial and private payers and there can be no
assurance that failure of the payers to remit amounts due to us will not have a material adverse effect on our future results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Budget Control Act of 2011 (the &#147;2011 Act&#148;) imposed annual spending limits for most federal
agencies and programs aimed at reducing budget deficits by $917&nbsp;billion between 2012 and 2021, according to a report released by the Congressional Budget Office. Among its other provisions, the law established a bipartisan Congressional
committee, known as the Joint Select Committee on Deficit Reduction (the &#147;Joint Committee&#148;), which was tasked with making recommendations aimed at </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
reducing future federal budget deficits by an additional $1.5 trillion over 10 years. The Joint Committee was unable to reach an agreement by the November&nbsp;23, 2011 deadline and, as a result,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">across-the-board</FONT></FONT> cuts to discretionary, national defense and Medicare spending were implemented on March&nbsp;1, 2013 resulting in Medicare payment reductions of up to
2% per fiscal year with a uniform percentage reduction across all Medicare programs. Current legislation has extended these reductions through 2032. We cannot predict whether Congress will restructure the implemented Medicare payment reductions or
what other federal budget deficit reduction initiatives may be proposed by Congress going forward; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uninsured and <FONT STYLE="white-space:nowrap">self-pay</FONT> patients treated at our acute care facilities
unfavorably impact our ability to satisfactorily and timely collect our <FONT STYLE="white-space:nowrap">self-pay</FONT> patient accounts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in our business strategies or development plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have exposure to fluctuations in foreign currency exchange rates, primarily the pound sterling. We have
international subsidiaries that operate in the United Kingdom. We routinely hedge our exposures to foreign currencies with certain financial institutions in an effort to minimize the impact of certain currency exchange rate fluctuations, but these
hedges may be inadequate to protect us from currency exchange rate fluctuations. To the extent that these hedges are inadequate, our reported financial results or the way we conduct our business could be adversely affected. Furthermore, if a
financial counterparty to our hedges experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, we may experience material financial losses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of a shift of care from inpatient to lower cost outpatient settings and controls designed to reduce
inpatient services on our revenue, and; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other factors referenced herein or in our other filings with the Securities and Exchange Commission.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given these uncertainties, risks and assumptions, as outlined above, you are cautioned not to place undue reliance on
such forward-looking statements. Our actual results and financial condition could differ materially from those expressed in, or implied by, the forward-looking statements. Forward-looking statements speak only as of the date the statements are made.
We assume no obligation to publicly update any forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except as may be required by law. All forward-looking
statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_5"></A>OUR COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal business is owning and operating, through our subsidiaries, acute care hospitals and outpatient facilities and behavioral health
care facilities. As of June&nbsp;30, 2024, we owned and/or operated 359 inpatient facilities and 48 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom and Puerto Rico. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Services provided by our hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology,
oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or and behavioral health services. We provide capital resources as well as a variety of management services to our facilities, including central purchasing,
information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Delaware corporation that was organized in 1979. Our principal executive offices are located at Universal Corporate Center, 367 South
Gulph Road, P.O. Box 61558, King of Prussia, PA 19406. Our telephone number is (610) <FONT STYLE="white-space:nowrap">768-3300.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business is subject to numerous risks, including those that are generally associated with operating in the health care industry. You
should carefully consider and evaluate all of the information included and incorporated by reference in this prospectus, including the risk factors incorporated by reference to our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT>
for the year ended December&nbsp;31, 2023 and each subsequently filed Quarterly Report, as well as any risk factors we may describe in any subsequent periodic reports or information we file with the SEC. In addition, when we offer and sell any
securities pursuant to a prospectus supplement, we may include additional risk factors relevant to such securities in such prospectus supplement. This prospectus also contains forward-looking statements that involve risks and uncertainties. If any
of these risks occur, our business, financial condition or results of operation could be adversely affected. Please read &#147;Forward-Looking and Cautionary Statements.&#148; It is possible that our business, financial condition, liquidity or
results of operations could be materially adversely affected by any of these risks. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem
immaterial may also affect our business operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise set forth in a prospectus supplement, we intend to use the net proceeds from sales of the securities for general corporate
purposes, which may include the following: refunding, repurchasing, retiring upon maturity or redeeming existing debt; funding for working capital; capital expenditures; repurchases of our capital stock; strategic investments and acquisitions; and
for other general corporate purposes. The exact amounts to be used and when the net proceeds will be applied will depend on a number of factors, including our funding requirements and the availability of alternative funding sources. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_8"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of the material terms of our Restated Certificate of Incorporation and amendments thereto and Amended and
Restated Bylaws as currently in effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized Capital </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of 12,000,000 shares of Class&nbsp;A common stock, $0.01 par value per share, 150,000,000 shares of
Class&nbsp;B common stock, $0.01 par value per share, 1,200,000 shares of Class&nbsp;C common stock, $0.01 par value per share, and 5,000,000 shares of Class&nbsp;D common stock, $0.01 par value per share. Shares of Class&nbsp;A, C and D common
stock may be converted into Class&nbsp;B common stock on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">share-for-share</FONT></FONT> basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Class&nbsp;A common stock,
Class&nbsp;B common stock, Class&nbsp;C common stock and Class&nbsp;D common stock are substantially similar except that each Class&nbsp;has different voting rights. Each share of Class&nbsp;A common stock has one vote per share; each share of
Class&nbsp;B common stock has <FONT STYLE="white-space:nowrap">one-tenth</FONT> vote per share; each share of Class&nbsp;C common stock has one hundred votes per share; and each share of Class&nbsp;D common stock has ten votes per share.
Notwithstanding the foregoing, if a holder of Class&nbsp;C or Class&nbsp;D common stock holds a number of shares of Class&nbsp;A or Class&nbsp;B common stock, respectively, which is less than ten times the number of shares of Class&nbsp;C or
Class&nbsp;D common stock, respectively, that such holder holds, then such holder will only be entitled to one vote per share of Class&nbsp;C common stock and <FONT STYLE="white-space:nowrap">one-tenth</FONT> vote per share of Class&nbsp;D common
stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
holders of Class&nbsp;B and Class&nbsp;D common stock, voting together as a separate class, with each share of Class&nbsp;B and Class&nbsp;D common stock having one vote per share, are entitled to elect the greater of 20% of our Board of Directors
or one director. The holders of Class&nbsp;B and Class&nbsp;D common stock are also permitted to vote together as a separate Class&nbsp;with respect to certain other matters or as required by applicable law. Holders of Class&nbsp;A and Class&nbsp;C
common stock, voting together as a separate class, with each share of Class&nbsp;A and Class&nbsp;C common stock having one vote per share, are entitled to elect the remaining directors and vote together with the holders of Class&nbsp;B and
Class&nbsp;D common stock on all other matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Restated Certificate of Incorporation provides for a Board of Directors of not fewer
than three members nor more than nine members, the exact number to be determined by the Board of Directors. The Board of Directors is currently comprised of seven members, and is divided into three classes, with members of each class serving for a
three-year term. At each annual meeting of stockholders, directors are chosen to succeed those in the class the term of which expires at such annual meeting. Holders of shares of our outstanding Class&nbsp;B and Class&nbsp;D Common Stock (voting
together as a single class) are entitled to elect two directors, currently one in Class&nbsp;II and one in Class&nbsp;III, and the holders of Class&nbsp;A and Class&nbsp;C Common Stock (voting together as a single class) are entitled to elect the
remaining directors, currently three in Class&nbsp;I, one in Class&nbsp;II, and one in Class&nbsp;III. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All common shares participate equally in distributions payable to shareholders when and as declared by our Board of Directors. We have a
history of paying quarterly cash dividends to our stockholders and it is our current intention to pay comparable dividends in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation
on Directors&#146; Liability and Indemnification </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(a) of the General Corporation Law of the State of Delaware (the
&#147;DGCL&#148;) grants each corporation organized thereunder the power to indemnify any person who was or is a party or is threatened to be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the
corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement that were actually and reasonably incurred by the person in connection with such action, suit
or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to
believe the person&#146;s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the
person did not act in good faith and in a manner which the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the
person&#146;s conduct was unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(b) of the DGCL grants each corporation organized thereunder the power to indemnify
any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a
director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses
(including attorneys&#146; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not
opposed to the best interests of the corporation and except that no indemnification shall be made pursuant to Section&nbsp;145(b) of the DGCL in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to
the corporation unless and only to the extent that the Delaware Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances
of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(c) of the DGCL provides that to the extent that a present or former director or officer of a corporation has been successful
on the merits or otherwise in defense of any action, suit or proceeding referred to in Sections 145(a) and (b)&nbsp;of the DGCL, as described in the preceding paragraphs, or in defense of any claim, issue or matter therein, such person shall be
indemnified against expenses (including attorneys&#146; fees) actually and reasonably incurred by such person in connection therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(g) of the DGCL provides, in general, that a corporation shall have the power to purchase and maintain insurance on behalf of
any person who is or was a director, officer, employee or agent of the corporation against any liability asserted against the person in any such capacity, or arising out of the person&#146;s status as such, regardless of whether the corporation
would have the power to indemnify the person against such liability under the provisions of the DGCL. We maintain a directors&#146; and officers&#146; insurance policy that insures our directors and officers against liabilities incurred in their
capacity as such for which they are not otherwise indemnified, subject to certain exclusions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;102(b)(7) of the DGCL enables
a corporation in its certificate of incorporation, or an amendment thereto, to eliminate or limit the personal liability of a director or officer to the corporation or its stockholders of monetary damages for violations of the directors&#146; or
officers&#146; fiduciary duty of care as a director or officer, except (i)&nbsp;for any breach of the director&#146;s or officer&#146;s duty of loyalty to the corporation or its stockholders, (ii)&nbsp;for acts or omissions not in good faith or that
involve intentional misconduct or a knowing violation of law, (iii)&nbsp;pursuant to Section&nbsp;174 of the DGCL (providing for director liability in the event of unlawful payment of dividends or unlawful stock purchases or redemptions) or
(iv)&nbsp;for any transaction from which a director or officer derived an improper personal benefit or (v)&nbsp;any action against an officer by or in the right of the corporation. Our Restated Certificate of Incorporation limits director liability
for monetary damages arising from a breach of fiduciary duty to the fullest extent permitted by the DGCL. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Restated Certificate of Incorporation indemnifies the directors and officers to the full
extent of the DGCL and also allows the Board of Directors to indemnify all other employees. Such right of indemnification is not exclusive of any right to which such officer or director may be entitled as a matter of law and shall extend and apply
to the heirs, executors and administrators of such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain a directors&#146; and officers&#146; insurance policy. The policy
insures directors and officers against unindemnified losses arising from certain wrongful acts in their capacities as directors and officers and reimburses us for those losses for which we have lawfully indemnified the directors and officers. The
policy contains various exclusions that are normal and customary for policies of this type. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summaries are subject to the
complete text of our Restated Certificate of Incorporation and Amended and Restated Bylaws and the DGCL and are qualified in their entirety by reference thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our Restated Certificate of Incorporation, Amended and Restated Bylaws and insurance policies are necessary to attract and
retain qualified persons to serve as directors and officers of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in
our Restated Certificate of Incorporation and Amended and Restated Bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against
directors and officers, even though an action, if successful, might benefit us and other stockholders. Furthermore, a stockholder&#146;s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against
directors and officers as required or allowed by these indemnification provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions or any other provisions described in this prospectus, we have been informed that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delaware
Anti-Takeover Statutes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain Delaware law provisions may make it more difficult for someone to acquire us through a tender offer,
proxy contest or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 of the DGCL provides that, subject to certain stated exceptions, an &#147;interested
stockholder&#148; is any person (other than the corporation and any direct or indirect majority-owned subsidiary) who owns 15% or more of the outstanding voting stock of the corporation or is an affiliate or associate of the corporation and was the
owner of 15% or more of the outstanding voting stock of the corporation at any time within the three-year period immediately prior to the date of determination, and the affiliates and associates of such person. A corporation may not engage in a
business combination with any interested stockholder for a period of three years following the time that such stockholder became an interested stockholder unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to such time the board of directors of the corporation approved either the business combination or
transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by (i)&nbsp;persons who are directors and also officers and (ii)&nbsp;employee stock plans in
which participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at or subsequent to such time, the business combination is approved by the board of directors and authorized at
an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The effect of these provisions may make a change in control of our business more difficult
by delaying, deferring or preventing a tender offer or other takeover attempt that a stockholder might consider in its best interest. This includes attempts that might result in the payment of a premium to stockholders over the market price for
their shares. These provisions also may promote the continuity of our management by making it more difficult for a person to remove or change the incumbent members of the board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Computershare Trust Company, N.A. is the transfer agent and registrar for our Class&nbsp;B common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Class&nbsp;B common stock
currently trades on the New York Stock Exchange under the symbol &#147;UHS.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_9"></A>DESCRIPTION OF DEBT SECURITIES AND GUARANTEES OF DEBT SECURITIES
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus describes certain general terms and provisions of our debt securities. When we offer to sell a particular series of
debt securities, we will describe the specific terms of the series in a supplement to this prospectus. We will also indicate in the applicable prospectus supplement whether the general terms and provisions described in this prospectus apply to a
particular series of debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt securities will be issued under an indenture among us and U.S. Bank Trust Company,
National Association, as trustee, or another trustee chosen by us, qualified to act as such under the Trust Indenture Act of 1939, as amended (the &#147;Trust Indenture Act&#148;), and appointed in a supplemental indenture with respect to a
particular series, and JPMorgan Chase Bank, N.A., as collateral agent. The indenture is governed by the Trust Indenture Act. We have summarized select portions of the indenture below. This summary is not complete. The indenture has been filed as an
exhibit to the registration statement and we urge you to read the indenture. Capitalized terms used in the summary have the meaning specified in the indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When we refer to &#147;we,&#148; &#147;our,&#148; &#147;us,&#148; the &#147;Company&#148; and &#147;UHS&#148; in this section, we mean
Universal Health Services, Inc. unless the context otherwise requires or as otherwise expressly stated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or
determined in the manner provided in an officers&#146; certificate or by a supplemental indenture. The particular terms of each series of debt securities will be described in a prospectus supplement relating to that series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in a supplement to this prospectus, the debt securities will be the direct, unsecured obligations of UHS and will
rank equally with all of its other unsecured and unsubordinated indebtedness. UHS&#146; payment obligations under any series of debt securities may be guaranteed by one or <FONT STYLE="white-space:nowrap">more&nbsp;co-registrants.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue an unlimited amount of debt securities under the indenture that may be in one or more series with the same or various maturities,
at par, at a premium or at a discount. We will set forth in a prospectus supplement relating to any series of debt securities being offered the aggregate principal amount and the following terms of such series of debt securities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the debt securities, whether the debt securities rank as senior debt securities, senior subordinated
debt securities or subordinated debt securities, or any combination thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt
securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate principal amount of the debt securities and any limit on the aggregate principal amount of the debt
securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates on which the principal on the debt securities will be payable and the amount of principal that
will be payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates (which may be fixed or variable) at which the debt securities will bear interest, if any, as
well as the dates from which interest will accrue, the dates on which interest will be payable and the record date for the interest payable on any payment date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the form and terms of any guarantee, including the terms of subordination, if any, of the debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any depositories, interest rate calculation agents or other agents with respect to the debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the right, if any, of holders of the debt securities to convert them into our common stock or other securities,
including any provisions intended to prevent dilution of such conversion rights; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where principal, premium, if any, and interest, if any, on the debt securities will be
payable and where debt securities which are in registered form can be presented for registration of transfer or exchange and the identification of any depositary or depositaries for any global debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions regarding our right to redeem, repay or purchase the debt securities or the right of holders to
require us to redeem, repay or purchase the debt securities, in whole or in part; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provision requiring or permitting us to make payments to a sinking fund to be used to redeem the debt
securities or a purchase fund to be used to purchase the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations in which the debt securities will be issued, if other than denominations of $2,000 and integral
multiples of $1,000 in excess thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the percentage of the principal amount at which debt securities will be issued and, if other than the full
principal amount thereof, the percentage of the principal amount of the debt securities which is payable if maturity of the debt securities is accelerated because of an event of default; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency or currencies in which principal, premium, if any, and interest, if any, will be payable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if payments of principal of, premium or interest on the debt securities will be made in one or more currencies
other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the manner in which the amounts of payment of principal of, or premium or interest on the debt securities will be
determined, if these amounts may be determined by reference to an index based on a currency or currencies other than that in which the debt securities are denominated or designated to be payable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions relating to any collateral provided to secure the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to or change in the events of default with respect to the debt securities and any change in the
right of the trustee or the requisite holders of the debt securities to declare the principal amount thereof due and payable upon the occurrence of an event of default; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to, change in or deletion from, the covenants described in this prospectus or in the indenture with
respect to the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trustee, registrar or paying agent for the debt securities, if different than U.S. Bank Trust Company,
National Association; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the collateral agent, if any, for the debt securities, if different than JPMorgan Chase Bank, N.A.;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, that the debt securities, in whole or in specific part, shall be defeasible and, if other than by
a board resolution, the manner in which any election by the Company to defease such debt securities shall be evidenced; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms of the debt securities, which may modify, supplement or delete any provision of the
indenture as it applies to that series; provided, however, that no such term may modify or delete any provision thereof if imposed by the Trust Indenture Act; and provided, further, that any modification or deletion of the rights, duties and
immunities of the trustee under the indenture shall have been consented to in writing by the trustee. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the
indenture does not limit our ability to issue subordinated debt securities. Any subordination provisions of a particular series of debt securities will be set forth in the officers&#146; certificate or supplemental indenture related to that series
of debt securities and will be described in the relevant prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide you with information on the material
United States federal income tax considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer and Exchange </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A holder will be able to transfer or exchange debt securities only in accordance with the indenture. The registrar may require a holder, among
other things, to furnish appropriate endorsements and transfer documents and to pay taxes and fees required by law or permitted by the indenture. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Change of Control </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we state
otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions that may afford holders of the debt securities protection in the event we undergo a change in control or in the event of a highly leveraged
transaction (whether or not such transaction results in a change in control) that could adversely affect holders of debt securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Covenants
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture will contain certain covenants that require us and our subsidiaries to, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pay or cause to be paid the principal, premium, if any, and interest on the debt securities on the dates and in
the manner provided in the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain an office or agency where the debt securities may be surrendered for registration of transfer or for
exchange and where notices and demands to or upon the us and, any guarantors may be served; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver to the trustee copies of the annual reports, information, documents, and other reports required to be
filed with the SEC pursuant to Section&nbsp;13 or 15(d) of the Exchange Act and comply with the other provisions Section&nbsp;314(a) of the Trust Indenture Act; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pay, prior to delinquency, all material taxes, assessments and governmental levies except such as are contested
in good faith and by appropriate negotiations or proceedings or where the failure to affect such payment is not adverse in any material respect to the holders; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain corporate existence. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, unless provided otherwise in the applicable prospectus supplement, the indenture will contain certain covenants that limit: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our and our subsidiaries&#146; ability to issue, assume or guarantee indebtedness or obligations secured by
mortgages (other than permitted liens) on, or enter into sale and lease-back transactions with respect to, our principal properties; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as described in &#147;&#151;Consolidation, Merger and Sale of Assets&#148; below, our ability to consolidate with
or merge into, or transfer or lease all or substantially all of our assets to, another person. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will set forth in the
applicable prospectus supplement any additional restrictive covenants applicable to any issue of debt securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger and Sale of
Assets </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not consolidate with or merge into, or transfer or lease all or substantially all of our assets to another person, which
we refer to as a successor person, without the consent of the holders of the debt securities of such series unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are the surviving entity, or the surviving entity is a corporation, partnership, limited partnership, limited
liability corporation or trust organized or existing under the laws of the United States, any state thereof, the District of Columbia, or any territory thereof; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">after giving effect to the transaction, no event of default, and no event which, after notice or lapse of time,
or both, would become an event of default, shall have occurred and be continuing under the indenture; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain other conditions are satisfied, including any that may be set forth in the applicable prospectus
supplement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise stated in the applicable prospectus supplement, an event of default with respect to any series of debt securities will be
defined in the indenture or applicable supplemental indenture as being: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to pay the principal or any premium on any of the debt securities of such series when due;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to pay any interest upon any debt security of such series when due, and that default continues for a
period of 30 days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to perform, or the breach of, any of our other agreements in the indenture with respect to such series,
and such default continues for a period of 60 days after we receive written notice by holders of at least 25% in principal amount of the outstanding debt securities of that series as provided in the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain events involving bankruptcy, insolvency or reorganization of the Company; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other event of default provided with respect to debt securities of that series which is described in the
applicable prospectus supplement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No event of default with respect to a particular series of debt securities (except as
to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an event of default with respect to any other series of debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an event of default (other than an event of default resulting from certain events of bankruptcy, insolvency or reorganization) with respect
to debt securities of any series at the time outstanding occurs and is continuing, then the trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series may, by a notice in writing to us,
declare the principal amount of, premium, if any, and accrued and unpaid interest, if any, on all the debt securities of such series to be due and payable immediately. In the case of an event of default resulting from certain events of bankruptcy,
insolvency or reorganization, the principal of, premium, if any, and accrued and unpaid interest, if any, on all outstanding debt securities of that series will become and be immediately due and payable without any declaration or other act on the
part of the trustee or any holder of outstanding debt securities of that series. At any time after a declaration of acceleration with respect to debt securities of any series has been made, the holders of a majority in principal amount of the then
outstanding debt securities of that series may rescind the acceleration and its consequences if the rescission would not conflict with any judgement or decree, all events of default, other than the non-payment of accelerated principal of, premium,
if any, and interest on the debt securities of that series that have become due solely by such declaration of acceleration, have been cured or waived as provided in the indenture, and all amounts due to the trustee in each of its capacities under
the indenture have been paid in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that the trustee will be under no obligation to exercise any of its rights
or powers under the indenture at the request of any holder of outstanding debt securities, unless the trustee receives indemnity and/or security satisfactory to it against any loss, liability or expense. Subject to certain rights of the trustee and
certain other limitations, the holders of a majority in aggregate principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the
trustee or exercising any trust or power conferred on the trustee with respect to the debt securities of that series. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless stated otherwise in the applicable prospectus supplement, no holder of any debt
security of any series will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment of a receiver or trustee, or for any remedy under the indenture, unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that holder has previously given to the trustee written notice of a continuing event of default with respect to
debt securities of that series; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holders of at least 25% in principal amount of the outstanding debt securities of that series have made
written request, and offered indemnity and/or security satisfactory to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of a majority in principal amount of the outstanding debt securities of that
series a direction inconsistent with that request and has failed to institute the proceeding within 60 days. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the right of any holder of any debt security to receive payment of principal of, premium, if any, and interest
on that debt security on or after the due dates expressed in that debt security, or to bring suit for the enforcement of payment on or after such respective dates, will not be impaired or affected without the consent of such holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture requires us, within 90 days after the end of our fiscal year (which fiscal year currently ends December&nbsp;31 of each year),
to furnish to the trustee a statement as to compliance with the indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment, Supplement and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may modify and amend the indenture or any series of debt securities without notice to or the consent of the holders to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to evidence the succession of another corporation to the Company and the assumption by such successor of the
covenants of the Company in compliance with the requirements set forth in the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add to the covenants for the benefit of the holders or to surrender any right or power conferred upon the
Company under the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add any additional events of default; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to change or eliminate any of the provisions of the indenture; provided that any such change or elimination shall
become effective only when there are no outstanding debt securities of such series created prior to the execution of such supplemental indenture that are entitled to the benefit of such provision and as to which such supplemental indenture would
apply; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add a guarantor to the debt securities of such series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to supplement any of the provisions of the indenture to such extent necessary to permit or facilitate the
defeasance and discharge of the debt securities of such series; provided that any such action does not adversely affect the interests of the holders of the debt securities of such series in any material respect; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to evidence and provide for the acceptance of appointment under the indenture by a successor trustee or
collateral agent and to add to or change any of the provisions of the indenture necessary to provide for or facilitate the administration of the trusts by more than one trustee or for the trustee to act as collateral agent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to cure any ambiguity, to correct or supplement any provision of the indenture which may be defective or
inconsistent with any other provision; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to conform the text of the indenture, the debt securities of such series, the guarantees or the security
documents to any provision of the &#147;Description of the notes&#148; section of the applicable prospectus supplement to the extent that such provision in such &#147;Description of the notes&#148; section was intended to
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
be a verbatim recitation of a provision of the indenture, the debt securities of such series, the guarantees or the security documents; provided that, in each instance, the Company delivers to
the trustee an officers&#146; certificate to such effect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to change any place or places where the principal of and premium, if any, and interest, if any, on the debt
securities of such series shall be payable, the debt securities of such series may be surrendered for registration or transfer, the debt securities of such series may be surrendered for exchange, and notices and demands to or upon the Company may be
served; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable to such series of debt securities, to mortgage, pledge, hypothecate or grant any other lien in
favor of the collateral agent for the benefit of the trustee and the holders of the debt securities of such series, as additional security for the payment and performance of all or any portion of the obligations under the indenture, in any property
or assets, including any which are required to be mortgaged, pledged or hypothecated, or in which a lien is required to be granted in favor of the collateral agent for the benefit of the trustee and the holders of the debt securities of such series
pursuant to the indenture, any of the security documents or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable to such series of debt securities, to release collateral from the lien of the indenture and the
security documents when permitted or required by the security documents or the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable to such series of debt securities, to add additional first lien secured parties to any security
documents in accordance with such security documents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">comply with any requirement of the SEC in connection with any required qualification of the indenture under the
Trust Indenture Act; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to establish additional series of Notes as permitted by the indenture. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions, we may amend the indenture or any series with the consent (which may include consents obtained in connection
with a tender offer or exchange offer for that series of securities) of the holders of at least a majority in aggregate principal amount of the series of the securities then outstanding, and any existing default under, or compliance with any
provision of, the indenture may be waived (other than any continuing default in the payment of the principal of or interest on the securities) with the consent (which may include consents obtained in connection with a tender offer or exchange offer
for that series of securities) of the holders of a majority in principal amount of the securities of that series then outstanding; provided that without the consent of each holder affected, we may not: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the stated maturity of the principal of, or installment of interest, if any, on, such debt securities of
such series, or reduce the principal amount thereof or the interest thereon or any premium payable upon redemption thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the currency in which the principal of (and premium, if any) or interest on such debt securities of such
series are denominated or payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive a default or event of default in the payment of principal of, premium, if any, or interest on the debt
securities of such series (except a rescission of acceleration of the debt securities of such series by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of such series with respect to a
nonpayment default and a waiver of the payment default that resulted from such acceleration); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the premium payable upon the redemption or repurchase of any debt securities of such series or change the
time at which any debt securities of such series may be redeemed or repurchased, whether through an amendment or waiver of provisions in the covenants, definitions or otherwise; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impair the right of any holder to receive payment of principal of, premium, if any, or interest on such
holder&#146;s debt securities of such series on or after the due dates therefor or impair the right to institute suit for the enforcement of any payment on or after the stated maturity thereof (or, in the case of redemption, on or after the
redemption date); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">modify the provisions that require holder consent to modify or amend the indenture or that permit holders to
waive compliance with certain provisions of the indenture or certain defaults; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change to or modify the ranking of such debt securities of such series or, if applicable to the debt
securities of such series, the ranking of the liens with respect to such debt securities of such series that would adversely affect the holders; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except as expressly permitted by the indenture, modify the guarantees of any guarantor in any manner adverse to
the holders of the debt securities of such series. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If applicable to the debt securities of such series, without the
consent of at least 75% in aggregate principal amount of the debt securities of such series then outstanding, an amendment, supplement or waiver may not modify any security document or the provisions of the indenture dealing with the security
documents or application of trust moneys, or otherwise release any collateral, in any manner materially adverse to the holders of the debt securities other than in accordance with the indenture and the security documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for certain specified provisions, the holders of at least a majority in aggregate principal amount of the outstanding debt securities
of any series may on behalf of the holders of all debt securities of that series waive our compliance with provisions of the indenture. The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of
the holders of all the debt securities of such series waive any past default under the indenture with respect to that series and its consequences, except a continuing default in the payment of the principal of or any interest on any debt security of
that series or in respect of a covenant or provision which cannot be modified or amended without the consent of the holder of each outstanding debt security of the series affected; provided, however, that, subject to certain limitations, the holders
of a majority in aggregate principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Defeasance and Covenant Defeasance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Legal Defeasance</I>. The indenture provides that, if so provided by the terms of the applicable series of debt securities, we may be
discharged from any and all obligations in respect of the debt securities of any series (except for certain obligations, including obligations to register the transfer or exchange of debt securities of such series, to replace stolen, lost or
mutilated debt securities of such series, and to maintain paying agencies and certain provisions relating to the treatment of funds held by paying agents and the rights, duties, indemnities and immunities of and obligations to the trustee). We will
be so discharged upon the deposit with the trustee, in trust, of money <FONT STYLE="white-space:nowrap">and/or&nbsp;non-callable&nbsp;U.S.</FONT> government obligations, that, through the payment of interest and principal in accordance with their
terms, will provide money in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants to pay the principal, premium and interest on the debt securities of that series on the stated date of payment thereof
or the applicable redemption date, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discharge may occur only if, among other things, we have delivered to the
trustee an opinion of counsel stating that we have received from, or there has been published by, the United States Internal Revenue Service a ruling or, since the applicable issue date, there has been a change in the applicable United States
federal income tax law, in either case to the effect that, and based thereon such opinion shall confirm that, the beneficial owners of the debt securities of that series will not recognize income, gain or loss for United States federal income tax
purposes as a result of the deposit, defeasance and discharge and will be subject to United States federal income tax on the same amounts, in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge
had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Defeasance of Certain Covenants</I>. The indenture provides that, if so provided by the terms of the applicable
series of debt securities, upon compliance with certain conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may omit to comply with certain covenants set forth in the indenture, as well as any additional covenants
which may be set forth in the applicable prospectus supplement; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any omission to comply with those covenants will not constitute a default or an event of default with respect to
the debt securities of that series, or covenant defeasance. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The conditions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">irrevocably depositing with the trustee, in trust, for the benefit of the holders, money and/or non-callable U.S.
government obligations that, through the payment of interest and principal in accordance with their terms, will provide money in an amount in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants to
pay the principal, premium and interest on the outstanding debt securities of that series on the stated date of payment thereof or the applicable redemption date, as the case may be; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering to the trustee an opinion of counsel to the effect that the beneficial owners of the debt securities
of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and related covenant defeasance and will be subject to United States federal income tax on the same amounts, in the same
manner and at the same times as would have been the case if the deposit and related covenant defeasance had not occurred. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Guarantees
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our payment obligations under any series of debt securities may be guaranteed by one or more of
<FONT STYLE="white-space:nowrap">the&nbsp;co-registrants.&nbsp;The</FONT> terms of any such guarantee will be set forth in the applicable prospectus supplement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Collateral and Security </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our payment
obligations under any series of debt securities may be secured by assets of UHS or one or more of the <FONT STYLE="white-space:nowrap">co-registrants.&nbsp;The</FONT> terms of any such security interest will be set forth in the applicable prospectus
supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some
or all of the debt securities of any series may be represented, in whole or in part, by one or more global securities, which will have an aggregate principal amount equal to that of the debt securities they represent. We will register each global
security in the name of a depositary or nominee identified in a prospectus supplement and deposit the global security with the depositary or nominee. Each global security will bear a legend regarding the restrictions on exchanges and registration of
transfer referred to below and other matters specified in the indenture or supplemental indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No global security may be exchanged
for debt securities registered, and no transfer of a global security may be registered, in the name of any person other than the depositary for the global security or any nominee of the depositary, unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the depositary has notified us that it is unwilling or unable to continue as depositary for the global security
or has ceased to be a clearing agency registered under the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we execute and deliver to the trustee an officer&#146;s certificate to the effect that the global security shall
be so exchangeable; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other circumstances exist that may be described in the indenture or supplemental indenture and prospectus
supplement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will register all securities issued in exchange for a global security or any portion of a global
security in the names specified by the depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As long as the depositary or its nominee is the registered holder of a global
security, the depositary or nominee will be considered the sole owner and holder of the global security and the debt securities that it </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
represents. Except in the limited circumstances referred to above, owners of beneficial interests in a global security will not: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be entitled to have the global security or debt securities registered in their names; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receive or be entitled to receive physical delivery of certificated debt securities in exchange for a global
security; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be considered to be the owners or holders of the global security or any debt securities for any purpose under the
Indenture. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will make all payments of principal, premium, and interest on a global security to the depositary or its
nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture will authorize the Company, the trustee and the paying agent to act in accordance with the applicable procedures
of the Depository Trust Company (&#147;DTC&#148;) or such other depositary for the debt securities. Ownership of beneficial interests in a global security will be limited to institutions that have accounts with the depositary or its nominee,
referred to as &#147;participants,&#148; and to persons that may hold beneficial interests through participants. In connection with the issuance of any global security, the depositary will credit, on its book-entry registration and transfer system,
the respective principal amounts of debt securities represented by the global security to the accounts of its participants. Ownership of beneficial interests in a global security will only be shown on records maintained by the depositary or the
participant. Likewise, the transfer of ownership interests will be effected only through the same records. Payments, transfers, exchanges, and other matters relating to beneficial interests in a global security may be subject to various policies and
procedures adopted by the depositary from time to time. Neither we, the trustee, nor any of our agents will have responsibility or liability for any aspect of the depositary&#146;s or any participant&#146;s records relating to, or for payments made
on account of, beneficial interests in a global security, or for maintaining, supervising, or reviewing any records relating to the beneficial interests. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concerning the Trustee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary
course of its business, U.S. Bank Trust Company, National Association, the trustee, may in the future provide, investment banking, commercial lending, financial advisory and other services for us. The indenture contains, or will contain, limitations
on the right of the trustee, should it become our creditor, to obtain payment of claims in specified cases or to realize on property received in respect of any such claim as security or otherwise. The indenture permits, or will permit, the trustee
to engage in other transactions; however, if it acquires any conflicting interest, it must eliminate such conflict or resign. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
indenture provides, or will provide, that in case an event of default occurs and is not cured, the trustee will be required, in the exercise of its power, to use the degree of skill and care of a prudent person under the circumstances in the conduct
of such person&#146;s own affairs. The trustee may refuse to perform any duty or exercise any right or power under the indenture, unless it receives indemnity and/or security satisfactory to it against any loss, liability or expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The laws of the State of
New York govern, or will govern, the indenture, the debt securities and the guarantees of debt securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_10"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell our securities to or through one or more underwriters or dealers, and also may sell our securities directly to other purchasers or
through agents. These firms may also act as our agents in the sale of our securities. Only underwriters named in the applicable prospectus supplement will be considered as underwriters of our securities offered by such prospectus supplement. We may
distribute our securities at different times in one or more transactions. We may sell our securities at fixed prices, which may change, at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at
negotiated prices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of our securities, underwriters may receive compensation from us or from purchasers of our
securities in the form of discounts, concessions or commissions. Underwriters, dealers and agents that participate in the distribution of our securities may be deemed to be underwriters. Discounts or commissions they receive and any profit on their
resale of our securities may be considered underwriting discounts and commissions under the Securities Act. We will identify any such underwriter or agent, and we will describe any such compensation, together with the terms of the offering of
securities, in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may agree to indemnify underwriters, dealers and agents who participate in the
distribution of our securities against certain liabilities, including liabilities under the Securities Act. We may also agree to contribute to payments which the underwriters, dealers or agents may be required to make in respect of such liabilities.
We may authorize dealers or other persons who act as our agents to solicit offers by certain institutions to purchase our securities from us under contracts which provide for payment and delivery on a future date. We may enter into these contracts
with commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and others. If we enter into these agreements concerning any class or series of our securities, we will indicate
that in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with an offering of our securities, underwriters may engage in transactions
that stabilize, maintain or otherwise affect the price of our securities. Specifically, underwriters may over&#150;allot in connection with the offering, creating a syndicate short position in our securities for their own account. In addition,
underwriters may bid for, and purchase, our securities in the open market to cover short positions or to stabilize the price of our securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Finally, underwriters may reclaim selling concessions allowed for distributing our securities in the offering if the underwriters repurchase
previously distributed securities in transactions to cover short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of our securities above independent market levels.
Underwriters are not required to engage in any of these activities and may end any of these activities at any time. Agents and underwriters may engage in transactions with, or perform services for, us and our affiliates in the ordinary course of
business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable prospectus supplement, the validity of the securities offered hereby and tax matters will be
passed upon for us by Norton Rose Fulbright US LLP, New York, New York. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc878488_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included
in Management&#146;s Report on Internal Control Over Financial Reporting) incorporated in this Prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 have been so
incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:110pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g884117g02g02.jpg" ALT="LOGO" STYLE="width:1.64583in;height:0.710919in;">
 </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d884117dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:uhs="http://www.uhs.com/20240918" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:srt="http://fasb.org/srt/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31">
<head>
<title>EX-FILING FEES</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;">
 <div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P09_18_2024To09_18_2024" id="ixv-538">0000352915</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="hidden121489332" contextRef="P09_18_2024To09_18_2024">UNIVERSAL HEALTH SERVICES INC</ix:nonNumeric><ix:nonNumeric name="ffd:SubmissnTp" id="hidden121489336" contextRef="P09_18_2024To09_18_2024">424B5</ix:nonNumeric><ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="P09_18_2024To09_18_2024" id="ixv-541">EX-FILING FEES</ix:nonNumeric><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" id="ixv-542">false</ix:nonNumeric><ix:nonNumeric name="ffd:OfferingSctyTitl" id="hidden121489370" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis">4.625% Senior Secured Notes due 2029</ix:nonNumeric><ix:nonNumeric name="ffd:OfferingSctyTitl" id="hidden121489371" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis">5.050% Senior Secured Notes due 2034</ix:nonNumeric><ix:nonNumeric name="ffd:OfferingSctyTitl" id="hidden121489372" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis">Guarantees of Subsidiary Guarantors</ix:nonNumeric><ix:nonFraction name="ffd:FeeRate" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="7" id="ixv-546">0.0001476</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"/></ix:references><ix:resources><xbrli:context id="P09_18_2024To09_18_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000352915</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-18</xbrli:startDate> <xbrli:endDate>2024-09-18</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000352915</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>1</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-18</xbrli:startDate> <xbrli:endDate>2024-09-18</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000352915</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>2</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-18</xbrli:startDate> <xbrli:endDate>2024-09-18</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000352915</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>3</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-18</xbrli:startDate> <xbrli:endDate>2024-09-18</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right;"><div style="font-weight:bold;display:inline;">Exhibit 107 </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Calculation of Filing Fee Tables </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="-sec-ix-hidden:hidden121489336;display:inline;">424(b)(5)</div> </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Form Type) </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="-sec-ix-hidden:hidden121489332;display:inline;">UNIVERSAL HEALTH SERVICES, INC.</div> </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Exact Name of Registrant as Specified in its Charter) </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Table 1: Newly Registered and Carry Forward Securities </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The prospectus supplement to which this Exhibit is attached is a final prospectus for the related offering. The maximum aggregate offering price of the securities to which the prospectus relates is $998,210,000. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt;width:99%;border:0">
<tr>
<td style="width:13%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:5%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:11%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:6%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:10%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:7%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:10%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:9%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:9%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:5%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:5%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:5%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:7%"/></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Security&#8201;<br/>Type&#8201;</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Security</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Class&#160;Title</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Fee<br/>Calculation<br/>or Carry<br/>Forward<br/>Rule</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Amount<br/>Registered</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Proposed<br/>Maximum<br/>Offering<br/>Price Per<br/>Unit</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Maximum<br/>Aggregate<br/>Offering Price</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Fee Rate</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Amount of<br/>Registration Fee</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Carry<br/>Forward<br/>Form<br/>Type</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Carry<br/>Forward<br/>File<br/>Number</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Carry<br/>Forward<br/>Initial<br/>effective<br/>date</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Filing Fee<br/>Previously<br/>Paid In<br/>Connection<br/>with Unsold</div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Securities&#160;to<br/>be Carried</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Forward</div></div></td></tr>
<tr style="font-size:1pt">
<td colspan="25" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td colspan="25" style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Newly Registered Securities</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.63em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" format="ixt:fixed-false" id="ixv-589">Fees to Be&#160;Paid</ix:nonNumeric></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" id="ixv-590">Debt</ix:nonNumeric>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="-sec-ix-hidden:hidden121489370;display:inline;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">4.625%&#160;Senior&#8201;</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Secured Notes&#8201;</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">due 2029</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" format="ixt:fixed-true" id="ixv-591">Rule 457(r)</ix:nonNumeric><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.9px">(1)</div>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-592">500,000,000</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="5" scale="-2" format="ixt:num-dot-decimal" id="ixv-593">99.957</ix:nonFraction>%&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-594">499,785,000</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:FeeRate" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-595">0.00014760</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:FeeAmt" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-596">73,768.27</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8195;&#8195;&#8195;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8195;&#8195;&#8195;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8195;&#8195;&#8195;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.63em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" format="ixt:fixed-false" id="ixv-597">Fees to Be&#160;Paid</ix:nonNumeric></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" id="ixv-598">Debt</ix:nonNumeric>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="-sec-ix-hidden:hidden121489371;display:inline;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">5.050%&#160;Senior&#8201;</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Secured Notes&#8201;</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">due 2034</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" format="ixt:fixed-true" id="ixv-599">Rule 457(r)</ix:nonNumeric><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.9px">(1)</div>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-600">500,000,000</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="5" scale="-2" format="ixt:num-dot-decimal" id="ixv-601">99.685</ix:nonFraction>%&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-602">498,425,000</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:FeeRate" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-603">0.00014760</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:FeeAmt" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-604">73,567.53</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" id="ixv-605">Other</ix:nonNumeric>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="-sec-ix-hidden:hidden121489372;display:inline;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Guarantees&#160;of&#8201;</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Subsidiary&#8201;</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Guarantors</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" format="ixt:fixed-true" id="ixv-606">Rules 457(n)</ix:nonNumeric><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.9px">(2)</div>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="display:inline;"><ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero" id="ixv-607">&#8212;</ix:nonFraction></div>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="display:inline;"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="-2" scale="-2" format="ixt:fixed-zero" id="ixv-608">&#8212;</ix:nonFraction></div>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="display:inline;"><ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="ixv-609">&#8212;</ix:nonFraction></div>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:FeeAmt" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="ixv-610">&#8212;</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.63em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Fees Previously Paid</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td colspan="25" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td colspan="25" style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Carry Forward Securities</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.63em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Carry Forward Securities</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8201;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">Total Offering Amounts</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="P09_18_2024To09_18_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-611">998,210,000</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TtlFeeAmt" contextRef="P09_18_2024To09_18_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-612">147,335.80</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">Total Fees Previously Paid</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="P09_18_2024To09_18_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="ixv-613">&#8212;</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">Total Fee Offsets<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.9px">(3)</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="P09_18_2024To09_18_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="ixv-614">&#8212;</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">Net Fee Due</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:NetFeeAmt" contextRef="P09_18_2024To09_18_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-615">147,335.80</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><ix:nonNumeric name="ffd:OfferingNote" contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis" escape="true" id="ixv-513"><ix:nonNumeric name="ffd:OfferingNote" contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis" escape="true" id="ixv-514">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Calculated in accordance with Rule 457(o) based on the proposed maximum aggregate offering price and Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In accordance with Rule 456(b) of the Securities Act, the registrant initially deferred payment of all of the registration fees for the registrant&#8217;s registration statement on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-3</div> (File <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">No.&#160;<ix:nonNumeric name="ffd:RegnFileNb" contextRef="P09_18_2024To09_18_2024" id="ixv-616">333-282135</ix:nonNumeric>)</div> (the &#8220;Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonNumeric name="ffd:FormTp" contextRef="P09_18_2024To09_18_2024" id="ixv-617">S-3</ix:nonNumeric>&#8221;),</div> filed with Securities and Exchange Commission on September&#160;16, 2024. The &#8220;Calculation of Filing Fee Tables&#8221; contain herein shall be deemed to update the &#8220;Calculation of Filing Fee Tables&#8221; in the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-3,</div> in accordance with Rules 456(b) and 457(r) under the Securities Act. </div></td></tr></table></ix:nonNumeric> </ix:nonNumeric> <ix:nonNumeric name="ffd:OfferingNote" contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis" escape="true" id="ixv-524">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The notes issued by the registrant will be guaranteed on a senior secured basis by all of the registrant&#8217;s existing and future direct and indirect subsidiaries that guarantee the registrant&#8217;s senior secured credit facility or the registrant&#8217;s other first lien obligations or any junior lien obligations. Pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable in respect of such guarantees. </div></td></tr></table></ix:nonNumeric>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(3)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The registrant does not have any fee offsets. </div></td></tr></table></div></div></div></div></div> <div>&#160;</div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g878488g08g08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878488g08g08.jpg
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M,C,T4F*"DL'"T>-359.C)"4F)T-$5&/#-83P161EI/'_Q  : 0 " P$!
M           $!0 #!@(!_\0 ,1$  @(  @@$!@(# 0       0(  P01!1(A
M,3(S47$4%4&A$U*!D;'1(F%"X? C_]H # ,!  (1 Q$ /P"Y^[/@'P@;ZK/[
MB.[/@'P@;ZK/[B2U""\2T?\ E574^WZCI=V? /A WU6?W$=V? /A WU6?W$E
MJ%/$M)Y55U/M^HZ7=GP#X0-]5G]Q'=GP#X0-]5G]Q):A3Q+2>55=3[?J/!8]
M*.#K[=:>VVJ\MJ*VH);%'VO*W;$ G=+0-P'A4T22Z#3M=*V'3_WW#_+<G:1%
M3EQF8LQN'7#N%7I!=%PK*>WT-165LHBIJ>-TLLA!R:UHS)U<@7>HWI+WO,3>
M;:CJW*PG(9P5!K,!/(.EW H&?VQ4_P#AR>ZOGNP8$\(8?\&7W4E"$'XEND>^
M55=3[?J.L=,. P,_MAA_P)?=7SW9,!>$,?JTWN)*T*>);I)Y55U/M^HZG=EP
M%X0Q^K3>XOGNSX!\(&^JS^XDM0IXENDGE574^WZCUX5T@88Q57R45@N@JZJ.
M,RN8(9&9-! )S<T#=(4I2I[%+? N'FU_61IK$34Y=<S%6+H6BS46"\?%.);3
MA:W,K[]5BDI'2"$2&-S\WD$@9-!.XTKV%3VRG&>C>G/%<8C]"1=.VJI(E5%8
MLL"'UGO]V? /A WU6?W$=V? /A WU6?W$EJ$)XEHZ\JJZGV_4=+NSX!\(&^J
MS^XCNSX!\(&^JS^XDM0IXEI/*JNI]OU'2[L^ ?"!OJL_N([L^ ?"!OJL_N)+
M4*>):3RJKJ?;]1_,+8EM&*K<^NL%8*NE9(8G/#',R< "1DX [A'I7L*E]BB<
M]']P&>Y<G]7&KH1:-K*"8FQ%8JL9!Z04=Q-C;#N&*F&GOUTBHYI6=D8Q[7$N
M;GEGJ!X0I$E>V6?PNLWD)ZQRYL<HN8G>$I%]@1I=#=+>!G;F(J7I8\?PKGNL
M8'\(Z3]E_P#))&A#^);I&OE574QW1I7P.=S$='TAP_<N>ZM@CPDHOI?R20H4
M\2W23RJKYC'@;I4P0[<Q)0])(_<N>ZE@GPDH/VC_ "2/(4\2W23RJOYC-AM!
M64]PHH*RBE;-33L$D4C=Q[2,P1T+O48T6[W&&/-M/U84G18.8SB-UU6(@A==
M1/%3023U$K(H8VE[Y'N#6M W22=P)<M*6GF:62:V8(=V*$9M?<7-[Y_R8.X/
MTCKX@-U<NX09F6T8=[VR02[\6XUP_A.';WVYPT\A&;81W\K^9@U].XJ7Q-LC
MSMGQX9LHRX)Z]V[^HT_Q)>ZNIGK*F2HJYI9ZB0[9\DKBYSCQDG65TH5L0QW;
M(ZIT94FU]IE@WG3%C>Z%VVO4E+&?B4C&Q9=(&V^=1.MQ%>JXDUMXN-03N]EJ
M7N^LKRD*DL3O,-6I$X5 GT][GG-[G./&3FLBCN-;1'.BK*BG/'%*YGU%8J%Y
M+,A)30Z0\7T.7:^)+KD-P/J'2#T.)4NM&GK&E!M14S45P:/^IIP#Z6%JJA"Z
M#L-QE+8>I^)1&4PYLCZ669D>(K+)3L.HSTDG9 /U#D<NDJZ<,XFL^)Z+MNQ7
M""LA^-M#DYG(YIUM/.$@2]"QWFXV&XQUUGK)J.KCW)(G9'+B/ 1R'4K4Q##B
MVP*[1E;#.O8?:;!$*G]#^F2EQ6Z*TW\14=[/>QO&J*IYOS7?H\/!Q*X$6K!A
MF(DMJ>IM5Q!"$+J5S78YNU<6G@.2X7W-^.?XQ7PE4V4E.#\ XBQA3U$^'Z 5
M45.X,D<9HX\B1F!WQ&:D'<0Q[_<K/7(??5I[$GX.W_RMGL*^$770K*"8FQ.D
M+:K2B@9#_NL0K%^$+UA"K@IL048I9IV=DC E9)MFYY;K25X"OC9:_"2Q>2/]
MM4.A[%"L0(RPUAMJ#MO,G&A([72IAP__ '!'T7)W$D&A8Y:4L-^5 ?1*=]%8
M;A,4:5Y@[?N"C>DO>\Q-YMJ.K<I(HWI+WO,3>;:CJW*]MQBZKC'>(>A"$KFO
MDMLVCG%EYML%PM=DJ*BCG!,<K7- < 2.$\8*S.Y+CGP<JOVF>\F?T$;T^'OD
MG]:]3Q%KAU(!SB2S2=B.5 &PS7S>K5762YSVZZTSZ:M@R$D3\LVY@$;G(05@
MJQ-D&"-+M_SX3 ?\B-5VAF&1(CBIRZ*Q]0)=&Q2WP+AYM?UD::Q*GL4M\"X>
M;7]9&FL1F'X(@TESSV$%3^RFWMH/.$7L2*X%4.RDWM(_+XO9>N[> RC!\]>\
M4E"$)=-3)Q2Z)\;U36NBP[5;5PS!>YC/K<%S-HEQS$'%^':G)HS.U>QWU.3J
MT7Y'!\FWZE]S?B9/%*-\,O6(?-;<]PFNY"$(*/HU&Q./^PEU'%<G'_*C5V*D
M-B:?]C+P. 7#/_+8KO3&K@$R^-Y[02N[+,C[;[,.'M#_ ,CDT25O99?#2T>;
MQUCUS?P2W1O/'UE'K,M-MK+O<(:&V4TE363$B.*,9N=D"3ET K#5@: M]O#_
M (\O4O02C,@306MJ(6'H)AMT6XV=N8;K^EH'[UB7O1]BJQVV6X7:R55-1Q$!
M\KLB&YG(9Y'CU)ZU7VG_ 'I+_P"+%US$2V'4 G.**M)V.X4@;3$L0A"$CJ/;
MHMWN,,>;:?JPI.XAK27$ #62>!1C1;O<88\VT_5A0/9*8U=8<,QV2@EVE?=
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MR1_MJAU?&RU^$EB\D?[:H=!W<9CS \A9--"^^CAORH?44\"1W0X<M)^&LO\
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M\4+F7\4_F*:S'>LUW;BX7U)^&[G7RE4V,:'8EG_9.]MX16@_Y85YJB-B2?\
M9N_#@%6P_05[IC3P"9C'<]H)6MEE\-;0/_QXZQZ:5*SLL?AQ:O-S>MD7-_!+
M-&\\?64BK T!;[>'_'EZEZK]6!H"WV\/^/+U+T&G$(]Q'*?L?Q'45?:?]Z2_
M^+%US%8*@&GP Z),0Y_F1=<Q,'X3,SA^:O<?F)4A"$LFLCVZ+=[C#'FVGZL)
M2=,V('8CTBW>J#]M3P2=JP:]09'FW5SG-W2FFP?6.MVABUUK/PZ:R,F'.V'/
M]R2-SBYQ<XDN)S)/"BKS_$"*-'5YVV/.%*-&V$Y\:8MH[3"XLB=]\J)1_P .
M)OX1Y]P#E(473$[$FS]]?[T]NX&4<;OIO'L*FM=9@(?BK354SC?&"ME#36RW
MTU#0Q-AI:>,111MW&M R 7-RKJ:VT%16UTS8:6G89)9';C6@9DK(5%;*O$<E
M'8+;8:=Y::]YFGRX8V99-/(7'/\ 51SMJ+G,W14;[ G65SI,TT7K$E7-2V.>
M:UV8$M:(G;668<;W#6,_S1JX\U5#W.>XN>XN<3F23F2OE?<4;Y9&1Q,<^1Y#
M6M:,R2=P )>S%CF9J*ZDJ75093X0K3L^@G&EQIFS24U)0APS#*J?)W2&@Y=*
MCF-M'&),&Q,GO-$.U'NVC:F!XDCSXB1K'2!FO2C 9D3E<14S:H89SP[#B"[8
M?J>V++<:JBEX3#(6AW.-PCD*9;0?I>=B:46/$TD;;P<S3SAH:VH&Z6D#4'CD
MU$<HUJJLBW5D]NKZ>MHY#%4T\C98WC=:YIS!]*]KL*&<8C"I>I!&WK-ABKK3
MMA&'%&!*V1L6VN-N8ZIIG@=]J&;V<H+0=7&!Q*78/O+<0X6M5V: TUE,R5S1
MN-<1WPZ#F.A>NX!S2' $'40>%'D!AE,TC-2^8WB:ZT*1:0[(W#N-KU:HOQ5/
M4N$?(P]\WZ)"CJ6D9'*:U6# ,/6,AL3;^Y]/></ROS$1;60 \ />OZ,]IZ2F
M$2<;'*X]H:5+<PNR95Q2TSNEI</G:$XZ.H.:3.Z234O)'KMFO*N %;4 ;@D<
M/G*Z%D5_Y=4_*N^LK'0,T8W1G-B3\';_ .5L]A7PJ'V)/P=O_E;/85\)A3P"
M9C'<]HL>RU^$EB\D?[:H=7QLM?A)8O)'^VJ'0=W&8\P/(63'0YOGX:\L8GC2
M.:'-\_#7EC$\:(PW"8MTKS%[04;TE[WF)O-M1U;E)%&])>]YB;S;4=6Y7MN,
M6U<8[Q#T(0E<U\=O0;O4X=^0=[;E.5!]!XRT58<^0/MN4X3-.$3)7\UNY_,$
M*H-(>FR#!V*:NR/L<M6^G#"914A@.V:';FU/&HR[9*P_%PO(>>N'N+DVH#D3
M+5P5[@,J[#VC"H2[G9+,SU86=EY?_37P=DN[(Y84&?G#^DO/CIUG?E^(^7W'
M[C%JI-E /]V)UC\MB^IRA;MDM-EWN%XP>6N)_P#&H=I0TP5&.\/Q6I]HCH8V
M5#9R]M09"[)KAEEM1^=\RX>Y"I ,NPV!N2U68; >HE5H0A!1_-B,((A8#NAH
M7,OXM_,5]-W N'_@.YDUF-FNZ35(_G*^5V3_ (Z3QC]:ZTKFR$9G8D'_ %'B
M$<53$?HE7VD[T.Z48='U'<X)[7)7=MR,>"R81[7:@CA!SW58GW2E'X-5'K8]
MU&56JJ@$Q#B\'=9<S*NR, E8V6)'V\VH</V.;ULBD_W2E'X-5'K8]U5)I>QS
M%C[$-+<H:%]$V&E%/V-\@>20][L\\A^=\RYML5ER!G>!PEM5NLXR$@RL#0%O
MMX?\>7J7JOU8&@+?;P_X\O4O0Z<0C7$<I^Q_$=10#3WO2XA^3BZYBGZ@&GO>
MEQ#\G%US$P?A,S.'YJ]Q^8E2$(2R:R.722=BV/#7\6&SEZN4FB=7#]#]DM!5
M%0@9FHL#8ASF#(?.DJ1%^Y8LT<=MG>":_8J;W=;YRDZN-*@FDV)U=%+@^[T(
M/WZ"M[*X?HO8T ^ECEYA^.6:2'_@?I+P2M[+(R?;G: ?Q7V/[WG[(_/]R:14
M3LJL,S5UDMU_I6%_:#G0U  SRC>1D[F#AE^LB;AFABG1[!;QG%A4[T'5MMM^
MDVS5%Y=&RF#W-:^0=ZR0M(83Q=\1KX-U01" 4Y'.:.Q-=2O6;%%XF.+5%>L'
MWFW3L#VSTLC0"-QVU):><. /0E9P3IOQ-ANFCI*LQ7>BCU-;5$]D:.(2#7Z0
M5;6'=D+AJO+67BDK+7(=U^79HQTM[[Z*.%R,,C,\^!OJ;-1GETBL=JU']A+^
MP4=JU']A+^P4^U@Q+8\01;>RW2CK1EF6Q2 N;SMW1TA>QD.(*H88'<86=*E3
MD4]_]2N]CYV0:)K*V4.#FF89.W0.S/5B(0BE&0 BBQ]=R_6)_LCK;+%I3N$L
M<+W-J889<VM)'X ;_"JQ[5J/["7]@K8=D.)&0X@AVP^9)SC*K29K0)JYY?W_
M *B0Z'Z>=FDW#;G0R- K&9DM(3O(R'$A6UU_#&4$Q6)\0P;++*:];KJNE9E_
M;/\ :*Q5EW;5=*W/^V?[16(E\TZ[HSFQ)^#M_P#*V>PKX5#[$GX.W_RMGL*^
M$PIX!,SCN>T6/9:_"2Q>2/\ ;5#J^-EK\)+%Y(_VU0Z#NXS'F!Y"R7Z("1I-
MPUE_UL8^=/*D:T0[YN&O+H_K3RHC#<)BW2O,7M!1O27O>8F\VU'5N4D4;TE[
MWF)O-M1U;E>VXQ;5QCO$/0A"5S7QW="&]5ASR<^VY3=0C0AO58<\G/MN4W3-
M.$3)7\QNY_,3;9&;[5W\2#JFJM%9>R,WVKOXD'5-5:)?9Q&:;#<E.P@A3C1/
M@%VD"\5E"VX"@%/!V<O,79-MWP&668XU:'W-+_"AOJ/]1>K6S#,">68NFIM5
MSD?K%W0F(^YI?X4-]1_J(^YI?X4-]1_J+WX+])7YAA_F]C%W7(&9 &ZF'^YI
M?X4-]1_J+EFQK>UP/VT-U'/\A_J*?!?I)YAA_F]C&+;N!</_  '<RY&X@ZP0
MF$S,UWU RGD!_./UKK3%R[&Q\DKW_;0T;9Q.7:/]1?'W-+_"AOJ/]1 ?!?I-
M,-(8?YO8Q=T)B/N:7^%#?4?ZB/N:7^%#?4?ZB\^"_23S##_-[&+NA,1]S2_P
MH;ZC_41]S2_PH;ZC_44^"_23S##_ #>QB[JP- 6^WA_QY>I>K(^YI?X4-]1_
MJ*0:/]!C\)XNM][-_;5"D+SV'M3:;;;,<W=VYR_"SW%TE+A@2)7=CJ&K90VT
M@^AEV* Z>07:)<0@?V<9_P UBGR@>G7>GQ%\DSK6HQ^$Q'A^:O<?F).A"$LF
MLCVZ+AGHWPP#N?8V#JPDKQE9IL/8INEJJ6;1]-.Y@'&W/-I'(6D'I3J:+=[C
M#'FVGZL*G=E5A/-M#BFDCW,J2KR'.8W'YVY^*C+5S0'I$6!N"8AD/K%T5E:
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M'"NR PS<VLCO451:*@[I<#+%GR.:,_2T*T;-?[1>XNR6>YT=:S+/[Q,UY'.
M<QTK7ZON&62&1LD,CXY&G,.8<B.E7KB&&^+K-%UMM0Y>\V(H206/2EC.S;44
ME_JY(V_$J2)VY<7?YY="L*P[(Z[P;5M\L]'6,W"^G>Z%W/D=L#\RM&(4[X$^
MC+EX<C&<>QKV%CVAS2,B",P5!L4:)\'XAC?VQ:(J2H=_S%$!"\'CR VIZ05Y
M6%]-^#[VYD5152VJH=JVM:W:MS\<$M])"LNGFBJ8634\K)87C-KV.#FN'&"-
MU69JXZP0BW#GU!BLXSV/U]M?9)\.5$=VIAK[$<HY@.8]Z[H(/(J=KZ*JMU7+
M2U]/-35,1R?%,PL<T\H.M;#% ]*6C6UX[H,Y VEN\3<H*QK=?BO'QF_..#AS
MI?#C>L8X?2; ZMV[K$G4@P/BNY8.OT-TM4F3V][+$X]Y,SA:X<7U'6L#$5FK
M</WJLM5SC['5TKRQXX#Q$'A!&1!XBO.0FT&.2%L7([08^F!L66W&5@ANEJD[
MUW>RQ./?POX6N_\ FL:U($FNQ^Q0[#ND*CAEE+:&Y?Z),TGO=L[\!V7&'9#/
MB)3E)A4^NN<S6,P_A[-4;CNFOK$'_KUR\ID]HK 6;>W;>\U[MW.HD/TBL)+S
M-,NX1G-B3\';_P"5L]A7PJ'V)/P=O_E;/85\)A3P"9G'<]HL>RU^$EB\D?[:
MH=7QLM?A)8O)'^VJ'0=W&8\P/(62S1-OEX9\OB]H)Z$B^B;?+PSY?%[03T*_
M#;C%NE>8O:"C>DO>\Q-YMJ.K<I(HWI+WO,3>;:CJW(AMQBVKC'>(>A"$KFOC
MOZ%MZW#?DH]HJ:J%:%MZW#?DH]HJ:IFG")DKN8W<Q-MD9OM7?Q(.J:JT3V7W
M &%K]<9*^[V6FJJR0 /E?M@79#(;AX@L#N3X'\'*3TO_ )H9L.Q).<:TZ2KK
MK5"#L$2)"=HZ(\"DY_:[3?MR>\N#HBP*1E]KM/\ XDGO+SPS=99YK5T/M^XD
MR$['<@P)X.P?XTOO*JMD1@'#>&,)T%?8;8RCJ'UK87N;(]VV:6/.63B1NM"Y
M:AE&<LJTC7:X0 [8OB[J,[6K@=Q2-/SKI7W <IHR-T.'UJF,#-B(W%U5GY)/
M\F[ZBNT;@756?DD_R;OJ*:3'":\$(0E4V,$)A=CU@##.*,&UE=?K6VLJF5KH
MFO=+(W)H8P@9-<!NDJSCH:P&3G]@&#FJ9O?5ZT,PS$ MTC76Y0@[/^ZQ+$)T
M#H6P$?\ Z%_^U-[Z7G3[ABTX4QI!06&E--2NHF2EAD<_OB]X)S<2=P!>/2R#
M,SJC'5WMJ*#G*U5@: M]O#_CR]2]5^K T!;[>'_'EZEZX3B$OQ'*?L?Q'44%
MTY[U&(OD6]8U3I073EO4XB^0;UC4P?A,S%'-7N/S$E0A"636Q[=%N]QACS;3
M]6%)U%M%+P_1MA@MW!;X6^A@'[E*4S7<)D;>-N\$);M*NE_%.&L?7:T6N6C;
M1TSHQ&)( YVN-KCF<^,E1/N^8V_MJ#U8?S59O4'*%IHZYU##+;&AQ/A*PXG@
M[%?;735>K(2.;E(WF>,G#H*IO$^QQI97/EPS>'TY.ML%8W;MYMNW6!T%8.B7
M2_B?$F/[7:;O+1NHJDR!XC@#79B-SAD<^,!,<H EHSRGC-?@FU=;]1*,2:),
M96 N=/9Y:N!O_&HOOS3RY#OAT@*"S120R.CFC?'(TY.:\9$<X6Q%>=>+%:KU
M%V.[VVCK699 5$+7Y<V8U+AL,/0PFO2K#C7[37XA.!?]!&#;GMG4E/56R4\-
M+,2W/Q7[8>C)5EBG8[W>@IIZBPW.&Y"-I<*>2,Q2NY&ZR">D*EJ'$-KTC0^S
M/+O*,4KP+CZ_8+JVR6BL<:8NSDI)270R<[> \HR*B\T;X97Q3,<R1CBUS7#(
MM(U$$<:^%4"0<Q#&57&3#,1Z=&^.+=CJPBOH,XIXR&5-,XYNA?\ O!X#P\X(
M$K28Z L1RV#2/;HP\BEN+A1S,X#MCDP\X=M?2>-.<CZGUUS,S6-PXHLR&X[I
M1.RBP;%5V6+%-*T-JJ,MAJ<A^,B<[)IYPX@<SN0)84_&.;4V^8.O-M=E_I-+
M(QN? [:DM/00"D'0^(7)L^L:Z+M+U%3Z3Z8]T;VO8XM>TY@@Y$'C3XZ/;Z<2
M8*L]VDR$M33@R>..]=](%(8KST;:1VV+!=NMKI #!V343QR.=^]>4/JDYSK2
M-!M0:N\&4S>X7T]YKX9OQD=1(QW.'$%82F&F"A^QVDW$D&60-6Z8#D?W_P#$
MH>JB,B1#:VUD#=8SFQ)^#M_\K9["OA++L3;SV&^WJS2.[VI@;4Q@_G,.1RYP
M_P"BF:1U!S03.X]2+VSBW[+BD<*W#=8&G:.CFB+LM0(+2!\Y2]IW=,>#W8TP
M354%.&]OPN%12EW#(T'O<^4$CI"2:>*2":2&9CHY8W%CV.&1:0<B".-#7KDV
M?6-=&VAZ=7U$]7!MWCL.*[1=9HW2Q4=3',]C3D7!KLR!RIZK!>[=B"V0W"SU
M<552RC-KV'<Y"-T'D*U^+)H:ZKM\W9:"JGII?SX9"QWI!7E5OPYWB\&,1D<\
MB)L+5.;(;']!:L*UE@H*MDMWKV]B>R-VV[#$3WY=Q$C,9;NO-+748OQ)4Q&*
MHQ!=I8SNM?62$'HS7ADDDDG,E=OB,QD!!J-&:CAG;/*<(0I)H\PM58OQ716J
MEC>Z-[PZH>-R*($;9Q/-N<I 0X&9R$:LP4%CN$</1'2R4>C3#<,PR?VFQY'$
M'=\/F*EJ^((HZ>".&%H9%&T,8T;@ &0"XJIXJ6FEJ*AXCAB89'O.XUH&9/H"
M9@9#*9!VUV+=9V+@.!.H@]*0*_WNJNE[N-<:B8=M5$DV6W.K;.)R^=><V>5C
MLVRR-/&'$(;Q/]1L-$DC:_M_N;#T*C]BG02C#%XNE0^1[JFJ;"S;N)[V-N>8
MZ7GT*\$0C:PSBR^OX3E,\\H*FME6W/1Y1.XKE'U<BN54YLJ=[BD\Y1=7*N;>
M RS!\]>\4Y"$)=-3-B;3FT$;A"ZZS\DG^3=]17-*=M31.&X6 _,N*S\DG^3=
M]1368X;YKP0A"538QKMBGO>UWG%_5QJYE5.QEBC9HO@>QC6O?4R[=P&1=D[(
M9GA5K)C5P"9;%G.]^\$I^RI&6D6D/';H^LD38)4-E7OAT7FV/K)%S?P2_1G/
M^DII6!H"WV\/^/+U+U7ZL#0%OMX?\>7J7H-.(1YB.4_8_B.HH5IIA,^BW$C&
M[HIMOT-<''ZE-5Y6+* W3"UXH&MVSJJCFA:.,N80/G*8L,P1,M4VJX/0Q $+
MD@@D$9$<"X2N:^.UH,G[8T4X=>#GM871_LR.;^Y3I4'L4,1=GM-UP_,_-],\
M54 /YCM3@.0. /ZROQ,JCF@F5Q:%+F!ZQ-MD71FETKW5YW*B.&9O-V-K?K:5
M6B9394X3?44E!B:CB<YU..U:LM&>3"26./("2,_T@EK05JY.9H,%8'I4CTV?
M:>]@.\MP_C&S763/L5+4L?)EN[3/)WS$I](I&2QLDB<'QO <UP.8(.X0M=JM
M;1CIGNV#Z5MNN$)NMJ;D(V/DVLD(XFNR.8_1/1DNZ; FPRC'X1K\F3>(WR%6
M-ETXX)N-.U]1<)K?*=V*I@=F.EH<WYU((=)>#)6;9F)K8!^G,&GT%%AU/K$C
M8>U=A4_:2Y"AU3I/P53,V\F);<X?]N3LA]#<RH;B[3]AJWT$HP\9;I7D$1YQ
M.CB:>-Q=D2.0#7R;J\-BC>9ZF&M<Y!3*:V1=#346E.X]J-:WL\<4\C6[@>6Z
M_3EGTJLUGWZ[UM]N]5<[I.9ZRI?MY'GAX  .  9 #B"P$O8YDF:>E"E:J?03
MV\#1RS8TL$< SE=7P!G/V1J?E)]L<,./O6D2"L<T]JVIIJ7NRU;?<8.?,Y_J
ME."B\,,E)B72K@V!1Z"==2,Z>4'<+"/F6O%XR>X<J>W29=?L+@"_UX=M7QTC
MVL/$]PVK?I."1!<8D[0)?HE3JLW:"FF'<%S7:ST]:P.VLNVRRY'$?N4+3D:%
M\-,@T8V 5D0$TD+IM>[M7O<]OT7!55)KG*&8R_X" CK*UV5N&>P7.VXDIV=Y
M4M[5J"!\=N983REN8_5"H%/EI!PO!C#"==9JAXB,S0Z*7+/L<C3FUWIU'D)2
M/XCLE=AV\U5KNL)AJZ=VU<T[AXG \((U@KN],FSZRG1MX>O4.\?B9&#<0U6%
ML2T%XHM<M-)MBPG(/:=3FGG!(3SX:OE#B.R4MUM4PEI:AFV:>%IX6D<!!U$+
M7\IUHMTCW/ 5Q)@!JK7,X&HHW.R#OTFGXKN7AX>#+RFW4.1W3K'83XXUEXA'
M:55:5]#ENQB]]QM;X[=>CK?)M?O<_C@;A_2'3GP3'!6-;'C*A%19*QDCP 9*
M=_>RQ>,W]XS'*I(C"%<1$CV8=\QL(B/8MT98KPMMWW&U2R4K?^9IOOL>7&2-
M;?U@%#%L46#5V>V5F?;=NHY\]WLL#7?6$.<,/0QBFEB!_-9KY67;[;77&9L5
MOHZFJE<<@R&)SR3S )[J?"6'*:4RT^'[1%*?CLHXVGTAJ]F.-D3 V)C6-&X&
MC(+P8;J9VVEA_BOO%'PIH&Q5>-I+<Q#9Z8Z\Z@[>7+D8WZB0F1T?8%L^![6:
M6TQ%TT@'9ZJ37),1Q\0X@-0^=2E?,LC(HW22O:R-HS<YQR '&2KTJ5-HB^_&
M6W[&.SI/I49LE-($5NM+\+6N8.KZMH[<<P_B8MW:GE=Q?FY\81I3TZ45LBFM
MN#I&5M>06NK1KAA\7\]WT>?<2R5E3/6U4M35S235$KB^221VV<YQW22=TJJZ
MX9:JPW X%BPLL&P;A.E<@$D #,E<*V]CQ@-^)<3,N]?$3:+8\/[X:IIAK:SE
M U./0.%"JI8Y"-[;5J0NWI&+T38??AG1]9[;.W:U+8NRS#A#WDN(/-GET*7(
M0F0&0RF3=B[%CZP5.;*G>XI/.475RJXU3&RL=EH^H!QW)G5R+BW@,OP?/7O%
M20A"734S8=1?D<'R;?J7-9^23_)N^HKBB_(X/DV_4N:S\DG^3=]1368[UFO!
M"$)5-C'!V-&]92>4S>TK356;&C>LI/*9O:5IIE7P"97%<Y^Y@E1V58(TAT1X
M#;8^LD37)4]E;O@6_P VLZV5<7\$(T9S_I*75@: M]O#_CR]2]5^K T!;[>'
M_'EZEZ#3B$>8CE/V/XCJ(0A,IDXEFG/"WVKZ0:Z.%FUHJT]MT^K4 XG;-Z';
M8<V2KY.)I_P--B_"L=1;(Q)=;:YTL3 -<K"._8.74".49<*3QP+7%K@00<B#
MP)?:FJTTV!O^-4,]XWR2:.\5U.#,54EWIF]D8P[2>+^TB/X3>?A'* GBLMTI
M+U:J6Y6V834E3&)(WCA!X^(C<(X"M?"MC0II7?@I[K7=V23V.:3;9MUOIG'=
M<T<+3PCI'"#W39JG([I5C\(;AKIQ#WC;U=-#64LU-51,FIYF%DD;QFUS2,B"
M.)*?I;T-W##$M1=+"Q];8R2\M:,Y*8<3APM'YWIXRU5JN5'=[?#76RIBJJ29
MNVCEC=F'#_YP++1+UAQMB?#XE\,VSZB:ZT)U<7Z(\)8GE=/44!HJMVMT]$1$
MYQXR,BTGE(S59WK8VGOG63$ /%'60?QM/\*%:AQNCFO25+<6R+LA6M5Z!,;0
M2.;%3T-2T;CHJIH!_:R*\Z;0MCV+/_46WR_,JH3_ !*OX;=(2,52?\Q]Y72%
M8U%H5QW5.R-E$ _.FJ8F_P 6:D-!L=L539&KKK33-X1V1[W?,W+YUZ*W/I/&
MQ=*[V$IA>UA+#-TQ7>(K;9:9TT[];G;C(V\+G'@ _P#YK3)X3V/N'K;M);]4
MSW><:RS\3#Z =L?3T*VK1:;?9Z44UIH::CIQ_P .",,'/JW2K4PY/% KM*(!
ME6,S/!T:8+H\#X:BMM*1+4./9*FHRR,LG'S#< XNE2M"JC39I4@P=1OMEG>R
M:_S-U;A;2M/QG?I<3>DZMTHD(O\ 44*KXBS(;29 ME#C?MBKBPI;Y?O4!$U:
M6G\)^ZQG0.^/*1Q)?UVU51-5U,M152OFGE<7R2/=FYSCK))X2NI+W8N<YIL/
M2**P@GL80LLF(<3VNTQ9[:KJ&1$CXK2>^=T#,]"?BGACIZ>*"!@9%&T,8T;C
M6@9 *B-C)@/M*B=BNYQ95%2TQT+7#6R/XTG.[<')GQJ^T70FJN9]8DTE>++-
M0;A^8*N-,VC:#'5I;-1]CAOE*T]KS.U"1O#&\\7$> \Y5CH5S*&&1@-=C5,'
M7>)KYO5IKK)<IK?=J66EK(3D^.09$<O*.4:BL%/1I"P%9L<6WM>ZQ;2I8#V"
MKC $D1Y^$<;3JYCK2K8VT3XHPK)-)+0OKK>PG*KI1MV[7C<T:V](RY2@;*2F
M[=-#AL<EPR;89"*&LJ;?51U-#434U1&<V2PO+'-/(1K5L85T_8HM+&0W:.GO
M$#=6VE'8Y<O';J/2"53Z%6K%=QA5E-=HR<9QJ[/LB<,U+6BYT%RH9.$AK96#
MI!!^BI/2Z9\!U#01?6QGBDIY6_PI+4*X8AQ FT72=V8CLR:7<"QMS.(J<^+'
M(?J:O'N.GC!%(TF"KK*TC@@I7#/]O:A)\A3Q#3P:*I&\G_OI&(Q!LD7%KF8>
ML0:?BS5LN?T&^\JAQ?I Q+BTN;>;G*^G)S%-%][B'ZHW><YE15"K:QFWF%58
M6JK:J[8(65;;?67.K92VZEGJJEYR;%"PO<>@*\]'6Q_JJE\5;C63M:GU.%#"
MX&1_(]PU-'(,SRA>*A?=.KL172,W,KK1=HZN>.[H&0-=3VN)P[9K'-[UH_-;
MQNY/2G+PY9*##MFIK7:8!#1T[=JQHW3QDGA).LE=]JMU'::"&AME-%2TD+=J
MR*)N36A92-KJ"#^YGL5BVQ!Z#I!"$*V"05*;+!V6!;6..XMZN176J.V63LL'
M6=O'7Y_Y;_YJNW@,*P7/6*XA"$NFHGM,Q9B)@R9?[LT<0K)!_$NPXRQ,6%IQ
M%>"TC:D&MDR(XOPEX*%[F9S\->D$(0O)U'!V-&]92>4S>TK356;&C>LI/*9O
M:5IIE7P"97%<Y^Y@E4V5H_W@6_S:SK94U:5;98?#VV>;&=;*N+^"$:-YX[&4
MHK T!;[>'_'EZEZK]6!H"WV\/^/+U+T&G$(\Q'*?L?Q'40A"93)P2[:?=$T\
M]7-B7"U*93)F^NI(AWVV_M&#ASX0.'7PE,2A<.@<9&747M0^LLUV$$'(ZB%P
MFXTL:&;?BL37*Q]BM][.;G:LHJ@_I ;COTAT@[H5S$F'KKANX.HKY0S4E0-P
M/&IPXVNW'#E"!>LIOFCP^*3$#^._I/:P!I"ON!ZE[K1.U]+*<Y:2<%T3SQY9
M@@\HR5^X0V06'[GM(<04\UHJ#J,@^^PD\X[X=(Z4J:%$M9-T\NP=5VUAMZS8
M/:KO;KO )K57TM9$1GMH)6O'S%9JUX4U1-33-EII9(96[CXW%KATA3.RZ5\:
MVAH;37^JEC&K:U64_P [P3\Z(&)'J(N?1+?X-]X[B$HU-L@,:0Y=D-LG^4IB
M/9<%Z V1N*-ID;992[C['+EZ.R+KQ"2@Z,O'2-2A*?)LB,7O_!I+*SQ8)/WR
M%>+=--V.:_,,ND=(P_%IJ=C?G()^=0XA)Z-%W'?E'*)R&9W%#L2:3<(X>V[:
M^]TSYV[L-.>S/SXB&YY=.23:[XJO]X:YMTO5QJV.W62U#W-_9SR7BJLXGH(3
M7HD?YM]I>ND;3[6W2)]%@^*6W4SAD^KER[.[Q0"0SGS)YE1LTLD\KY9GNDE>
M2YSWG,N)W23PKX793PRU$S(:>-\LSR&L8QI<YQX@!NJAG+G;&=5%=(R093K5
MHZ%]%M3C6N;7W)KX+! _OW[CJAP^(SDXSP<^Y(='&@2XW)\-=BYQM]%F'=IM
M_'2#B=^8/GY F;M]%36ZB@HZ&"."E@8&1Q1C)K6C< "NJI)VM%^,T@%&I4<S
MUG93PQTT$<$$;8X8VAC&-&0:T#( #B7VA",B*"$(4D@A"%))!\8Z+,*8J+Y*
MZW-IJQVLU5)E%(3QG(9.Z054]\V-U0TN=8K_ !/'!'60EI'ZS<\_V0F00JVJ
M5MXA-6,NJV*VR)Y<=!6.*0GL-#2U@'#!4L&?[>U*\.?17C>$Y/PW7'Q U_U$
MIWT*LX984-*VC>!$<&C+&A.0PU<NF+)9]'H<QW5$;6PR1CCEFC9];LTZB%/#
M+UGITK;Z 14[3L=\45):;C6VVA9PC;NE>.@#+YU8.'=COAZB<V2]5]9<WC=8
MW*",] S=])76A=BE!Z2A](7OLSR[3R\/X=M&'J;M>R6VEHHSN]AC +O&.Z>D
MKU$(5H&4#)).9@A"%)Y!"$*207DXBPY:,24T5/?*"&MAB?MV,ESR:[++/5R+
MUD*99ST$J<Q(7W*\$>#=#Z'?S1W*\$>#=#Z'?S4T0N=1>DL^/9\Q^\A?<KP1
MX-T/H=_-'<KP1X-T/H=_-31"FHO23X]GS'[R%]RO!'@W0^AW\T=RO!'@W0^A
MW\U-$*:B])/CV?,?O,"Q6:WV&WMH;/21TE(UQ<(HQJ!)S)6>A"ZW2LDDYF"C
M^(L&8=Q'61U5\M--6U$<8B;)*#F&YDY;O&3Z5($+P@'?(K%3FIRD+[E>"/!N
MA]#OYK,L^C_"MFN,-?:[)24U9"28Y6 YMS!!RU\1*E"%YJKTG9NL(R+'[P0A
M"ZE<$(0I)!8%[LUMOE$ZCO%#3UM,[XDS X \8XCRC6L]"D]!(.8E&XKV.]GK
M'/FPY<)[;(=8@F'9HN8'4X=)*JF_Z$<:VDN,5!%<81\>CE#OHG)WS)R$*EJ$
M,-JTC<FPG/O-?ETLEUM3RRZ6RMHW#@J('1_6%YRV)N:U[2UX#FG=!&8*C.(\
M+V"II))*BQVJ63(]])21N/I(5+49>L84Z2-AR*^\1)"N''MHMM++,*:WT<(!
MU=C@:W+T!5/7M:VH(: !Q *@C*,D?6$QD+-M;&OG(>UKARC-79HWL5IJYHA5
MVN@G!RS[+3L=]84 SGCOJ#.4. 2<AK*DEAP)BB_.;]B[%72L=N2NB+(_VW9-
M^=.S9K#9[=$QUOM-OI79;L%,QA^8+UD0F'!VDQ7=I-D.2K%JPGL<ZR;:38IN
MK*9FZ:>C&W?S%YU \P*NK!NC[#>$!MK+;F,J2-JZIE/9)3^L=SF&04K0KUK5
4=PBVW%VW;&.R"$(5D&@A"%))_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g884117g01g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g884117g01g01.jpg
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M*"@H*"@H*"@H*"@H*"@H*/_  !$( (X!H0,!(@ "$0$#$0'_Q  =   #  ,
M P$             !P@%!@D" P0!_\0 6Q   0($ 04&#0X, P@#     0(#
M  0%!A$'"!(A,1-!46%Q@148(C=5=)&4H;&ST=(4%A<R-#94<G-UDJ*CLB,S
M0E)35F*"D\'"TR0E8S5#162#A,/P)D1E_\0 &@$  @,! 0
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M,N-ZU-PEB>9IS6\W*,I'A5I'PQKDQE'O*8.+ES54?$F%(^Z1$#4M1#<*E.9
M5T1ZYAAF9:+<PTVZV=J5I"@>8Q$TEE6O>3PW*XYQ6'Z71=^\#&\6UG$5Z2T&
MZ](2M3;&UQO\ YRZL4GN"/14-.:B_#)FZVV*>-P9+[/KC#B)FARC#BQ^.E$!
ME:3P@IV\X,(7*!D&K%#;?G;>>Z*R#8*RV1HOH2.+8OFU\44-D_OBD7Q2C-TA
MTI=;U/RSF <9/&. [Q&H]V-HB1C8\75,=5/3NT2>Q7.N"'KG'9.&:,\;HHR
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MBN:6G6$X;&TG@&)U[Y)XHZ%A<Z_)2KYVQ1%O$IA1H&7FH-4_)77"[[9]"9=
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(!1!!!'+E_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g884117g02g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g884117g02g02.jpg
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M<GH@ZRV-4>.>Q5Z$SGXMUH]_J_\ A,43THZ%:#!V#:N]4EVJZF2!\;>AR1M
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MW'-G2Q]D(0F9CP2MZV77G:/F\><>FD2MZV77G:/F\><>J;^@/RWMUZE'H0A
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M-2<*,SU4K_TZJ_C.]*:#56J9JG!-T-1+)*YMP< 7N+CET-G*E332ZII_X+O
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M13H\K\=WD,8U\%I@<#5567 T>Y;RN/BWGG<^SVRDL]LIK?;8&P4=.P1QQMW
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)$*$!"$*$/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm44878556899936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Sep. 18, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000352915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">UNIVERSAL HEALTH SERVICES INC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-282135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm44878554592528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Sep. 18, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">4.625% Senior Secured Notes due 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.99957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 499,785,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 73,768.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Calculated in accordance with Rule 457(o) based on the proposed maximum aggregate offering price and Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In accordance with Rule 456(b) of the Securities Act, the registrant initially deferred payment of all of the registration fees for the registrant&#8217;s registration statement on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-3</div> (File <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">No.&#160;333-282135)</div> (the &#8220;Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-3&#8221;),</div> filed with Securities and Exchange Commission on September&#160;16, 2024. The &#8220;Calculation of Filing Fee Tables&#8221; contain herein shall be deemed to update the &#8220;Calculation of Filing Fee Tables&#8221; in the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-3,</div> in accordance with Rules 456(b) and 457(r) under the Securities Act. </div></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">5.050% Senior Secured Notes due 2034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.99685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 498,425,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 73,567.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Calculated in accordance with Rule 457(o) based on the proposed maximum aggregate offering price and Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In accordance with Rule 456(b) of the Securities Act, the registrant initially deferred payment of all of the registration fees for the registrant&#8217;s registration statement on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-3</div> (File <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">No.&#160;333-282135)</div> (the &#8220;Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-3&#8221;),</div> filed with Securities and Exchange Commission on September&#160;16, 2024. The &#8220;Calculation of Filing Fee Tables&#8221; contain herein shall be deemed to update the &#8220;Calculation of Filing Fee Tables&#8221; in the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-3,</div> in accordance with Rules 456(b) and 457(r) under the Securities Act. </div></td></tr></table> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Guarantees of Subsidiary Guarantors<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The notes issued by the registrant will be guaranteed on a senior secured basis by all of the registrant&#8217;s existing and future direct and indirect subsidiaries that guarantee the registrant&#8217;s senior secured credit facility or the registrant&#8217;s other first lien obligations or any junior lien obligations. Pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable in respect of such guarantees. </div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm44878554514816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Sep. 18, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 998,210,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">147,335.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 147,335.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M -Q?<4B.LJ'?&56O_*;_ %!+ P04    "  +,3-91?3A/T "  #9!0  &
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M%Y1-P/5<2G,,;#]HNWGR%U!+ P04    "  +,3-9148CB#4#   T$P  #0
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M;R..8 I  X9$4;T/'NQ'X7:?"G?_)YO^!E!+ P04    "  +,3-9EXJ[',
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M P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSQ9,Y#H,P$$6O@GP
MAB5)$0%5&MJ("U@P+&*QY9DH</L0*,!2BC2(ROIC^?U7C*,G=I(;-5#=:'+&
MOALH%C6SO@-07F,OR54:A_FF5*:7/$=3@99Y*RN$P/-N8/8,D41[II--&O\A
MJK)L<GRH_-7CP#_ \%:FI1J1A9-)4R'' L9N&Q,LA^_.9.&D12Q,6O@"SA8*
M+*'@?*'0$@H/%"*>.J3-9LU6_>7 >I[?XM:^Q'5H+\GUZP#65T@^4$L#!!0
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MQUL([6]?N7X53AE_Y,OA75M] %!+ 0(4 Q0    (  LQ,UD'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ "S$S61E<+^_N    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ "S$S69E<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  +,3-9
M00%.^7$"  #3!@  &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ "S$S6839P\D&!@  _AL  !@
M     ("!M H  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M  LQ,UE%].$_0 (  -D%   8              " @? 0  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    "  +,3-9148CB#4#   T$P  #0
M            @ %F$P  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  LQ,UF7
MBKL<P    !,"   +              "  <86  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    (  LQ,UE2<6^U70$  $@#   /              "  :\7  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  +,3-9NVSJ[+H    : P  &@
M        @ $Y&0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  +,3-9IOQ*6R,!  #?!   $P              @ $K&@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "P + ,H"  !_&P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="d884117dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d884117dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d884117dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="d884117dexfilingfees.htm">d884117dexfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d884117dexfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "d884117dexfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 9,
    "http://xbrl.sec.gov/ffd/2024q2": 7,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 39,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P09_18_2024To09_18_2024",
      "name": "ffd:RegnFileNb",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "ffd:OfferingNote",
       "ffd:OfferingNote",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d884117dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P09_18_2024To09_18_2024",
      "name": "ffd:RegnFileNb",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "ffd:OfferingNote",
       "ffd:OfferingNote",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d884117dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d884117dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d884117dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "P09_18_2024To09_18_2024",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d884117dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P09_18_2024To09_18_2024",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d884117dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-24-221733-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-221733-xbrl.zip
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MX''Q%"X7L<GVE3HC3JEIM8X;S=JAZ,Q&QXB\0DFN;BY?((]:[+R1/1)'AJ*
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MSP$M-(2=ZPJQNEXK=;_QH3@88:]CV"D'K&]I-'AQH5? ,:^_$S'L^<5CNQ#
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M^.^>C+DTV8$\C/HQ$IC+Z&'!GTBS99$^ K$(I10CS@=AN5E(A*P1!MT?$I_
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>9F5E<RYH=&U02P4&      $  0!&    *1$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d884117dexfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="P09_18_2024To09_18_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000352915</identifier>
        </entity>
        <period>
            <startDate>2024-09-18</startDate>
            <endDate>2024-09-18</endDate>
        </period>
    </context>
    <context id="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000352915</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-18</startDate>
            <endDate>2024-09-18</endDate>
        </period>
    </context>
    <context id="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000352915</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-18</startDate>
            <endDate>2024-09-18</endDate>
        </period>
    </context>
    <context id="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000352915</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-18</startDate>
            <endDate>2024-09-18</endDate>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="P09_18_2024To09_18_2024" id="ixv-538">0000352915</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="P09_18_2024To09_18_2024" id="hidden121489332">UNIVERSAL HEALTH SERVICES INC</dei:EntityRegistrantName>
    <ffd:SubmissnTp contextRef="P09_18_2024To09_18_2024" id="hidden121489336">424B5</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="P09_18_2024To09_18_2024" id="ixv-541">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:PrevslyPdFlg
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      id="ixv-542">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTitl
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      id="hidden121489370">4.625% Senior Secured Notes due 2029</ffd:OfferingSctyTitl>
    <ffd:OfferingSctyTitl
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      id="hidden121489371">5.050% Senior Secured Notes due 2034</ffd:OfferingSctyTitl>
    <ffd:OfferingSctyTitl
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      id="hidden121489372">Guarantees of Subsidiary Guarantors</ffd:OfferingSctyTitl>
    <ffd:FeeRate
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      decimals="7"
      id="ixv-546"
      unitRef="Unit_pure">0.0001476</ffd:FeeRate>
    <ffd:PrevslyPdFlg
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      id="ixv-589">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      id="ixv-590">Debt</ffd:OfferingSctyTp>
    <ffd:Rule457rFlg
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      id="ixv-591">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-592"
      unitRef="Unit_shares">500000000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      decimals="5"
      id="ixv-593"
      unitRef="Unit_pure">0.99957</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-594"
      unitRef="Unit_USD">499785000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      decimals="INF"
      id="ixv-595"
      unitRef="Unit_pure">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      decimals="2"
      id="ixv-596"
      unitRef="Unit_USD">73768.27</ffd:FeeAmt>
    <ffd:PrevslyPdFlg
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      id="ixv-597">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      id="ixv-598">Debt</ffd:OfferingSctyTp>
    <ffd:Rule457rFlg
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      id="ixv-599">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-600"
      unitRef="Unit_shares">500000000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      decimals="5"
      id="ixv-601"
      unitRef="Unit_pure">0.99685</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-602"
      unitRef="Unit_USD">498425000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      decimals="INF"
      id="ixv-603"
      unitRef="Unit_pure">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      decimals="2"
      id="ixv-604"
      unitRef="Unit_USD">73567.53</ffd:FeeAmt>
    <ffd:OfferingSctyTp
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      id="ixv-605">Other</ffd:OfferingSctyTp>
    <ffd:FeesOthrRuleFlg
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      id="ixv-606">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-607"
      unitRef="Unit_shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      decimals="-2"
      id="ixv-608"
      unitRef="Unit_pure">0</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-609"
      unitRef="Unit_USD">0</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-610"
      unitRef="Unit_USD">0</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="P09_18_2024To09_18_2024"
      decimals="0"
      id="ixv-611"
      unitRef="Unit_USD">998210000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="P09_18_2024To09_18_2024"
      decimals="2"
      id="ixv-612"
      unitRef="Unit_USD">147335.8</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="P09_18_2024To09_18_2024"
      decimals="0"
      id="ixv-613"
      unitRef="Unit_USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="P09_18_2024To09_18_2024"
      decimals="0"
      id="ixv-614"
      unitRef="Unit_USD">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="P09_18_2024To09_18_2024"
      decimals="2"
      id="ixv-615"
      unitRef="Unit_USD">147335.8</ffd:NetFeeAmt>
    <ffd:OfferingNote
      contextRef="P09_18_2024To09_18_2024_2TypedMemberffdOfferingAxis"
      id="ixv-513">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Calculated in accordance with Rule 457(o) based on the proposed maximum aggregate offering price and Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). In accordance with Rule 456(b) of the Securities Act, the registrant initially deferred payment of all of the registration fees for the registrant&#x2019;s registration statement on Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;S-3&lt;/div&gt; (File &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;No.&#160;333-282135)&lt;/div&gt; (the &#x201c;Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;S-3&#x201d;),&lt;/div&gt; filed with Securities and Exchange Commission on September&#160;16, 2024. The &#x201c;Calculation of Filing Fee Tables&#x201d; contain herein shall be deemed to update the &#x201c;Calculation of Filing Fee Tables&#x201d; in the Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;S-3,&lt;/div&gt; in accordance with Rules 456(b) and 457(r) under the Securities Act. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P09_18_2024To09_18_2024_1TypedMemberffdOfferingAxis"
      id="ixv-514">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Calculated in accordance with Rule 457(o) based on the proposed maximum aggregate offering price and Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). In accordance with Rule 456(b) of the Securities Act, the registrant initially deferred payment of all of the registration fees for the registrant&#x2019;s registration statement on Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;S-3&lt;/div&gt; (File &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;No.&#160;333-282135)&lt;/div&gt; (the &#x201c;Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;S-3&#x201d;),&lt;/div&gt; filed with Securities and Exchange Commission on September&#160;16, 2024. The &#x201c;Calculation of Filing Fee Tables&#x201d; contain herein shall be deemed to update the &#x201c;Calculation of Filing Fee Tables&#x201d; in the Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;S-3,&lt;/div&gt; in accordance with Rules 456(b) and 457(r) under the Securities Act. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:OfferingNote>
    <ffd:RegnFileNb contextRef="P09_18_2024To09_18_2024" id="ixv-616">333-282135</ffd:RegnFileNb>
    <ffd:FormTp contextRef="P09_18_2024To09_18_2024" id="ixv-617">S-3</ffd:FormTp>
    <ffd:OfferingNote
      contextRef="P09_18_2024To09_18_2024_3TypedMemberffdOfferingAxis"
      id="ixv-524">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The notes issued by the registrant will be guaranteed on a senior secured basis by all of the registrant&#x2019;s existing and future direct and indirect subsidiaries that guarantee the registrant&#x2019;s senior secured credit facility or the registrant&#x2019;s other first lien obligations or any junior lien obligations. Pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable in respect of such guarantees. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
